Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
CSHL1	"CS-5, CSHP1, CSL, hCS-L, MGC149868"	ENSG00000204414	"Chorionic somatomammotropin hormone like 1"	Q14406	17	63909597-63918838	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	864	"pituitary gland: 334.1;placenta: 293.7"	"Cell line enhanced"	"Detected in some"		"MCF7: 1.3;SCLC-21H: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB025646, HPA043715"	Enhanced				"Secreted to blood"					"CAB025646: , HPA043715: AB_2678632"																		0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.0	334.1	293.7	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
GH2	"GH-V, GHL, GHV, hGH-V"	ENSG00000136487	"Growth hormone 2"	P01242	17	63880215-63881935	"Cancer-related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	309	"pituitary gland: 47.3;placenta: 138.4"	"Cell line enriched"	"Detected in single"	20	"BEWO: 13.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043715	Supported				"Secreted to blood"					"HPA043715: AB_2678632"															"unprognostic (1.02e-1)"			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.3	138.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FSHB		ENSG00000131808	"Follicle stimulating hormone beta subunit"	P01225	11	30231016-30235261	"Cancer-related genes, Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	90	"pituitary gland: 70.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"CAB023410, HPA069703"	Enhanced				"Secreted to blood"	47000	47000			"CAB023410: AB_324983, HPA069703: AB_2686176"												"unprognostic (1.04e-1)"						0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	70.7	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.5	0.0	0.0	0.3	0.3	0.0
CGB8		ENSG00000213030	"Chorionic gonadotropin beta subunit 8"	P0DN86	19	49047638-49049106	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	85	"pituitary gland: 7.0;placenta: 22.2"	"Group enriched"	"Detected in some"	7	"BEWO: 60.5;U-251 MG: 21.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 5.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038925, HPA038934"	Supported		Approved	Cytosol	"Secreted to blood"			Cytosol	Cytosol	"HPA038925: AB_2676272, HPA038934: AB_2676277"		"unprognostic (3.35e-2)"				"unprognostic (1.72e-1)"					"unprognostic (7.44e-3)"				"unprognostic (4.70e-1)"		"unprognostic (1.67e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.1	7.0	22.2		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.3	0.0	0.0	0.0	0.0	60.5	0.0	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	1.2	2.5	0.2	21.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PRL		ENSG00000172179	Prolactin	P01236	6	22287244-22297501	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	81	"pituitary gland: 1739.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 17.6;SCLC-21H: 6.6;U-937: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 1.2;non-classical monocyte: 1.0"	"Group enriched"	"Detected in many"	12	"monocytes: 1.0;T-cells: 1.2"					"Not detected"	"Not detected"			"CAB023353, HPA042416, HPA062017"	Enhanced				"Secreted to blood"	3300000	3300000			"CAB023353: AB_617369, HPA042416: AB_2677987, HPA062017: AB_2684660"	"unprognostic (1.66e-1)"	"unprognostic (4.08e-3)"	"unprognostic (5.89e-3)"	"unprognostic (4.83e-3)"	"unprognostic (2.87e-1)"			"unprognostic (1.11e-4)"	"unprognostic (4.54e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.79e-2)"			"unprognostic (4.29e-5)"	"unprognostic (2.20e-1)"			0.2	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1739.5	21.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.6	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	1.2	0.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.3	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.2	0.0	0.0	1.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0
TSHB		ENSG00000134200	"Thyroid stimulating hormone beta"	P01222	1	115029824-115034309	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	77	"pituitary gland: 192.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.0;SH-SY5Y: 1.0;U-937: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 2.0"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB022202, HPA042681"	Enhanced				"Secreted to blood"					"CAB022202: , HPA042681: AB_2732500"											"unprognostic (2.14e-4)"	"unprognostic (1.37e-1)"		"unprognostic (1.73e-1)"				0.1	0.0	0.1	0.9	0.1	2.4	0.1	0.1	0.9	0.1	0.1	0.1	0.1	0.0	1.4	0.1	1.4	0.0	1.8	0.1	0.1	0.0	0.3	0.1	1.4	0.1	0.1	0.1	0.1	1.6	0.0	192.4	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	1.0	0.6	0.1	0.1	0.1	0.4	1.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.0	0.2	0.1	2.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1
CGA	"FSHA, GPHa, GPHA1, HCG, LHA, TSHA"	ENSG00000135346	"Glycoprotein hormones, alpha polypeptide"	P01215	6	87085498-87095406	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	62	"pituitary gland: 398.8;placenta: 489.3"	"Cell line enriched"	"Detected in some"	19	"BEWO: 105.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 13.0"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	11	"hypothalamus: 69.2"	"CAB023350, HPA029698"	Enhanced				"Secreted to blood"					"CAB023350: AB_617281, HPA029698: AB_2673153"	"unprognostic (1.66e-1)"	"unprognostic (2.10e-1)"		"unprognostic (3.22e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.69e-2)"	"unprognostic (3.17e-1)"			"unprognostic (7.04e-3)"	"unprognostic (1.51e-1)"		"unprognostic (2.85e-1)"	"unprognostic (4.32e-2)"	"unprognostic (8.32e-2)"	"unprognostic (9.15e-3)"	0.1	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	3.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	398.8	489.3	0.2	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.6	0.0	0.1	7.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.2	1.9	3.5	1.5	1.1	2.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	105.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	2.3	1.1	1.0	1.7	0.5	0.7	1.3	0.8	1.4	0.6	2.2	1.2	2.1	3.5	1.1	1.5	1.9	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0
POU1F1	"GHF-1, PIT1, POU1F1a"	ENSG00000064835	"POU class 1 homeobox 1"	P28069	3	87259404-87276587	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	49	"pituitary gland: 138.8"	"Cell line enhanced"	"Detected in some"		"A549: 1.8;SiHa: 1.1;U-87 MG: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA041646, HPA050624"	Enhanced									"HPA041646: AB_10794672, HPA050624: AB_2681192"	"unprognostic (1.88e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.27e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.60e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.87e-2)"	"unprognostic (7.63e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.87e-2)"		"unprognostic (1.22e-1)"	"unprognostic (1.05e-4)"	0.3	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.2	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	138.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	2.8	0.3	0.1	0.0	0.0	0.4	0.2	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.4	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.7	0.2	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GHRHR		ENSG00000106128	"Growth hormone releasing hormone receptor"	Q02643	7	30938669-30993254	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	36	"pituitary gland: 108.9"	"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.0"	"Cancer enhanced"	"Detected in single"		"liver cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Intracellular and membrane"						"unprognostic (8.32e-2)"		"unprognostic (1.45e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.39e-1)"		"unprognostic (7.23e-2)"	"unprognostic (4.15e-1)"		"unprognostic (2.28e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.87e-3)"		0.4	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	108.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
POMC	"ACTH, CLIP, LPH, MSH, NPP, POC"	ENSG00000115138	Proopiomelanocortin	P01189	2	25160853-25168903	"Cancer-related genes, Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	36	"pituitary gland: 811.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.6;HMC-1: 4.1;THP-1: 5.4"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 18.5"	"Region enriched"	"Detected in single"	5	"hypothalamus: 1.8"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"hypothalamus: 77.9"	"CAB002762, HPA046135, HPA063644"	Enhanced				"Secreted to blood"					"CAB002762: , HPA046135: AB_2679552, HPA063644: AB_2685071"	"unprognostic (8.02e-2)"	"unprognostic (1.47e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.96e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.30e-2)"	"unprognostic (8.74e-3)"	"unprognostic (1.38e-1)"	"prognostic favourable (5.70e-4)"	"unprognostic (8.02e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.84e-2)"	1.0	3.2	0.3	0.8	0.3	0.5	0.3	0.3	0.7	0.3	0.3	0.3	0.3	0.1	0.3	0.5	0.3	0.0	0.3	0.3	0.3	1.8	0.5	0.3	0.3	0.6	0.3	0.3	0.3	22.2	0.0	811.1	0.9	0.3	0.3	0.0	0.3	0.4	0.3	3.6	0.9	0.3	0.3	0.3	1.3	0.4	2.9	0.3	0.3	0.3	0.4	0.3	0.3	0.3	13.7	22.2	6.6	10.1	12.6	10.5	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.1	0.0	4.1	1.1	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	9.9	6.6	9.8	10.1	7.7	12.8	7.5	9.3	12.5	13.7	9.9	10.5	3.1	12.6	5.9	22.2	7.9	7.6	0.3	0.3	0.3	0.3	0.3	1.8	0.3	0.3	0.3	0.3
AVPR1B	AVPR3	ENSG00000198049	"Arginine vasopressin receptor 1B"	P47901	1	206109692-206117699	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	23	"pituitary gland: 52.8"	"Cell line enhanced"	"Detected in single"		"PC-3: 3.5"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA075404	Enhanced									"HPA075404: AB_2732291"		"unprognostic (4.87e-2)"		"unprognostic (1.44e-1)"	"unprognostic (4.82e-1)"			"unprognostic (2.82e-1)"		"unprognostic (2.87e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.96e-2)"	"unprognostic (6.23e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.66e-3)"	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.6	0.5	0.1	1.3	0.0	0.0	1.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	52.8	0.1	0.1	0.2	0.8	0.0	0.0	0.4	0.0	0.0	1.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.9	3.5	0.0	0.0	0.2	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.6	0.1	0.0	0.1	0.0	0.0	0.1	0.0
GPR50	"H9, Mel1c"	ENSG00000102195	"G protein-coupled receptor 50"	Q13585	X	151176653-151181465	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"pituitary gland: 64.9"	"Cell line enriched"	"Detected in some"	8	"HEK 293: 10.6"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	6	"hypothalamus: 16.8"	"Region enriched"	"Detected in single"	9	"hypothalamus: 6.4"	"HPA049862, HPA054678"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA049862: AB_2680920, HPA054678: AB_2682570"						"unprognostic (8.84e-3)"		"unprognostic (5.59e-2)"							"unprognostic (1.15e-1)"			0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.3	1.4	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	64.9	3.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.6	0.0
NKX1-1	"HSPX153, SAX2"	ENSG00000235608	"NK1 homeobox 1"	Q15270	4	1402932-1406331	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	19	"pituitary gland: 1.0;testis: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"pons and medulla: 0.2"	HPA029367	Uncertain									"HPA029367: AB_2673011"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	1.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GNRHR	"GRHR, LHRHR"	ENSG00000109163	"Gonadotropin releasing hormone receptor"	P30968	4	67739328-67754360	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	14	"pituitary gland: 56.6"	"Cell line enhanced"	"Detected in some"		"K-562: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"							HPA013424	Enhanced									"HPA013424: AB_2668840"	"unprognostic (2.77e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.65e-1)"	"unprognostic (8.75e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.03e-2)"	"unprognostic (3.23e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.22e-3)"	"unprognostic (3.99e-2)"	0.1	3.9	0.1	0.4	0.2	0.2	0.1	0.3	1.7	0.3	0.1	0.1	0.1	0.7	0.1	0.1	1.6	0.0	0.2	0.2	0.2	0.2	0.1	0.1	0.1	1.1	0.1	0.1	0.2	0.3	0.0	56.6	0.1	0.5	0.2	0.0	0.1	0.3	0.1	0.2	0.9	0.1	0.1	0.1	0.2	0.3	0.3	0.1	0.2	1.0	0.1	0.4	0.1	0.5	1.3	0.2	0.0	0.0	0.4	0.3	0.0	0.2	1.5	1.5	1.6	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.5	1.7	1.2	0.2	0.0	0.5	0.0	0.0	0.0	0.3	0.5	0.2	0.3	0.7	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.7	0.6	0.4	0.9	0.0	0.6	1.2	0.6	0.0	0.0	0.8	2.0	0.0	0.3	0.0	0.3	0.2	1.0	0.1	0.2	0.6	0.2	1.1	0.3	0.6	1.4	0.8	0.9	0.0	0.0	0.0	0.2	0.0	0.2	0.5	0.1	0.0	0.0	1.3	0.1	0.3	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.2	0.3	0.3	0.2	0.2	0.1	0.1	0.5	0.1
OTOG	"FLJ46346, mlemp, OTGN"	ENSG00000188162	Otogelin	Q6ZRI0	11	17547373-17647150	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"pituitary gland: 4.8;testis: 3.5"	"Cell line enriched"	"Detected in some"	14	"CACO-2: 14.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"						"unprognostic (1.25e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.85e-6)"	"unprognostic (1.89e-1)"	"unprognostic (3.60e-1)"	"unprognostic (5.14e-5)"	"unprognostic (1.78e-1)"		"unprognostic (8.97e-2)"	"unprognostic (1.57e-2)"		"unprognostic (4.72e-5)"	"unprognostic (5.55e-2)"	"unprognostic (1.48e-1)"			0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	4.8	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
RAX	RX	ENSG00000134438	"Retina and anterior neural fold homeobox"	Q9Y2V3	18	59267035-59274086	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"pituitary gland: 12.9;retina: 45.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 1.4;HEK 293: 1.3;HMC-1: 6.0;SH-SY5Y: 3.1;THP-1: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"															"unprognostic (4.14e-2)"				"unprognostic (1.79e-1)"		"unprognostic (3.76e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.22e-1)"				"unprognostic (1.33e-1)"	"unprognostic (3.46e-1)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.1	2.1	0.0	45.2	0.0	0.0	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.4	0.2	0.0	0.0	0.1	0.1
UGT2A2		ENSG00000271271	"UDP glucuronosyltransferase family 2 member A2"	Q9Y4X1	4	69589309-69639642	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"cervix, uterine: 1.6;kidney: 2.6;liver: 5.4;pituitary gland: 3.8;skin 1: 1.8"	"Cell line enhanced"	"Detected in single"		"U-266/70: 2.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA045108	Uncertain									"HPA045108: AB_2679218"																		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	5.4	0.0	0.0	0.0		0.0	0.0	0.0	3.8	0.0		0.0	0.0		0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
LHB	"CGB4, hLHB, LSH-B"	ENSG00000104826	"Luteinizing hormone beta polypeptide"	P01229	19	49015980-49017081	"Cancer-related genes, Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"pituitary gland: 301.4"	"Cell line enhanced"	"Detected in many"		"A549: 6.5;U-266/84: 7.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.8;T-reg: 1.3"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.8"									"CAB022241, CAB022707, HPA038925"	Enhanced		Approved	Cytosol	"Secreted to blood"			Cytosol	Cytosol	"CAB022241: , CAB022707: , HPA038925: AB_2676272"	"unprognostic (8.12e-2)"	"unprognostic (3.59e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.41e-2)"	"unprognostic (8.89e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.90e-3)"	"unprognostic (5.69e-2)"	"unprognostic (7.04e-2)"	"unprognostic (6.06e-2)"	"prognostic unfavourable (6.78e-4)"	"unprognostic (2.47e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.46e-1)"	"unprognostic (9.52e-2)"	"unprognostic (4.86e-2)"	0.1	0.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	3.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.4	0.1	23.1	0.0	301.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.5	0.5	0.1	0.1	0.1	0.5	1.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	1.8	0.1	1.3	6.5	0.2	1.3	0.0	0.0	1.8	0.5	0.0	1.0	0.5	5.3	1.9	1.7	0.1	0.0	0.5	0.0	0.4	0.0	1.7	5.1	0.3	1.7	2.5	0.3	0.4	1.7	0.0	0.0	0.3	0.0	0.3	4.7	2.8	0.3	0.3	0.1	0.6	0.7	0.5	2.8	1.1	1.3	0.0	1.3	3.0	1.2	1.9	0.4	2.2	2.0	0.0	0.0	2.6	2.7	0.3	3.3	2.4	7.0	1.8	1.3	3.0	1.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.1
LHX3		ENSG00000107187	"LIM homeobox 3"	Q9UBR4	9	136196250-136205128	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"pituitary gland: 33.4"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 1.6;U-266/70: 5.1;U-698: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"															"unprognostic (4.17e-2)"			"unprognostic (4.72e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.57e-1)"							"unprognostic (3.31e-2)"	"unprognostic (6.18e-2)"			0.0	0.0	0.0	0.4	0.0	1.2	0.0	0.0	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	33.4	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	5.1	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
CAMK2N2	CaM-KIIN	ENSG00000163888	"Calcium/calmodulin dependent protein kinase II inhibitor 2"	Q96S95	3	184259213-184261463	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"adrenal gland: 14.2;brain: 38.3;pancreas: 37.0;pituitary gland: 12.5"	"Cell line enhanced"	"Detected in many"		"REH: 18.7;SCLC-21H: 19.6;U-138 MG: 20.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050835, HPA075200"	Approved		Supported	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"	"Nucleoplasm, Centrosome"	"HPA050835: AB_2681253, HPA075200: "	"unprognostic (7.28e-2)"	"prognostic favourable (9.77e-4)"	"unprognostic (1.24e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.98e-2)"	"unprognostic (9.72e-3)"	"unprognostic (5.17e-9)"	"unprognostic (3.47e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.76e-3)"	1.3	14.2	22.2	1.3	9.6	1.1	1.3	29.7	38.3	1.3	1.3	3.2	0.0	1.4	1.2	1.2	1.2	1.3	1.3	1.2	12.3	32.7	1.3	1.7	1.2	1.2	18.0	8.2	1.1	37.0	2.0	12.5	1.3	25.1	1.4	1.3	1.1	1.2	1.4	1.1	1.2	1.4	1.4	9.3	1.2	1.7	1.3	4.5	0.0	1.3	0.0	1.2	1.2	0.0	0.0	0.5	0.0	0.2	0.0	0.3	0.0	11.1	0.2	1.4	0.6	0.4	0.4	1.0	0.3	4.1	2.6	2.7	0.4	0.5	0.4	2.7	0.2	1.4	0.7	0.4	1.5	9.1	0.4	0.3	0.2	0.4	0.1	0.2	1.4	0.3	0.6	0.4	1.9	0.0	0.0	3.3	0.4	5.9	0.1	0.1	7.9	3.6	18.7	5.4	1.5	0.6	2.1	19.6	4.2	1.8	0.5	0.1	6.0	0.1	0.0	20.4	8.9	1.9	3.3	2.2	3.3	2.7	4.7	1.1	1.7	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	22.2	9.6	29.7	38.3	12.3	32.7	18.0	8.2	25.1	4.5
CFC1	"CRYPTIC, HTX2"	ENSG00000136698	"Cripto, FRL-1, cryptic family 1"	P0CG37	2	130592168-130599575	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	12	"brain: 13.0;pancreas: 21.9;pituitary gland: 22.4;prostate: 7.6;stomach 1: 9.4"	"Group enriched"	"Detected in some"	21	"RPMI-8226: 19.1;SCLC-21H: 10.9"	"Cancer enriched"	"Detected in some"	7	"pancreatic cancer: 4.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA041773	Uncertain				"Secreted - unknown location"					"HPA041773: AB_2677664"					"unprognostic (6.65e-2)"						"unprognostic (2.19e-3)"	"unprognostic (1.11e-3)"			"unprognostic (2.01e-1)"			0.1	0.1	0.9	0.0	2.1	0.0	0.0	2.3	1.1	0.1	0.5			0.1	0.1	0.1	0.0	1.2	0.1	0.3	0.2	13.0	0.1	0.0	0.0	0.0	2.5		0.1	21.9	0.0	22.4	0.0		7.6	0.3		0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	9.4	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1										
ECE2	"KIAA0604, MGC2408"	ENSG00000145194	"Endothelin converting enzyme 2"	O60344	3	184276011-184293031	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	12	"adrenal gland: 14.4;brain: 25.1;pancreas: 29.0;pituitary gland: 7.6"	"Cell line enriched"	"Detected in some"	8	"REH: 13.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043346	Uncertain									"HPA043346: AB_10794181"	"unprognostic (2.70e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.91e-2)"	"prognostic unfavourable (8.41e-5)"	"unprognostic (1.37e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (5.80e-4)"	"unprognostic (1.47e-2)"	"unprognostic (3.69e-1)"	"unprognostic (2.65e-3)"	"unprognostic (1.70e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.63e-9)"	"unprognostic (3.66e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.25e-2)"	0.7	14.4	9.1	0.9	17.1	0.7	0.7	17.6	10.5	0.7	1.1	2.2	0.0	0.8	0.7	1.6	0.8	0.9	0.7	1.5	4.6	25.1	0.7	0.7	0.7	0.7	10.3	3.0	0.7	29.0	0.7	7.6	0.7	7.5	1.6	0.9	1.4	1.1	1.1	0.7	0.7	0.8	0.9	2.9	0.7	1.0	0.8	3.3	0.0	0.7	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	1.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	17.1	17.6	5.2	4.6	25.1	10.3	3.0	7.5	3.3
ASB4	ASB-4	ENSG00000005981	"Ankyrin repeat and SOCS box containing 4"	Q9Y574	7	95478444-95540232	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"adrenal gland: 28.6;pituitary gland: 40.1;skeletal muscle: 20.7"	"Cell line enhanced"	"Detected in some"		"A549: 6.8;Hep G2: 11.1;SCLC-21H: 7.0"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.2"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basal ganglia: 10.0;hypothalamus: 37.1"	"Region enriched"	"Detected in single"	7	"midbrain: 3.7"	HPA055240	Uncertain									"HPA055240: AB_2682753"	"unprognostic (1.41e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.66e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.24e-1)"	"unprognostic (9.13e-7)"	"unprognostic (1.71e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.99e-1)"	"unprognostic (7.23e-2)"	0.3	28.6	0.7	0.1	1.1	0.3	0.2	0.1	1.3	0.1	0.1	1.3	0.1	0.2	0.1	0.3	0.1	0.2	0.4	2.6	0.7	0.6	0.1	1.0	0.4	0.1	1.7	0.5	0.1	0.4	0.0	40.1	1.3	0.2	0.2	0.0	0.1	0.3	0.1	20.7	0.2	0.2	0.1	1.6	0.1	0.4	0.2	0.1	0.2	0.2	2.5	0.4	0.1	0.1	1.0	0.6	1.3	0.3	0.9	0.7	0.0	0.3	6.8	0.3	2.5	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.8	1.3	0.2	0.1	0.2	0.3	0.0	0.0	0.0	0.2	0.2	0.1	0.5	11.1	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.1	0.1	0.6	0.0	0.2	0.2	0.3	0.2	1.5	0.1	0.2	0.0	0.2	0.2	7.0	0.0	0.1	0.3	0.7	0.1	0.3	0.3	0.4	0.4	0.1	0.1	0.8	0.2	0.4	0.2	0.4	0.2	0.3	0.3	0.5	0.6	0.1	0.7	1.0	0.6	0.5	0.2	1.0	0.7	0.7	1.3	0.9	0.3	0.6	0.3	0.0	0.7	1.1	0.1	1.3	0.7	0.6	1.7	0.5	0.2	0.1
BPIFB3	"C20orf185, dJ726C3.4, LPLUNC3, RYA3"	ENSG00000186190	"BPI fold containing family B member 3"	P59826	20	33055424-33073628	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"blood: 1.2;pituitary gland: 2.8;salivary gland: 3.1;testis: 3.0"	"Group enriched"	"Detected in some"	27	"HEL: 8.1;HMC-1: 5.8"	"Cancer enriched"	"Detected in single"	7	"ovarian cancer: 1.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045741	Uncertain				"Intracellular and membrane"					"HPA045741: AB_2679439"										"unprognostic (4.33e-2)"					"unprognostic (1.06e-3)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	2.8	0.0		0.0	0.0		3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0			0.2		0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.2										
GPR149	"IEDA, PGR10, R35"	ENSG00000174948	"G protein-coupled receptor 149"	Q86SP6	3	154337672-154429715	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	11	"brain: 23.5;pituitary gland: 6.5;seminal vesicle: 8.7"	"Cell line enhanced"	"Detected in single"		"SCLC-21H: 2.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"basal ganglia: 23.5;pons and medulla: 6.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 15.0"	"Low region specificity"	"Detected in all"			HPA018020	Uncertain									"HPA018020: AB_1849334"																		0.2	0.3	0.2	0.2	23.5	0.2	0.2	0.0	0.8	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	1.9	0.2	0.2	0.2	0.2	0.8	0.0	0.2	0.2	0.2	6.5	0.2	6.5	0.3	0.3	0.4	0.2	8.7	0.2	0.3	0.3	0.2	0.6	0.2	0.5	1.1	2.1	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	23.5	0.0	0.8	0.2	1.9	0.8	0.0	6.5	2.1
DGKK		ENSG00000274588	"Diacylglycerol kinase kappa"	Q5KSL6	X	50365409-50470738	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"adrenal gland: 9.8;brain: 29.6;pituitary gland: 33.5"	"Cell line enriched"	"Detected in some"	20	"Hep G2: 27.3"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	6	"gdTCR: 2.4;memory CD8 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	25	"T-cells: 2.4"	"Region enhanced"	"Detected in some"		"hypothalamus: 12.9"	"Group enriched"	"Detected in many"	5	"basal ganglia: 3.5;hypothalamus: 1.8;midbrain: 4.3;pons and medulla: 1.1"												"unprognostic (3.99e-1)"		"unprognostic (1.18e-1)"	"unprognostic (4.18e-3)"	"unprognostic (1.23e-1)"		"unprognostic (5.83e-3)"	"unprognostic (9.58e-2)"		"unprognostic (2.41e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.28e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.49e-2)"	"unprognostic (4.64e-3)"	0.1	9.8	0.0	0.0	29.6	0.2	0.3	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2		0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	33.5	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5										
DMRTA2		ENSG00000142700	"DMRT like family A2"	Q96SC8	1	50417550-50423500	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 8.5;esophagus: 3.8;pituitary gland: 5.4;testis: 4.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.1;HBEC3-KT: 4.2;RH-30: 15.3;SH-SY5Y: 3.2;SiHa: 3.1"	"Cancer enhanced"	"Detected in many"		"glioma: 5.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA043098, HPA062958"	Uncertain		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"			Mitochondria	Mitochondria	"HPA043098: AB_10796684, HPA062958: AB_2684911"	"unprognostic (1.60e-1)"	"unprognostic (4.56e-3)"	"unprognostic (2.62e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.75e-2)"		"unprognostic (1.15e-2)"	"unprognostic (3.29e-1)"	"unprognostic (6.89e-2)"	"unprognostic (4.79e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.21e-3)"	"unprognostic (7.08e-3)"	"unprognostic (4.16e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.68e-3)"	0.2	0.1	0.4	0.1	1.5	0.2	0.2	0.4	2.1	0.3	0.3	8.5	0.0	0.4	0.2	0.1	3.8	0.2	0.1	0.1	1.2	0.7	0.2	0.2	0.2	0.2	1.2	0.0	0.2	0.1	0.4	5.4	0.2	2.1	0.2	0.3	0.0	0.5	0.2	0.3	0.1	0.2	0.1	2.0	0.3	0.2	4.0	3.7	0.3	0.2	0.5	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.2	0.0	0.0	1.2	4.2	0.0	0.0	0.1	1.0	0.1	0.0	0.0	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	3.2	3.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.4	1.8	1.2	0.7	1.2	0.0	2.1	3.7
VWC2L		ENSG00000174453	"Von Willebrand factor C domain containing protein 2 like"	B2RUY7	2	214411065-214578959	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 8.9;pituitary gland: 2.3"	"Cell line enhanced"	"Detected in single"		"AF22: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA044815, HPA059414"	Uncertain				"Secreted - unknown location"					"HPA044815: AB_10962359, HPA059414: AB_2684007"	"unprognostic (8.77e-2)"				"unprognostic (2.83e-3)"			"unprognostic (2.05e-2)"		"unprognostic (8.49e-2)"	"unprognostic (1.51e-3)"	"unprognostic (4.36e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.05e-1)"		"unprognostic (3.89e-1)"		0.3	0.3	1.9	0.3	3.2	0.3	0.3	0.2	8.9	0.3	0.3	0.0	0.0	0.3	0.3	0.5	0.3	0.4	0.3	0.3	2.4	6.6	0.3	0.3	0.5	0.3	3.9	2.9	0.3	0.3	0.3	2.3	0.3	6.6	0.4	0.3	0.1	0.3	0.4	0.5	0.4	0.3	0.3	1.0	0.3	0.4	0.5	0.0	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	3.2	0.2	8.5	2.4	6.6	3.9	2.9	6.6	0.0
XKR7	"C20orf159, dJ310O13.4"	ENSG00000260903	"XK related 7"	Q5GH72	20	31968002-32003387	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 28.0;pituitary gland: 12.3"	"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 21.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 28.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 25.6"	HPA040854	Uncertain									"HPA040854: AB_10795481"	"unprognostic (2.74e-2)"	"unprognostic (5.60e-3)"	"unprognostic (8.03e-2)"	"unprognostic (3.74e-7)"	"unprognostic (4.29e-2)"	"unprognostic (9.34e-2)"		"unprognostic (1.45e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.68e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.26e-3)"	"unprognostic (3.08e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-5)"	"unprognostic (1.99e-1)"	0.5	1.5	2.9	0.6	4.4	0.5	0.4	28.0	10.0	0.4	0.5	0.0	0.0	0.6	0.4	0.5	0.4	0.5	0.5	0.4	1.2	1.5	0.5	0.4	0.5	0.4	0.8	4.6	0.4	1.8	0.4	12.3	0.4	3.5	0.4	0.6	2.0	0.4	0.5	0.4	0.5	0.5	0.4	0.6	0.5	1.7	1.2	0.0	0.0	0.4	0.0	0.4	0.4	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	21.2	4.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.9	4.4	28.0	8.7	1.2	1.5	0.8	4.6	3.5	0.0
CALY	"CALCYON, DRD1IP, NSG3"	ENSG00000130643	"Calcyon neuron specific vesicular protein"	Q9NYX4	10	133324072-133336935	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"adrenal gland: 26.5;brain: 98.9;pituitary gland: 47.7"	"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 2.7;U-266/70: 2.6"	"Group enriched"	"Detected in some"	14	"glioma: 1.7;pancreatic cancer: 7.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.3;naive CD4 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042283	Enhanced									"HPA042283: AB_10794417"	"unprognostic (1.43e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.41e-2)"	"unprognostic (7.32e-2)"	"unprognostic (9.81e-3)"	"unprognostic (2.56e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.18e-1)"	"prognostic favourable (3.54e-4)"	"unprognostic (1.23e-2)"	"unprognostic (4.19e-10)"	"unprognostic (8.04e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.63e-1)"	1.8	26.5	27.1	2.7	57.4	1.8	1.8	12.7	67.1	1.7	2.6	3.6	0.0	5.0	1.7	1.9	1.8	2.0	1.8	1.7	31.8	98.9	1.7	1.7	1.9	2.0	25.1	39.8	1.7	6.3	1.7	47.7	1.7	33.9	1.8	2.4	0.7	2.1	2.0	1.7	1.9	3.8	2.1	14.3	1.9	4.1	4.3	4.8	0.0	1.9	0.0	1.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.6	0.1	0.8	0.3	0.0	0.0	0.0	0.3	0.6	0.6	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.8	1.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.4	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.3	0.0	0.1	2.6	0.0	0.0	0.3	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	27.1	57.4	12.7	45.9	31.8	98.9	25.1	39.8	33.9	4.8
CFC1B		ENSG00000152093	"Cripto, FRL-1, cryptic family 1B"	P0CG36	2	130521197-130528604	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	9	"brain: 3.4;pancreas: 13.0;pituitary gland: 8.1"	"Group enriched"	"Detected in some"	9	"SCLC-21H: 2.2;U-2 OS: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA041773	Approved				"Secreted - unknown location"					"HPA041773: AB_2677664"																		0.3	0.1	0.4	0.1	1.6	0.1	0.1	1.5	0.5	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.3	0.1	0.3	0.1	3.4	0.2	0.1	0.2	0.1	0.6	0.1	0.1	13.0	0.1	8.1	0.1	1.0	0.8	0.7	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.4	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	1.6	1.5	0.5	0.1	3.4	0.6	0.1	1.0	0.1
IGSF1	"IGCD1, IGDC1, INHBP, KIAA0364, MGC75490, PGSF2"	ENSG00000147255	"Immunoglobulin superfamily member 1"	Q8N6C5	X	131273506-131578899	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"pituitary gland: 138.7"	"Group enriched"	"Detected in some"	5	"Hep G2: 23.0;SH-SY5Y: 20.7"	"Cancer enriched"	"Detected in many"	8	"thyroid cancer: 65.8"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA012732, HPA035582"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	430000	430000	Cytosol	Cytosol	"HPA012732: AB_2732404, HPA035582: AB_2674687"	"unprognostic (1.40e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.11e-1)"	"prognostic unfavourable (4.25e-8)"	"unprognostic (1.01e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.52e-3)"	"unprognostic (8.03e-3)"	"unprognostic (9.36e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.13e-2)"	0.8	11.9	1.4	0.4	5.3	0.0	2.7	0.6	6.2	2.7	0.5	3.3	1.2	0.2	1.1	1.5	1.3	1.6	0.8	5.6	3.3	15.4	0.5	1.5	0.2	0.0	3.8	1.9	1.0	1.7	0.0	138.7	0.6	4.7	3.9	0.2	2.2	2.0	6.4	0.3	0.6	0.4	3.2	2.7	0.2	0.5	11.8	1.9	0.2	5.3	0.8	0.5	0.6	0.5	0.6	0.4	1.5	0.3	0.3	0.3	0.2	0.3	0.4	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.1	0.0	0.0	1.2	0.0	0.0	4.0	0.3	0.0	1.7	23.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.1	1.9	20.7	0.0	0.2	0.0	0.4	0.0	0.0	0.3	0.6	0.0	2.3	0.7	0.3	0.0	0.0	0.0	0.0	1.5	0.3	0.2	0.2	0.1	0.2	0.3	0.3	0.3	0.1	0.6	0.3	0.2	1.2	0.3	0.1	0.4	0.3	0.2	1.4	5.3	0.6	2.3	3.3	15.4	3.8	1.9	4.7	1.9
SIX3	HPE2	ENSG00000138083	"SIX homeobox 3"	O95343	2	44941898-44946077	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 40.2;parathyroid gland: 32.1;pituitary gland: 30.9;retina: 66.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 6.8;SCLC-21H: 36.7;SH-SY5Y: 14.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"basal ganglia: 40.2"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 38.7"	HPA067988			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA067988: AB_2685939"	"unprognostic (1.19e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.76e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.76e-2)"		"unprognostic (1.31e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.49e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.76e-1)"		"unprognostic (2.73e-2)"	0.4	0.4	3.7	0.5	40.2	0.5	0.5	0.7	0.7	1.5	0.4	1.5	0.0	0.5	0.4	0.4	0.5	0.4	0.5	0.4	1.6	7.2	0.4	0.4	0.5	0.5	1.1	2.7	0.4	1.0	32.1	30.9	0.4	0.1	0.4	0.4	66.5	0.4	0.4	1.1	0.5	0.4	0.4	0.0	0.4	0.5	0.8	6.5	0.0	0.4	0.0	0.4	0.4	0.0	1.1	1.1	4.5	2.2	1.9	1.7	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	6.8	0.0	0.0	0.3	3.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.2	0.1	0.0	0.2	0.0	0.0	0.0	36.7	14.7	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.6	1.2	1.0	1.1	1.7	1.1	1.1	0.8	0.8	1.1	1.3	1.4	1.7	1.9	2.2	1.1	1.3	0.7	3.7	40.2	0.7	0.7	1.6	7.2	1.1	2.7	0.1	6.5
TGFBR3L		ENSG00000260001	"Transforming growth factor beta receptor 3 like"	H3BV60	19	7916145-7919097	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"pituitary gland: 56.6"	"Cell line enhanced"	"Detected in some"		"PC-3: 5.6;REH: 13.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdTCR: 2.9"	"Lineage enriched"	"Detected in single"	8	"T-cells: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA074356	Enhanced		Approved	Vesicles				Vesicles	Vesicles	"HPA074356: AB_2686681"	"unprognostic (1.57e-1)"	"unprognostic (6.92e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.01e-2)"	"unprognostic (2.63e-1)"	"unprognostic (7.65e-2)"	"unprognostic (9.51e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.96e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.62e-3)"	0.3	2.0	1.6	0.2	2.8	0.6	0.3	1.9	6.4	5.0	0.6	0.0	0.3	6.0	2.8	0.5	0.3	0.7	0.2	2.1	0.7	0.8	3.7	4.0	0.3	0.1	0.5	1.7	0.3	0.3	0.9	56.6	0.4	1.9	2.5	0.1	0.6	0.8	0.7	0.3	0.5	5.7	2.0	0.6	0.3	0.4	0.5	0.0	0.0	0.3	0.0	0.1	1.1	0.8	0.1	0.3	0.0	0.1	0.0	2.9	0.1	0.1	0.2	0.1	0.5	0.1	0.0	3.3	2.6	0.0	0.2	0.0	0.5	0.0	0.1	3.0	0.1	1.9	0.0	0.0	0.0	3.4	1.1	0.5	0.2	0.6	0.2	1.7	0.3	0.2	0.1	0.0	0.0	0.0	0.7	0.5	0.0	1.5	1.2	0.2	0.6	5.6	13.6	0.0	3.0	0.2	0.0	1.0	2.5	0.3	0.0	0.6	0.9	0.5	0.2	1.8	2.9	2.0	0.9	0.8	0.9	0.8	0.4	0.0	0.7	0.0	0.0	0.0	2.9	0.0	0.6	0.1	0.9	1.9	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.3	0.0	0.1	1.6	2.8	1.9	6.4	0.7	0.8	0.5	1.7	1.9	0.0
UCMA	C10orf49	ENSG00000165623	"Upper zone of growth plate and cartilage matrix associated"	Q8WVF2	10	13221767-13234334	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 6.2;heart muscle: 3.2;ovary: 5.4;pituitary gland: 2.4"	"Cell line enhanced"	"Detected in single"		"THP-1: 3.5"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"	"Group enriched"	"Detected in some"	6	"amygdala: 6.2;basal ganglia: 3.7;cerebral cortex: 6.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA046718	Uncertain				"Secreted to extracellular matrix"					"HPA046718: AB_2679771"															"unprognostic (4.25e-1)"			0.0	0.0	6.2	0.2	3.7	0.0	0.0	0.2	6.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	3.2	0.7	0.2	0.0	0.1	0.5	0.0	0.1	0.9	5.4	0.0	0.0	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	3.7	0.2	6.1	0.7	0.2	0.1	0.9	0.0	0.0
DRD2		ENSG00000149295	"Dopamine receptor D2"	P14416	11	113409615-113475691	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	8	"adrenal gland: 17.3;brain: 52.0;pituitary gland: 51.6"	"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 44.2"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"basal ganglia: 52.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	10	"basal ganglia: 183.8"	"Group enriched"	"Detected in many"	9	"basal ganglia: 126.7;midbrain: 41.7"	"HPA015139, HPA015691"	Supported	Supported								"HPA015139: , HPA015691: "	"unprognostic (8.49e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.29e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.15e-1)"		"unprognostic (1.97e-2)"	"unprognostic (5.89e-2)"	"unprognostic (4.40e-2)"	"unprognostic (8.33e-4)"	"unprognostic (1.10e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.82e-2)"	"unprognostic (8.49e-3)"	0.6	17.3	0.9	0.5	52.0	0.2	2.1	0.2	3.3	1.3	0.6	1.5	0.0	0.3	2.3	0.4	0.9	2.1	0.6	0.5	0.3	4.1	0.3	0.2	0.6	0.2	9.9	0.2	0.3	0.4	0.3	51.6	0.2	2.4	1.5	0.9	3.9	5.1	1.7	1.7	0.3	0.5	3.2	0.2	0.2	0.5	1.6	9.5	0.0	0.2	0.0	0.3	0.3	0.3	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.8	0.0	0.5	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.5	0.0	0.0	4.7	0.0	0.0	0.0	44.2	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.9	52.0	0.2	3.3	0.3	4.1	9.9	0.2	2.4	9.5
GAL	"GAL-GMAP, GALN, GLNN, GMAP"	ENSG00000069482	"Galanin and GMAP prepropeptide"	P22466	11	68683779-68691175	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"pituitary gland: 149.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 46.9;HEK 293: 21.9;K-562: 24.3;NB-4: 86.7;SH-SY5Y: 35.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	8	"hypothalamus: 18.8"	"Cell type enriched"	"Detected in single"	15	"intermediate monocyte: 1.5"	"Lineage enriched"	"Detected in single"	15	"monocytes: 1.5"	"Region enhanced"	"Detected in many"		"hypothalamus: 111.6"	"Low region specificity"	"Detected in all"			"HPA049864, CAB079779"	Enhanced	Supported	Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"			"Golgi apparatus"	"Golgi apparatus"	"CAB079779: , HPA049864: AB_2680922"	"unprognostic (8.56e-2)"	"unprognostic (1.45e-2)"	"unprognostic (7.50e-2)"	"prognostic unfavourable (1.22e-4)"	"unprognostic (2.70e-1)"	"unprognostic (2.27e-2)"	"unprognostic (8.07e-3)"	"prognostic unfavourable (8.17e-4)"	"unprognostic (5.98e-2)"	"unprognostic (1.07e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.85e-2)"	"unprognostic (7.88e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.24e-2)"	2.8	0.2	0.1	14.8	0.5	0.4	4.5	0.6	2.0	0.2	6.0	0.1	0.4	1.7	0.2	0.7	0.7	0.2	0.3	0.6	1.3	18.8	0.3	0.2	0.2	0.1	0.2	0.6	0.2	2.9	0.0	149.9	0.9	2.2	0.7	4.1	0.6	0.5	1.8	0.3	4.5	2.2	9.7	0.3	0.2	1.5	0.5	0.4	0.7	0.2	0.4	0.3	1.5	0.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.9	0.2	0.0	0.0	0.0	4.4	6.6	0.0	0.1	0.0	46.9	1.7	0.0	2.4	0.2	0.0	0.0	0.0	0.0	0.0	21.9	1.1	14.1	0.0	0.2	0.6	0.0	0.3	0.7	0.0	0.0	1.1	24.3	0.0	0.0	13.3	0.0	86.7	11.2	4.2	0.0	0.0	8.9	0.1	0.0	9.1	35.0	4.6	0.2	0.0	0.2	10.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	0.7	1.3	18.8	0.2	0.6	2.2	0.4
GNB3		ENSG00000111664	"G protein subunit beta 3"	P16520	12	6839954-6847393	"Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"pituitary gland: 27.0;retina: 79.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 8.4;NTERA-2: 10.1;U-698: 25.4"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.5"	"Lineage enriched"	"Detected in single"	9	"B-cells: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA040736	Uncertain		Approved	"Golgi apparatus,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA040736: AB_2677106"	"unprognostic (3.86e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.96e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.53e-2)"	"unprognostic (5.74e-3)"	"unprognostic (5.98e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.25e-5)"	"unprognostic (3.21e-2)"	"unprognostic (4.77e-11)"	"unprognostic (2.43e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.07e-2)"	0.8	1.6	0.9	1.4	2.0	0.5	0.8	6.9	1.6	1.1	1.0	0.8	0.8	2.3	2.7	0.8	0.8	1.0	1.1	5.4	1.0	1.3	0.8	0.8	0.8	1.4	1.1	0.8	3.5	0.8	3.2	27.0	0.8	1.6	1.6	0.4	79.9	2.6	1.8	1.5	0.6	1.6	4.1	0.9	0.9	0.9	0.8	0.8	0.8	1.2	1.0	1.8	2.1	0.8	1.5	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.4	4.9	0.8	0.6	0.8	0.5	2.9	0.6	1.6	1.1	1.0	0.2	8.4	0.0	3.1	0.3	4.8	0.2	1.5	0.7	1.1	2.1	2.6	0.7	0.5	0.6	1.4	1.2	0.2	1.5	2.1	1.3	0.8	0.7	0.4	0.4	0.4	0.4	10.1	0.3	0.3	1.7	0.5	0.3	0.2	0.8	1.2	0.2	0.0	0.6	0.0	0.5	2.6	1.3	2.0	2.4	3.8	0.7	0.5	25.4	0.6	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	2.0	6.9	1.5	1.0	1.3	1.1	0.8	1.6	0.8
MC2R	ACTHR	ENSG00000185231	"Melanocortin 2 receptor"	Q01718	18	13882044-13915707	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"adrenal gland: 31.7;pituitary gland: 14.3"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.8;MCF7: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.3"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA079148	Enhanced									"HPA079148: "											"unprognostic (2.09e-1)"			"unprognostic (3.63e-2)"	"unprognostic (1.85e-2)"			0.0	31.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	14.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.1	0.1	1.3	0.3	0.1	0.1	0.0	0.2	0.0	0.1	0.3	0.1	0.3	1.1	0.2	0.0	0.1	0.3	0.1	0.2	0.0	0.0	0.4	0.3	0.1	0.9	0.1	0.0	0.5	0.0	1.8	0.2	0.0	0.2	0.0	0.0	0.9	0.0	0.6	0.0	0.1	0.4	0.0	3.7	0.0	0.0	0.6	0.1	0.2	0.5	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.2	0.3	0.5	0.0	0.2	0.2	0.0	0.1	0.4	0.0	1.3	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.5	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
PROP1		ENSG00000175325	"PROP paired-like homeobox 1"	O75360	5	177992235-177996242	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	8	"pituitary gland: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA049839	Enhanced									"HPA049839: AB_2732557"										"unprognostic (2.90e-1)"		"unprognostic (4.90e-1)"		"unprognostic (2.13e-2)"				0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	4.7	0.0		0.4	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TBX19	"dj747L4.1, TPIT"	ENSG00000143178	"T-box 19"	O60806	1	168281040-168314426	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	8	"pituitary gland: 50.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 9.5;HDLM-2: 8.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005800, HPA072686"	Enhanced		Approved	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA005800: , HPA072686: AB_2732209"	"unprognostic (2.47e-1)"	"unprognostic (1.20e-2)"	"unprognostic (8.76e-4)"	"unprognostic (1.43e-2)"	"unprognostic (3.09e-2)"	"unprognostic (8.36e-2)"	"unprognostic (7.14e-7)"	"unprognostic (1.83e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.58e-2)"	"unprognostic (9.78e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (4.55e-9)"	"unprognostic (8.57e-2)"	"unprognostic (6.63e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.05e-2)"	1.0	0.4	1.0	1.0	1.0	0.5	2.5	1.0	1.0	1.5	1.3	1.0	1.0	0.8	5.3	1.0	1.1	2.0	1.4	1.0	1.0	0.8	1.0	1.0	2.2	2.1	1.0	1.0	2.9	1.0	0.2	50.4	1.0	1.0	1.2	1.1	1.0	2.2	1.4	1.0	1.9	1.0	3.6	1.0	2.1	0.6	1.0	1.0	1.0	1.0	1.0	1.3	1.3	1.2	1.6	6.3	2.7	2.4	2.6	3.1	1.3	1.6	0.1	1.4	5.3	2.5	1.2	1.7	2.9	1.5	1.0	1.6	2.4	1.7	1.5	2.9	1.1	9.5	0.8	0.7	1.4	8.1	1.4	0.3	1.7	0.7	2.9	2.6	3.6	2.2	2.6	0.3	1.5	1.2	1.8	2.4	1.3	0.3	1.4	2.4	0.4	1.0	2.2	0.7	0.5	2.3	0.7	1.9	2.8	1.6	1.2	1.6	0.4	2.2	2.1	1.0	2.4	2.0	2.9	1.6	1.3	1.2	0.2	0.8	2.8	0.5	1.8	0.8	3.1	1.3	1.4	1.2	2.2	2.0	1.8	1.6	1.5	1.3	2.7	2.6	2.4	6.3	2.0	1.3	1.0	1.0	1.0	1.0	1.0	0.8	1.0	1.0	1.0	1.0
TEX15	CT42	ENSG00000133863	"Testis expressed 15, meiosis and synapsis associated"	Q9BXT5	8	30831544-30913003	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 5.4;endometrium 1: 10.0;pituitary gland: 6.9;smooth muscle: 8.5;testis: 21.3"	"Cell line enhanced"	"Detected in some"		"HAP1: 8.7;HEL: 19.7;K-562: 5.5;NTERA-2: 3.7;SCLC-21H: 4.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"			HPA036800	Enhanced		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA036800: AB_10671714"	"unprognostic (3.10e-1)"	"unprognostic (2.56e-1)"		"unprognostic (3.30e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.45e-2)"		"unprognostic (2.15e-3)"	"unprognostic (2.80e-3)"	"unprognostic (4.52e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.61e-5)"	"unprognostic (8.88e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.92e-1)"	0.1	0.1	0.7	0.2	5.4	0.1	0.1	0.1	1.1	1.2	0.1	0.0	0.0	0.1	10.0	0.6	0.2	0.1	0.8	0.1	1.7	0.5	0.1	0.1	0.1	0.1	0.3	0.3	0.4	0.1	0.1	6.9	0.1	0.9	0.1	0.1	0.3	0.1	0.5	0.1	0.1	0.2	8.5	0.4	0.4	0.9	21.3	1.4	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	8.7	1.1	0.0	1.1	3.1	19.7	0.0	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.2	5.5	0.0	0.0	0.1	0.1	0.1	3.7	0.3	0.0	0.0	0.0	0.0	0.0	4.3	1.4	0.0	0.0	3.7	0.2	1.1	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	5.4	0.1	1.1	1.7	0.5	0.3	0.3	0.9	1.4
AC008687.1		ENSG00000267335			19	49022953-49036895	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	7	"pancreas: 8.2;pituitary gland: 19.9"	"Cell line enhanced"	"Detected in some"		"HMC-1: 7.2;U-251 MG: 10.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA038925	Uncertain		Approved	Cytosol	"Secreted - unknown location"			Cytosol	Cytosol	"HPA038925: AB_2676272"																		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	8.2	0.0	19.9	0.5		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.6	0.9	0.2	0.1	0.2	0.0	1.8	0.0	0.0	0.1	0.3	0.1	1.2	0.0	0.3	0.0	1.0	0.0	0.0	0.6	0.2	0.9	0.0	0.9	0.1	0.0	0.1	7.2	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.5	0.2	0.0	0.0	0.1	1.2	0.2	0.0	0.0	0.0	0.7	0.2	0.0	0.4	0.1	0.5	0.2	0.4	0.0	2.6	2.3	0.6	10.4	0.5	2.4	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
C2CD4A	"FAM148A, NLF1"	ENSG00000198535	"C2 calcium dependent domain containing 4A"	Q8NCU7	15	62066977-62070917	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"endometrium 1: 6.8;liver: 25.9;pancreas: 20.4;pituitary gland: 21.9"	"Cell line enriched"	"Detected in some"	18	"RPTEC TERT1: 25.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"																						"unprognostic (3.85e-2)"	"unprognostic (6.68e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.38e-3)"	"unprognostic (5.49e-3)"	"unprognostic (3.85e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.99e-1)"	"prognostic unfavourable (4.15e-4)"	"unprognostic (4.72e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.35e-1)"	0.3	1.0	0.5	1.3	0.4	0.3	0.5	0.2	0.7	1.0	1.2	0.1	0.1	2.2	6.8	0.3	0.2	0.1	0.9	0.2	0.4	0.9	2.5	25.9	2.0	0.3	0.3	0.1	0.4	20.4	0.0	21.9	0.8	1.3	1.1	1.4	0.2	1.2	0.1	0.8	1.1	1.1	0.1	0.4	0.2	2.2	0.2	0.1	1.2	0.9	0.1	1.2	1.3	0.1	0.8	0.9	2.5	0.5	0.9	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.1	0.9	0.0	0.0	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	25.8	0.6	1.1	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	1.2	0.5	0.4	0.4	0.2	0.4	0.5	0.4	0.2	0.1	0.8	0.5	0.3	2.5	0.9	0.2	0.9	1.0	0.1	0.5	0.4	0.2	0.4	0.4	0.9	0.3	0.1	1.3	0.1
CRHR1	"CRF-R, CRF1, CRHR"	ENSG00000120088	"Corticotropin releasing hormone receptor 1"	P34998	17	45784280-45835828	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	7	"brain: 23.2;pituitary gland: 16.5"	"Group enriched"	"Detected in some"	4	"RT4: 7.9;SH-SY5Y: 4.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											CAB025251	Enhanced				"Intracellular and membrane"					"CAB025251: "	"unprognostic (4.59e-2)"	"unprognostic (1.43e-2)"		"unprognostic (2.59e-7)"	"unprognostic (1.76e-1)"	"unprognostic (2.71e-1)"		"unprognostic (3.94e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.55e-4)"	"unprognostic (1.65e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.33e-4)"	"unprognostic (2.07e-5)"	"unprognostic (3.26e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.59e-1)"	0.8	0.6	14.7	0.5	5.1	0.5	1.5	23.2	11.5	1.4	0.6	1.1	0.0	0.8	2.7	1.1	0.5	1.6	0.7	0.5	3.2	2.2	0.6	0.5	0.6	0.5	1.8	5.2	0.6	0.5	0.6	16.5	0.6	2.9	1.3	0.6	1.9	1.2	2.5	0.6	1.4	1.0	1.2	1.0	0.5	0.5	1.0	2.8	0.0	0.9	0.0	0.5	1.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	1.6	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	5.1	23.2	11.5	3.2	2.2	1.8	5.2	2.9	2.8
DEUP1	"CCDC67, FLJ25393"	ENSG00000165325	"Deuterosome assembly protein 1"	Q05D60	11	93329971-93438487	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"fallopian tube: 6.0;pituitary gland: 13.0;testis: 19.9"	"Cell line enhanced"	"Detected in some"		"AF22: 1.4;Karpas-707: 1.0;NTERA-2: 4.0;SCLC-21H: 1.6;U-2 OS: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"														"unprognostic (4.68e-1)"	"unprognostic (3.25e-1)"	"unprognostic (3.93e-1)"	"unprognostic (7.24e-3)"	"unprognostic (2.09e-1)"	"unprognostic (4.13e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.79e-2)"		"unprognostic (1.16e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.33e-1)"	"unprognostic (6.03e-3)"	"unprognostic (8.59e-2)"	"unprognostic (2.25e-1)"	0.0	0.7	0.2	0.0	0.8	0.0	0.4	0.0	0.2	0.1	0.1	0.8	0.8	0.0	0.2	1.5	0.2	6.0	0.1	0.0	0.3	1.0	1.0	0.0	0.6	0.0	0.3	0.0	1.6	0.9	0.1	13.0	0.0	0.7	1.1	0.1	0.1	1.6	1.8	1.3	0.2	0.1	0.1	1.0	0.0	0.1	19.9	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.2	4.0	0.0	0.2	0.2	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.9	0.0	0.0	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.2	0.3	1.0	0.3	0.0	0.7	0.0
ELMOD1	DKFZp547C176	ENSG00000110675	"ELMO domain containing 1"	Q8N336	11	107591091-107666779	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 51.1;pituitary gland: 20.8;skin 1: 34.7"	"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 11.6;RH-30: 26.5"	"Cancer enriched"	"Detected in single"	15	"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038435, HPA066479"			Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA038435: AB_10795575, HPA066479: "	"unprognostic (2.74e-1)"	"unprognostic (1.72e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.13e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.59e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.29e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.34e-4)"	"unprognostic (1.91e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.39e-1)"	1.5	4.2	10.7	1.5	41.1	1.3	4.1	12.8	51.1	1.5	1.4	1.7	0.0	1.4	1.6	1.3	1.2	3.6	1.2	4.8	13.8	14.3	4.7	1.3	1.6	1.3	8.7	15.2	1.2	1.2	1.2	20.8	1.2	14.8	2.1	1.3	1.4	1.3	1.2	2.8	34.7	1.3	1.4	6.6	1.2	1.2	2.9	3.9	0.0	1.3	0.0	1.2	1.1	0.1	0.9	0.7	2.4	0.9	1.8	0.5	0.2	0.0	0.0	4.4	0.1	0.0	0.0	0.1	0.2	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.2	0.4	2.1	0.3	0.4	0.0	1.8	0.1	0.0	0.0	1.2	0.1	0.0	0.4	0.1	0.0	0.0	11.6	0.0	0.1	0.8	0.0	0.0	0.1	0.5	1.7	0.0	26.5	0.0	0.0	0.0	0.2	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.6	0.1	0.0	0.0	3.5	0.0	2.0	1.6	0.9	0.6	0.4	0.6	0.4	0.5	0.5	0.2	0.2	0.9	0.4	0.5	2.4	1.8	0.6	0.7	0.4	0.2	10.7	41.1	12.8	26.9	13.8	14.3	8.7	15.2	14.8	3.9
FNDC9	"C5orf40, MGC27121"	ENSG00000172568	"Fibronectin type III domain containing 9"	Q8TBE3	5	157341600-157345721	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"adrenal gland: 9.4;brain: 24.0;pituitary gland: 10.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.7;HeLa: 1.8;Karpas-707: 3.0;U-266/70: 1.6"	"Cancer enriched"	"Detected in single"	16	"glioma: 0.8"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"basal ganglia: 21.9;hypothalamus: 28.4"	"Low region specificity"	"Detected in all"			HPA011115	Uncertain									"HPA011115: AB_1079374"	"unprognostic (2.35e-3)"	"unprognostic (3.80e-2)"	"unprognostic (2.93e-1)"		"unprognostic (3.53e-3)"	"unprognostic (4.90e-3)"		"unprognostic (3.40e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.35e-6)"	"unprognostic (3.63e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.12e-3)"	0.6	9.4	3.9	1.5	21.1	2.0	0.6	9.1	24.0	0.5	1.1	0.0	0.0	0.6	0.6	0.9	0.5	0.6	0.6	0.7	1.9	22.0	0.7	0.6	0.5	0.9	1.3	3.8	0.5	0.5	0.5	10.0	0.6	5.8	0.6	1.2	0.0	0.5	0.6	0.6	0.6	0.8	0.8	1.3	0.6	0.6	0.5	0.4	0.0	0.6	0.0	0.5	0.6	0.0	0.5	0.3	0.8	0.8	0.0	1.9	0.1	0.0	0.2	0.4	0.4	0.0	0.0	0.4	1.0	0.0	0.2	0.0	0.2	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	1.8	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.2	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.5	1.0	0.3	0.3	1.6	0.0	1.0	0.3	0.0	0.1	0.0	0.0	0.8	1.9	0.2	0.1	0.0	0.6	1.3	0.0	0.5	0.8	1.5	0.2	0.0	0.8	0.3	0.0	0.1	3.9	21.1	9.1	13.3	1.9	22.0	1.3	3.8	5.8	0.4
HTR4	5-HT4	ENSG00000164270	"5-hydroxytryptamine receptor 4"	Q13639	5	148451032-148677235	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"brain: 18.1;heart muscle: 7.2;intestine: 14.6;pituitary gland: 5.9"	"Cell line enriched"	"Detected in single"	5	"Karpas-707: 2.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 18.1"	"Cell type enriched"	"Detected in single"	8	"T-reg: 1.5"	"Lineage enriched"	"Detected in single"	15	"T-cells: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA040591	Enhanced									"HPA040591: AB_2677028"	"unprognostic (1.12e-1)"	"unprognostic (4.60e-2)"	"unprognostic (7.74e-2)"		"unprognostic (2.37e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.77e-2)"	"unprognostic (4.68e-2)"			"unprognostic (1.10e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.49e-2)"	"unprognostic (8.83e-5)"	0.4	1.4	1.9	1.1	18.1	0.1	0.2	0.1	3.2	0.6	4.3	0.0	0.0	8.0	0.3	0.1	0.3	0.4	1.5	7.2	5.2	0.6	0.1	0.2	0.3	0.2	0.5	1.3	0.2	0.1	0.1	5.9	0.1	0.1	0.1	4.9	0.0	0.2	0.2	0.2	0.2	14.6	1.1	0.3	0.2	0.2	0.2	2.4	0.0	0.2	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	1.9	18.1	0.1	3.2	5.2	0.6	0.5	1.3	0.1	2.4
LRRC10B		ENSG00000204950	"Leucine rich repeat containing 10B"	A6NIK2	11	61508800-61511018	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	7	"brain: 27.8;fallopian tube: 36.2;pituitary gland: 14.8"	"Group enriched"	"Detected in some"	5	"AF22: 11.9;RH-30: 12.8;SCLC-21H: 6.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 27.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	7	"basal ganglia: 202.0"	"Group enriched"	"Detected in many"	5	"basal ganglia: 39.3;hippocampal formation: 35.0"	HPA047619	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoplasm	"HPA047619: AB_2680106"	"unprognostic (9.95e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.10e-2)"	"unprognostic (9.22e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.62e-1)"	"unprognostic (9.21e-3)"	"unprognostic (2.52e-2)"	"unprognostic (5.27e-4)"	"unprognostic (5.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.63e-2)"	2.4	1.6	4.8	0.9	27.8	0.5	1.9	0.2	5.8	3.4	1.6	1.2	1.0	0.9	2.2	3.7	1.1	36.2	0.8	1.2	5.2	1.9	0.9	0.6	3.7	0.5	1.1	4.3	3.0	1.5	2.1	14.8	1.2	1.2	0.9	1.0	0.0	1.1	1.2	0.7	0.5	0.9	2.5	0.2	0.6	1.0	2.4	8.3	0.9	0.8	0.2	0.5	0.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.3	0.0	0.0	12.8	0.0	0.0	0.0	6.7	0.6	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	27.8	0.2	5.8	5.2	1.9	1.1	4.3	1.2	8.3
NNAT	Peg5	ENSG00000053438	Neuronatin	Q16517	20	37521215-37523693	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	7	"brain: 117.2;pituitary gland: 165.1;placenta: 69.1"	"Cell line enriched"	"Detected in some"	22	"SH-SY5Y: 124.5"	"Group enriched"	"Detected in many"	16	"glioma: 87.5;testis cancer: 55.0;urothelial cancer: 37.4"	"Region enhanced"	"Detected in all"		"basal ganglia: 117.2"	"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"														"unprognostic (1.18e-2)"	"unprognostic (7.41e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavourable (9.66e-4)"	"unprognostic (7.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.36e-1)"	"unprognostic (4.05e-2)"	"unprognostic (7.52e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.15e-3)"	"unprognostic (5.90e-2)"	17.0	11.6	35.4	2.6	117.2	2.3	3.5	4.9	68.4	2.3	7.0	11.1	0.0	3.4	4.6	2.5	2.6	2.8	4.2	1.7	35.0	21.4	1.4	1.1	1.7	1.9	4.9	14.0	1.3	1.6	1.0	165.1	69.1	7.9	2.4	3.9	1.5	3.4	1.5	8.0	3.8	3.2	4.4	2.1	1.8	2.1	2.9	3.8	0.2	1.5	0.0	1.1	3.3	0.6	0.7	0.7	0.3	0.3	0.0	1.0	0.0	0.3	0.2	2.2	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.3	0.1	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.5	0.1	0.1	0.5	0.0	0.0	0.0	5.5	0.0	0.3	0.0	0.1	0.9	0.1	0.1	0.2	0.0	0.6	0.0	0.0	3.1	0.2	124.5	0.1	0.7	0.0	0.2	0.0	0.1	0.9	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.1	1.0	0.3	0.0	0.0	0.7	0.0	0.0	35.4	117.2	4.9	41.0	35.0	21.4	4.9	14.0	7.9	3.8
OTOS	OTOSP	ENSG00000178602	Otospiralin	Q8NHW6	2	240139026-240144562	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"pituitary gland: 39.1;thyroid gland: 41.0"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.0;hTEC/SVTERT24-B: 1.8;U-138 MG: 2.2"	"Group enriched"	"Detected in some"	13	"glioma: 6.5;thyroid cancer: 28.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"hippocampal formation: 1.8"	"Low region specificity"	"Detected in all"								"Secreted in other tissues"						"unprognostic (8.52e-2)"			"unprognostic (1.73e-1)"	"unprognostic (9.01e-3)"					"unprognostic (1.35e-1)"					"unprognostic (2.72e-1)"	"unprognostic (3.27e-3)"		0.3	0.3	4.5	0.3	4.6	0.3	0.4	0.3	3.8	0.5	0.3	0.7	0.0	0.3	0.4	0.7	0.3	0.4	0.3	0.3	2.4	1.1	0.3	0.3	0.3	0.3	0.6	2.0	0.3	0.3	0.3	39.1	0.3	5.5	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.8	0.3	0.3	0.4	0.8	0.0	41.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.3	0.0	0.0	0.0	0.5	0.0	0.0	2.2	0.7	0.0	0.5	0.0	0.1	0.0	0.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	4.6	0.3	3.8	2.4	1.1	0.6	2.0	5.5	0.8
RAB3C		ENSG00000152932	"RAB3C, member RAS oncogene family"	Q96E17	5	58582221-58859394	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adrenal gland: 13.6;brain: 47.4;pituitary gland: 14.1"	"Cell line enhanced"	"Detected in some"		"AF22: 2.4;HEL: 3.4;SCLC-21H: 14.3;SH-SY5Y: 5.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"							"HPA003160, HPA048156"	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"HPA003160: AB_1079731, HPA048156: AB_2680291"	"unprognostic (1.30e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.94e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.73e-3)"	"unprognostic (3.40e-2)"	"unprognostic (6.90e-2)"	"unprognostic (7.58e-2)"	"unprognostic (9.52e-4)"	"unprognostic (1.51e-3)"	"unprognostic (3.70e-5)"	"unprognostic (4.70e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.61e-3)"	2.5	13.6	19.8	2.5	36.1	1.1	1.3	7.7	47.4	1.3	1.8	2.1	0.0	3.1	2.1	1.0	1.3	1.3	1.9	1.1	22.9	23.6	1.2	1.2	1.2	1.3	14.5	23.6	1.2	3.3	1.4	14.1	1.2	25.6	1.1	2.1	0.0	1.1	1.1	1.1	1.1	3.3	2.0	3.2	1.0	2.3	1.3	4.1	0.0	1.1	0.0	1.4	1.7	0.4	0.3	0.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	1.7	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	14.3	5.2	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	19.8	36.1	7.7	32.4	22.9	23.6	14.5	23.6	25.6	4.1
STX1A	"HPC-1, p35-1, STX1"	ENSG00000106089	"Syntaxin 1A"	Q16623	7	73699206-73719672	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 73.7;pituitary gland: 26.9"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 49.9;U-87 MG: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdTCR: 2.5;T-reg: 2.4"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.5"	"Group enriched"	"Detected in many"	5	"amygdala: 253.0;basal ganglia: 94.3;cerebral cortex: 362.2;hippocampal formation: 251.5"	"Group enriched"	"Detected in all"	8	"amygdala: 69.4;cerebral cortex: 158.6;hippocampal formation: 149.3"	"CAB008372, HPA069176"	Enhanced				"Intracellular and membrane"					"CAB008372: AB_592786, HPA069176: AB_2686098"	"unprognostic (5.12e-3)"	"prognostic unfavourable (3.63e-4)"	"unprognostic (3.94e-2)"	"prognostic unfavourable (1.94e-5)"	"unprognostic (3.12e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.02e-8)"	"unprognostic (1.11e-2)"	"unprognostic (6.97e-2)"	"unprognostic (3.52e-2)"	"unprognostic (6.34e-2)"	"unprognostic (7.70e-3)"	"unprognostic (4.18e-6)"	"unprognostic (2.65e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.14e-3)"	"unprognostic (6.20e-2)"	1.4	5.6	27.4	2.4	20.9	7.6	1.4	33.7	73.7	1.7	2.6	1.3	0.8	3.7	2.8	1.8	1.7	2.3	5.5	1.2	22.0	8.3	1.1	1.2	1.8	1.4	4.0	28.0	2.2	5.7	1.5	26.9	2.2	2.6	1.9	2.1	0.1	1.9	1.8	1.1	1.9	3.5	2.6	1.3	1.3	6.2	2.0	0.7	0.0	1.6	0.0	1.1	2.8	1.1	0.4	0.0	0.1	0.2	0.0	2.5	2.7	1.5	7.3	1.2	3.5	1.6	4.2	0.8	5.0	3.3	2.1	1.4	2.5	4.3	1.9	0.7	3.5	1.3	1.7	3.1	1.6	3.4	1.3	0.6	2.6	1.4	1.8	0.8	1.8	2.5	1.4	14.6	5.1	3.6	1.6	2.3	3.9	3.7	0.6	7.1	0.9	16.7	0.0	0.8	1.9	1.7	1.3	49.9	7.9	1.5	4.2	1.0	1.4	0.6	13.6	10.3	3.4	7.9	13.3	1.3	0.8	0.9	33.2	0.7	12.1	0.0	0.2	0.0	2.5	0.0	0.9	0.4	0.4	0.6	0.0	0.1	0.8	0.3	0.1	0.0	0.0	0.0	2.4	2.7	27.4	20.9	33.7	49.9	22.0	8.3	4.0	28.0	2.6	0.7
UNC13A	"KIAA1032, Munc13-1"	ENSG00000130477	"Unc-13 homolog A"	Q9UPW8	19	17601328-17688365	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 48.4;pituitary gland: 16.7"	"Cell line enhanced"	"Detected in some"		"HMC-1: 11.1;NTERA-2: 16.0;SCLC-21H: 26.5;SH-SY5Y: 6.3"	"Cancer enhanced"	"Detected in some"		"glioma: 2.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.50e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.98e-3)"	"unprognostic (2.13e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.33e-3)"	"unprognostic (1.40e-2)"	"unprognostic (8.19e-3)"	"unprognostic (1.94e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.00e-1)"	1.3	4.9	15.8	1.7	25.3	1.2	1.2	24.6	48.4	1.3	1.4	1.9	0.0	1.5	1.3	1.3	1.2	1.3	1.3	1.1	16.8	7.5	1.3	1.1	1.3	1.5	4.1	16.3	1.3	2.5	1.3	16.7	1.4	8.2	1.2	1.5	1.2	1.2	1.3	1.1	1.2	1.4	1.4	1.9	3.8	2.4	2.1	1.6	0.0	1.2	0.0	1.6	1.2	0.1	0.4	0.3	1.1	0.2	0.2	0.3	0.0	0.0	1.6	1.4	0.3	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	1.6	0.4	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.1	0.0	0.0	0.0	1.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	16.0	0.4	0.4	0.0	0.2	0.0	0.0	26.5	6.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.4	0.2	0.3	1.1	0.2	0.1	0.3	0.0	0.0	15.8	25.3	24.6	35.4	16.8	7.5	4.1	16.3	8.2	1.6
VGF	"SCG7, SgVII"	ENSG00000128564	"VGF nerve growth factor inducible"	O15240	7	101162509-101165593	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 59.4;pituitary gland: 30.4"	"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 35.9;SK-MEL-30: 96.8;U-2 OS: 17.6;WM-115: 29.0"	"Cancer enriched"	"Detected in many"	6	"melanoma: 236.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA055177, HPA072505"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	2800000	2800000	"Golgi apparatus, Vesicles"	"Golgi apparatus, Vesicles"	"HPA055177: AB_2682728, HPA072505: AB_2686528"	"unprognostic (3.04e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.19e-3)"	"prognostic unfavourable (4.25e-4)"	"prognostic unfavourable (3.31e-4)"	"unprognostic (1.51e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.25e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.84e-3)"	"unprognostic (3.70e-3)"	"unprognostic (9.82e-3)"	"unprognostic (3.79e-1)"	"unprognostic (7.23e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.21e-1)"	3.8	3.1	10.9	2.3	25.2	1.3	1.1	1.3	59.4	1.1	1.5	1.3	0.0	1.3	2.2	1.1	1.1	1.1	1.2	1.2	12.2	51.0	1.4	1.1	1.1	1.1	3.9	22.8	1.1	6.2	1.1	30.4	1.2	41.2	1.2	1.2	0.5	1.1	1.1	1.1	1.4	1.3	1.5	6.6	1.2	3.6	1.4	0.5	0.0	1.2	0.0	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	1.9	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.6	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.7	0.4	0.0	4.6	0.0	0.4	3.6	0.4	0.1	0.0	0.0	0.0	0.0	2.9	35.9	0.0	0.1	96.8	0.0	0.0	0.0	0.0	17.6	0.0	0.4	0.0	0.1	0.9	2.8	0.0	29.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	25.2	1.3	59.4	12.2	51.0	3.9	22.8	41.2	0.5
ATP8A2	"ATPIB, ML-1"	ENSG00000132932	"ATPase phospholipid transporting 8A2"	Q9NTI2	13	25372071-26025851	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 34.9;pituitary gland: 37.0;testis: 10.4"	"Cell line enriched"	"Detected in some"	6	"HMC-1: 21.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.3;naive CD8 T-cell: 3.3"	"Lineage enriched"	"Detected in single"	12	"T-cells: 3.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039926, HPA040033"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA039926: AB_10794205, HPA040033: AB_2676809"	"unprognostic (3.79e-2)"	"unprognostic (4.28e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.95e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.97e-3)"	"unprognostic (2.77e-1)"	"unprognostic (3.66e-1)"	"unprognostic (4.96e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.20e-5)"	"unprognostic (9.10e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.22e-2)"	1.1	4.9	11.2	1.4	11.4	0.8	2.2	34.9	30.2	1.1	1.3	1.3	0.0	1.4	2.1	4.8	0.9	0.9	1.0	1.0	9.4	11.8	1.3	0.8	2.3	1.9	6.7	10.4	1.2	1.9	0.9	37.0	1.2	19.8	1.1	1.3	3.1	1.0	1.0	1.3	0.9	1.5	1.0	3.5	1.3	1.8	10.4	1.4	0.0	1.0	0.0	1.2	1.2	0.3	0.0	0.0	0.2	0.0	0.2	3.3	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.7	1.0	0.0	0.6	1.4	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	21.9	0.2	0.0	0.0	0.0	0.5	0.0	0.0	1.7	0.3	3.7	0.0	2.0	0.7	0.0	2.7	1.0	0.2	0.1	3.3	0.0	0.2	0.3	0.1	0.0	0.4	0.2	0.1	1.1	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.8	0.6	0.0	0.0	2.3	3.3	0.2	0.2	0.0	0.0	0.7	0.6	11.2	11.4	34.9	18.4	9.4	11.8	6.7	10.4	19.8	1.4
CCDC175	C14orf38	ENSG00000151838	"Coiled-coil domain containing 175"	P0C221	14	59504539-59576831	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 17.1;pituitary gland: 6.6;testis: 8.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.5;SCLC-21H: 1.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"cerebellum: 17.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA004200	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	Nucleoplasm	"HPA004200: AB_1078743"	"unprognostic (3.64e-3)"		"unprognostic (8.05e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.21e-1)"					"unprognostic (3.83e-1)"			"unprognostic (2.02e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.27e-1)"			0.2	0.1	0.9	0.2	2.9	0.5	0.2	17.1	3.3	0.2	0.9	1.2	0.0	0.3	0.2	1.0	0.2	1.3	0.5	0.2	0.8	0.5	0.4	0.2	0.5	0.2	0.8	0.9	0.2	0.1	0.3	6.6	0.1	3.0	0.2	1.8	0.6	0.2	0.2	0.2	0.3	0.9	0.2	0.4	0.4	0.2	8.2	1.5	0.0	0.3	0.0	0.2	0.1	0.1	0.0	0.1	0.5	0.1	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.4	0.9	2.9	17.1	3.3	0.8	0.5	0.8	0.9	3.0	1.5
CHRNE	ACHRE	ENSG00000108556	"Cholinergic receptor nicotinic epsilon subunit"	Q04844	17	4897774-4903074	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"heart muscle: 53.3;pituitary gland: 19.0"	"Group enriched"	"Detected in some"	13	"HEL: 5.9;HMC-1: 14.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"gdTCR: 5.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in single"	14	"basal ganglia: 5.7"												"unprognostic (2.00e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.35e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.27e-3)"	"unprognostic (7.80e-4)"	"unprognostic (7.75e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.69e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.42e-4)"	"unprognostic (1.39e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.83e-2)"	"unprognostic (5.70e-2)"	0.3	0.1	0.1	0.4	0.1	0.4	0.1	0.3	0.4	0.1	0.2	0.1	0.1	0.3	0.4	0.8	0.2	0.1	0.4	53.3	0.1	0.0	0.1	1.3	0.3	0.2	0.3	0.1	0.3	0.6	0.3	19.0	0.4	0.2	0.1	0.0	0.5	0.5	0.1	1.0	0.8	0.1	0.2	0.1	0.7	0.1	0.2	0.1	0.1	0.1	1.4	0.2	0.1	0.1	1.0	0.3	1.0	0.4	1.6	5.9	1.5	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.2	5.9	0.0	0.7	0.5	0.0	14.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	5.9	0.2	0.0	0.0	0.0	2.1	0.2	1.0	0.1	1.6	0.2	1.6	0.4	0.3	0.0	1.5	0.1	0.1	0.3	0.4	0.1	0.0	0.3	0.1	0.2	0.1
GJB7	"bA136M9.1, CX25"	ENSG00000164411	"Gap junction protein beta 7"	Q6PEY0	6	87282978-87329278	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"fallopian tube: 12.3;pituitary gland: 10.0;placenta: 4.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 6.7;HDLM-2: 10.8;MCF7: 5.9;RT4: 5.3"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.3"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in many"														"unprognostic (8.30e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.06e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.07e-3)"		"unprognostic (2.61e-1)"	"unprognostic (5.13e-3)"	"unprognostic (6.69e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.82e-2)"	"unprognostic (4.15e-2)"	"unprognostic (3.24e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.10e-2)"	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.0			0.0	0.1	0.0	0.0	12.3	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0		0.0	0.0	0.0	10.0	4.5		0.0	0.0		0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	1.3			0.0		0.1	0.5	0.0	0.7	0.1	1.0	0.0	0.0	1.3	0.0	2.1	0.0	0.1	0.2	0.0	0.0	6.7	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	10.8	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.0	5.9	0.0	0.1	1.9	0.0	0.2	0.0	0.0	0.0	5.3	0.1	0.0	1.2	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	0.1	0.6	1.3	0.0	0.4	0.0	0.0	0.0	0.2	0.0										
GPR148	PGR6	ENSG00000173302	"G protein-coupled receptor 148"	Q8TDV2	2	130729070-130730336	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"brain: 2.6;pancreas: 1.1;pituitary gland: 2.2;stomach 1: 3.5"	"Group enriched"	"Detected in some"	11	"CACO-2: 2.5;SCLC-21H: 2.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA060527	Uncertain									"HPA060527: AB_2684307"											"unprognostic (7.16e-4)"				"unprognostic (3.38e-1)"			0.0	0.2	0.1	0.0	0.4	0.0	0.0	2.6	0.4	0.0	0.2			0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.1		0.0	1.1	0.0	2.2	0.0		0.0	0.3		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.5	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
IRS4	"IRS-4, PY160"	ENSG00000133124	"Insulin receptor substrate 4"	O14654	X	108732482-108736409	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"pituitary gland: 56.0"	"Cell line enhanced"	"Detected in some"		"HEK 293: 13.6;NTERA-2: 1.7;RT4: 4.0;WM-115: 3.0"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	7	"hypothalamus: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basal ganglia: 12.8;hypothalamus: 52.4"	"Group enriched"	"Detected in some"	6	"basal ganglia: 21.5;hypothalamus: 55.3"	HPA017372	Uncertain									"HPA017372: AB_2669600"	"unprognostic (3.74e-3)"				"unprognostic (3.27e-2)"			"unprognostic (1.32e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.65e-1)"		"unprognostic (1.05e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.28e-4)"	"unprognostic (8.71e-2)"	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.6	1.9	0.0	0.1	0.3	0.1	2.6	0.3	0.3	0.5	0.0	0.0	0.3	4.6	0.0	0.0	0.1	0.0	0.5	0.1	9.5	0.0	0.0	56.0	0.1	0.6	0.2	0.0	2.7	0.0	0.5	0.0	0.6	0.0	1.0	0.2	0.1	0.5	0.1	0.5	5.1	3.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.3	0.3	4.6	0.5	0.1	0.6	0.5
MYO15A	"DFNB3, MYO15"	ENSG00000091536	"Myosin XVA"	Q9UKN7	17	18108706-18179806	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"pituitary gland: 46.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.6;EFO-21: 2.8;HSkMC: 2.2;RPMI-8226: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"basophil: 3.8"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	15	"hippocampal formation: 2.7"	HPA078501	Enhanced									"HPA078501: AB_2732383"	"unprognostic (2.48e-3)"	"unprognostic (5.31e-2)"	"unprognostic (2.87e-3)"	"unprognostic (7.35e-3)"	"unprognostic (4.92e-3)"	"unprognostic (2.33e-1)"	"unprognostic (8.32e-4)"	"unprognostic (4.51e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.66e-3)"	"unprognostic (8.38e-2)"	"unprognostic (4.18e-3)"	"unprognostic (5.69e-3)"	"unprognostic (9.89e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.21e-2)"	0.5	0.0	0.5	0.6	0.7	0.0	0.5	2.3	1.6	0.5	0.5	0.5	0.5	0.2	1.7	3.4	0.5	1.0	0.5	0.5	0.5	1.2	0.5	0.8	1.5	0.5	0.5	0.5	3.0	0.5	2.2	46.1	0.5	0.7	0.5	0.4	0.5	0.5	1.6	0.5	0.1	0.9	0.5	0.5	0.5	0.6	7.4	0.5	0.5	0.9	0.5	0.5	0.5	0.5	0.7	0.4	3.8	0.9	0.6	0.3	0.1	0.1	0.0	1.5	0.0	0.9	2.6	0.4	0.1	0.9	0.0	0.0	0.5	0.3	0.2	2.8	0.9	0.4	0.0	0.8	0.0	1.3	0.6	0.0	0.3	0.0	0.4	0.0	0.0	2.2	0.0	0.4	0.6	0.0	0.1	0.4	0.0	0.5	0.1	0.5	0.1	0.0	0.2	0.4	3.4	0.0	0.0	0.1	0.2	0.0	0.0	0.2	1.4	0.4	0.2	0.0	0.1	0.0	0.0	1.0	1.4	0.1	0.0	0.1	0.4	3.8	0.5	0.5	0.2	0.9	0.3	0.7	0.1	0.1	0.2	0.4	0.2	0.3	1.4	0.6	0.2	0.4	0.1	0.1	0.5	0.7	2.3	1.5	0.5	1.2	0.5	0.5	0.7	0.5
NEUROD4	"ATH-3, Atoh3, bHLHa4, MATH-3"	ENSG00000123307	"Neuronal differentiation 4"	Q9HD90	12	55019945-55030014	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"pituitary gland: 54.8"	"Group enriched"	"Detected in some"	6	"AF22: 3.6;SCLC-21H: 7.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA015545	Enhanced									"HPA015545: AB_2669215"					"unprognostic (1.78e-2)"													0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	54.8	0.0	0.7	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.7	0.0
NYAP2	KIAA1486	ENSG00000144460	"Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2"	Q9P242	2	225399710-225654018	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 17.9;pituitary gland: 13.5"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.9;SH-SY5Y: 2.0;SiHa: 6.1;U-2 OS: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045531	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"				Nucleoplasm	Nucleoplasm	"HPA045531: AB_10960749"	"unprognostic (2.49e-1)"	"unprognostic (3.34e-1)"		"unprognostic (1.24e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.35e-1)"		"unprognostic (6.13e-3)"		"unprognostic (3.33e-1)"	"unprognostic (2.08e-1)"		"unprognostic (1.32e-8)"	"unprognostic (9.83e-2)"	"unprognostic (2.92e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.27e-1)"	0.8	1.1	10.8	1.0	16.4	1.4	0.7	17.9	11.9	0.6	0.7	0.8	0.0	1.0	0.7	0.7	1.2	0.6	0.8	0.7	8.5	2.5	0.7	0.7	1.9	1.1	2.6	8.5	0.6	0.8	0.6	13.5	0.7	2.5	0.7	0.8	0.0	0.7	0.6	2.6	1.2	0.9	0.6	2.7	0.9	0.8	1.0	2.9	0.0	0.6	0.0	0.8	1.2	0.6	0.5	0.5	2.1	0.3	0.2	0.4	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.0	2.0	6.1	0.0	0.0	0.0	0.0	0.0	0.1	2.4	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	2.1	0.3	0.2	0.3	0.2	0.4	0.3	0.2	0.1	0.0	0.5	0.3	0.4	1.2	0.2	0.2	0.5	0.1	0.1	10.8	16.4	17.9	11.9	8.5	2.5	2.6	8.5	2.5	2.9
PCDHGB1	PCDH-GAMMA-B1	ENSG00000254221	"Protocadherin gamma subfamily B, 1"	Q9Y5G3	5	141350102-141512979	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	6	"brain: 32.2;pituitary gland: 13.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 14.9;ASC TERT1: 7.7;T-47d: 9.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"naive CD8 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580, HPA076182"	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Focal adhesion sites,Midbody"				"Vesicles, Plasma membrane"	"Vesicles, Plasma membrane"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA076182: "	"unprognostic (1.53e-2)"	"unprognostic (1.94e-3)"	"unprognostic (3.21e-1)"	"unprognostic (4.38e-3)"	"unprognostic (2.98e-1)"	"unprognostic (8.36e-3)"	"unprognostic (2.37e-1)"	"unprognostic (9.57e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.78e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.63e-3)"	2.3	2.7	8.2	1.4	7.5	1.0	2.1	4.3	32.2	2.5	1.4	9.4	0.1	1.2	3.7	2.0	1.7	1.9	2.1	2.2	7.6	5.7	2.1	1.3	2.4	1.2	5.5	5.0	4.1	2.8	1.4	13.7	1.6	7.0	2.5	1.4	2.6	1.7	3.1	1.1	1.4	1.3	3.0	6.9	1.4	1.2	1.5	5.6	0.0	2.5	0.0	1.2	1.4	1.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	2.1	1.8	0.0	14.9	7.7	0.1	1.4	3.6	0.5	0.8	0.2	0.5	0.5	4.7	0.5	0.6	0.4	0.2	0.5	0.0	0.9	0.0	0.2	1.3	0.2	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.2	0.2	3.3	1.9	0.4	0.3	0.2	0.0	0.0	2.8	0.1	0.0	0.0	1.1	0.8	0.0	0.9	0.1	9.6	0.0	1.1	0.2	1.6	1.2	0.0	0.0	2.6	0.3	2.9	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	8.2	7.5	4.3	9.6	7.6	5.7	5.5	5.0	7.0	5.6
SCG2	"CHGC, SgII, SN"	ENSG00000171951	"Secretogranin II"	P13521	2	223596940-223602503	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 133.0;brain: 94.1;pituitary gland: 76.5"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 26.2;HSkMC: 22.4;SCLC-21H: 22.8;SH-SY5Y: 9.9;WM-115: 16.7"	"Group enriched"	"Detected in many"	8	"glioma: 70.0;pancreatic cancer: 52.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011893, HPA075062"	Enhanced	Supported	Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	54000	54000	"Golgi apparatus"	"Golgi apparatus"	"HPA011893: AB_1856656, HPA075062: AB_2732277"	"unprognostic (2.93e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.82e-4)"	"unprognostic (2.51e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.77e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.69e-2)"	"prognostic favourable (5.58e-4)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (7.01e-10)"	"unprognostic (2.47e-3)"	"unprognostic (4.02e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.90e-3)"	3.5	133.0	13.3	11.0	94.1	0.9	0.9	5.6	55.9	1.4	5.4	5.8	0.0	17.3	2.1	0.9	1.0	0.8	2.2	1.4	10.5	79.4	1.0	0.8	1.9	0.9	21.7	11.0	1.3	10.7	1.1	76.5	1.1	57.7	2.1	5.5	1.5	0.9	1.3	0.8	1.0	8.0	5.2	10.3	0.8	8.0	0.9	5.0	0.0	3.1	0.0	0.8	1.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.4	4.9	4.1	1.1	26.2	0.1	0.2	0.9	1.9	4.9	0.2	0.4	0.0	0.4	0.3	0.1	0.1	0.0	2.5	0.0	0.2	0.0	0.3	0.0	0.3	0.3	2.2	22.4	0.1	2.7	0.9	0.0	0.1	0.2	2.4	0.1	0.0	0.1	3.5	0.0	0.0	0.1	0.0	0.3	0.0	22.8	9.9	0.0	0.2	1.1	0.0	0.0	0.0	2.6	1.0	0.1	1.7	0.0	0.0	0.1	0.7	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	13.3	94.1	5.6	23.0	10.5	79.4	21.7	11.0	57.7	5.0
SEPT14	FLJ44060	ENSG00000154997	"Septin 14"	Q6ZU15	7	55793544-55862789	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"pituitary gland: 6.5;testis: 25.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 10.0"	"Cancer enriched"	"Detected in some"	10	"glioma: 6.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA073255	Enhanced									"HPA073255: AB_2686590"					"unprognostic (1.29e-1)"					"unprognostic (3.50e-1)"				"unprognostic (1.98e-2)"	"unprognostic (1.57e-1)"			0.3	0.2	0.3	0.7	0.3	1.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.4	0.4	0.3	0.2	0.3	0.3	0.3	0.3	0.4	1.4	0.3	0.3	0.3	0.3	0.5	0.3	1.0	6.5	0.4	0.3	0.5	0.2	0.3	0.3	0.3	0.3	0.7	0.3	0.3	0.3	0.5	0.2	25.5	0.3	0.3	0.5	0.3	0.3	0.3	0.3	1.2	0.7	2.5	0.6	2.0	0.6	0.3	1.8	0.6	2.1	4.7	2.1	1.7	10.0	1.4	1.2	1.1	1.4	0.5	1.3	1.5	0.4	0.7	1.8	2.3	1.6	2.8	2.4	1.2	1.0	3.2	3.5	4.6	2.1	2.4	1.8	2.9	1.3	2.5	1.1	3.5	2.2	1.6	1.0	2.8	2.8	1.7	0.4	1.1	2.0	2.1	1.7	1.5	1.7	2.1	0.6	1.3	1.9	1.4	2.9	0.9	1.4	1.4	1.4	0.9	2.8	8.6	2.1	1.1	7.2	2.1	2.5	0.6	0.5	0.6	0.4	0.5	0.6	0.5	0.5	0.3	1.2	0.6	0.6	1.8	2.0	0.6	0.7	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3
SYT14	"FLJ34198, sytXIV"	ENSG00000143469	"Synaptotagmin 14"	Q8NB59	1	209938174-210171389	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"brain: 17.4;pituitary gland: 31.1;testis: 9.5;thyroid gland: 15.9"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 13.1;SCLC-21H: 6.8;TIME: 10.9;U-138 MG: 8.3"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036963			Supported	Vesicles				Vesicles	Vesicles	"HPA036963: "	"unprognostic (1.38e-4)"	"unprognostic (8.62e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.90e-4)"	"unprognostic (1.97e-1)"	"unprognostic (4.43e-5)"		"unprognostic (1.92e-1)"	"unprognostic (1.88e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.81e-1)"	"unprognostic (4.85e-3)"	"unprognostic (2.30e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.33e-3)"	0.7	3.2	5.9	0.8	7.4	0.8	0.6	17.4	10.2	0.6	0.7	3.8	0.0	0.7	1.4	0.8	0.6	0.6	0.6	0.6	4.5	2.6	0.9	0.6	0.7	0.7	3.3	5.9	0.8	1.2	0.6	31.1	0.6	5.0	0.8	0.8	1.1	0.6	0.6	0.7	0.7	0.7	0.7	2.4	0.7	0.9	9.5	3.0	0.0	15.9	0.0	0.6	0.6	0.4	2.0	0.8	2.1	0.5	1.1	0.8	0.1	3.3	0.1	0.0	0.0	0.3	0.0	0.0	2.7	13.1	2.8	1.5	0.0	0.2	0.0	0.1	0.3	4.2	0.0	0.0	3.3	0.6	0.3	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	1.9	5.8	0.5	0.0	0.0	5.0	0.0	0.0	0.0	4.5	1.8	0.0	0.1	0.1	0.2	3.0	6.8	3.1	0.0	0.0	5.6	0.0	0.1	10.9	8.3	4.0	0.7	1.4	0.1	0.1	0.0	0.7	0.0	1.9	2.1	0.4	0.6	0.8	0.2	0.4	0.6	0.5	0.4	0.3	2.0	0.4	0.6	1.8	1.1	0.5	0.8	0.4	0.1	5.9	7.4	17.4	10.2	4.5	2.6	3.3	5.9	5.0	3.0
TPH1	"TPH, TPRH"	ENSG00000129167	"Tryptophan hydroxylase 1"	P17752	11	18017564-18042426	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 4.2;intestine: 16.2;pituitary gland: 5.4;stomach 1: 13.3"	"Cell line enhanced"	"Detected in many"		"HL-60: 4.5"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	6	"cerebral cortex: 4.2"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"							"CAB010767, HPA022483"	Approved		Uncertain	Cytosol				Cytosol	Cytosol	"CAB010767: AB_261587, HPA022483: AB_1858378"	"unprognostic (2.14e-4)"	"unprognostic (9.97e-2)"	"unprognostic (6.92e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.26e-5)"	"unprognostic (1.73e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.19e-4)"	"unprognostic (6.72e-2)"	"unprognostic (5.40e-8)"	"unprognostic (3.76e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.46e-5)"	0.7	0.0	0.7	0.7	0.7	0.6	0.9	0.7	4.2	0.7	7.1	0.7	0.7	8.2	0.7	0.7	0.7	1.5	0.7	0.7	0.7	0.3	0.7	0.7	0.7	0.7	0.7	0.7	1.0	0.7	0.0	5.4	0.7	0.7	1.3	16.2	0.7	0.7	0.7	0.7	1.0	9.1	0.7	0.7	1.0	13.3	0.9	0.7	0.7	0.7	0.7	0.7	0.7	0.7	1.4	0.8	1.5	0.5	0.9	1.6	0.2	0.4	0.1	1.7	1.5	0.1	0.0	0.6	0.6	0.5	0.2	1.1	1.8	0.3	1.4	0.3	0.0	0.6	0.4	1.5	0.7	1.3	3.1	2.2	0.8	3.5	0.0	4.5	1.2	0.0	1.8	0.2	0.6	0.7	0.9	0.8	0.1	0.5	1.0	0.7	0.5	0.3	1.7	0.3	0.0	0.0	1.0	1.3	0.9	0.2	0.4	0.9	0.3	2.9	0.2	0.4	1.3	0.5	1.7	0.2	0.3	1.1	0.2	1.0	1.4	1.5	0.4	0.4	1.6	0.2	0.8	0.5	0.5	0.4	0.1	1.4	0.6	0.6	1.5	0.9	0.5	0.8	0.6	0.2	0.7	0.7	0.7	4.2	0.7	0.3	0.7	0.7	0.7	0.7
UGT2A1		ENSG00000173610	"UDP glucuronosyltransferase family 2 member A1 complex locus"	Q9Y4X1	4	69588417-69653249	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"kidney: 10.6;liver: 14.5;pituitary gland: 21.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 3.1;HUVEC TERT2: 1.9;U-266/70: 3.5"	"Cancer enhanced"	"Detected in some"		"liver cancer: 0.7"	"Region enriched"	"Detected in single"	17	"pons and medulla: 1.7"	"Cell type enhanced"	"Detected in some"		"neutrophil: 2.0"	"Low lineage specificity"	"Detected in single"											"HPA017261, HPA045108"	Uncertain									"HPA017261: AB_10963582, HPA045108: AB_2679218"							"unprognostic (3.93e-3)"	"unprognostic (5.62e-1)"					"unprognostic (1.28e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.76e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	14.5	2.4	0.0	0.0	0.0	0.0	0.0	0.0	21.2	0.0	1.7	0.0	0.0	1.5	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.5	2.0	0.5	0.9	0.4	0.0	0.0	0.0	0.1	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	3.5	0.0	0.0	0.0	0.0	0.2	1.7	0.5	0.4	0.2	0.2	0.1	0.1	0.4	0.2	0.1	0.3	0.2	0.1	2.0	0.9	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0
ANKRD45	"CT117, FLJ45235"	ENSG00000183831	"Ankyrin repeat domain 45"	Q5TZF3	1	173609561-173669862	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 14.6;fallopian tube: 24.8;parathyroid gland: 16.8;pituitary gland: 7.9;testis: 20.8"	"Cell line enhanced"	"Detected in some"		"AF22: 11.8;BJ hTERT+: 4.2;BJ hTERT+ SV40 Large T+: 3.8;BJ hTERT+ SV40 Large T+ RasG12V: 6.4;HBF TERT88: 4.2;SH-SY5Y: 10.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031655, HPA031656, HPA031657"	Enhanced		Approved	"Plasma membrane,Centrosome,Cytosol"				Cytosol	Cytosol	"HPA031655: AB_10610975, HPA031656: AB_10600331, HPA031657: AB_10602196"	"unprognostic (1.93e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.02e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.69e-3)"	"unprognostic (4.15e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.49e-2)"	"unprognostic (8.80e-3)"	"unprognostic (2.91e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.61e-1)"	0.5	1.3	5.9	0.4	14.6	0.5	0.6	1.1	7.0	2.8	0.7	9.0	1.3	0.4	3.3	2.5	0.5	24.8	1.0	0.9	7.7	4.7	2.7	0.5	2.8	0.4	2.4	5.3	2.4	1.0	16.8	7.9	0.4	9.2	1.9	0.5	1.8	0.4	1.2	0.4	0.4	0.5	2.4	2.7	1.3	0.5	20.8	4.2	0.0	1.3	0.0	0.4	0.6	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.4	11.8	0.0	0.0	0.9	2.0	0.1	4.2	3.8	6.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.5	0.0	2.3	0.0	0.1	0.2	0.2	0.5	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.3	0.4	0.0	1.6	10.7	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.1	0.9	0.0	2.2	0.1	1.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.9	14.6	1.1	7.0	7.7	4.7	2.4	5.3	9.2	4.2
BSX	BSX1	ENSG00000188909	"Brain specific homeobox"	Q3C1V8	11	122977570-122981720	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"brain: 4.9;pituitary gland: 1.7;testis: 1.7"	"Group enriched"	"Detected in some"	21	"HDLM-2: 1.5;SCLC-21H: 2.6;SH-SY5Y: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"hypothalamus: 5.3"	"Region enriched"	"Detected in single"	8	"hypothalamus: 4.5"	HPA015654	Uncertain									"HPA015654: "																		0.0	0.0	0.9	0.0	0.8	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.2	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	1.7	0.0	4.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.8	0.0	0.8	0.0	4.9	0.0	1.2	4.5	0.0
CACNA1B	"CACNL1A5, CACNN, Cav2.2"	ENSG00000148408	"Calcium voltage-gated channel subunit alpha1 B"	Q00975	9	137877789-138124624	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 6.2;brain: 18.9;fallopian tube: 6.6;pituitary gland: 4.8;testis: 8.1"	"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 20.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA044347	Uncertain									"HPA044347: AB_10960837"	"unprognostic (1.34e-3)"	"unprognostic (2.70e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.51e-7)"	"unprognostic (8.10e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.36e-2)"	"unprognostic (9.73e-4)"	"unprognostic (5.98e-2)"	"unprognostic (6.63e-6)"	"unprognostic (4.25e-2)"	"unprognostic (4.72e-1)"	"unprognostic (7.77e-3)"	"unprognostic (8.69e-2)"	0.5	6.2	5.7	0.7	8.7	0.5	0.5	18.7	18.9	1.2	0.8	0.2	0.0	0.6	0.6	1.7	0.4	6.6	1.4	1.0	4.5	7.3	0.4	1.2	0.5	0.5	2.9	9.1	0.5	1.2	0.4	4.8	0.4	3.6	1.6	0.8	0.4	0.4	1.3	0.4	0.9	0.7	0.8	4.5	0.6	0.6	8.1	1.4	0.0	0.9	0.0	0.4	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	20.7	3.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	8.7	18.7	10.9	4.5	7.3	2.9	9.1	3.6	1.4
CARMIL3	"BC008134, C14orf121, crml-1, LRRC16B"	ENSG00000186648	"Capping protein regulator and myosin 1 linker 3"	Q8ND23	14	24052000-24069728	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 30.6;pituitary gland: 7.8;skin 1: 9.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 8.2;HMC-1: 5.8;Karpas-707: 5.2;SCLC-21H: 8.5;SH-SY5Y: 4.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030596	Uncertain									"HPA030596: AB_10603012"	"unprognostic (2.67e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.09e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.29e-4)"	"unprognostic (6.13e-2)"	"unprognostic (8.92e-4)"	"unprognostic (4.02e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.39e-4)"	"unprognostic (4.49e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.25e-2)"	"unprognostic (4.19e-1)"	"unprognostic (2.16e-1)"	0.6	1.6	6.5	1.4	5.2	1.0	0.8	30.6	7.9	0.6	0.9	3.3	0.0	2.3	0.6	0.5	1.0	0.6	1.6	0.4	7.4	5.2	1.0	0.8	0.9	1.4	2.8	2.4	0.6	1.3	0.5	7.8	0.5	7.2	0.8	1.0	1.7	1.6	0.7	0.5	9.4	1.6	0.7	2.9	1.0	1.2	3.1	2.8	0.0	1.0	0.0	2.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.1	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.1	0.3	0.0	0.0	1.3	0.0	0.1	0.1	0.1	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.3	1.2	0.0	0.5	0.1	0.6	0.0	0.0	0.0	0.0	8.5	4.2	0.0	0.3	0.6	0.1	0.0	0.0	0.0	0.1	0.1	0.0	1.3	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.5	5.2	30.6	7.7	7.4	5.2	2.8	2.4	7.2	2.8
CHST8	GALNAC-4-ST1	ENSG00000124302	"Carbohydrate sulfotransferase 8"	Q9H2A9	19	33621955-33773509	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 27.1;pituitary gland: 36.7"	"Group enriched"	"Detected in some"	4	"RPMI-8226: 18.4;SCLC-21H: 10.7;SH-SY5Y: 18.5"	"Cancer enhanced"	"Detected in many"		"glioma: 4.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016004	Enhanced				"Intracellular and membrane"					"HPA016004: AB_1846731"	"unprognostic (1.00e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.45e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.98e-8)"	"unprognostic (9.37e-3)"	"unprognostic (2.61e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.87e-2)"	2.0	3.8	3.6	1.7	2.8	0.4	7.0	16.6	9.2	3.4	1.1	1.0	0.0	0.5	1.3	0.4	0.7	2.0	4.0	0.8	9.2	7.9	0.5	0.7	0.6	2.0	5.3	1.5	1.4	3.4	0.4	36.7	0.4	27.1	1.8	0.5	1.4	0.7	0.8	0.6	0.9	0.8	0.8	7.2	3.3	0.9	2.9	0.9	0.0	0.6	0.3	1.4	0.9	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.3	0.0	0.1	0.0	0.0	0.0	1.2	0.0	3.8	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	2.9	0.0	0.0	0.1	18.4	0.0	0.3	10.7	18.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	3.6	2.8	16.6	9.2	9.2	7.9	5.3	1.5	27.1	0.9
CITED1	MSG1	ENSG00000125931	"Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1"	Q99966	X	72301638-72307187	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 247.1;pituitary gland: 62.8;testis: 89.9"	"Group enriched"	"Detected in some"	5	"AN3-CA: 17.5;SK-MEL-30: 69.6"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 134.9"	"Region enriched"	"Detected in many"	5	"hypothalamus: 18.9"	"Cell type enhanced"	"Detected in some"		"eosinophil: 2.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049051	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA049051: AB_2680612"	"unprognostic (7.04e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.79e-3)"	"unprognostic (8.81e-2)"	"unprognostic (5.67e-4)"	"unprognostic (3.40e-1)"	"unprognostic (9.55e-2)"	"unprognostic (4.60e-3)"	"unprognostic (4.38e-2)"	"unprognostic (6.33e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.62e-1)"	"prognostic favourable (6.10e-4)"	"prognostic favourable (3.95e-4)"	"unprognostic (2.99e-2)"	0.5	0.6	3.5	0.5	2.2	0.4	6.0	0.9	2.8	1.3	0.5	0.3	5.3	0.5	1.0	247.1	0.4	0.5	0.4	0.4	2.4	18.9	0.6	0.4	0.5	0.4	1.1	0.9	0.5	0.6	0.4	62.8	0.4	2.7	2.1	0.4	27.8	0.4	1.2	0.4	0.4	0.5	1.7	0.5	0.4	0.4	89.9	0.0	0.0	1.7	0.0	0.4	0.4	0.0	0.0	0.8	2.2	0.5	0.0	1.1	1.1	0.1	0.1	0.7	17.5	0.8	0.0	0.6	0.0	0.2	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.0	6.3	0.4	0.0	1.8	2.5	0.3	0.1	0.0	0.0	0.1	3.4	0.3	0.2	0.2	0.3	0.0	0.7	0.1	0.1	0.2	0.0	1.3	1.0	1.2	0.0	1.2	0.9	0.0	0.2	7.9	4.1	0.1	1.5	69.6	0.5	0.4	0.0	0.1	0.7	0.1	0.2	0.1	0.1	0.1	0.1	0.2	1.6	0.0	0.5	2.2	0.4	0.0	1.1	0.0	0.2	0.6	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	3.5	2.2	0.9	2.8	2.4	18.9	1.1	0.9	2.7	0.0
CNGA3	"ACHM2, CCNC1, CCNCa, CNCG3, CNG3"	ENSG00000144191	"Cyclic nucleotide gated channel alpha 3"	Q16281	2	98346155-98398601	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"pituitary gland: 32.0"	"Cell line enriched"	"Detected in some"	7	"U-87 MG: 12.5"	"Cancer enriched"	"Detected in some"	9	"glioma: 7.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"basal ganglia: 1.9;hypothalamus: 2.2"	"Not detected"	"Not detected"			"HPA049378, CAB079025"	Approved	Approved								"CAB079025: , HPA049378: AB_2732551"	"unprognostic (2.34e-2)"	"unprognostic (1.83e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.18e-1)"		"unprognostic (4.17e-4)"		"unprognostic (4.65e-2)"	"unprognostic (1.86e-3)"	"unprognostic (2.88e-1)"		"unprognostic (3.85e-3)"	"unprognostic (8.98e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.71e-2)"	0.1	0.0	0.3	1.4	0.7	0.0	0.7	0.1	2.9	0.1	6.1	2.4	0.1	2.8	0.1	0.1	4.6	0.8	0.4	0.1	1.2	4.0	0.1	0.1	0.2	0.1	0.8	0.4	0.1	1.5	0.0	32.0	0.1	4.9	0.1	3.2	1.2	0.2	0.5	0.1	0.0	4.0	2.2	4.3	0.1	3.0	1.1	0.3	0.1	0.1	0.1	0.1	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.7	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.1	1.5	1.2	4.0	0.8	0.4	4.9	0.3
COL2A1	"AOM, SEDC, STL1"	ENSG00000139219	"Collagen type II alpha 1 chain"	P02458	12	47972965-48004554	"Cancer-related genes, Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"epididymis: 22.7;pituitary gland: 11.0;retina: 8.1;stomach 1: 11.3"	"Cell line enhanced"	"Detected in some"		"AF22: 54.0;HAP1: 33.8;HEK 293: 12.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002214, HPA055753"	Supported		Approved	Nucleoplasm	"Secreted to extracellular matrix"			Nucleoplasm	Nucleoplasm	"CAB002214: AB_563666, HPA055753: AB_2682908"	"unprognostic (7.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.44e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.08e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.31e-4)"	"unprognostic (2.64e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.02e-1)"	0.0	0.0	0.1	2.2	0.3	0.0	0.7	0.9	0.9	0.0	0.2	0.3	0.0	0.0	0.3	22.7	0.0	0.0	0.0	0.0	0.5	1.3	0.0	0.0	1.4	0.0	0.0	0.7	1.3	0.0	0.0	11.0	0.4	1.9	2.6	0.4	8.1	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	11.3	2.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	33.8	0.0	0.0	0.0	12.5	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.9	0.9	0.5	1.3	0.0	0.7	1.9	0.0
CTXN2		ENSG00000233932	"Cortexin 2"	P0C2S0	15	48178122-48203756	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	5	"brain: 11.3;pituitary gland: 5.7;testis: 4.9"	"Cell line enhanced"	"Detected in single"		"SCLC-21H: 3.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.5"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA053168	Uncertain									"HPA053168: AB_2682066"	"unprognostic (1.90e-1)"			"unprognostic (3.85e-3)"	"unprognostic (7.43e-2)"					"unprognostic (2.18e-4)"	"unprognostic (6.81e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.80e-1)"		"unprognostic (4.61e-2)"			0.5	1.2	6.4	0.7	6.7	0.5	0.6	8.4	9.0	0.5	0.8	0.0	0.0	0.7	0.5	0.6	0.6	1.3	0.7	0.5	4.0	11.3	0.9	0.5	0.6	0.6	7.3	2.9	0.5	1.4	0.6	5.7	0.5	8.8	0.6	0.9	0.0	0.5	0.6	0.6	0.5	1.1	0.6	1.9	0.5	0.6	4.9	1.2	0.0	0.6	0.0	0.6	0.5	0.0	0.0	0.1	0.3	1.5	0.0	0.6	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.0	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	3.6	0.9	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.5	0.1	0.0	0.0	6.4	6.7	8.4	9.0	4.0	11.3	7.3	2.9	8.8	1.2
DLK1	"Delta1, FA1, pG2, Pref-1, ZOG"	ENSG00000185559	"Delta like non-canonical Notch ligand 1"	P80370	14	100725705-100738224	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 157.6;pituitary gland: 143.1;placenta: 244.9"	"Group enriched"	"Detected in some"	6	"AF22: 22.5;Hep G2: 75.2;SH-SY5Y: 89.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 28.1"	"Group enriched"	"Detected in some"	5	"hypothalamus: 2.6;pons and medulla: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"hypothalamus: 65.4"	"Region enhanced"	"Detected in many"		"midbrain: 159.6"	"CAB005872, HPA062262"	Enhanced		Approved	"Golgi apparatus"		160000	160000	"Golgi apparatus"	"Golgi apparatus"	"CAB005872: AB_731965, HPA062262: AB_2684729"	"unprognostic (2.16e-2)"			"prognostic unfavourable (2.31e-4)"	"unprognostic (1.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.89e-3)"	"unprognostic (5.75e-2)"		"unprognostic (1.87e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.24e-1)"		"unprognostic (3.11e-2)"	"unprognostic (6.57e-2)"			0.3	157.6	0.2	0.7	0.8	0.0	0.9	0.0	0.1	0.5	0.0	1.8	0.2	0.2	0.2	4.4	0.3	0.3	0.8	2.7	0.1	2.6	0.1	0.1	0.1	0.1	0.8	0.0	34.9	4.6	0.0	143.1	244.9	6.0	0.2	0.0	0.2	8.2	0.0	2.0	0.1	0.2	0.2	0.3	0.2	0.2	14.2	0.0	0.5	0.0	10.0	1.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	75.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.1	6.3	89.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.2	0.8	0.0	0.0	0.1	2.6	0.8	0.0	6.0	0.0
DNAI1	"CILD1, DIC1, PCD"	ENSG00000122735	"Dynein axonemal intermediate chain 1"	Q9UI46	9	34457414-34520989	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 14.6;fallopian tube: 32.2;pituitary gland: 36.4;testis: 47.0"	"Cell line enhanced"	"Detected in some"		"AF22: 1.8;BEWO: 5.6;HDLM-2: 4.0;RPTEC TERT1: 2.1;SK-BR-3: 2.9;T-47d: 1.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 3.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"HPA021649, HPA021843"	Enhanced									"HPA021649: AB_1847913, HPA021843: AB_1847914"	"unprognostic (9.61e-2)"	"unprognostic (5.16e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.44e-3)"	"unprognostic (3.72e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.39e-2)"	"unprognostic (4.38e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.16e-3)"	"unprognostic (8.14e-2)"	"unprognostic (2.74e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.13e-1)"	0.4	0.4	2.3	0.4	8.0	0.4	0.9	0.3	3.1	2.2	0.4	3.6	0.0	0.4	1.3	6.8	0.4	32.2	0.5	0.4	2.7	3.3	0.9	0.5	4.3	0.4	1.0	0.2	3.5	1.2	1.9	36.4	0.4	14.6	0.5	0.4	1.3	0.4	0.5	0.4	0.4	0.4	0.4	0.6	0.4	0.6	47.0	1.5	0.0	0.5	0.0	0.4	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.1	1.8	0.7	0.2	0.0	5.6	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	2.1	0.0	0.4	0.3	0.0	2.9	0.8	1.9	0.0	0.0	0.0	0.6	0.1	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	8.0	0.3	3.1	2.7	3.3	1.0	0.2	14.6	1.5
DSCAM	"CHD2-42, CHD2-52"	ENSG00000171587	"DS cell adhesion molecule"	O60469	21	40010999-40847139	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 22.2;pituitary gland: 9.1"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 5.4;MCF7: 12.0;NTERA-2: 3.3;SCLC-21H: 5.0;T-47d: 3.3"	"Cancer enriched"	"Detected in single"	14	"glioma: 3.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019324	Enhanced		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA019324: AB_2670118"	"unprognostic (1.47e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.99e-2)"	"unprognostic (9.98e-2)"	"unprognostic (5.49e-4)"	"unprognostic (1.78e-1)"	"unprognostic (9.58e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.85e-3)"	"unprognostic (2.12e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.75e-2)"	"unprognostic (5.46e-3)"	0.9	1.1	12.7	0.9	10.3	0.9	1.2	3.0	22.2	0.9	1.0	8.2	0.0	1.0	0.9	2.8	0.9	1.1	1.0	0.9	10.1	8.6	0.9	1.4	1.0	0.9	6.8	10.1	0.9	1.2	0.9	9.1	2.9	9.5	1.0	1.0	0.7	0.9	1.0	0.9	0.9	1.0	0.9	3.7	2.9	0.9	2.0	6.9	0.0	0.9	0.0	0.9	1.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.5	0.0	0.0	0.0	0.0	12.0	0.0	0.0	3.3	0.0	0.0	0.0	1.8	0.0	0.0	5.0	0.0	0.0	0.1	0.0	3.3	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	12.7	10.3	3.0	14.7	10.1	8.6	6.8	10.1	9.5	6.9
FAM153C	NY-REN-7-like	ENSG00000204677	"Family with sequence similarity 153 member C"	Q494X1	5	178006405-178055559	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"			"Group enriched"	"Detected in many"	5	"brain: 22.5;pituitary gland: 11.8;testis: 21.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.4;Karpas-707: 3.0;MCF7: 2.7;U-2 OS: 3.9"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.7"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA042585, HPA046691, HPA052337"	Uncertain									"HPA042585: AB_2678063, HPA046691: AB_2679754, HPA052337: AB_2681792"	"unprognostic (5.81e-2)"	"unprognostic (3.95e-1)"		"unprognostic (1.38e-1)"	"unprognostic (8.15e-2)"	"unprognostic (2.14e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.99e-2)"		"unprognostic (3.55e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.86e-3)"	"unprognostic (3.23e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.02e-1)"	0.9	1.1	1.2	0.5	3.9	0.7	0.0	22.5	5.1	0.0	0.0			0.1	0.3	2.0	0.5	0.4	0.1	0.0	2.3	0.7	0.0	0.1	1.0	1.2	0.0		2.0	3.6	0.0	11.8	0.0		2.8	0.0		0.6	1.1	0.1	2.1	0.3	0.0	0.0	1.4	0.0	21.9			1.9		0.5	0.0	0.1	1.1	3.0	0.7	0.0	1.8	3.2	0.7	0.0	1.0	0.0	0.0	0.1	0.0	0.4	0.0	0.9	0.3	0.0	0.0	0.4	2.4	0.4	0.0	0.3	0.5	0.0	0.0	0.6	1.4	0.0	0.3	0.0	1.0	0.0	0.5	0.0	0.0	0.1	1.0	0.2	0.4	3.0	0.3	2.7	0.3	0.0	0.3	0.0	1.2	2.1	0.5	0.0	0.7	1.9	0.0	0.2	0.3	0.0	0.4	2.3	0.0	0.0	3.9	0.3	0.0	1.7	0.0	1.4	0.0	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.1	0.9	0.3	0.1	0.0	1.1	3.2	1.9	0.0	1.8	0.0	3.0	2.2	0.7										
GCK	"HK4, MODY2"	ENSG00000106633	Glucokinase	P35557	7	44144271-44198170	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"pituitary gland: 46.8"	"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 12.0"	"Cancer enhanced"	"Detected in some"		"liver cancer: 4.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.4;naive CD4 T-cell: 4.8"	"Group enriched"	"Detected in many"	17	"B-cells: 4.4;T-cells: 4.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA007034, HPA007093"	Approved		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"	"Golgi apparatus, Cytosol"	"HPA007034: AB_1079050, HPA007093: AB_1079051"	"unprognostic (3.09e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.64e-7)"	"unprognostic (8.00e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.48e-2)"	"unprognostic (8.11e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.01e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.53e-1)"	1.1	0.5	3.2	0.7	2.8	0.0	0.7	9.5	3.7	1.4	1.4	1.3	0.7	0.3	1.5	1.5	0.7	2.3	0.9	7.1	2.1	7.5	0.7	8.7	0.7	0.7	2.9	1.2	2.2	2.9	0.0	46.8	3.3	1.6	0.8	0.5	0.8	0.7	1.6	0.7	1.2	0.7	0.7	1.7	0.7	0.9	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.9	4.4	0.2	0.0	0.0	0.0	4.8	0.7	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.2	0.6	0.3	0.0	0.0	0.0	0.1	0.8	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.6	0.9	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	2.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.1	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.6	4.4	1.6	0.4	0.2	0.7	4.8	0.9	0.0	0.0	0.0	0.0	0.0	0.7	3.2	2.8	9.5	2.4	2.1	7.5	2.9	1.2	1.6	0.7
GH1	"GH, GH-N, GHN, hGH-N"	ENSG00000259384	"Growth hormone 1"	P01241	17	63917200-63918838	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"pituitary gland: 994.5"	"Cell line enriched"	"Detected in some"	5	"U-698: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.1;T-reg: 2.2"	"Group enriched"	"Detected in many"	4	"B-cells: 2.1;T-cells: 2.2"									HPA043715	Supported				"Secreted to blood"	180000	180000			"HPA043715: AB_2678632"	"unprognostic (1.91e-2)"							"unprognostic (3.51e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.45e-4)"	"unprognostic (2.48e-1)"	"unprognostic (2.09e-4)"	"unprognostic (2.03e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.33e-1)"		0.3	0.0	0.0	0.5	0.0	1.1	0.2	0.1	0.1	0.4	0.4	0.0	0.0	3.3	1.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.6	0.0	0.0	0.0	0.0	0.3	994.5	217.7	0.1	0.2	0.5	0.0	0.1	0.2	0.8	0.9	0.4	0.1	0.0	1.6	0.3	0.5	0.0	0.0	0.0	0.0	0.6	0.1	0.0	2.1	0.0	0.0	0.5	0.0	2.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	1.5	7.4	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	2.1	0.3	0.0	0.0	0.0	0.5	0.0	2.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0
KNCN	"FLJ32011, KINO, L5"	ENSG00000162456	Kinocilin	A6PVL3	1	46545644-46551527	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"brain: 3.9;pituitary gland: 1.0;testis: 2.5"	"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA046357	Uncertain									"HPA046357: AB_10961149"				"unprognostic (6.99e-3)"	"unprognostic (2.28e-2)"					"unprognostic (2.80e-2)"								0.0	0.5	0.4	0.0	0.1	0.0	0.0	0.0	2.1	0.3	0.0			0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	3.9	0.0	0.0	0.0	0.0	1.6		0.0	0.0	0.0	1.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KSR2	FLJ25965	ENSG00000171435	"Kinase suppressor of ras 2"	Q6VAB6	12	117453012-117968983	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 27.4;pituitary gland: 24.6"	"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 7.2;SCLC-21H: 5.3;TIME: 10.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035536	Enhanced									"HPA035536: AB_10673485"	"unprognostic (1.74e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.29e-2)"	"unprognostic (9.11e-2)"	"unprognostic (8.42e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.10e-2)"	"unprognostic (5.78e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.05e-4)"	"unprognostic (1.19e-1)"	"unprognostic (9.28e-3)"	"unprognostic (5.02e-2)"	"unprognostic (5.68e-2)"	"unprognostic (8.14e-3)"	"unprognostic (5.74e-2)"	0.9	5.0	13.2	1.1	13.8	1.1	1.7	27.4	17.2	1.0	1.9	1.3	2.2	1.0	0.8	2.6	0.9	1.7	1.0	0.8	12.9	4.8	3.5	0.8	1.2	1.6	2.2	10.8	0.8	3.0	0.9	24.6	0.9	7.7	1.3	2.3	0.2	1.2	3.4	0.9	1.0	1.0	0.9	2.9	1.0	1.7	3.2	3.0	0.0	3.8	0.0	1.5	2.3	0.5	0.1	0.2	0.8	0.1	0.2	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	1.1	0.0	0.2	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	1.5	0.1	0.0	0.5	1.2	0.0	0.0	0.1	0.7	1.4	5.3	0.1	0.0	0.0	0.0	1.1	0.0	10.8	0.0	0.8	0.0	0.2	0.9	1.5	0.0	0.4	0.0	0.1	0.5	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.8	0.2	0.1	0.2	0.0	0.0	13.2	13.8	27.4	17.2	12.9	4.8	2.2	10.8	7.7	3.0
LRRTM3		ENSG00000198739	"Leucine rich repeat transmembrane neuronal 3"	Q86VH5	10	66926006-67099830	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 7.3;brain: 29.1;ovary: 8.0;pituitary gland: 26.6"	"Cell line enhanced"	"Detected in some"		"AF22: 3.7;Daudi: 2.2;HAP1: 10.6;NTERA-2: 2.3;RPMI-8226: 1.8"	"Cancer enriched"	"Detected in single"	7	"glioma: 2.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA070444, HPA078598"			Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	Nucleoplasm	"HPA070444: , HPA078598: "					"unprognostic (1.21e-2)"					"unprognostic (4.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.02e-2)"		"unprognostic (1.15e-4)"	"unprognostic (8.11e-2)"		"unprognostic (4.77e-1)"	0.9	7.3	12.9	1.0	18.7	0.9	0.9	19.7	29.1	1.7	0.9	3.2	0.0	1.0	1.2	0.9	1.4	0.9	0.9	0.9	7.0	6.5	1.0	0.9	1.4	0.9	3.7	16.0	8.0	3.7	0.9	26.6	0.9	4.5	1.2	0.9	0.0	1.0	1.2	1.0	0.9	1.1	1.0	2.8	0.9	0.9	1.9	5.9	0.0	0.9	0.0	0.9	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.3	0.4	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	18.7	19.7	21.3	7.0	6.5	3.7	16.0	4.5	5.9
NIM1K	"MGC42105, NIM1"	ENSG00000177453	"NIM1 serine/threonine protein kinase"	Q8IY84	5	43192071-43280850	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"brain: 23.7;pituitary gland: 9.7"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 4.4;HDLM-2: 4.8;PC-3: 5.5;U-87 MG: 6.0"	"Cancer enriched"	"Detected in some"	11	"glioma: 6.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.2"	"Group enriched"	"Detected in many"	10	"dendritic cells: 1.2;T-cells: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007695	Uncertain		Approved	Cytosol				Cytosol	Cytosol	"HPA007695: AB_2667897"	"unprognostic (7.97e-2)"	"unprognostic (9.79e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.28e-2)"	"unprognostic (8.84e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.55e-5)"	"unprognostic (2.18e-1)"	"unprognostic (2.66e-1)"	"unprognostic (6.46e-3)"	"unprognostic (4.98e-3)"	1.4	3.5	9.4	1.6	10.9	0.9	1.3	4.9	23.7	1.6	1.4	6.3	0.0	1.1	1.2	1.6	1.6	1.4	1.5	1.8	8.7	7.7	1.4	1.2	3.6	1.2	5.6	5.8	1.2	1.5	1.2	9.7	1.8	6.4	1.4	1.7	1.7	2.3	2.4	2.0	1.8	1.2	1.3	4.9	1.0	3.0	1.4	8.1	0.0	2.7	0.0	1.0	1.1	0.8	0.1	1.2	0.0	0.0	0.2	3.2	0.0	0.2	0.6	0.1	0.1	0.9	0.5	0.0	1.0	3.1	1.1	4.4	0.1	0.0	0.4	0.6	0.8	0.3	0.6	0.0	2.7	4.8	0.3	0.1	0.6	0.2	1.6	0.2	0.6	1.9	0.1	0.5	0.0	0.0	0.2	0.3	0.9	0.2	0.3	0.2	0.0	5.5	0.2	0.3	0.5	0.1	0.7	0.9	0.1	1.7	0.5	0.3	0.4	1.5	0.0	0.9	0.8	0.7	0.7	1.6	0.4	0.3	6.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	1.2	3.2	0.0	9.4	10.9	4.9	11.6	8.7	7.7	5.6	5.8	6.4	8.1
OR10G3		ENSG00000169208	"Olfactory receptor family 10 subfamily G member 3"	Q8NGC4	14	21568520-21580076	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	5	"blood: 3.4;bone marrow: 2.0;pituitary gland: 4.3;skin 1: 1.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.1"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"neutrophil: 3.4"	"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			HPA019766	Uncertain									"HPA019766: AB_1854780"																		0.3	0.4	0.0	0.2	0.0	2.0	0.2	0.0	0.2	0.1	0.1			0.0	0.3	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0		0.1	0.0	0.1	4.3	0.0		0.0	0.1		0.0	0.0	0.2	1.2	0.6	0.0	0.0	0.1	0.2	0.6			0.1		0.0	0.0	0.0	1.0	0.9	3.4	1.0	0.7	0.7	0.0	0.1	0.0	0.7	0.7	0.0	0.0	0.6	0.5	0.0	0.0	0.0	2.1	0.6	0.8	0.1	0.0	0.4	0.7	0.0	0.3	0.6	0.0	0.0	0.8	0.0	0.0	0.7	0.3	0.0	0.0	0.0	1.0	0.4	0.1	0.4	0.4	0.0	0.6	0.4	0.6	0.5	0.2	0.0	0.0	0.0	0.3	0.1	0.4	0.0	0.0	1.0	1.2	0.0	0.0	0.9	0.6	0.9	0.1	0.2	0.2	0.2	0.6	0.5	0.3	0.9	1.0	0.5	0.6	0.2	0.3	0.4	0.5	0.4	0.2	1.0	0.7	0.5	3.4	0.7	0.3	0.9	0.3	0.0										
OR3A2	"OLFRA04, OR17-228, OR228"	ENSG00000221882	"Olfactory receptor family 3 subfamily A member 2"	P47893	17	3276942-3386317	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"blood: 3.6;brain: 8.6;lymphoid tissue: 6.5;pituitary gland: 5.5;testis: 10.9"	"Cell line enriched"	"Detected in some"	6	"HDLM-2: 15.4"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"																						"unprognostic (7.58e-2)"				"unprognostic (5.10e-2)"						"unprognostic (6.89e-2)"		"unprognostic (1.12e-1)"		"unprognostic (1.32e-1)"			0.5	0.5	2.2	0.5	8.6	0.5	0.6	0.4	2.8	0.6	0.4	1.2	0.0	0.4	0.5	1.5	0.4	0.3	0.2	0.4	2.5	1.2	0.5	0.3	0.8	6.5	1.4	0.6	1.0	0.4	0.2	5.5	1.0	2.7	0.7	0.4	1.3	0.3	0.5	0.8	0.6	0.5	0.4	1.9	0.9	0.4	10.9	2.1	2.3	0.3	0.0	0.7	0.6	0.4	3.0	3.4	3.6	0.6	0.7	1.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	15.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.6	0.6	0.7	0.9	0.3	1.6	3.0	1.2	0.3	0.8	0.8	1.2	1.8	1.6	0.7	0.4	3.4	0.5	0.8	2.2	8.6	0.4	2.8	2.5	1.2	1.4	0.6	2.7	2.1
RTBDN	FLJ36353	ENSG00000132026	Retbindin	Q9BSG5	19	12825478-12835428	"Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 17.3;pituitary gland: 25.8;retina: 57.0"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 8.0;SH-SY5Y: 5.3;U-266/84: 20.6;U-87 MG: 4.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 1.7;neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"							"Not detected"	"Not detected"			HPA052511			Approved	"Endoplasmic reticulum"	"Secreted in other tissues"			"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA052511: AB_2797243"	"unprognostic (4.55e-4)"	"unprognostic (3.94e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.54e-4)"	"unprognostic (3.33e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.55e-1)"	"unprognostic (6.48e-2)"	"unprognostic (7.04e-3)"	"unprognostic (7.66e-9)"	"unprognostic (3.55e-2)"	"unprognostic (1.00e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.24e-2)"	0.3	6.9	10.2	0.5	3.4	0.9	0.3	2.7	17.3	0.2	0.9	0.4	0.0	1.0	0.3	1.5	0.3	0.3	0.4	0.3	7.3	5.1	0.2	0.4	0.5	0.4	2.8	2.8	0.3	2.5	0.2	25.8	0.3	4.0	0.4	0.9	57.0	0.3	0.3	0.3	0.5	1.0	0.6	1.0	0.4	2.5	3.5	0.0	7.0	0.4	0.0	0.4	0.3	0.0	0.3	0.2	1.8	0.2	0.4	0.2	0.0	0.9	0.1	0.1	0.6	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.3	0.1	0.8	0.9	0.0	0.2	0.3	0.0	0.0	0.1	0.1	0.0	0.4	0.8	0.0	0.1	2.3	0.0	0.0	0.4	0.2	0.0	1.2	2.6	0.0	0.1	0.0	0.0	0.9	1.1	0.7	0.1	1.0	0.0	0.0	8.0	5.3	0.1	0.1	0.4	2.7	0.7	0.0	0.8	1.0	0.7	0.1	1.2	20.6	3.9	4.7	0.0	0.0	1.7	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.3	0.2	0.2	1.8	0.4	0.2	0.2	0.1	0.0	10.2	3.4	2.7	8.6	7.3	5.1	2.8	2.8	4.0	0.0
RXFP3	"GPCR135, RLN3R1, RXFPR3, SALPR"	ENSG00000182631	"Relaxin/insulin like family peptide receptor 3"	Q9NSD7	5	33936386-33938237	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"adrenal gland: 3.1;brain: 1.1;pancreas: 1.7;pituitary gland: 1.1"	"Cell line enhanced"	"Detected in single"		"RPTEC TERT1: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA027833	Uncertain									"HPA027833: AB_1849247"	"unprognostic (1.93e-2)"					"unprognostic (3.66e-1)"		"unprognostic (2.89e-1)"		"unprognostic (2.86e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.72e-1)"		"unprognostic (8.67e-3)"				0.0	3.1	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3		0.0	1.7	0.0	1.1	0.0		0.0	0.0		0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SCN3A	Nav1.3	ENSG00000153253	"Sodium voltage-gated channel alpha subunit 3"	Q9NY46	2	165087522-165204067	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 13.6;brain: 28.5;pituitary gland: 13.7"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 8.5;MOLT-4: 24.1;RPTEC TERT1: 12.1;SH-SY5Y: 5.4"	"Cancer enriched"	"Detected in some"	6	"glioma: 3.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	31	"memory B-cell: 8.4;naive B-cell: 13.6"	"Lineage enriched"	"Detected in single"	38	"B-cells: 13.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035396	Approved									"HPA035396: AB_2674607"	"unprognostic (1.80e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.50e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.96e-4)"	"unprognostic (2.46e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.21e-4)"	"unprognostic (4.55e-2)"	"unprognostic (5.87e-3)"	"unprognostic (2.88e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.93e-2)"	2.6	4.0	16.7	1.9	28.5	1.0	2.5	19.6	19.7	2.1	2.1	0.8	0.0	1.2	1.4	0.7	1.5	1.4	1.8	2.1	9.8	11.3	1.8	1.0	1.0	2.7	4.8	9.8	1.8	1.7	2.3	13.7	0.8	9.1	0.9	2.1	0.0	0.7	1.4	0.9	0.5	1.9	1.7	4.0	1.8	2.7	1.8	4.9	2.0	1.3	0.0	3.5	1.7	0.5	13.6	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.1	2.3	0.0	0.0	0.1	0.0	0.0	0.2	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.1	0.0	24.1	0.0	0.0	2.0	0.1	1.1	0.0	12.1	0.0	3.1	5.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.7	0.0	1.3	0.4	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	13.6	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.1	16.7	28.5	19.6	17.2	9.8	11.3	4.8	9.8	9.1	4.9
SGCZ	ZSG1	ENSG00000185053	"Sarcoglycan zeta"	Q96LD1	8	14089864-15238339	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 21.2;ovary: 11.3;pituitary gland: 7.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.2;REH: 2.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in all"	4	"amygdala: 5.6;basal ganglia: 9.5;cerebellum: 21.2;cerebral cortex: 6.8;pons and medulla: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							HPA017585	Uncertain									"HPA017585: AB_1856799"					"unprognostic (3.83e-1)"						"unprognostic (1.41e-1)"			"unprognostic (5.87e-4)"	"unprognostic (1.21e-1)"			1.1	0.4	5.6	0.5	9.5	0.6	2.6	21.2	6.8	0.8	0.7	0.0	0.0	0.7	0.9	1.4	0.4	0.5	0.7	0.5	1.4	2.2	1.0	0.7	0.4	0.4	1.3	2.3	11.3	0.7	0.4	7.3	0.5	5.3	0.8	0.5	0.1	0.4	0.6	0.4	0.9	0.5	0.9	3.2	0.5	0.7	1.4	1.1	0.0	0.4	0.0	0.5	1.5	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	5.6	9.5	21.2	6.8	1.4	2.2	1.3	2.3	5.3	1.1
TMEM130	"DKFZp761L1417, FLJ42643"	ENSG00000166448	"Transmembrane protein 130"	Q8N3G9	7	98846488-98870771	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 28.2;brain: 82.2;pituitary gland: 24.0;testis: 26.4"	"Cell line enhanced"	"Detected in some"		"BJ: 3.9;BJ hTERT+: 8.8;EFO-21: 8.6;NTERA-2: 5.1;SH-SY5Y: 10.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 9.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012928	Approved		Supported	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA012928: AB_1858085"	"unprognostic (1.36e-2)"	"unprognostic (1.33e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.97e-1)"	"prognostic favourable (7.84e-4)"	"unprognostic (1.07e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.86e-3)"	"unprognostic (7.90e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.73e-1)"	1.3	28.2	27.3	2.0	53.8	1.4	1.8	14.1	82.2	3.5	1.8	2.8	0.0	1.6	1.8	8.0	2.2	1.7	2.2	1.4	29.3	47.0	2.8	1.1	5.4	2.4	13.4	35.1	1.7	1.6	1.5	24.0	1.3	25.8	2.7	1.9	1.0	1.3	6.2	2.1	1.3	2.1	1.6	9.2	1.4	1.4	26.4	3.9	0.1	1.4	0.0	1.2	1.7	1.2	1.0	0.6	4.8	0.9	1.0	0.7	0.3	0.0	0.7	0.0	0.0	0.3	0.0	0.2	3.9	8.8	0.7	0.6	0.1	0.1	0.1	8.6	2.2	0.1	0.0	0.0	0.1	0.2	0.4	0.1	0.3	0.2	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.4	0.2	0.7	0.4	0.7	0.2	0.2	5.1	0.0	0.2	0.0	0.8	0.1	0.0	0.6	10.5	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.2	0.4	0.3	0.1	0.4	0.5	0.2	2.2	0.9	0.6	0.5	0.4	0.4	0.7	0.5	0.4	0.2	1.0	0.7	0.6	4.8	1.0	0.6	0.6	0.4	0.3	27.3	53.8	14.1	44.2	29.3	47.0	13.4	35.1	25.8	3.9
TMEM179	"C14orf90, FLJ42486, TMEM179A"	ENSG00000258986	"Transmembrane protein 179"	Q6ZVK1	14	104474678-104605647	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 20.2;brain: 30.4;pituitary gland: 23.0"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 6.4;SCLC-21H: 27.6;SH-SY5Y: 8.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002942			Uncertain	Mitochondria				Mitochondria	Mitochondria	"HPA002942: "	"unprognostic (8.65e-2)"	"unprognostic (8.24e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.89e-4)"	"unprognostic (8.68e-3)"	"unprognostic (1.56e-1)"	"unprognostic (9.71e-6)"	"unprognostic (1.70e-2)"	1.1	20.2	11.8	1.5	18.9	0.9	0.9	10.3	30.4	1.0	1.8	3.4	0.0	1.4	1.0	1.6	1.1	1.1	1.1	1.2	12.4	21.7	1.0	1.1	0.9	0.9	13.7	7.2	1.0	4.8	1.0	23.0	2.3	8.3	1.4	1.4	2.2	1.1	1.3	1.0	1.0	1.8	1.4	6.1	0.9	1.8	3.1	4.5	0.0	1.0	0.0	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.1	0.0	0.0	27.6	8.7	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	18.9	10.3	16.7	12.4	21.7	13.7	7.2	8.3	4.5
TRHR		ENSG00000174417	"Thyrotropin releasing hormone receptor"	P34981	8	109086621-109119584	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"brain: 1.0;pituitary gland: 3.3;thyroid gland: 1.6"	"Cell line enhanced"	"Detected in some"		"PC-3: 1.6;SH-SY5Y: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA055162	Approved									"HPA055162: AB_2732592"										"unprognostic (1.92e-2)"				"unprognostic (8.58e-2)"		"unprognostic (1.17e-1)"		0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	1.0	0.0	0.2			0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	3.3	0.0		0.0	0.3		0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0			1.6		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	1.6	0.0	0.4	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.3	0.2	0.3	0.5	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
UCN3	"SPC, UCNIII"	ENSG00000178473	"Urocortin 3"	Q969E3	10	5365009-5374692	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 14.9;pancreas: 10.6;pituitary gland: 5.6;stomach 1: 4.6"	"Cell line enriched"	"Detected in single"	8	"SCLC-21H: 5.4"	"Group enriched"	"Detected in many"	5	"lung cancer: 5.1;pancreatic cancer: 15.4;stomach cancer: 3.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"hypothalamus: 5.9"	"Region enriched"	"Detected in single"	7	"hypothalamus: 4.7"	HPA038281	Uncertain				"Secreted to blood"					"HPA038281: AB_10672408"			"unprognostic (2.00e-2)"	"unprognostic (2.31e-1)"				"unprognostic (1.60e-1)"		"unprognostic (2.10e-1)"	"unprognostic (3.18e-3)"	"unprognostic (8.42e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.91e-2)"				0.1	0.9	0.1	0.1	0.4	0.0	0.1	0.4	0.4	0.1	14.4	0.1	0.1	11.6	0.1	0.1	0.1	1.2	1.2	0.1	0.1	1.7	0.8	0.1	1.3	0.1	0.1	0.5	0.1	10.6	0.0	5.6	0.1	1.6	0.2	3.1	0.3	0.1	0.1	0.1	0.0	14.9	0.1	0.5	0.1	4.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.0	5.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.4	0.4	0.1	1.7	0.1	0.5	1.6	0.1
VWDE	FLJ14712	ENSG00000146530	"Von Willebrand factor D and EGF domains"	Q8N2E2	7	12330885-12403941	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"pituitary gland: 29.5"	"Cell line enhanced"	"Detected in many"		"K-562: 10.6;NTERA-2: 5.3;SCLC-21H: 8.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"HPA026619, HPA036044"	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"			Cytosol	Cytosol	"HPA026619: AB_2671920, HPA036044: AB_2674916"	"unprognostic (6.39e-2)"	"unprognostic (1.65e-3)"	"unprognostic (5.36e-3)"	"unprognostic (1.78e-4)"	"unprognostic (1.39e-2)"	"unprognostic (4.19e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.73e-1)"	0.4	0.5	1.6	0.3	2.7	2.3	2.3	0.4	2.3	0.8	0.9	0.0	0.9	0.2	0.7	4.9	0.8	1.5	0.7	4.1	0.8	0.5	0.7	0.5	0.7	0.2	0.4	0.5	0.5	0.9	0.0	29.5	0.3	0.5	1.5	0.3	0.1	5.7	5.5	0.4	0.6	0.6	0.2	0.4	0.5	2.0	0.6	0.0	0.1	6.2	0.0	1.3	1.0	0.9	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.6	0.0	0.5	0.0	0.3	1.7	0.0	2.0	0.7	0.8	0.4	3.0	0.2	0.0	0.0	0.4	2.1	1.9	0.6	3.9	2.2	3.5	4.7	0.0	0.0	1.0	2.3	0.1	0.3	0.0	1.2	0.8	10.6	0.0	0.0	1.2	0.0	0.0	5.3	0.6	0.0	0.0	1.6	0.0	1.3	8.5	1.3	0.0	1.7	0.0	0.0	1.1	0.1	0.0	1.0	0.0	0.8	3.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.9	0.1	1.6	2.7	0.4	2.3	0.8	0.5	0.4	0.5	0.5	0.0
AC026786.1		ENSG00000256825			12	133130984-133202369	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in many"	4	"pituitary gland: 21.5"	"Cell line enhanced"	"Detected in some"		"A549: 1.5;BJ: 1.6;CACO-2: 3.6;TIME: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 1.8"	"Low lineage specificity"	"Detected in many"																																							1.4	1.5	1.5	1.3	3.3	1.3	1.3	3.9	2.7	2.1	1.4	1.9	4.5	1.3	3.7	4.4	1.9	1.6	2.7	1.6	1.5	1.4	1.4	1.9	2.0	1.3	2.1	1.3	3.2	1.5	1.3	21.5	1.3	2.1	1.8	1.3	2.3	1.4	5.3	2.4	1.8	1.3	3.6	2.2	1.5	1.4	5.3	1.9	1.4	2.4	0.8	1.3	1.4	1.4	0.3	1.8	0.0	0.7	0.0	1.3	0.2	0.4	1.5	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	3.6	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.3	0.3	0.2	1.3	0.0	0.0	0.0	0.7	0.0	0.0	0.7	1.8	0.1	0.2	1.5	3.3	3.9	2.7	1.5	1.4	2.1	1.3	2.1	1.9
AC117457.1		ENSG00000275163			3	178419123-178843300	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	4	"brain: 11.1;epididymis: 11.8;fallopian tube: 12.2;kidney: 5.2;pituitary gland: 19.9"	"Cell line enriched"	"Detected in single"	14	"HSkMC: 5.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.1	0.0	0.1	2.9	0.0	0.0	0.0	11.8	0.0	12.2	0.3	0.2	0.3		5.2	0.2	1.5	0.0	0.0	0.0	2.6	2.9	0.0	19.9	0.0	11.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0										
ADGRB3	"BAI3, KIAA0550"	ENSG00000135298	"Adhesion G protein-coupled receptor B3"	O60242	6	68635367-69389511	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 55.0;pituitary gland: 17.1"	"Group enriched"	"Detected in some"	5	"SCLC-21H: 9.1;SH-SY5Y: 19.6"	"Cancer enriched"	"Detected in single"	10	"glioma: 3.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"plasmacytoid DC: 2.6"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									9200	9200				"unprognostic (1.71e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.72e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.08e-5)"	"unprognostic (4.93e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.16e-3)"	2.7	8.0	20.0	2.8	22.5	1.5	2.1	46.9	55.0	3.1	3.4	6.2	0.0	2.2	5.2	3.1	2.7	2.4	3.0	3.2	17.6	15.2	2.4	2.4	3.6	1.6	9.0	22.7	4.3	1.9	1.8	17.1	1.8	9.6	2.6	3.6	1.2	3.2	3.9	1.9	1.9	3.2	6.7	10.1	2.4	1.9	4.4	11.1	0.0	2.1	0.0	1.6	2.9	1.8	0.0	2.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	1.0	0.0	1.2	1.0	0.0	0.0	9.1	19.6	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	20.0	22.5	46.9	25.1	17.6	15.2	9.0	22.7	9.6	11.1
BPIFA1	"bA49G10.5, LUNX, PLUNC, SPLUNC1"	ENSG00000198183	"BPI fold containing family A member 1"	Q9NP55	20	33235995-33243311	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix, uterine: 8.0;lung: 20.2;lymphoid tissue: 25.2;pituitary gland: 16.9;tongue: 11.9"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 1.3;NTERA-2: 2.2;REH: 1.2;U-266/70: 1.6"	"Cancer enriched"	"Detected in many"	27	"lung cancer: 262.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			CAB025669	Supported				"Secreted in other tissues"	1200000	1200000			"CAB025669: "						"unprognostic (1.06e-1)"		"unprognostic (1.53e-1)"						"unprognostic (3.65e-1)"		"unprognostic (1.80e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	11.9	25.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	2.2	0.0	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C1QTNF8	"CTRP8, UNQ5829"	ENSG00000184471	"C1q and TNF related 8"	P60827	16	1090005-1096244	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 2.6;brain: 2.1;fallopian tube: 4.5;pituitary gland: 4.1"	"Cell line enhanced"	"Detected in single"		"A549: 1.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in some"			HPA056438	Uncertain				"Secreted - unknown location"					"HPA056438: AB_2683134"			"unprognostic (8.65e-2)"		"unprognostic (2.56e-2)"									"unprognostic (5.46e-2)"				0.0	2.6	0.7	0.0	1.7	0.0	0.0	0.0	0.5	0.1	0.0			0.2	0.0	0.0	0.0	4.5	0.0	0.0	0.8	2.1	0.1	0.0	0.3	0.0	0.4		0.0	0.0	0.0	4.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.2	0.8			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CCNB3		ENSG00000147082	"Cyclin B3"	Q8WWL7	X	50202713-50351910	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 6.1;epididymis: 11.6;pituitary gland: 3.7;testis: 14.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.8;Karpas-707: 3.9;U-2 OS: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdTCR: 2.2"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			HPA000496			Supported	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA000496: AB_1078605"	"unprognostic (1.57e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.96e-3)"	"unprognostic (8.11e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.48e-3)"	"unprognostic (6.93e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.63e-2)"	0.7	0.7	0.9	0.3	3.5	0.2	0.8	0.4	1.7	0.4	0.4	5.8	0.0	0.4	0.3	11.6	0.4	0.7	0.6	0.6	1.3	1.5	0.7	1.1	0.7	0.4	2.4	2.0	0.4	0.9	0.7	3.7	0.9	4.3	0.5	0.4	0.0	0.5	0.8	1.4	1.0	0.3	0.3	6.1	0.6	1.0	14.8	1.3	0.1	0.9	1.1	0.5	0.4	0.2	0.3	0.3	0.0	0.5	0.0	2.2	0.1	0.4	1.5	0.8	0.5	0.2	0.2	0.0	0.1	0.3	0.3	0.4	1.2	4.8	1.4	1.0	0.3	0.2	0.7	0.5	0.3	1.2	1.6	1.0	0.0	0.0	1.3	1.1	1.0	0.8	0.2	0.3	0.9	0.5	0.2	3.9	1.2	0.0	0.6	0.2	0.7	0.1	0.0	1.7	0.1	0.2	0.5	0.1	0.9	0.4	0.2	1.0	3.4	0.3	0.4	2.0	3.5	0.9	0.6	1.0	0.7	2.1	0.6	0.4	0.3	0.0	0.0	0.0	2.2	0.5	0.3	0.3	0.5	0.0	0.3	0.3	0.4	1.0	0.0	0.0	0.3	0.0	0.1	0.1	0.9	3.5	0.4	1.7	1.3	1.5	2.4	2.0	4.3	1.3
CDK5R2	"NCK5AI, P39, p39nck5ai"	ENSG00000171450	"Cyclin dependent kinase 5 regulatory subunit 2"	Q13319	2	218959655-218962162	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 48.6;pituitary gland: 14.3"	"Group enriched"	"Detected in some"	9	"SCLC-21H: 18.2;SH-SY5Y: 13.2"	"Cancer enhanced"	"Detected in some"		"glioma: 3.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.96e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.85e-5)"	"unprognostic (1.73e-6)"	"unprognostic (3.67e-2)"	"unprognostic (2.83e-4)"		"unprognostic (1.27e-3)"	"unprognostic (7.21e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.71e-3)"	"unprognostic (3.53e-3)"	"unprognostic (2.34e-10)"	"unprognostic (1.54e-1)"	"unprognostic (1.64e-4)"		"unprognostic (6.46e-2)"	1.2	7.0	13.2	1.6	26.0	1.2	1.2	8.3	48.6	1.2	1.5	2.2	0.0	1.7	1.2	1.2	1.2	1.2	1.2	1.2	16.5	14.4	1.2	1.2	1.2	1.2	10.0	11.9	1.2	2.6	1.2	14.3	1.2	13.8	1.2	1.4	4.4	1.2	1.2	1.2	1.2	1.8	1.3	1.6	1.2	2.7	1.6	2.0	0.0	1.2	0.0	1.2	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	18.2	13.2	0.7	0.0	0.1	0.0	0.0	0.0	0.2	1.4	0.0	0.3	0.0	0.0	0.0	0.6	0.1	1.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	26.0	8.3	42.2	16.5	14.4	10.0	11.9	13.8	2.0
CLVS1	"C6orf212L, CRALBPL, MGC34646, RLBP1L1"	ENSG00000177182	"Clavesin 1"	Q8IUQ0	8	61057158-61501645	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 33.8;pituitary gland: 10.3"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 8.2;SH-SY5Y: 3.6;U-266/70: 3.6"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076650	Approved									"HPA076650: "	"unprognostic (1.86e-2)"	"unprognostic (3.09e-4)"	"unprognostic (2.79e-1)"	"unprognostic (2.96e-7)"	"unprognostic (1.11e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.99e-1)"	"unprognostic (8.02e-4)"	"unprognostic (2.23e-1)"	"unprognostic (8.44e-3)"	"unprognostic (7.25e-3)"	"unprognostic (2.94e-1)"	"unprognostic (5.79e-8)"	"unprognostic (2.49e-1)"	"unprognostic (3.19e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.14e-2)"	4.0	1.1	9.7	1.3	20.5	1.1	1.9	33.8	16.8	0.7	1.0	2.3	0.0	0.9	0.6	0.7	4.4	1.8	1.3	1.4	5.9	7.7	0.7	0.8	1.0	1.6	4.4	8.0	0.7	0.5	0.5	10.3	0.8	10.2	1.1	0.8	0.5	3.3	0.6	1.6	4.1	1.2	0.6	2.3	1.5	0.8	5.3	3.7	0.0	3.7	0.0	2.6	0.7	0.4	2.2	1.2	4.3	1.2	2.6	1.4	0.7	0.4	0.8	0.4	1.3	0.4	0.1	0.1	0.4	0.0	0.0	0.3	0.4	0.3	3.1	0.0	0.0	0.6	0.0	0.5	0.2	0.4	0.8	0.2	0.6	0.2	0.0	0.3	0.8	0.0	0.0	0.4	0.3	0.2	0.0	0.8	0.0	0.2	0.3	1.1	1.7	0.6	2.7	2.2	0.3	0.9	0.1	8.2	3.6	0.3	0.4	0.0	0.6	1.1	0.7	0.5	0.5	0.3	0.4	3.6	1.6	0.6	2.1	0.2	0.1	2.7	1.2	0.8	1.0	0.9	0.6	1.3	1.1	0.7	0.2	2.2	0.7	1.4	4.3	2.6	0.6	1.2	0.3	0.7	9.7	20.5	33.8	13.7	5.9	7.7	4.4	8.0	10.2	3.7
COL11A2	"DFNA13, DFNB53, HKE5"	ENSG00000204248	"Collagen type XI alpha 2 chain"	P13942	6	33162681-33192499	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"pituitary gland: 28.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.0;HMC-1: 2.1;U-266/70: 2.3;U-698: 2.9"	"Cancer enriched"	"Detected in many"	8	"melanoma: 13.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"	720000	720000				"unprognostic (4.62e-1)"	"unprognostic (8.69e-2)"	"unprognostic (1.65e-4)"	"unprognostic (5.15e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.26e-6)"	"unprognostic (8.27e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.96e-2)"	1.6	0.7	0.8	0.6	1.5	0.2	0.4	6.6	2.8	1.2	0.4	2.5	0.1	1.2	0.6	1.2	0.4	0.3	0.5	1.6	1.1	0.9	0.4	0.8	0.7	0.3	2.7	0.1	0.5	1.7	0.2	28.8	0.5	1.7	0.8	0.2	2.6	2.2	0.6	2.5	1.6	1.5	0.9	2.2	0.8	3.5	4.5	1.8	1.1	2.1	0.9	0.6	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.9	0.3	0.2	0.0	0.0	0.5	0.0	0.0	0.5	0.1	0.1	0.2	0.1	2.0	0.3	1.6	0.9	0.2	0.2	0.0	0.0	0.5	0.3	0.2	0.4	0.0	0.0	0.0	0.3	2.1	0.3	0.0	0.1	0.1	0.1	0.5	0.8	0.1	0.3	0.0	0.6	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	1.4	1.2	0.4	0.2	0.8	1.5	0.0	0.1	2.3	1.7	2.9	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.4	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.8	1.5	6.6	1.2	1.1	0.9	2.7	0.1	1.7	1.8
CRYBA2		ENSG00000163499	"Crystallin beta A2"	P53672	2	218990189-218993421	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 4.6;intestine: 5.8;pancreas: 16.2;pituitary gland: 12.2;stomach 1: 6.1"	"Cell line enriched"	"Detected in some"	7	"BEWO: 39.9"	"Cancer enriched"	"Detected in some"	15	"pancreatic cancer: 16.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062293	Supported									"HPA062293: AB_2732680"	"unprognostic (5.29e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.19e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.75e-1)"		"prognostic favourable (7.62e-4)"	"unprognostic (2.91e-1)"		"unprognostic (1.90e-1)"	"unprognostic (2.19e-1)"			0.3	4.6	0.3	0.3	2.0	0.0	0.3	0.3	0.8	0.3	5.8	0.3	0.3	3.5	0.3	0.3	0.3	0.0	0.3	0.3	0.6	0.5	0.3	0.3	0.3	0.3	0.6	0.3	0.3	16.2	0.1	12.2	0.3	0.7	0.5	2.8	0.8	0.3	0.3	0.3	0.1	4.7	0.3	0.3	0.3	6.1	1.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	39.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	5.8	1.4	1.1	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.0	0.3	0.8	0.6	0.5	0.6	0.3	0.7	0.3
FAM133A	"CT115, FLJ37659, RP1-32F7.2"	ENSG00000179083	"Family with sequence similarity 133 member A"	Q8N9E0	X	93674013-93712274	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"brain: 14.8;pituitary gland: 8.2;testis: 16.1"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 21.8;U-2197: 11.3;U-266/70: 17.0;U-266/84: 37.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA066175, HPA069513"			Uncertain	Nucleoplasm,Nucleoli				Nucleoli	Nucleoli	"HPA066175: AB_2685629, HPA069513: AB_2686143"	"unprognostic (1.75e-1)"	"unprognostic (1.21e-1)"		"unprognostic (1.67e-3)"	"unprognostic (4.45e-1)"	"unprognostic (4.05e-2)"	"unprognostic (3.86e-3)"	"unprognostic (4.22e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.39e-2)"	"unprognostic (7.12e-4)"	"unprognostic (1.67e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.99e-3)"	0.5	3.0	4.7	0.4	14.8	0.3	0.8	2.3	7.7	1.7	0.5	0.5	0.0	0.4	1.0	0.8	0.4	1.1	0.7	2.2	2.5	4.5	0.4	0.4	0.5	0.4	2.3	4.4	1.4	0.4	0.4	8.2	0.4	3.7	0.4	0.5	0.2	0.4	0.5	0.3	0.6	0.5	0.8	4.5	0.5	0.4	16.1	2.6	0.0	0.9	0.0	0.3	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	21.8	0.0	0.0	0.0	0.0	0.5	5.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.4	0.5	11.3	0.4	17.0	37.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	14.8	2.3	7.3	2.5	4.5	2.3	4.4	3.7	2.6
FFAR4	"GPR120, GPR129, O3FAR1, PGR4"	ENSG00000186188	"Free fatty acid receptor 4"	Q5NUL3	10	93566665-93604480	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"intestine: 15.8;lung: 11.7;pituitary gland: 39.2"	"Cell line enhanced"	"Detected in some"		"A549: 3.3;CACO-2: 2.7;HaCaT: 5.5;NB-4: 6.1"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 4.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA042563			Uncertain	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA042563: AB_10794762"	"unprognostic (1.96e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.14e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.98e-4)"	"unprognostic (1.41e-3)"	"unprognostic (1.20e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.87e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.85e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.49e-1)"	5.2	0.6	1.8	2.8	1.7	0.2	1.9	0.1	2.6	0.2	11.3	1.1	0.0	0.7	0.1	0.1	0.4	1.4	2.6	1.2	0.9	1.6	0.3	0.6	11.7	1.3	0.6	1.0	0.3	1.1	0.1	39.2	0.4	0.8	0.2	15.8	0.3	0.9	0.1	0.5	1.3	1.0	0.3	2.6	0.2	0.7	2.0	0.9	0.7	0.2	0.0	0.6	0.3	0.2	0.5	3.4	1.3	3.0	0.7	0.3	0.8	0.1	3.3	0.1	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.0	2.7	0.8	0.2	0.5	0.0	5.5	0.0	0.0	0.0	0.4	0.1	0.0	0.5	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	6.1	0.3	0.0	0.1	0.1	0.0	0.0	0.4	0.4	0.1	0.1	0.1	0.0	1.1	0.2	0.3	0.1	0.2	0.3	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.9	3.0	0.2	0.3	0.6	0.2	0.4	0.2	0.2	3.4	0.5	0.2	0.3	1.3	0.7	0.4	0.4	0.1	0.8	1.8	1.7	0.1	2.6	0.9	1.6	0.6	1.0	0.8	0.9
GABRB1		ENSG00000163288	"Gamma-aminobutyric acid type A receptor beta1 subunit"	P18505	4	46993723-47426444	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 34.5;pituitary gland: 14.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.3;REH: 4.1;SCLC-21H: 1.1;U-87 MG: 6.7"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051297	Uncertain									"HPA051297: AB_2681427"	"unprognostic (3.11e-2)"		"unprognostic (7.56e-3)"		"unprognostic (5.10e-2)"	"unprognostic (1.83e-1)"			"unprognostic (1.11e-1)"		"unprognostic (4.98e-3)"		"unprognostic (8.16e-3)"	"unprognostic (6.22e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.34e-1)"		1.0	1.3	19.9	1.0	34.5	0.9	1.0	14.7	27.9	1.0	1.2	2.7	0.0	1.6	1.2	1.0	1.0	1.2	1.2	6.0	16.3	4.2	1.8	1.1	1.1	0.9	2.8	18.5	1.1	0.9	0.9	14.7	1.3	5.6	1.0	1.2	0.0	0.9	0.9	0.9	0.9	1.3	1.0	3.4	1.0	1.0	1.1	6.7	0.0	1.3	0.0	0.9	0.9	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.6	0.0	0.0	0.0	6.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	34.5	14.7	16.6	16.3	4.2	2.8	18.5	5.6	6.7
GLRA3		ENSG00000145451	"Glycine receptor alpha 3"	O75311	4	174636914-174829314	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"brain: 15.2;breast: 6.1;pituitary gland: 12.5"	"Group enriched"	"Detected in some"	5	"HEL: 2.6;Karpas-707: 6.2;U-698: 2.2"	"Cancer enhanced"	"Detected in single"		"breast cancer: 1.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"														"unprognostic (2.75e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.78e-2)"		"unprognostic (1.36e-1)"	"unprognostic (9.02e-2)"		"unprognostic (3.82e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.64e-5)"	"unprognostic (4.61e-4)"	"unprognostic (2.24e-1)"		"unprognostic (1.15e-2)"	0.5	2.6	13.3	0.6	7.3	0.6	6.1	0.7	15.2	0.5	0.5	0.3	0.0	0.5	0.7	0.5	0.5	0.4	0.6	0.4	2.7	7.4	0.5	0.4	0.5	0.9	4.6	8.7	0.4	1.4	0.5	12.5	0.5	4.4	0.5	0.5	0.0	0.5	0.5	0.4	0.7	0.5	0.8	2.1	0.6	0.5	1.7	0.0	0.0	0.5	0.0	0.9	0.4	0.2	2.7	0.1	1.1	0.0	0.3	0.5	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.6	0.0	0.6	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.0	2.2	0.1	0.1	0.1	0.6	0.0	0.4	0.1	0.0	0.5	2.7	0.2	0.1	0.0	0.5	0.2	0.2	1.1	0.3	0.0	0.1	0.1	0.0	13.3	7.3	0.7	14.5	2.7	7.4	4.6	8.7	4.4	0.0
IGFBPL1	bA113O24.1	ENSG00000137142	"Insulin like growth factor binding protein like 1"	Q8WX77	9	38408994-38424447	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 11.0;pituitary gland: 7.4;thyroid gland: 27.2"	"Group enriched"	"Detected in some"	6	"AF22: 68.0;NTERA-2: 18.7;RH-30: 19.5;SCLC-21H: 70.0;SH-SY5Y: 67.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basal ganglia: 12.5;olfactory region: 16.2"	"Low region specificity"	"Detected in many"			HPA051354	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted to blood"			"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA051354: "	"unprognostic (5.63e-2)"	"unprognostic (3.33e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.94e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.59e-2)"	"unprognostic (6.67e-2)"	1.6	2.6	3.8	1.1	11.0	0.3	0.4	4.7	4.7	0.7	1.0	1.0	0.0	1.9	2.1	0.5	0.7	1.0	1.9	3.7	3.3	2.3	0.7	0.6	1.2	0.4	1.4	1.5	0.5	1.6	0.4	7.4	1.1	1.8	1.6	0.7	0.2	0.5	2.9	0.3	0.3	1.2	2.1	0.6	0.4	2.5	3.3	1.5	2.6	27.2	0.0	0.4	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	68.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	8.1	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	18.7	0.1	0.0	19.5	0.1	0.0	0.0	70.0	67.9	1.1	0.0	0.0	0.3	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	11.0	4.7	4.7	3.3	2.3	1.4	1.5	1.8	1.5
KIF6	"C6orf102, dJ1043E3.1, dJ137F1.4, dJ188D3.1, DKFZp451I2418, MGC33317"	ENSG00000164627	"Kinesin family member 6"	Q6ZMV9	6	39329990-39725405	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 18.8;fallopian tube: 9.9;pituitary gland: 5.6;testis: 12.6"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 10.4;SCLC-21H: 14.6;SK-MEL-30: 5.9;U-2197: 3.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA038811, HPA058624"	Enhanced		Approved	Centrosome				Centrosome	Centrosome	"HPA038811: AB_10795140, HPA058624: AB_2683781"	"unprognostic (4.94e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.25e-4)"	"unprognostic (3.12e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.48e-2)"	"unprognostic (9.12e-4)"	"unprognostic (1.08e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.10e-2)"	"unprognostic (5.09e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.99e-1)"	1.3	1.4	5.1	0.7	9.1	0.9	1.9	2.2	11.4	1.4	1.0	18.8	0.1	1.7	1.0	2.6	1.3	9.9	1.6	1.3	7.3	7.1	1.4	1.3	2.4	1.2	11.8	3.2	1.8	1.6	1.2	5.6	1.2	8.6	1.1	0.9	1.7	1.0	0.9	1.6	1.2	1.1	0.8	10.6	0.9	0.9	12.6	7.8	0.0	2.0	0.0	0.9	0.7	0.4	1.2	2.7	2.5	0.6	1.3	0.7	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.1	0.1	1.2	0.3	0.7	0.1	0.1	0.1	0.1	1.2	0.2	0.1	0.1	0.3	0.0	0.4	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.6	10.4	0.3	0.1	14.6	0.2	0.0	0.1	5.9	0.1	0.1	0.2	0.1	0.2	3.4	0.8	0.2	0.0	0.0	0.8	0.1	1.8	1.9	0.6	0.4	0.5	0.3	0.5	0.7	0.5	0.4	0.2	1.2	0.6	0.7	2.5	1.3	0.4	2.7	0.3	0.1	5.1	9.1	2.2	5.4	7.3	7.1	11.8	3.2	8.6	7.8
KLRD1	CD94	ENSG00000134539	"Killer cell lectin like receptor D1"	Q13241	12	10226058-10329600	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 85.5;lymphoid tissue: 31.0;pituitary gland: 44.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"gdTCR: 67.2;memory CD8 T-cell: 28.0;naive CD8 T-cell: 30.3;NK-cell: 85.5"	"Group enriched"	"Detected in many"	63	"NK-cells: 85.5;T-cells: 67.2"	"Not detected"	"Not detected"							HPA069688	Uncertain									"HPA069688: AB_2686170"	"unprognostic (3.75e-2)"	"unprognostic (2.15e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.48e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.60e-3)"	"unprognostic (2.26e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.94e-3)"	"unprognostic (4.53e-3)"	"unprognostic (8.78e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.37e-2)"	5.2	1.3	0.9	6.4	1.1	6.9	1.7	0.8	0.9	1.4	2.7	0.6	0.2	1.5	3.3	1.9	2.0	1.1	1.5	1.7	1.0	1.0	1.5	3.7	12.3	10.2	3.8	0.7	0.9	1.9	0.0	44.6	2.3	0.8	2.0	0.9	2.1	1.2	0.5	1.1	0.8	10.6	0.5	2.6	31.0	1.8	1.4	0.4	2.2	1.3	0.3	3.6	6.3	1.3	0.1	0.2	1.2	0.2	85.5	67.2	16.2	0.9	0.7	1.1	1.5	1.5	0.6	0.9	2.3	0.1	0.2	0.7	1.4	1.0	1.3	1.1	1.8	1.1	0.5	1.3	0.2	2.2	2.8	1.7	2.6	0.6	2.7	1.0	2.1	0.7	1.7	0.4	1.2	0.3	1.0	4.9	0.3	1.9	1.0	1.3	1.7	1.4	0.6	1.6	1.2	0.7	2.1	2.4	1.2	1.1	2.2	0.5	0.8	2.0	1.7	1.7	3.1	1.5	0.7	2.0	1.8	1.1	2.6	1.6	1.6	0.1	0.1	0.1	67.2	0.2	7.6	0.1	0.4	28.0	0.2	0.1	0.1	30.3	1.2	85.5	0.1	0.2	0.1	16.2	0.9	1.1	0.8	0.9	1.0	1.0	3.8	0.7	0.8	0.4
LAIR2	CD306	ENSG00000167618	"Leukocyte associated immunoglobulin like receptor 2"	Q6ISS4	19	54497879-54510687	"CD markers, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 12.8;lymphoid tissue: 19.6;pituitary gland: 7.1;placenta: 15.5"	"Group enriched"	"Detected in some"	5	"BEWO: 6.8;Hep G2: 3.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"T-reg: 12.8"	"Lineage enriched"	"Detected in single"	21	"T-cells: 12.8"														"Secreted - unknown location"						"unprognostic (1.99e-3)"	"unprognostic (7.49e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.86e-4)"	"unprognostic (1.06e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.93e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.68e-9)"	"unprognostic (1.21e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.40e-5)"	"unprognostic (6.71e-2)"	0.9	0.5	0.6	5.9	1.7	1.6	0.5	0.2	1.3	0.4	0.6	1.3	0.0	0.4	0.5	1.3	0.7	0.5	1.3	0.4	1.4	3.0	0.6	0.8	3.2	12.3	0.6	0.5	0.2	0.9	0.1	7.1	15.5	1.3	0.8	1.3	0.4	0.5	0.4	0.6	0.5	1.2	0.5	1.5	6.6	1.0	1.2	0.4	19.6	0.5	0.0	2.0	0.3	0.3	0.0	0.0	0.1	0.1	0.6	12.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	3.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.7	0.3	0.1	0.0	1.0	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.0	3.0	2.0	0.0	0.0	0.8	2.7	0.1	0.6	0.1	0.0	12.8	1.8	0.6	1.7	0.2	1.3	1.4	3.0	0.6	0.5	1.3	0.4
MGAT4C	HGNT-IV-H	ENSG00000182050	"MGAT4 family member C"	Q9UBM8	12	85955666-86838904	"Enzymes, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"brain: 12.8;epididymis: 10.9;pituitary gland: 25.9;testis: 7.8;thyroid gland: 18.0"	"Group enriched"	"Detected in some"	13	"NTERA-2: 10.9;SCLC-21H: 4.8"	"Cancer enriched"	"Detected in single"	19	"thyroid cancer: 2.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA016418	Approved									"HPA016418: AB_2732416"	"unprognostic (5.23e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.32e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.64e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.88e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.32e-3)"	"unprognostic (3.51e-2)"	"unprognostic (6.85e-10)"	"unprognostic (3.15e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.74e-3)"	1.0	3.0	5.5	1.0	12.3	1.1	0.9	4.9	12.8	1.3	1.2	2.5	0.4	0.9	1.0	10.9	1.1	1.1	1.2	3.6	9.4	3.9	1.0	0.9	1.0	0.9	3.0	9.3	0.9	0.9	0.9	25.9	0.8	10.6	1.1	1.2	0.0	0.9	2.4	0.8	1.0	1.0	1.0	4.3	0.9	1.0	7.8	5.1	0.0	18.0	0.0	0.8	0.9	0.6	0.5	0.3	0.8	0.2	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.1	0.1	0.2	0.0	0.2	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.1	0.0	10.9	0.1	0.0	0.1	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.8	0.2	0.1	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.5	0.2	0.1	0.8	0.2	0.1	0.3	0.2	0.0	5.5	12.3	4.9	12.8	9.4	3.9	3.0	9.3	10.6	5.1
MIA	CD-RAP	ENSG00000261857	"Melanoma inhibitory activity"	Q16674	19	40771648-40777490	"Cancer-related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 16.1;breast: 28.7;pituitary gland: 33.5;salivary gland: 22.7;stomach 1: 28.9"	"Group enriched"	"Detected in some"	35	"AN3-CA: 21.3;CAPAN-2: 17.8;SK-MEL-30: 62.1;WM-115: 58.8"	"Cancer enriched"	"Detected in many"	5	"melanoma: 58.6"	"Region enriched"	"Detected in some"	8	"midbrain: 16.1"	"Cell type enhanced"	"Detected in some"		"basophil: 1.6;neutrophil: 3.0"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.0"									HPA042369	Approved				"Secreted to blood"					"HPA042369: AB_10794420"	"prognostic favourable (2.08e-4)"	"unprognostic (1.30e-1)"	"unprognostic (3.15e-1)"	"unprognostic (9.02e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.37e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.19e-1)"	"unprognostic (3.29e-8)"	"unprognostic (5.88e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.56e-1)"	0.7	1.5	0.6	3.5	0.6	1.4	28.7	0.9	0.4	3.7	6.1	0.5	2.2	0.8	2.8	3.2	4.0	1.0	3.2	4.1	0.4	0.4	0.9	0.8	1.4	0.7	16.1	0.4	2.6	0.4	0.0	33.5	0.9	2.1	2.2	1.9	6.0	22.7	1.7	0.8	4.5	2.2	3.4	3.1	2.4	28.9	1.0	0.4	0.5	1.1	5.9	4.4	2.0	1.5	0.7	0.0	3.0	0.1	0.0	0.3	0.1	0.0	0.1	0.2	21.3	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.1	17.8	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	62.1	0.1	0.2	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.2	0.0	0.1	58.8	1.6	0.0	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	3.0	0.0	0.1	0.0	0.0	0.1	0.6	0.6	0.9	0.4	0.4	0.4	16.1	0.4	2.1	0.4
NPAS4	"bHLHe79, Le-PAS, NXF, PASD10"	ENSG00000174576	"Neuronal PAS domain protein 4"	Q8IUM7	11	66421004-66426707	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"brain: 18.7;pituitary gland: 19.5"	"Cell line enhanced"	"Detected in some"		"AF22: 1.6;BJ: 1.4;HMC-1: 1.2;Karpas-707: 4.4;SCLC-21H: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 4.3;basal ganglia: 3.2;cerebral cortex: 8.0;hippocampal formation: 7.1;olfactory region: 5.3"	"Low region specificity"	"Detected in all"			HPA039255	Uncertain									"HPA039255: AB_10674282"	"unprognostic (7.81e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.78e-3)"		"unprognostic (4.97e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.29e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.24e-1)"	"unprognostic (3.21e-2)"	1.1	1.1	1.4	1.7	12.7	0.2	0.5	18.7	12.6	1.1	1.6	1.0	2.4	0.7	4.4	2.0	1.3	0.9	0.8	0.4	4.3	3.1	0.3	0.3	0.4	0.2	0.2	1.5	0.6	1.3	0.7	19.5	0.3	2.9	2.1	0.6	1.5	0.5	2.9	0.3	0.2	0.8	4.0	0.4	0.5	0.9	0.7	0.0	0.0	0.2	0.0	0.2	1.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.4	0.2	0.6	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.0	4.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	1.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	1.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	12.7	18.7	12.6	4.3	3.1	0.2	1.5	2.9	0.0
NPTX2		ENSG00000106236	"Neuronal pentraxin 2"	P47972	7	98617297-98629868	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 24.0;brain: 45.6;pancreas: 19.5;pituitary gland: 71.6;testis: 20.7"	"Cell line enriched"	"Detected in some"	12	"LHCN-M2: 125.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	16	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	16	"dendritic cells: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB020801, HPA049799, HPA058320"	Enhanced		Approved	"Golgi apparatus,Actin filaments,Centrosome"	"Secreted to blood"	320000	320000	"Golgi apparatus, Actin filaments"	"Golgi apparatus, Actin filaments"	"CAB020801: , HPA049799: AB_2680889, HPA058320: "	"unprognostic (1.18e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.56e-2)"	"prognostic unfavourable (5.46e-5)"	"unprognostic (1.91e-3)"	"unprognostic (9.20e-2)"	"unprognostic (2.42e-2)"	"unprognostic (6.04e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.64e-2)"	"unprognostic (2.35e-1)"	"prognostic unfavourable (5.46e-9)"	"unprognostic (1.06e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.33e-2)"	"unprognostic (3.69e-2)"	4.3	24.0	7.1	2.3	8.4	1.0	1.4	0.2	45.6	8.2	3.8	3.2	0.1	1.1	1.8	3.9	2.2	1.5	1.6	3.2	9.2	11.0	0.9	0.9	0.8	0.7	9.4	2.2	1.5	19.5	0.8	71.6	0.8	7.0	2.1	1.4	1.3	1.5	2.2	2.9	4.0	1.3	2.9	2.9	6.1	1.9	20.7	5.0	0.0	1.6	0.1	0.9	1.4	2.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.4	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	125.7	0.0	0.9	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	10.8	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	7.1	8.4	0.2	24.6	9.2	11.0	9.4	2.2	7.0	5.0
PAK3	"bPAK, hPAK3, MRX30, MRX47"	ENSG00000077264	"P21 (RAC1) activated kinase 3"	O75914	X	110944285-111227361	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 26.2;pancreas: 46.5;pituitary gland: 37.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 9.7;HAP1: 8.7;HDLM-2: 10.9;NTERA-2: 8.5;SCLC-21H: 11.1;SH-SY5Y: 6.9;U-2197: 6.7;U-251 MG: 11.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"MAIT T-cell: 4.3"	"Lineage enriched"	"Detected in single"	7	"T-cells: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044791, HPA060219"	Approved		Approved	Cytosol				Cytosol	Cytosol	"HPA044791: , HPA060219: AB_2684223"	"unprognostic (1.80e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.27e-4)"	"unprognostic (2.46e-1)"	"unprognostic (5.63e-3)"	"unprognostic (7.29e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.80e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.89e-4)"	"unprognostic (5.71e-3)"	"unprognostic (6.81e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.30e-2)"	2.0	6.8	17.6	2.5	17.5	1.0	6.4	1.8	24.6	3.7	1.6	0.9	9.1	1.0	6.8	7.6	1.7	3.7	2.6	1.2	26.2	20.8	1.6	1.1	1.8	2.5	7.9	21.9	7.9	46.5	0.9	37.2	1.6	12.9	4.8	1.7	1.4	3.0	7.1	2.4	2.0	1.4	6.1	5.8	2.9	3.0	3.6	1.9	0.0	7.7	0.0	1.7	2.0	1.5	0.1	0.1	0.6	0.1	0.2	4.3	0.0	0.0	0.6	1.3	0.0	0.0	0.0	0.0	0.2	0.3	0.9	0.0	0.0	0.0	0.0	9.7	1.0	0.0	8.7	0.5	1.2	10.9	0.3	0.0	1.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	2.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	8.5	1.9	0.1	4.0	0.0	0.8	0.0	11.1	6.9	0.0	0.4	0.0	0.0	0.0	0.0	0.6	4.3	6.7	11.6	0.0	0.1	0.1	1.2	0.0	0.1	0.6	0.1	0.1	0.1	0.0	4.3	0.0	0.7	0.4	0.0	0.1	0.1	0.1	0.5	0.2	0.1	0.1	0.3	0.0	17.6	17.5	1.8	18.5	26.2	20.8	7.9	21.9	12.9	1.9
PEG10	"HB-1, KIAA1051, Mar2, Mart2, MEF3L, RGAG3, RTL2, SIRH1"	ENSG00000242265	"Paternally expressed 10"	Q86TG7	7	94656325-94669695	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 67.5;brain: 143.8;pituitary gland: 102.6;placenta: 171.4"	"Cell line enhanced"	"Detected in many"		"AF22: 93.1;HAP1: 120.8;Hep G2: 93.1;SCLC-21H: 59.1"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 143.8"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.1;naive B-cell: 2.6;NK-cell: 2.7"	"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hypothalamus: 130.3"	"Low region specificity"	"Detected in all"			"HPA021324, HPA029915, HPA051038"	Enhanced		Approved	Nucleoplasm,Cytosol				Cytosol	Cytosol	"HPA021324: AB_1855181, HPA029915: , HPA051038: AB_2630372"	"unprognostic (1.03e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavourable (8.15e-4)"	"unprognostic (1.06e-1)"	"unprognostic (5.70e-3)"	"unprognostic (9.70e-3)"	"unprognostic (2.61e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.48e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.40e-2)"	2.3	67.5	32.0	2.1	143.8	1.4	10.6	25.6	16.8	4.2	2.1	7.4	0.0	1.5	3.3	1.9	2.0	5.1	2.4	1.8	21.0	47.0	4.0	2.0	7.3	2.9	13.1	21.3	27.0	5.4	2.3	102.6	171.4	27.4	2.2	1.9	1.8	4.3	2.2	1.9	1.4	1.6	2.6	14.4	1.8	2.1	19.8	11.1	1.5	5.4	0.0	2.3	1.8	1.0	2.6	0.0	0.0	0.0	2.7	0.7	0.2	2.6	13.1	93.1	39.3	1.9	3.5	5.4	7.1	4.2	5.1	7.0	21.8	4.3	0.2	0.2	8.2	0.8	120.8	5.0	7.2	0.3	12.7	0.0	15.0	93.1	1.4	14.8	0.0	7.8	1.6	12.7	8.9	3.0	0.0	29.1	10.0	0.6	0.0	0.0	42.6	8.4	5.6	29.8	7.8	23.4	9.7	59.1	3.4	0.0	2.0	7.0	12.6	0.0	0.0	4.1	0.2	0.5	5.4	7.8	5.2	11.6	9.3	0.0	1.7	0.0	0.0	0.0	0.3	0.0	0.0	2.1	0.0	0.7	0.0	2.6	0.0	0.1	0.0	2.7	0.0	0.0	0.1	0.2	32.0	143.8	25.6	14.4	21.0	47.0	13.1	21.3	27.4	11.1
PPFIA3	"KIAA0654, LPNA3, MGC126567, MGC126569"	ENSG00000177380	"PTPRF interacting protein alpha 3"	O75145	19	49119389-49151026	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 22.1;pituitary gland: 14.9;skin 1: 25.3"	"Cell line enhanced"	"Detected in many"		"PC-3: 23.0;SK-BR-3: 18.8;U-266/70: 13.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043567, HPA050340"	Enhanced		Uncertain	"Nucleoli fibrillar center,Vesicles"				"Nucleoli fibrillar center, Vesicles"	"Nucleoli fibrillar center, Vesicles"	"HPA043567: AB_2678558, HPA050340: AB_2681096"	"prognostic unfavourable (3.09e-4)"	"unprognostic (4.70e-2)"	"unprognostic (5.14e-3)"	"prognostic favourable (8.65e-4)"	"unprognostic (3.46e-1)"	"prognostic favourable (6.46e-7)"	"prognostic unfavourable (2.24e-5)"	"unprognostic (1.27e-1)"	"unprognostic (8.36e-2)"	"unprognostic (9.41e-3)"	"unprognostic (5.21e-3)"	"unprognostic (8.52e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.32e-1)"	1.6	3.9	13.9	1.6	9.3	0.9	2.2	22.1	20.8	1.2	4.3	1.6	1.7	5.1	1.6	1.1	4.4	1.3	1.4	1.4	12.8	12.2	1.1	1.6	1.8	1.6	7.4	13.7	1.0	4.9	4.1	14.9	1.1	7.3	3.4	2.0	1.6	2.7	1.6	1.7	25.3	4.6	1.2	2.4	1.3	2.3	2.1	1.8	0.0	1.8	1.2	2.2	1.1	1.9	0.0	0.0	0.0	0.0	0.2	1.1	0.3	1.9	2.0	2.0	5.1	0.0	0.0	3.9	0.2	0.2	1.0	1.4	1.4	0.8	4.5	2.7	0.2	1.0	3.1	0.4	0.2	4.8	6.8	2.8	1.8	1.0	0.2	1.1	7.3	0.2	1.1	0.6	0.3	0.0	5.4	7.1	0.1	8.7	1.4	1.9	0.9	23.0	4.6	4.0	2.2	0.3	1.0	4.2	5.8	0.8	18.8	2.0	10.4	2.7	0.4	1.1	4.0	0.7	0.1	13.3	10.9	3.3	1.1	4.5	2.6	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.2	0.4	0.0	0.0	1.1	0.2	0.0	0.2	0.0	0.0	0.0	0.3	13.9	9.3	22.1	19.8	12.8	12.2	7.4	13.7	7.3	1.8
PRR36		ENSG00000183248	"Proline rich 36"	Q9H6K5	19	7868719-7874379	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 20.5;pituitary gland: 6.5"	"Cell line enhanced"	"Detected in some"		"REH: 21.8;SCLC-21H: 6.3;SH-SY5Y: 14.2;T-47d: 7.1"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA062741	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"	"Nucleoplasm, Golgi apparatus"	"HPA062741: AB_2684860"	"unprognostic (3.15e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.23e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.20e-2)"	"unprognostic (9.62e-2)"	"unprognostic (3.46e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.99e-1)"	"unprognostic (5.69e-3)"	"unprognostic (7.89e-2)"	"prognostic favourable (7.74e-4)"	"unprognostic (3.56e-1)"	"unprognostic (8.52e-3)"	0.4	2.0	11.8	0.5	11.4	0.3	1.5	12.0	20.5	0.7	0.4	0.8	0.0	0.8	1.2	0.8	0.3	1.1	0.5	0.3	8.0		1.1	0.4	1.3	0.4	0.0	10.6	0.9	3.2	1.6	6.5	0.3	5.5	2.5	0.4	0.5	3.0	1.0	0.3	0.8	0.4	0.4	0.7	0.4	1.4	0.7	1.2	0.0	1.0	0.0	0.3	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.7	5.2	4.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.0	2.3	0.0	1.5	0.0	0.1	4.0	0.0	0.0	0.0	5.0	0.0	0.2	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.3	0.2	0.2	2.0	0.4	21.8	0.0	0.2	2.9	4.2	6.3	14.2	0.0	0.2	0.0	7.1	0.0	0.0	0.0	2.6	0.1	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0										
PRRT3	FLJ33674	ENSG00000163704	"Proline rich transmembrane protein 3"	Q5FWE3	3	9945542-9952394	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 26.0;fallopian tube: 10.8;parathyroid gland: 24.7;pituitary gland: 6.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 12.5;MCF7: 15.8;SK-BR-3: 23.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035127, HPA035128, HPA069859"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	18000	18000	"Plasma membrane"	"Plasma membrane"	"HPA035127: AB_10602822, HPA035128: AB_2674482, HPA069859: "	"unprognostic (1.55e-1)"	"unprognostic (8.41e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.15e-4)"	"unprognostic (2.27e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.25e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.09e-1)"	1.4	2.9	8.4	1.8	11.9	2.1	2.0	13.4	26.0	2.4	1.4	4.2	0.0	1.0	2.0	2.2	1.7	10.8	1.9	1.6	5.9	3.2	1.5	0.9	1.4	1.8	2.7	8.3	2.9	2.9	24.7	6.9	0.8	11.4	4.0	0.8	1.8	2.0	2.9	1.5	2.5	1.2	1.7	2.3	1.5	1.5	3.9	3.2	1.2	3.4	0.0	2.0	2.1	1.8	1.8	1.5	0.9	0.6	1.7	3.8	1.0	0.2	0.7	2.5	3.3	12.5	1.7	0.8	1.2	2.4	1.4	3.3	0.2	2.4	1.3	0.3	2.9	0.2	0.9	3.1	0.6	6.7	1.4	0.5	1.3	0.0	1.2	0.3	1.2	3.2	0.2	1.2	0.5	0.6	0.7	3.3	1.8	15.8	3.0	0.2	6.1	1.5	1.8	0.3	1.3	0.7	0.2	4.8	3.2	1.2	23.8	0.4	6.4	0.2	0.6	0.3	3.4	0.6	0.9	4.3	4.4	0.4	7.9	0.2	0.9	0.9	0.6	0.5	3.3	0.3	3.7	1.6	3.4	3.3	0.2	1.8	3.8	3.5	0.8	1.7	0.4	1.5	0.6	1.0	8.4	11.9	13.4	26.0	5.9	3.2	2.7	8.3	11.4	3.2
RXRG	NR2B3	ENSG00000143171	"Retinoid X receptor gamma"	P48443	1	165400917-165445355	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 14.9;pituitary gland: 29.8;retina: 13.5;skeletal muscle: 44.8"	"Cell line enriched"	"Detected in some"	7	"SK-MEL-30: 28.3"	"Group enriched"	"Detected in many"	13	"melanoma: 25.7;thyroid cancer: 34.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"basal ganglia: 89.8"	"Low region specificity"	"Detected in all"			"CAB002615, HPA012933"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"CAB002615: , HPA012933: AB_2732406"	"unprognostic (2.29e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.29e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.95e-2)"	"unprognostic (5.41e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.18e-1)"	"prognostic favourable (9.40e-5)"	"unprognostic (5.03e-2)"	1.9	3.9	5.4	1.0	14.9	0.6	1.0	0.3	5.9	4.0	2.5	5.3	0.6	1.3	1.8	1.3	1.7	3.6	1.2	5.8	7.5	8.9	0.7	0.8	3.4	0.8	4.1	4.3	1.7	2.7	0.8	29.8	1.3	14.1	1.1	2.7	13.5	1.9	2.1	44.8	2.9	2.0	1.8	8.9	1.0	1.1	1.5	5.4	0.0	1.1	2.5	0.6	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	28.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	14.9	0.3	5.9	7.5	8.9	4.1	4.3	14.1	5.4
SATL1		ENSG00000184788	"Spermidine/spermine N1-acetyl transferase like 1"	Q86VE3	X	85092287-85243961	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 2.7;brain: 5.4;pituitary gland: 7.2;testis: 4.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.3;HAP1: 3.4;HEL: 1.1;RH-30: 1.5;SH-SY5Y: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA060369	Uncertain									"HPA060369: AB_2684265"					"unprognostic (1.77e-1)"	"unprognostic (2.06e-1)"				"unprognostic (4.69e-3)"			"unprognostic (7.88e-2)"					0.3	2.7	2.9	0.4	2.6	0.4	0.4	5.4	4.6	0.4	0.4	0.2	0.0	0.3	0.4	0.3	0.3	0.4	0.3	0.5	2.2	2.0	1.1	0.4	0.3	0.3	1.1	2.7	0.4	0.3	0.3	7.2	0.4	2.2	0.5	0.4	0.0	0.4	0.3	0.7	0.6	0.3	0.3	1.4	0.4	0.3	4.8	0.4	0.0	0.4	0.2	0.3	0.4	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	3.4	0.0	0.0	0.0	0.6	1.1	0.1	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.1	0.0	1.5	0.0	0.0	0.1	0.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	2.6	5.4	4.6	2.2	2.0	1.1	2.7	2.2	0.4
SCN8A	"CerIII, CIAT, MED, NaCh6, Nav1.6, PN4"	ENSG00000196876	"Sodium voltage-gated channel alpha subunit 8"	Q9UQD0	12	51590266-51812864	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 27.6;pituitary gland: 9.7"	"Cell line enhanced"	"Detected in many"		"AF22: 11.8;ASC TERT1: 12.4;BJ hTERT+: 11.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022169, HPA043937, HPA073590"			Approved	"Vesicles,Plasma membrane,Cell Junctions"				"Plasma membrane"	"Plasma membrane"	"CAB022169: , HPA043937: , HPA073590: "	"unprognostic (2.96e-2)"	"unprognostic (8.49e-2)"	"unprognostic (6.93e-2)"	"unprognostic (3.52e-6)"	"unprognostic (8.13e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.77e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.73e-4)"	"unprognostic (1.69e-2)"	"unprognostic (1.29e-5)"	"unprognostic (4.38e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.75e-2)"	1.1	3.0	9.1	1.5	18.1	1.9	1.9	16.7	27.6	1.0	2.0	1.6	0.0	1.1	1.5	2.0	0.9	1.1	2.5	0.9	12.6	4.5	1.9	4.3	1.0	1.3	3.2	13.7	1.8	3.2	1.5	9.7	0.9	14.8	1.8	2.5	0.9	1.7	1.2	1.0	1.1	1.2	1.0	2.2	1.7	2.7	3.8	1.6	0.0	1.7	0.0	1.2	1.0	0.6	0.4	0.2	0.0	0.0	0.0	1.0	0.0	1.3	1.0	11.8	0.1	1.6	12.4	0.2	6.7	11.0	7.7	7.2	1.9	1.3	0.3	1.5	8.7	0.0	1.9	0.0	9.1	1.2	0.6	0.1	0.1	0.2	0.1	0.2	0.9	1.7	0.0	5.1	1.1	8.2	0.1	0.1	4.8	0.8	1.9	0.1	4.0	3.8	0.0	0.6	0.0	0.0	0.4	4.7	1.9	3.4	1.7	0.2	0.3	0.1	2.2	7.5	5.0	2.7	4.2	0.1	0.1	0.0	1.5	1.6	10.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.7	1.0	0.0	0.4	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	9.1	18.1	16.7	25.0	12.6	4.5	3.2	13.7	14.8	1.6
SIX6	"OPTX2, Six9"	ENSG00000184302	"SIX homeobox 6"	O95475	14	60508951-60512850	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"pituitary gland: 43.3"	"Cell line enriched"	"Detected in some"	16	"MOLT-4: 29.4"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.0"	"Region enriched"	"Detected in single"	8	"hypothalamus: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA001403	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA001403: AB_1079993"					"unprognostic (2.76e-1)"				"unprognostic (6.14e-2)"			"unprognostic (8.18e-2)"			"unprognostic (5.75e-2)"			0.1	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.3	0.0	0.0	0.4	0.0	10.6	0.3	0.0	2.2	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.4	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0
SLC7A14	"KIAA1613, PPP1R142"	ENSG00000013293	"Solute carrier family 7 member 14"	Q8TBB6	3	170459584-170586074	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 33.4;pituitary gland: 14.5"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 7.0;SCLC-21H: 7.0"	"Group enriched"	"Detected in some"	11	"glioma: 0.8;pancreatic cancer: 0.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045929	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Cytosol"	"Vesicles, Cytosol"	"HPA045929: AB_2679501"	"unprognostic (1.00e-1)"		"unprognostic (9.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.68e-3)"	"unprognostic (6.36e-2)"	"unprognostic (3.03e-6)"	"unprognostic (1.54e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.24e-3)"	1.1	5.8	12.1	1.9	17.7	1.4	1.1	14.9	33.4	1.0	1.8	8.0	0.0	1.6	1.1	1.2	1.1	1.1	1.3	1.1	11.5	12.1	1.3	1.2	1.1	1.1	6.7	12.8	1.3	2.4	1.1	14.5	1.1	11.8	1.2	1.9	0.1	1.1	1.1	1.2	1.3	1.7	1.3	9.0	1.1	1.5	1.3	6.3	0.0	1.1	0.0	1.1	1.1	0.3	1.0	0.6	2.1	0.5	0.7	0.6	0.1	0.0	0.0	0.4	0.1	1.2	2.0	0.1	0.6	0.2	0.8	0.8	0.1	0.1	0.1	0.0	0.8	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.1	1.8	0.0	0.1	1.2	0.2	0.0	0.2	7.0	0.0	0.0	0.2	0.9	0.1	0.1	0.0	0.1	0.0	0.1	7.0	2.0	0.0	0.1	0.0	0.1	0.1	1.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.1	2.1	0.5	0.5	0.4	0.3	0.3	0.8	0.3	0.3	0.1	1.0	0.6	0.5	1.2	0.7	0.3	0.6	0.3	0.1	12.1	17.7	14.9	16.9	11.5	12.1	6.7	12.8	11.8	6.3
SNTG1	"G1SYN, SYN4"	ENSG00000147481	"Syntrophin gamma 1"	Q9NSN8	8	49909789-50796691	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"brain: 22.7;lymphoid tissue: 7.8;pituitary gland: 10.4"	"Cell line enriched"	"Detected in some"	8	"RH-30: 10.6"	"Cancer enhanced"	"Detected in single"		"glioma: 2.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072282	Enhanced									"HPA072282: AB_2686506"					"unprognostic (4.60e-2)"		"unprognostic (1.72e-2)"		"unprognostic (2.47e-1)"		"unprognostic (1.05e-2)"			"unprognostic (6.94e-2)"	"unprognostic (2.03e-1)"		"unprognostic (1.16e-3)"	0.7	1.9	7.4	0.6	13.3	1.6	0.7	2.4	22.7	0.7	0.8	1.1	0.0	0.7	0.7	2.0	0.6	0.9	0.8	0.5	11.9	4.7	1.6	1.9	0.8	0.8	3.3	9.1	0.7	1.4	0.6	10.4	0.7	3.3	0.8	1.0	0.0	0.8	1.0	0.6	1.1	0.7	0.8	2.1	7.8	0.8	3.1	3.8	0.0	0.8	0.0	0.6	2.3	0.3	1.3	0.8	2.3	1.2	0.5	1.0	0.5	0.0	0.0	1.0	0.0	0.2	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.3	0.0	0.3	0.0	0.2	0.2	1.1	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.5	0.4	0.1	0.3	1.4	0.0	0.2	0.8	0.1	0.0	0.1	10.6	0.0	0.4	0.3	0.4	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.2	0.1	0.2	0.4	0.1	0.2	2.3	0.5	0.5	0.7	0.5	0.7	1.3	0.8	0.8	0.3	1.3	1.0	0.8	1.1	0.5	1.2	0.8	1.0	0.5	7.4	13.3	2.4	22.7	11.9	4.7	3.3	9.1	3.3	3.8
TCEAL6	WEX2	ENSG00000204071	"Transcription elongation factor A like 6"	Q6IPX3	X	102140476-102142970	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 14.3;brain: 48.4;pituitary gland: 20.7;testis: 21.9"	"Cell line enhanced"	"Detected in some"		"BJ: 1.1;SCLC-21H: 1.9"	"Cancer enriched"	"Detected in single"	9	"glioma: 3.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"											"HPA045564, HPA058982"	Supported									"HPA045564: AB_2679369, HPA058982: AB_2683870"	"unprognostic (5.43e-2)"			"unprognostic (6.54e-2)"	"unprognostic (1.87e-3)"			"unprognostic (6.69e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.18e-1)"		1.1	14.3	16.6	1.3	15.2	1.0	1.1	31.4	48.4	1.2	1.4	2.5	0.0	1.3	5.3	2.8	1.1	3.2	1.1	1.1	11.3	26.0	1.2	1.0	1.0	1.0	15.2	7.5	6.1	1.3	1.1	20.7	1.0	12.5	1.9	1.3	2.0	3.1	1.9	1.0	1.0	1.3	1.9	7.5	1.0	1.0	21.9	2.8	0.0	1.8	0.0	1.0	1.0	1.7	0.7	0.6	0.1	0.5	1.3	0.7	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.3	0.0	0.0	0.7	0.0	0.3	0.1	0.5	0.1	0.5	0.3	0.7	0.4	0.2	0.3	0.5	0.7	0.4	0.6	0.0	1.3	0.0	0.6	0.6	0.6	16.6	15.2	31.4	26.0	11.3	26.0	15.2	7.5	12.5	2.8
TTC25	DKFZP434H0115	ENSG00000204815	"Tetratricopeptide repeat domain 25"	Q96NG3	17	41930635-41965651	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 7.7;fallopian tube: 24.6;pituitary gland: 10.6;testis: 29.6"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 6.9;U-87 MG: 8.3"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 1.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023908	Enhanced									"HPA023908: AB_2241243"	"unprognostic (3.08e-3)"	"unprognostic (4.51e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.93e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.31e-4)"	"unprognostic (2.95e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.21e-3)"	"unprognostic (3.76e-1)"	"unprognostic (2.71e-1)"	0.3	0.8	2.0	0.1	5.3	2.3	0.7	0.5	4.0	1.5	0.3	3.8	1.5	0.3	2.1	4.1	0.3	24.6	0.7	0.5	2.0		1.5	0.3	2.8	0.6	0.6	2.5	2.9	0.8	4.0	10.6	2.2	7.7	0.7	0.3	2.8	0.3	0.8	0.9	0.3	0.2	0.9	0.6	0.2	0.5	29.6	1.7	0.0	1.8	0.0	0.2	0.4	0.0	0.5	1.8	0.0	0.5	0.0	1.0	0.3	0.1	2.7	3.5	4.6	0.7	0.8	0.5	0.1	1.9	0.8	1.5	0.4	3.2	0.3	1.6	0.7	0.6	0.6	0.4	0.8	0.7	0.6	1.3	0.8	0.1	0.9	0.0	2.0	0.6	0.6	2.5	0.2	0.1	0.1	2.6	0.5	1.8	1.8	0.5	0.8	0.3	0.0	0.1	1.7	4.5	0.3	6.9	5.4	0.0	0.9	3.5	1.9	0.7	0.0	0.2	2.0	1.6	0.9	2.6	2.6	0.2	8.3	0.1	1.3	0.0	0.5	0.0	0.2	0.0	0.0	0.0	1.0	0.0	1.1	0.5	1.0	0.2	0.0	0.0	0.0	1.8	0.0	0.3										
UNC80	"C2orf21, FLJ33496, KIAA1843, UNC-80"	ENSG00000144406	"Unc-80 homolog, NALCN channel complex subunit"	Q8N2C7	2	209771993-209999300	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 10.0;brain: 27.2;pituitary gland: 20.1;testis: 6.9"	"Group enriched"	"Detected in some"	5	"AF22: 5.1;SCLC-21H: 8.3;SH-SY5Y: 4.7"	"Cancer enhanced"	"Detected in some"		"glioma: 0.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042472, HPA050959"	Enhanced		Approved	"Nuclear bodies,Vesicles"				"Nuclear bodies"	"Nuclear bodies"	"HPA042472: AB_10965318, HPA050959: "	"unprognostic (7.91e-3)"	"unprognostic (2.25e-4)"	"unprognostic (1.44e-2)"	"unprognostic (3.20e-4)"	"unprognostic (1.92e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.31e-3)"	"unprognostic (5.36e-2)"	"unprognostic (5.16e-1)"	"unprognostic (7.85e-2)"	"unprognostic (5.24e-3)"	"unprognostic (8.94e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.40e-3)"	0.9	10.0	10.2	0.9	19.3	0.9	0.9	27.2	23.4	1.0	1.0	2.1	0.0	1.0	1.3	1.8	0.9	1.7	3.6	1.0	8.0	7.4	1.0	0.9	1.1	0.8	5.4	13.5	2.1	3.2	1.4	20.1	0.9	14.5	3.2	1.1	3.0	0.9	1.5	0.8	1.2	1.1	1.3	2.2	1.1	1.9	6.9	4.9	0.0	1.5	0.0	0.8	1.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	1.1	0.0	0.0	0.0	8.3	4.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	19.3	27.2	20.2	8.0	7.4	5.4	13.5	14.5	4.9
ABCC8	"ABC36, HHF1, HI, HRINS, MRP8, PHHI, SUR, SUR1, TNDM2"	ENSG00000006071	"ATP binding cassette subfamily C member 8"	Q09428	11	17392498-17476879	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.0;pancreas: 25.5;pituitary gland: 26.6"	"Group enriched"	"Detected in some"	5	"A549: 4.6;AN3-CA: 3.7;SCLC-21H: 6.5"	"Cancer enriched"	"Detected in some"	9	"pancreatic cancer: 16.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"CAB011451, HPA042318"	Approved		Approved	"Nucleoli,Golgi apparatus,Cytosol"				Nucleoli	Nucleoli	"CAB011451: , HPA042318: AB_2677947"	"unprognostic (4.30e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.09e-2)"	"unprognostic (4.73e-2)"	"unprognostic (9.48e-3)"	"unprognostic (2.23e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.53e-3)"	"unprognostic (6.04e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.72e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.96e-2)"	"unprognostic (6.88e-5)"	"unprognostic (2.72e-2)"	"unprognostic (1.85e-1)"	1.3	6.7	4.4	0.8	6.1	0.9	4.0	28.0	12.3	3.0	1.3	2.6	7.7	1.9	3.1	3.7	0.8	1.2	0.9	2.9	5.1	4.8	1.0	0.8	2.9	0.8	3.6	7.2	0.9	25.5	1.0	26.6	1.6	8.5	2.8	1.3	0.7	0.9	8.5	2.3	1.1	1.5	1.3	4.0	0.9	3.5	1.1	2.3	0.0	6.2	0.0	0.8	0.7	0.8	0.1	0.0	0.5	0.0	0.1	0.2	0.0	0.0	4.6	0.1	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	6.5	0.9	0.0	0.1	0.1	0.1	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.5	0.1	0.0	0.0	0.0	0.0	4.4	6.1	28.0	12.3	5.1	4.8	3.6	7.2	8.5	2.3
AC098582.1		ENSG00000285385			4	88523810-88649847	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"pituitary gland: 8.8"	"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 4.4;RPTEC TERT1: 3.4"									"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.8"	"Low lineage specificity"	"Detected in single"																																							1.4	0.1	2.4	2.5	3.3	2.8	2.4	2.8	6.3	0.9	0.4	3.3	1.3	0.1	1.1	3.2	0.7	2.2	0.3	0.7	1.4		1.3	0.5	1.3	0.6	0.8	3.5	1.3	0.1	0.1	8.8	1.0	4.8	1.3	2.0	2.2	2.4	1.5	3.1	0.8	0.9	1.1	3.0	2.0	0.1	1.8	1.7	0.0	3.6	0.1	0.7	0.7	0.5	0.9	0.0	0.0	0.2	0.6	2.8	0.7	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.7	0.7	0.0	1.8	0.0	1.0	0.0	0.5	1.4	0.4	0.0	0.0	0.0	0.9	0.0	1.4	0.0	0.6	0.9	0.0	0.0	0.9	1.3	0.0	4.4	1.3	1.2	0.9	0.0	0.0	0.9	0.3	0.0	0.6	1.1	0.4	0.4	3.4	0.0	0.0	1.6	0.0	0.4	0.1	0.5	0.0	0.0	0.5	0.7	0.0	1.9	2.2	0.0	0.0	2.1	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.4	0.3	1.4	0.3	0.0	0.9	2.8	1.5	0.0	0.6	0.2	0.0	0.7	0.7										
AC243547.3		ENSG00000280778			1	145927258-145977811	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"pituitary gland: 7.2;testis: 9.9"	"Group enriched"	"Detected in some"	25	"U-698: 1.2;U-87 MG: 3.7"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in some"	5	"neutrophil: 5.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 5.2"																																					0.7	0.7	1.8	0.7	2.2	0.7	0.7	5.9	2.6	0.7	0.7	2.3	0.7	0.7	0.7	1.2	0.7	0.7	0.7	0.7	1.2		0.9	0.7	0.7	0.8	1.9	1.1	0.7	3.5	0.7	7.2	0.7	3.0	0.7	0.7	0.8	2.1	0.7	0.7	0.7	0.7	0.7	1.6	0.7	0.7	9.9	2.2	4.2	0.7	0.3	0.7	0.7	0.0	1.0	0.0	5.2	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	3.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	1.5										
AC244197.3		ENSG00000241489			X	149482543-149533935	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"pituitary gland: 17.9"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"																						"unprognostic (1.57e-2)"	"unprognostic (2.77e-2)"	"unprognostic (5.48e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.81e-2)"	"unprognostic (9.16e-3)"	"unprognostic (4.51e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.01e-3)"	"unprognostic (4.33e-2)"	"unprognostic (1.37e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.90e-2)"	"unprognostic (3.27e-4)"	1.6	2.6	0.3	0.9	1.0	1.1	2.6	1.1	0.9	3.4	2.8			1.5	5.2	16.4	3.1	7.5	2.1	3.8	0.5	1.0	3.3	1.7	3.6	1.4	0.4		6.4	2.9	4.2	17.9	1.3		5.6	3.3		3.3	5.0	1.0	4.1	2.2	3.0	0.7	2.2	2.2	1.8			5.3		1.9	3.2	3.6	1.5	1.8	14.0	4.3	2.6	5.5	4.3	4.7	16.5	9.5	3.5	5.6	5.3	1.6	3.1	3.9	2.7	7.3	2.3	7.8	8.7	7.7	7.1	13.0	1.6	5.8	2.6	9.2	4.7	1.5	11.0	1.1	2.3	1.9	12.1	8.7	4.8	6.9	5.3	3.4	1.2	10.8	3.6	12.1	1.7	1.3	0.8	5.2	1.8	2.4	5.1	7.6	4.7	5.4	5.4	2.2	4.1	1.0	3.3	1.5	7.1	5.0	6.3	4.9	3.4	8.3	3.6	3.4	8.1	3.9	2.4	0.2	2.7	14.0	5.5	2.6	2.9	1.5	1.9	2.7	1.8	0.8	0.9	0.9	10.4	2.6	4.3	1.7	4.9	4.3										
AC244517.6		ENSG00000279068			5	141182409-141188582	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"pituitary gland: 14.9"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 8.1;ASC diff: 4.5;EFO-21: 3.6;RH-30: 5.0;U-138 MG: 10.2;U-2197: 6.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (2.86e-4)"				"unprognostic (2.14e-2)"	"unprognostic (4.28e-3)"		"unprognostic (1.59e-1)"	"unprognostic (4.32e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.19e-2)"		"unprognostic (1.04e-1)"	"unprognostic (1.44e-2)"	4.0	2.0	1.5	2.0	2.1	0.4	2.4	8.2	2.4	7.0	0.9	4.3	0.0	0.4	5.2	6.2	2.6	1.9	2.9	3.6	1.3		1.8	0.9	2.5	0.7	1.2	0.1	8.2	0.6	0.4	14.9	1.8	2.7	5.1	0.8	5.9	1.0	1.0	2.9	1.1	0.6	2.6	1.9	0.9	1.9	1.7	4.1	0.0	2.4	0.0	0.7	5.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	4.5	2.9	0.0	0.0	1.5	0.3	0.2	0.0	0.0	0.1	3.6	0.2	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	1.5	1.7	0.0	0.0	0.0	0.1	0.2	0.0	5.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.8	2.1	0.0	0.0	10.2	0.2	6.7	0.3	0.0	0.0	0.1	2.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ADGRD2	"GPR144, PGR24"	ENSG00000180264	"Adhesion G protein-coupled receptor D2"	Q7Z7M1	9	124451425-124478589	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"breast: 2.8;pituitary gland: 7.2;seminal vesicle: 5.8"	"Cell line enriched"	"Detected in single"	15	"SCLC-21H: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	4	"hypothalamus: 0.7;midbrain: 1.9;pons and medulla: 0.7"												"unprognostic (7.39e-4)"	"unprognostic (1.34e-2)"	"unprognostic (4.21e-2)"	"unprognostic (8.01e-3)"	"unprognostic (6.29e-2)"	"unprognostic (3.23e-6)"		"unprognostic (1.15e-1)"	"unprognostic (3.15e-1)"	"unprognostic (5.82e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.63e-2)"		"unprognostic (2.25e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.41e-1)"	0.0	0.6	0.1	0.0	0.1	0.0	2.8	0.1	0.0	0.2	0.0			0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.2	7.2	0.0		0.3	0.0		0.0	5.8	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ADGRV1	"DKFZp761P0710, FEB4, GPR98, KIAA0686, MASS1, USH2C, VLGR1"	ENSG00000164199	"Adhesion G protein-coupled receptor V1"	Q8WXG9	5	90529344-91164437	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 95.3;pituitary gland: 35.4"	"Cell line enhanced"	"Detected in many"		"AF22: 12.4;HAP1: 18.4;K-562: 7.4;NTERA-2: 9.6;SCLC-21H: 9.0;U-266/70: 10.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067503	Approved		Approved	"Lipid droplets"				"Lipid droplets"	"Lipid droplets"	"HPA067503: AB_2685856"	"unprognostic (1.29e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.95e-3)"	"unprognostic (7.50e-3)"	"unprognostic (9.73e-7)"	"unprognostic (1.87e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.48e-2)"	"unprognostic (7.14e-2)"	0.5	95.3	21.9	0.6	19.8	0.8	2.2	13.9	14.7	0.7	1.0	3.1	1.2	0.7	0.6	0.9	1.0	0.6	6.3	0.6	26.5	1.5	10.6	19.4	5.5	0.5	1.1	7.0	0.6	1.3	1.1	35.4	2.4	4.9	1.1	1.0	4.9	0.7	2.4	0.6	1.5	0.7	0.6	0.4	0.7	1.0	1.1	5.3	0.0	4.2	0.0	0.7	5.4	0.4	4.1	2.2	8.4	1.7	1.7	3.4	0.4	0.4	1.6	12.4	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	1.3	0.1	0.2	0.3	0.0	0.1	18.4	0.1	0.0	0.7	3.4	3.1	1.5	1.1	0.0	0.2	0.1	0.0	3.8	0.0	0.1	0.0	7.4	2.0	0.0	1.5	0.1	0.1	9.6	3.3	0.0	0.3	1.6	0.0	0.4	9.0	2.2	2.7	1.8	0.1	4.7	0.0	0.6	0.3	1.5	0.4	0.8	10.8	3.0	0.4	0.6	0.1	0.0	4.9	1.7	4.8	2.0	1.3	3.2	2.5	2.2	2.6	0.9	4.1	3.4	1.8	8.4	1.7	1.0	2.2	2.7	0.4	21.9	19.8	13.9	14.7	26.5	1.5	1.1	7.0	4.9	5.3
AFF2	"FMR2, FRAXE"	ENSG00000155966	"AF4/FMR2 family member 2"	P51816	X	148500619-149000663	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.6;brain: 13.6;epididymis: 15.1;pituitary gland: 17.4;placenta: 17.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 29.6;HL-60: 12.5;U-698: 43.2;U-937: 9.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"basophil: 1.7;eosinophil: 2.5;neutrophil: 4.5"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003139	Approved									"HPA003139: AB_1078107"	"unprognostic (5.68e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.60e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.88e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.00e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.08e-2)"	"unprognostic (5.31e-2)"	"unprognostic (6.80e-2)"	"unprognostic (9.78e-5)"	"unprognostic (2.54e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.34e-2)"	1.9	0.6	4.2	5.3	3.7	13.6	1.1	13.6	5.9	4.8	0.4	0.2	1.2	0.2	0.8	15.1	0.5	0.6	2.9	1.3	10.7	5.2	0.7	0.3	3.6	6.3	2.3	5.9	2.0	0.5	0.2	17.4	17.4	3.9	1.0	0.3	0.2	0.8	2.1	0.4	1.3	0.5	0.3	2.4	0.8	0.4	2.8	0.0	5.5	1.1	0.0	7.3	1.0	0.7	0.1	0.0	4.5	0.1	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.6	0.0	1.7	0.0	4.6	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	12.5	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.6	3.8	1.1	0.0	3.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.0	0.5	0.0	1.3	0.1	0.1	43.2	0.0	9.2	0.0	1.7	0.1	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	4.5	0.0	0.0	0.0	0.0	0.0	4.2	3.7	13.6	5.9	10.7	5.2	2.3	5.9	3.9	0.0
AGBL4	"CCP6, FLJ14442"	ENSG00000186094	"ATP/GTP binding protein like 4"	Q5VU57	1	48532855-50023913	"Enzymes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 20.4;pituitary gland: 31.5"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.6;SCLC-21H: 5.2;SH-SY5Y: 2.0;U-937: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA037994	Approved									"HPA037994: AB_10673036"	"unprognostic (3.06e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.58e-2)"	"unprognostic (3.31e-4)"	"unprognostic (3.42e-4)"	"unprognostic (1.72e-1)"	"unprognostic (3.86e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.85e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.51e-4)"	"unprognostic (5.95e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.85e-1)"	1.4	4.5	7.8	0.8	13.6	1.1	1.5	1.3	20.4	1.0	0.8	3.0	0.1	0.7	1.0	4.5	0.9	7.8	1.0	3.7	7.1	7.2	10.2	4.6	1.6	0.8	3.2	11.6	1.3	2.7	3.6	31.5	2.7	6.7	1.0	0.7	4.6	0.8	1.5	0.9	1.5	0.8	0.7	1.5	1.3	1.1	10.7	1.9	0.0	3.4	0.0	0.8	0.7	0.7	0.8	0.5	2.2	0.3	0.6	1.8	0.2	0.0	0.5	0.8	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.1	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.3	0.1	0.4	3.6	0.4	0.1	0.1	0.1	0.1	0.3	5.2	2.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	1.4	0.2	0.0	0.2	0.0	0.1	0.1	2.2	0.5	2.2	0.3	0.4	0.3	0.3	1.8	0.5	0.2	0.1	0.2	0.8	0.4	0.2	1.0	0.6	0.2	0.5	0.3	0.2	7.8	13.6	1.3	20.4	7.1	7.2	3.2	11.6	6.7	1.9
AHI1	"FLJ20069, JBTS3, ORF1"	ENSG00000135541	"Abelson helper integration site 1"	Q8N157	6	135283532-135497776	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 54.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031698, HPA046684"	Approved		Approved	Centrosome				Centrosome	Centrosome	"HPA031698: AB_2673997, HPA046684: AB_2679752"	"unprognostic (4.00e-2)"	"unprognostic (2.86e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.70e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.58e-2)"	"prognostic favourable (7.51e-5)"	"unprognostic (2.81e-2)"	"prognostic unfavourable (4.07e-9)"	"unprognostic (2.49e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.36e-2)"	"unprognostic (6.19e-3)"	6.7	16.2	16.8	6.4	16.5	5.9	12.5	35.3	26.5	11.7	8.7	4.2	13.2	4.9	14.4	32.1	7.8	9.0	9.0	7.6	15.9	19.9	8.4	6.8	8.1	6.0	11.4	19.6	13.9	11.6	11.5	54.2	8.3	18.2	16.3	13.1	10.0	8.2	15.9	6.7	6.1	5.7	11.1	18.5	4.3	10.7	29.2	13.1	3.3	11.6	5.0	6.3	8.9	12.0	10.6	16.6	4.8	1.7	3.8	4.2	0.5	5.2	7.1	8.4	10.8	13.7	14.9	3.7	9.6	12.1	9.7	14.9	2.7	5.6	8.1	4.7	9.3	4.0	6.3	3.0	14.5	6.4	8.4	2.9	20.2	5.2	5.9	15.1	3.3	7.0	4.9	15.0	8.2	8.0	13.4	0.5	13.1	5.5	14.3	3.4	5.0	4.4	7.2	3.4	2.7	4.9	5.2	14.6	7.8	12.8	4.7	5.7	3.8	6.8	7.5	8.4	10.4	14.4	7.5	10.6	9.8	3.8	11.9	2.2	10.0	4.8	1.7	0.6	4.2	0.5	2.6	8.2	4.0	4.2	2.6	10.6	3.2	4.1	0.1	3.8	0.5	16.6	2.4	0.5	16.8	16.5	35.3	26.5	15.9	19.9	11.4	19.6	18.2	13.1
AL035425.2		ENSG00000260548			X	108722070-108732687	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"ovary: 13.0;pituitary gland: 7.4;thyroid gland: 8.9"	"Cell line enhanced"	"Detected in some"		"HEK 293: 18.6;NTERA-2: 2.6;RT4: 4.8;WM-115: 4.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.6	2.9	0.0			0.0	3.9	0.9	0.0	0.5	0.0	0.0	0.1	5.1	0.0	0.0	0.0	0.0	0.5		13.0	0.9	0.0	7.4	0.0		0.1	0.0		0.0	0.7	0.0	1.1	0.0	1.5	0.1	0.0	0.4	0.0			8.9		0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ALK	CD246	ENSG00000171094	"ALK receptor tyrosine kinase"	Q9UM73	2	29192774-29921566	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.1;pituitary gland: 17.9"	"Cell line enriched"	"Detected in some"	6	"SH-SY5Y: 26.4"	"Group enriched"	"Detected in some"	5	"glioma: 1.0;melanoma: 1.5;ovarian cancer: 0.7;thyroid cancer: 1.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010694	Approved		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA010694: AB_1078133"	"unprognostic (4.96e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.56e-7)"	"unprognostic (7.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.07e-3)"	"unprognostic (6.29e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.67e-4)"	"unprognostic (3.70e-2)"	"unprognostic (2.06e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.61e-2)"	1.8	3.1	3.6	1.2	4.4	0.3	1.1	0.5	8.1	0.7	2.1	2.0	0.0	0.7	0.5	0.5	0.6	0.5	1.2	0.4	3.4	4.9	0.4	0.5	1.1	0.5	2.7	4.2	0.6	0.4	0.4	17.9	0.5	5.5	0.5	1.2	2.4	0.9	0.8	0.3	0.9	1.5	0.9	2.1	0.5	0.8	4.9	0.9	0.0	1.6	0.0	0.3	0.6	1.2	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	3.5	0.0	0.0	0.1	0.3	26.4	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	3.1	0.0	4.0	0.0	0.1	0.0	0.7	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.6	4.4	0.5	5.9	3.4	4.9	2.7	4.2	5.5	0.9
ANKRD31	FLJ40191	ENSG00000145700	"Ankyrin repeat domain 31"	Q8N7Z5	5	75068275-75236878	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"pituitary gland: 5.7;testis: 13.2"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.1"	"Not detected"	"Not detected"							HPA057566	Enhanced									"HPA057566: AB_2683470"	"unprognostic (1.37e-1)"	"unprognostic (4.28e-2)"	"unprognostic (5.25e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.52e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.00e-2)"	"unprognostic (4.46e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.40e-1)"	0.5	0.6	1.7	0.3	2.4	0.3	0.8	0.5	2.8	1.7	0.4	0.8	0.0	0.5	0.6	1.0	2.1	0.9	0.7	0.8	1.1	0.5	0.9	0.5	0.4	1.0	0.5	2.2	0.9	0.6	1.5	5.7	0.3	4.3	0.5	0.3	0.8	1.7	0.5	0.3	0.5	0.6	0.9	1.1	0.6	0.5	13.2	0.4	1.7	0.5	0.0	0.7	0.5	1.8	0.5	0.1	0.0	0.0	0.0	2.1	0.2	1.1	0.4	0.7	4.5	0.1	0.5	2.1	0.3	0.3	0.3	0.3	1.1	1.1	0.5	0.5	0.0	0.1	0.7	0.3	0.5	0.5	0.9	0.6	0.1	0.0	0.1	0.2	0.2	0.3	0.5	0.1	0.6	0.0	0.6	1.2	0.0	0.8	1.1	0.1	1.0	0.0	0.3	0.1	0.0	0.1	0.3	1.2	1.5	0.1	0.1	0.8	0.9	0.1	0.0	0.9	0.6	0.6	0.3	1.3	1.0	0.8	0.8	0.3	0.3	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.8	0.6	0.0	0.5	2.1	1.4	0.0	0.0	0.0	0.1	1.8	0.2	1.7	2.4	0.5	2.8	1.1	0.5	0.5	2.2	4.3	0.4
ARC	"Arg3.1, KIAA0278"	ENSG00000198576	"Activity regulated cytoskeleton associated protein"	Q7LC44	8	142611044-142614472	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 25.8;seminal vesicle: 67.7"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.8;HEK 293: 8.4;SCLC-21H: 20.0;U-2 OS: 9.7;U-87 MG: 10.9"	"Cancer enriched"	"Detected in many"	12	"glioma: 36.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"gdTCR: 1.6"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.6"	"Group enriched"	"Detected in many"	5	"amygdala: 48.9;basal ganglia: 51.6;cerebral cortex: 144.6;hippocampal formation: 99.8;olfactory region: 50.5"	"Group enriched"	"Detected in many"	7	"basal ganglia: 25.3;cerebral cortex: 87.7;hippocampal formation: 55.8;olfactory region: 47.5"	"HPA056430, CAB079013"		Supported	Approved	Vesicles,Microtubules				"Vesicles, Microtubules"	"Vesicles, Microtubules"	"CAB079013: , HPA056430: AB_2683130"	"unprognostic (1.40e-3)"	"unprognostic (2.95e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.87e-4)"	"unprognostic (6.83e-2)"	"unprognostic (8.12e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.07e-2)"	"unprognostic (9.43e-2)"	"unprognostic (4.15e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.01e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.35e-2)"	18.1	15.9	6.1	1.0	6.5	0.7	1.0	0.8	17.0	1.5	0.9	4.2	11.8	0.8	1.4	1.8	0.9	1.2	3.5	0.5	13.9	7.1	1.5	0.7	2.7	0.4	2.4	2.1	0.5	6.2	0.4	25.8	1.8	4.0	1.0	0.6	0.0	0.5	67.7	0.5	3.5	0.7	0.9	1.2	0.7	2.1	0.6	1.1	0.0	1.5	0.8	1.9	0.6	1.5	0.0	0.0	0.0	0.5	0.0	1.6	0.0	0.0	0.1	0.3	6.8	0.1	0.7	0.0	1.4	0.0	0.3	0.1	0.1	0.0	0.0	0.9	0.2	0.1	0.4	0.0	0.0	0.0	8.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.0	2.8	0.0	0.0	3.1	1.5	0.0	0.6	0.0	0.0	0.0	20.0	4.7	0.4	0.0	0.2	0.0	0.1	0.0	1.1	9.7	0.7	0.2	1.8	0.0	0.0	10.9	0.0	2.9	0.0	0.0	0.0	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.1	6.5	0.8	17.0	13.9	7.1	2.4	2.1	4.0	1.1
ARHGAP36	FLJ30058	ENSG00000147256	"Rho GTPase activating protein 36"	Q6ZRI8	X	131058242-131089883	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 58.4;brain: 25.5;pituitary gland: 50.3"	"Cell line enriched"	"Detected in single"	164	"SH-SY5Y: 62.9"	"Cancer enriched"	"Detected in some"	21	"thyroid cancer: 62.5"	"Region enriched"	"Detected in many"	5	"hypothalamus: 25.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"hypothalamus: 104.3"	"Group enriched"	"Detected in many"	5	"basal ganglia: 19.8;hypothalamus: 57.8;midbrain: 27.1;pons and medulla: 20.1"	"HPA002064, HPA076209"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane"				Nucleoplasm	Nucleoplasm	"HPA002064: AB_1078891, HPA076209: "	"unprognostic (2.92e-2)"			"unprognostic (7.71e-9)"	"unprognostic (2.19e-1)"	"unprognostic (8.15e-2)"				"unprognostic (1.67e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.73e-1)"		"unprognostic (1.40e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.31e-1)"		6.9	58.4	1.4	0.2	3.6	0.1	1.0	0.0	2.7	0.5	0.2	0.0	0.0	0.1	0.1	2.0	0.3	0.2	0.2	0.1	1.0	25.5	0.1	0.1	0.1	0.1	0.5	0.0	0.1	0.1	0.1	50.3	0.3	5.4	0.3	0.2	0.6	0.2	0.2	13.7	0.1	0.1	0.1	0.8	0.1	0.2	0.6	0.0	0.5	0.5	4.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	62.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	3.6	0.0	0.4	1.0	25.5	0.5	0.0	5.4	0.0
ARHGEF38	FLJ20184	ENSG00000236699	"Rho guanine nucleotide exchange factor 38"	Q9NXL2	4	105552620-105708093	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 35.5"	"Group enriched"	"Detected in some"	8	"RPTEC TERT1: 16.0;SK-BR-3: 8.9;T-47d: 9.1"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA036510, HPA045484"	Uncertain		Approved	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"	"Nucleoplasm, Centrosome"	"HPA036510: AB_10672357, HPA045484: AB_2679345"	"unprognostic (1.49e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.47e-3)"	"unprognostic (2.79e-1)"	"unprognostic (6.14e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.53e-3)"	"unprognostic (3.16e-8)"	"unprognostic (2.33e-3)"	"unprognostic (6.16e-2)"	"unprognostic (3.19e-3)"	"unprognostic (6.45e-3)"	0.2	0.2	0.2	3.2	0.2	0.0	10.8	0.2	0.2	3.5	7.6	0.0	1.6	2.3	1.4	15.7	0.4	1.1	11.7	0.2	0.2	0.2	13.8	0.4	16.1	0.0	0.2	0.0	1.3	12.9	0.0	35.5	0.4	0.0	14.6	5.6	0.2	13.9	0.5	0.2	1.0	9.6	0.0	0.2	0.2	4.1	0.6	0.0	0.0	8.0	0.7	2.0	0.5	0.4	0.0	0.0	0.1	0.2	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.1	16.0	0.0	0.0	0.0	0.0	8.9	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.1	0.2	0.1	0.0	0.3	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0
ARMC4	"CILD23, DKFZP434P1735, FLJ10376, FLJ10817"	ENSG00000169126	"Armadillo repeat containing 4"	Q5T2S8	10	27812164-27999048	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 19.6;pituitary gland: 18.5;testis: 22.0"	"Cell line enhanced"	"Detected in some"		"AF22: 6.4;BJ: 6.4;fHDF/TERT166: 7.5;HEK 293: 5.4;NTERA-2: 5.6;RH-30: 16.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA037829	Enhanced									"HPA037829: AB_10670960"	"unprognostic (1.03e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.48e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.64e-1)"	"unprognostic (4.28e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.11e-3)"	"unprognostic (7.72e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.24e-2)"	0.3	0.9	0.9	0.8	2.2	0.3	0.3	0.1	1.0	2.1	1.2	3.4	0.6	0.1	1.1	3.0	0.4	19.6	1.0	0.4	1.6	1.6	0.3	0.4	2.3	0.2	0.3	1.3	4.3	0.1	0.1	18.5	0.2	5.5	4.9	0.3	0.8	0.1	3.1	0.1	0.1	0.2	2.7	0.9	0.2	0.5	22.0	0.8	0.6	0.5	0.0	0.1	1.0	0.4	0.0	0.3	0.0	0.0	0.0	0.8	0.1	0.0	0.0	6.4	0.0	0.0	0.0	0.2	6.4	2.4	3.6	2.9	0.0	0.3	0.0	0.0	7.5	0.0	1.0	0.0	4.3	0.0	5.4	0.0	3.2	0.0	0.5	0.0	0.0	1.3	0.0	0.0	0.0	1.1	0.0	0.0	0.8	0.0	2.6	0.2	5.6	1.8	0.1	16.1	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.6	0.3	0.1	0.0	2.3	0.1	3.0	0.0	0.0	0.0	1.3	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.8	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	2.2	0.1	1.0	1.6	1.6	0.3	1.3	5.5	0.8
ASCL1	"ASH1, bHLHa46, HASH1"	ENSG00000139352	"Achaete-scute family bHLH transcription factor 1"	P50553	12	102957686-102960516	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 19.3;liver: 23.0;pituitary gland: 29.4"	"Group enriched"	"Detected in some"	22	"SCLC-21H: 32.6;SH-SY5Y: 17.6"	"Group enriched"	"Detected in many"	6	"glioma: 21.4;lung cancer: 11.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA029217, HPA076307"	Enhanced		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA029217: , HPA076307: "	"unprognostic (7.92e-2)"	"unprognostic (4.37e-3)"		"unprognostic (4.55e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.10e-6)"	"unprognostic (3.40e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.76e-1)"	"unprognostic (5.52e-2)"	0.9	2.8	11.1	0.7	6.9	0.7	0.7	3.3	19.3	1.3	0.9	6.6	0.0	0.9	1.0	0.8	0.7	2.2	0.8	0.7	8.5	5.8	0.8	23.0	1.7	1.4	7.6	4.7	1.6	0.9	0.7	29.4	0.8	13.9	1.1	1.0	0.0	0.7	0.8	0.8	0.7	0.8	0.9	18.7	0.7	3.2	0.9	7.3	6.0	1.0	0.0	0.8	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.6	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	6.9	3.3	10.7	8.5	5.8	7.6	4.7	13.9	7.3
ASIC4	"ACCN4, BNAC4"	ENSG00000072182	"Acid sensing ion channel subunit family member 4"	Q96FT7	2	219514170-219538772	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 17.7;pituitary gland: 20.6"	"Group enriched"	"Detected in some"	30	"HEL: 18.7;HMC-1: 5.6;K-562: 10.7;SH-SY5Y: 5.1"	"Cancer enriched"	"Detected in single"	38	"glioma: 8.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 65.5"	"Low region specificity"	"Detected in many"			"HPA036042, HPA057078"			Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane,Centriolar satellite"				"Golgi apparatus, Centriolar satellite"	"Golgi apparatus, Centriolar satellite"	"HPA036042: , HPA057078: "	"unprognostic (3.48e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.54e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.90e-2)"	"unprognostic (9.46e-3)"	"unprognostic (1.88e-1)"	"unprognostic (7.80e-8)"	"unprognostic (3.82e-2)"	"unprognostic (2.30e-1)"	"unprognostic (5.51e-1)"	"unprognostic (2.48e-2)"	0.8	3.3	4.9	0.6	4.7	0.5	0.6	6.9	17.7	1.0	0.5	1.6	0.0	0.5	0.8	0.6	0.5	0.6	0.6	0.6	3.9	4.5	0.5	0.6	0.9	0.6	4.8	2.9	0.5	0.5	0.5	20.6	0.6	3.0	0.6	0.5	4.9	0.6	0.8	0.5	0.6	0.5	0.7	1.9	0.6	0.7	1.6	3.1	0.0	0.5	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	10.7	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	4.7	6.9	4.9	3.9	4.5	4.8	2.9	3.0	3.1
BAIAP3	"BAP3, KIAA0734"	ENSG00000007516	"BAI1 associated protein 3"	O94812	16	1333601-1349441	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.1;pituitary gland: 88.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 19.7;MCF7: 6.0;RT4: 5.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.9"	"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hypothalamus: 144.1"	"Low region specificity"	"Detected in many"			"HPA015627, HPA015979"	Uncertain	Supported								"HPA015627: AB_10603678, HPA015979: "	"unprognostic (1.37e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.44e-2)"	"unprognostic (3.92e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.60e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.02e-1)"	"prognostic favourable (1.52e-5)"	"unprognostic (5.26e-2)"	"unprognostic (3.11e-1)"	"unprognostic (7.12e-3)"	"unprognostic (6.43e-2)"	2.2	20.6	30.6	1.3	16.5	1.2	1.4	0.2	24.1	1.4	1.9	9.5	0.7	4.3	1.6	2.6	1.0	28.1	0.9	1.5	19.4	38.4	2.8	3.0	3.1	1.5	4.1	39.1	1.2	7.8	5.1	88.2	2.1	18.5	3.5	1.1	0.0	4.6	3.0	2.8	1.5	3.8	0.4	4.2	2.6	7.0	7.6	6.1	0.0	0.7	0.0	1.1	1.0	0.5	4.9	0.0	1.8	0.0	1.3	1.6	0.3	0.1	2.3	4.0	1.3	0.4	0.0	1.0	0.2	0.1	0.2	0.0	3.6	19.7	0.3	2.7	0.0	0.1	0.0	0.2	0.0	0.2	1.3	0.1	0.3	1.4	0.4	0.0	2.7	0.0	0.0	0.2	0.1	0.1	0.6	0.0	0.0	6.0	0.0	0.8	2.3	3.4	0.6	0.0	3.7	2.3	5.4	0.5	0.2	0.0	1.8	0.1	4.2	0.3	0.2	0.0	2.2	0.5	0.0	1.5	0.5	0.1	0.1	0.4	0.1	0.0	0.0	0.5	1.0	0.0	0.5	4.9	0.5	1.6	0.0	0.3	0.0	0.1	1.8	1.3	0.0	0.0	0.0	0.3	30.6	16.5	0.2	24.1	19.4	38.4	4.1	39.1	18.5	6.1
BEX1		ENSG00000133169	"Brain expressed X-linked 1"	Q9HBH7	X	103062651-103064240	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 150.2;pituitary gland: 64.3"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 42.0;BJ hTERT+ SV40 Large T+ RasG12V: 62.4;HBF TERT88: 69.6;HL-60: 152.4;SCLC-21H: 47.7;THP-1: 43.1;U-937: 47.8"	"Cancer enhanced"	"Detected in many"		"glioma: 111.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 6.4"	"Low lineage specificity"	"Detected in many"											"HPA045384, HPA078630"	Approved		Approved	Cytosol				Cytosol	Cytosol	"HPA045384: AB_2679305, HPA078630: "	"prognostic favourable (6.43e-4)"	"unprognostic (1.51e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.28e-3)"	"unprognostic (2.09e-1)"	"prognostic favourable (8.16e-8)"	"unprognostic (1.14e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (6.88e-4)"	"unprognostic (7.34e-2)"	1.8	37.4	66.4	2.8	65.1	16.3	1.9	44.7	150.2	1.8	3.0	6.2	0.0	3.3	7.7	25.2	1.6	10.1	1.8	3.6	77.4	81.0	4.5	3.0	2.1	1.7	38.9	67.8	9.5	30.9	48.1	64.3	1.5	35.8	3.8	3.1	4.7	2.2	2.9	1.3	1.5	3.9	3.3	24.3	2.3	5.0	27.5	12.0	0.0	12.1	0.0	1.5	1.5	0.4	2.4	0.2	6.4	0.5	1.7	3.1	1.5	0.0	0.0	3.8	0.0	0.0	0.0	0.1	2.1	0.0	42.0	62.4	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	69.6	0.0	0.1	12.7	0.0	8.2	0.7	152.4	0.2	0.9	0.0	9.1	0.0	0.0	0.0	0.0	8.4	0.0	28.6	0.0	34.7	6.2	0.0	0.0	0.7	0.0	0.0	47.7	27.5	0.0	0.0	0.1	0.0	43.1	0.0	0.0	14.4	0.1	1.6	7.4	0.2	0.0	5.6	47.8	2.7	0.6	0.5	6.4	0.7	0.1	0.7	1.2	2.0	1.2	0.1	2.4	3.1	1.4	1.2	1.7	0.4	0.2	0.9	1.5	66.4	65.1	44.7	89.0	77.4	81.0	38.9	67.8	35.8	12.0
BPIFB4	"C20orf186, dJ726C3.5, LPLUNC4"	ENSG00000186191	"BPI fold containing family B member 4"	P59827	20	33079644-33111751	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"parathyroid gland: 4.0;pituitary gland: 12.2"	"Group enriched"	"Detected in some"	4	"HSkMC: 5.3;U-2 OS: 8.5"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted - unknown location"							"unprognostic (1.32e-1)"		"unprognostic (1.16e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.31e-3)"	"unprognostic (4.70e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.98e-4)"			"unprognostic (1.31e-1)"	"unprognostic (1.82e-1)"		"unprognostic (8.97e-2)"	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	4.0	12.2	0.0		0.0	0.0		2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8			0.0		0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.5	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
C10orf67	"bA215C7.4, C10orf115, LINC01552, MGC46732"	ENSG00000179133	"Chromosome 10 open reading frame 67"	Q8IYJ2	10	23201916-23344845	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 7.3;pituitary gland: 9.0;testis: 13.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 5.2;SiHa: 8.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 4.2"	"Low lineage specificity"	"Detected in many"											"HPA038130, HPA038131"	Approved		Approved	"Nucleoplasm,Nucleoli,Nuclear speckles"				Nucleoplasm	Nucleoplasm	"HPA038130: AB_2675847, HPA038131: AB_10670658"	"unprognostic (4.76e-4)"	"unprognostic (2.38e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.92e-2)"	"unprognostic (9.67e-3)"	"unprognostic (1.91e-1)"		"unprognostic (1.54e-1)"	"unprognostic (1.78e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.46e-3)"	"unprognostic (3.98e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.84e-3)"	"unprognostic (9.58e-2)"	0.1	0.1	1.3	1.7	2.6	0.2	0.0	0.1	1.9	0.3	0.5	0.4	1.3	0.5	0.2	4.6	0.1	7.3	0.2	3.2	1.6	1.4	5.0	0.5	4.0	0.3	0.9	0.5	1.8	0.3	0.4	9.0	0.1	1.2	0.1	0.0	0.2	0.1	0.1	0.6	1.9	0.4	0.0	0.7	0.2	0.1	13.8	0.6	0.0	0.6	0.7	0.1	0.1	0.1	1.1	1.1	1.0	0.5	1.1	4.2	0.0	1.5	0.1	1.9	0.2	0.0	0.5	0.4	0.2	0.1	2.0	1.6	0.1	2.4	0.2	0.2	1.5	5.2	0.2	0.7	1.6	0.5	0.4	0.1	0.7	0.3	1.0	0.1	0.0	0.6	1.7	0.6	1.0	0.0	0.2	0.7	0.0	0.3	0.1	0.5	0.9	0.1	0.1	0.2	0.4	1.7	0.3	0.9	0.4	8.4	0.3	0.1	0.3	0.3	0.2	0.4	1.5	0.4	0.1	1.0	0.2	0.1	2.5	0.2	0.1	1.0	0.5	0.6	0.7	0.3	0.6	1.1	1.5	0.8	0.1	1.0	1.1	1.0	0.8	1.1	0.3	1.1	4.2	0.0	1.3	2.6	0.1	1.9	1.6	1.4	0.9	0.5	1.2	0.6
C14orf39	SIX6OS1	ENSG00000179008	"Chromosome 14 open reading frame 39"	Q8N1H7	14	60396469-60515543	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 16.9;salivary gland: 6.7;testis: 14.9"	"Cell line enhanced"	"Detected in some"		"HEL: 5.4;HSkMC: 4.2;MOLT-4: 20.4;RH-30: 5.6;U-2 OS: 11.5"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA059518	Uncertain		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA059518: AB_2684049"	"unprognostic (6.17e-2)"	"unprognostic (1.73e-3)"		"unprognostic (3.00e-6)"	"unprognostic (2.78e-1)"	"unprognostic (6.97e-2)"		"unprognostic (7.55e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.78e-1)"		"unprognostic (7.46e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.09e-1)"	1.0	2.7	0.0	0.6	0.2	0.0	0.1	0.0	0.5	0.5	0.8	0.0	0.0	0.3	0.6	0.0	0.7	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.4	1.7	0.0	0.6	16.9	0.0	0.2	1.6	0.0	1.6	6.7	0.1	3.8	0.0	0.3	0.1	0.5	0.0	0.6	14.9	0.0	0.0	0.4	1.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.7	5.4	0.0	0.0	0.0	0.0	0.3	4.2	0.0	0.7	0.0	0.0	0.0	0.0	1.8	0.0	20.4	0.2	2.7	1.3	0.0	5.6	0.0	0.3	1.5	0.1	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	1.4	0.1	0.4	0.2	0.0
C17orf107		ENSG00000205710	"Chromosome 17 open reading frame 107"	Q6ZR85	17	4899418-4902932	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pituitary gland: 25.7;salivary gland: 26.0"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 5.4;HMC-1: 7.2;hTCEpi: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"neutrophil: 6.7"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 6.7"	"Not detected"	"Not detected"							HPA069713	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA069713: AB_2686181"	"prognostic favourable (5.06e-5)"	"unprognostic (1.63e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.13e-3)"	"unprognostic (9.61e-2)"	"unprognostic (5.03e-2)"	"unprognostic (4.15e-1)"	"unprognostic (2.05e-1)"	"prognostic favourable (8.61e-4)"	"unprognostic (1.17e-1)"	"prognostic favourable (2.68e-4)"	"unprognostic (9.29e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.12e-1)"	2.4	3.7	5.0	2.3	5.1	4.2	3.0	7.7	8.7	3.9	1.4	0.2	5.9	2.1	1.9	5.9	1.3	1.8	3.3	15.3	3.8	4.3	2.2	8.8	2.9	1.0	1.6	4.2	6.4	7.7	6.2	25.7	1.5	1.7	4.5	0.9	2.1	26.0	6.4	0.6	3.3	1.6	1.2	2.2	2.1	4.6	4.7	0.6	0.1	1.9	0.6	2.7	3.3	1.9	0.0	0.0	6.7	0.2	0.0	0.9	0.1	0.6	0.8	1.0	0.3	2.1	1.7	1.5	3.8	0.5	0.2	0.5	0.7	0.7	0.4	0.6	5.4	1.4	0.1	0.5	0.3	0.1	0.8	2.0	0.6	0.7	3.0	0.0	7.2	1.7	6.5	0.1	0.4	0.2	0.0	0.1	0.1	0.7	0.1	0.6	0.3	0.7	0.3	0.2	2.8	0.3	0.3	0.1	0.5	0.6	2.3	0.3	0.6	1.0	0.5	0.3	0.7	0.6	0.5	0.6	0.6	0.1	0.4	0.1	0.3	0.0	0.2	0.8	0.2	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.8	6.7	0.0	0.1	0.0	0.0	0.1	5.0	5.1	7.7	8.7	3.8	4.3	1.6	4.2	1.7	0.6
C1GALT1C1	"C1GALT2, COSMC"	ENSG00000171155	"C1GALT1 specific chaperone 1"	Q96EU7	X	120625793-120630150	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 83.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 72.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA015632	Approved		Approved	Cytosol				Cytosol	Cytosol	"HPA015632: AB_1845625"	"prognostic unfavourable (5.66e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.07e-2)"	"unprognostic (5.26e-3)"	"unprognostic (4.34e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.18e-2)"	"unprognostic (8.10e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.98e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.05e-3)"	"unprognostic (3.78e-2)"	16.5	28.0	8.4	11.1	9.2	3.0	21.1	9.0	9.9	19.2	16.7	10.8	16.5	12.7	13.0	23.1	15.0	15.1	11.6	17.7	9.0	10.9	25.9	35.2	12.4	12.9	11.0	7.5	13.2	18.8	18.7	83.5	13.3	11.5	14.1	19.4	10.9	19.4	15.5	7.4	5.8	20.6	12.4	12.0	16.5	14.6	9.6	10.6	16.3	19.8	12.3	12.4	13.9	12.3	17.2	23.0	31.3	22.3	15.1	23.8	16.2	8.5	8.3	4.6	7.9	72.7	13.9	7.3	15.6	22.1	8.3	15.7	5.4	27.5	5.5	7.8	31.4	12.0	9.0	7.6	13.2	9.4	10.9	3.5	7.7	7.9	11.3	6.2	5.6	12.0	6.8	10.3	3.4	26.0	2.2	6.5	9.7	11.6	2.1	5.9	5.1	8.3	0.9	3.6	15.2	16.7	5.7	5.1	4.8	14.8	10.2	7.7	8.8	6.1	23.8	3.8	4.7	15.2	14.6	2.8	4.2	4.4	13.9	12.3	8.3	13.3	17.7	27.0	17.6	22.3	19.4	17.2	22.9	19.0	20.1	10.6	23.8	18.9	31.3	15.1	17.5	23.0	21.0	16.2	8.4	9.2	9.0	9.9	9.0	10.9	11.0	7.5	11.5	10.6
C21orf58		ENSG00000160298	"Chromosome 21 open reading frame 58"	P58505	21	46300181-46323875	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"fallopian tube: 27.2;lymphoid tissue: 22.7;pituitary gland: 25.1"	"Cell line enhanced"	"Detected in many"		"REH: 29.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.2"	"Low lineage specificity"	"Detected in many"											"HPA035110, HPA035111"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	Nucleoplasm	"HPA035110: AB_10603683, HPA035111: AB_2674468"	"unprognostic (2.19e-1)"	"unprognostic (6.74e-3)"	"unprognostic (2.51e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.08e-2)"	"prognostic favourable (7.00e-4)"	"unprognostic (4.74e-3)"	"unprognostic (6.14e-2)"	"prognostic unfavourable (7.48e-4)"	"unprognostic (1.38e-1)"	"prognostic favourable (4.20e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.01e-10)"	"unprognostic (1.04e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.07e-2)"	1.3	1.8	2.2	4.3	5.0	11.1	5.2	3.6	3.1	3.2	3.5	4.6	3.3	4.7	2.2	9.7	3.1	27.2	3.2	2.6	2.9	2.9	1.3	1.3	9.1	5.9	2.9	1.8	8.0	3.2	1.4	25.1	2.1	5.8	2.3	2.7	1.9	2.5	1.7	1.6	5.3	4.3	1.5	1.8	2.8	3.7	5.7	2.2	22.7	1.8	2.1	4.6	1.7	2.1	2.1	1.8	8.2	0.5	0.7	1.8	0.9	12.2	5.6	14.9	9.3	1.5	2.0	8.3	7.6	2.8	5.3	5.2	2.6	9.0	8.9	1.9	2.1	9.9	4.0	3.2	1.6	9.2	8.7	14.3	14.7	1.4	0.3	4.0	8.2	0.9	0.7	3.8	0.9	3.3	8.1	23.7	4.3	5.0	19.9	5.5	6.4	2.8	29.6	6.7	7.9	1.6	2.3	12.3	7.7	5.7	4.1	1.8	10.0	8.1	2.3	3.3	9.4	3.2	4.5	9.6	4.2	4.2	5.8	17.7	8.5	8.2	0.5	1.1	0.9	0.3	0.5	0.2	1.1	1.2	0.1	2.1	1.8	1.4	0.7	0.7	0.2	1.8	1.3	0.9	2.2	5.0	3.6	3.1	2.9	2.9	2.9	1.8	5.8	2.2
C21orf62	"B37, C21orf120, PRED81"	ENSG00000205929	"Chromosome 21 open reading frame 62"	Q9NYP8	21	32793564-32813743	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 13.4;kidney: 18.2;ovary: 16.2;pituitary gland: 38.6"	"Group enriched"	"Detected in some"	11	"AF22: 7.0;RPTEC TERT1: 4.0"	"Cancer enriched"	"Detected in some"	6	"glioma: 11.0"	"Region enriched"	"Detected in many"	4	"pons and medulla: 13.4"	"Cell type enhanced"	"Detected in some"		"T-reg: 1.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA016899	Enhanced				"Secreted - unknown location"					"HPA016899: AB_1845704"	"unprognostic (1.31e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.37e-3)"	"unprognostic (9.56e-2)"	"unprognostic (3.05e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.78e-1)"	"prognostic favourable (1.14e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.07e-2)"	2.2	0.4	1.6	1.1	2.1	0.3	0.3	0.3	2.4	0.1	0.3	3.9	0.0	0.1	0.2	8.4	0.3	1.2	0.4	0.4	3.0	2.4	18.2	0.3	0.2	0.2	1.5	1.0	16.2	5.6	0.1	38.6	0.1	13.4	4.1	0.1	0.0	0.3	0.3	0.3	0.3	0.6	0.3	1.8	0.2	0.3	0.4	3.1	0.0	0.2	0.0	1.1	0.2	0.3	0.0	0.4	1.1	0.0	0.0	1.7	0.1	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.0	0.1	0.0	0.8	0.0	0.3	0.6	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.4	1.7	0.1	1.6	2.1	0.3	2.4	3.0	2.4	1.5	1.0	13.4	3.1
C2orf15	MGC29762	ENSG00000273045	"Chromosome 2 open reading frame 15"	Q8WU43	2	99141485-99151487	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 22.2"	"Cell line enhanced"	"Detected in many"		"RT4: 10.9;SCLC-21H: 10.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 3.2;NK-cells: 6.5;T-cells: 7.4"					"Low region specificity"	"Detected in all"														"unprognostic (2.61e-2)"	"unprognostic (7.88e-2)"	"unprognostic (4.22e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.99e-2)"	"unprognostic (5.37e-2)"	"unprognostic (9.05e-3)"	"unprognostic (1.62e-2)"	"prognostic favourable (4.95e-4)"	"unprognostic (2.54e-3)"	"unprognostic (1.04e-1)"	"prognostic favourable (1.23e-4)"	"unprognostic (2.06e-1)"	"unprognostic (4.22e-4)"	"unprognostic (5.08e-1)"	"unprognostic (2.97e-2)"	1.0	1.7	4.2	1.2	7.7	1.6	5.4	9.3	4.9	3.9	4.9	0.9	5.4	5.9	1.8	9.3	2.5	6.1	3.9	0.7	7.4	4.5	12.1	1.2	2.1	6.3	3.4	2.9	2.0	6.0	8.0	22.2	1.6	3.7	2.2	3.5	2.1	5.8	4.6	0.7	2.7	4.5	0.3	3.5	2.6	5.5	3.4	2.3	2.4	9.5	0.8	2.1	3.7	1.4	3.2	0.5	1.3	0.4	6.5	7.4	2.2	8.5	1.4	0.3	1.1	0.1	0.0	6.4	0.0	0.7	0.4	0.3	9.0	6.1	3.6	2.8	0.0	5.3	1.3	1.1	0.0	0.7	3.9	0.3	1.4	5.5	0.1	1.2	1.5	0.1	2.0	0.0	0.7	0.0	0.3	0.6	0.3	7.4	1.1	1.6	2.0	2.0	0.6	0.1	4.1	8.7	10.9	10.9	1.4	0.7	8.7	0.3	7.0	0.4	0.0	0.4	0.4	0.3	0.3	2.5	4.1	1.2	0.2	1.1	0.1	0.2	0.4	0.3	3.2	0.2	7.4	3.2	4.9	4.0	0.3	3.2	6.8	3.3	1.3	6.5	0.2	0.5	2.6	2.2	4.2	7.7	9.3	4.9	7.4	4.5	3.4	2.9	3.7	2.3
C2orf66	UNQ6411	ENSG00000187944	"Chromosome 2 open reading frame 66"	Q6UXQ4	2	196805002-196810276	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 7.0;pituitary gland: 6.4"	"Group enriched"	"Detected in some"	4	"HEL: 9.2;RT4: 3.4;TIME: 3.8"	"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA020869	Uncertain				"Secreted - unknown location"					"HPA020869: AB_1851545"	"unprognostic (1.19e-1)"	"unprognostic (4.85e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.61e-2)"	"unprognostic (6.80e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.10e-3)"	"unprognostic (4.54e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.75e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.86e-2)"	7.0	4.0	0.4	0.2	0.7	0.2	1.0	0.1	0.4	0.0	0.2			0.0	0.1	1.2	0.1	1.1	0.4	0.7	0.4	2.8	0.3	0.0	0.2	0.0	0.7		0.3	0.6	0.0	6.4	0.1		0.3	0.4		0.0	0.2	0.0	2.8	0.3	0.1	0.0	0.2	0.0	2.6			0.1		0.2	0.8	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.4	0.1	0.1	0.4	1.0	0.5	0.2	0.0	0.5	0.2	0.2	0.3	0.1	0.2	0.1	0.0	0.1	0.0	0.0	1.1	0.2	0.3	0.5	9.2	1.0	0.1	0.0	0.1	0.8	0.7	1.3	0.2	0.2	0.8	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	3.4	0.4	0.1	0.0	0.1	0.1	0.0	0.0	3.8	0.3	0.3	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.4										
C2orf73	FLJ40298	ENSG00000177994	"Chromosome 2 open reading frame 73"	Q8N5S3	2	54330034-54383742	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.8;pituitary gland: 11.9;testis: 39.2"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.5;BJ hTERT+: 1.6;CAPAN-2: 1.6;HSkMC: 1.7;RPTEC TERT1: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA055221, HPA059596"	Uncertain									"HPA055221: AB_2682744, HPA059596: AB_2684077"	"unprognostic (1.56e-2)"	"unprognostic (7.00e-3)"		"unprognostic (1.51e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.46e-2)"		"unprognostic (2.74e-2)"	"unprognostic (6.69e-3)"	"unprognostic (2.36e-2)"	"unprognostic (1.62e-3)"	"unprognostic (7.69e-2)"	"unprognostic (3.00e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.17e-2)"	"unprognostic (8.99e-2)"	"unprognostic (3.80e-2)"	0.4	0.9	2.0	0.3	6.4	0.3	0.4	0.9	1.6	0.7	0.4	4.1	1.6	0.3	0.6	3.5	0.4	7.3	0.3	0.4	2.7	1.2	0.8	0.4	1.6	0.3	0.9	4.4	0.9	0.9	1.0	11.9	0.3	11.8	0.6	0.3	0.3	0.4	0.6	0.4	0.4	0.4	0.3	1.5	0.4	0.4	39.2	1.7	0.0	1.7	0.0	0.3	0.4	0.4	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.3	0.4	0.7	0.0	2.5	0.0	0.0	1.6	0.0	0.8	0.0	1.6	0.0	0.6	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.7	0.4	1.0	0.0	0.1	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.7	0.0	0.0	0.0	2.6	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	6.4	0.9	1.6	2.7	1.2	0.9	4.4	11.8	1.7
C6orf118	"bA85G2.1, MGC23884"	ENSG00000112539	"Chromosome 6 open reading frame 118"	Q5T5N4	6	165279664-165309607	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 14.5;fallopian tube: 23.9;pituitary gland: 10.4;testis: 9.6"	"Group enriched"	"Detected in some"	5	"AF22: 7.2;SCLC-21H: 4.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"HPA029787, HPA029789"	Approved		Uncertain	Mitochondria				Mitochondria	Mitochondria	"HPA029787: AB_10599999, HPA029789: AB_10601002"	"unprognostic (2.84e-1)"	"unprognostic (3.09e-4)"		"unprognostic (2.70e-2)"	"unprognostic (7.99e-2)"	"unprognostic (5.34e-2)"		"unprognostic (1.41e-1)"		"unprognostic (2.50e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.89e-2)"	"unprognostic (8.18e-9)"	"unprognostic (3.22e-3)"	"unprognostic (3.03e-2)"	"unprognostic (6.55e-3)"	"unprognostic (4.50e-1)"	0.3	0.3	4.4	0.3	11.4	0.3	0.3	0.1	0.8	1.5	0.3	7.5	0.1	0.3	1.0	7.2	0.3	23.9	0.3	0.3	4.3	2.7	0.3	0.3	4.7	0.3	0.3	1.0	3.4	0.3	0.3	10.4	0.3	14.5	0.3	0.3	0.0	0.3	0.4	0.3	0.3	0.3	0.3	0.8	0.3	0.3	9.6	3.9	0.0	0.5	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	7.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.2	0.0	0.2	0.0	4.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	11.4	0.1	0.8	4.3	2.7	0.3	1.0	14.5	3.9
C9orf135		ENSG00000204711	"Chromosome 9 open reading frame 135"	Q5VTT2	9	69820793-69906232	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 17.6;fallopian tube: 31.8;pituitary gland: 35.4;testis: 18.4"	"Group enriched"	"Detected in some"	7	"HAP1: 9.3;NTERA-2: 24.7"	"Cancer enriched"	"Detected in some"	6	"testis cancer: 7.8"	"Region enriched"	"Detected in many"	5	"pons and medulla: 17.6"	"Group enriched"	"Detected in some"	5	"naive CD4 T-cell: 3.3;naive CD8 T-cell: 4.0;T-reg: 3.6"	"Lineage enriched"	"Detected in single"	41	"T-cells: 4.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021261, HPA021325"	Uncertain									"HPA021261: AB_1845811, HPA021325: AB_1845812"	"unprognostic (1.05e-2)"			"unprognostic (4.39e-1)"	"unprognostic (1.97e-1)"			"unprognostic (1.39e-1)"		"unprognostic (1.90e-1)"	"unprognostic (5.22e-3)"	"unprognostic (5.72e-1)"	"unprognostic (3.25e-3)"	"unprognostic (4.11e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.60e-2)"		0.1	0.5	3.2	0.1	2.4	0.1	0.1	0.0	0.1	0.8	0.1	3.1	0.0	0.1	0.6	9.8	0.1	31.8	1.3	0.1	2.2	2.2	1.3	0.3	7.0	0.1	0.3	0.0	3.2	0.7	3.1	35.4	0.1	17.6	0.1	0.1	0.4	0.2	0.4	0.5	0.1	0.1	0.1	0.4	0.1	0.2	18.4	0.4	0.2	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.7	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.1	0.0	0.0	3.3	4.0	0.0	0.0	0.0	0.0	3.6	0.1	3.2	2.4	0.0	0.1	2.2	2.2	0.3	0.0	17.6	0.4
CASC1	"FLJ10921, LAS1, PPP1R54"	ENSG00000118307	"Cancer susceptibility 1"	Q6TDU7	12	25108420-25195162	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 17.1;pituitary gland: 21.5;testis: 25.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 3.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.2"	"Group enriched"	"Detected in many"	5	"B-cells: 2.6;granulocytes: 4.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039662	Enhanced									"HPA039662: AB_10795468"	"unprognostic (6.42e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.04e-3)"	"unprognostic (4.62e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.91e-2)"	"unprognostic (6.21e-4)"	"unprognostic (2.54e-2)"	"prognostic favourable (3.13e-4)"	"unprognostic (2.01e-1)"	"unprognostic (8.74e-3)"	"unprognostic (7.16e-2)"	"unprognostic (1.19e-1)"	0.6	1.0	3.1	0.5	7.6	0.8	2.0	0.7	4.6	2.7	0.6	3.7	1.9	0.2	2.2	12.4	0.9	17.1	1.0	0.9	3.5	4.0	3.6	0.3	4.8	0.7	1.5	4.1	5.4	1.3	5.5	21.5	0.4	12.2	1.4	0.3	1.1	1.0	3.4	0.4	1.4	0.4	0.7	2.4	0.5	1.0	25.3	2.5	0.0	5.2	0.0	0.4	0.6	0.6	2.6	0.7	4.2	0.4	0.2	0.6	0.3	0.6	1.1	1.2	0.9	0.0	0.7	0.7	0.0	0.9	0.8	0.8	0.1	3.3	3.4	1.1	0.0	0.6	0.1	0.6	0.7	1.0	0.2	0.0	0.1	0.0	0.0	0.5	1.4	0.0	0.5	0.6	0.0	0.0	1.7	1.2	0.0	0.0	0.5	1.3	0.4	0.0	1.1	0.5	0.0	3.2	0.3	2.1	0.8	0.5	0.0	0.6	3.2	0.2	0.0	0.2	2.6	1.6	0.3	1.4	0.6	2.7	0.9	0.6	0.6	0.4	0.3	0.8	0.3	0.3	0.3	1.6	0.1	0.6	0.1	2.6	0.4	0.5	4.2	0.2	0.4	0.7	0.0	0.3	3.1	7.6	0.7	4.6	3.5	4.0	1.5	4.1	12.2	2.5
CBARP	"BARP, C19orf26, DOS, MGC40084"	ENSG00000099625	"CACN beta subunit associated regulatory protein"	Q8N350	19	1228287-1238027	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.9;pituitary gland: 13.1"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 8.6"	"Cancer enhanced"	"Detected in many"		"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA012777			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA012777: AB_2067005"	"unprognostic (1.31e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.54e-5)"	"unprognostic (3.48e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.86e-3)"	"unprognostic (3.03e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.40e-1)"	"unprognostic (7.42e-5)"	2.3	8.1	7.2	1.5	12.1	1.0	1.2	3.6	17.9	1.2	1.3	5.2	0.0	1.3	1.8	1.1	1.5	1.1	1.8	1.5	8.5	5.6	1.8	1.5	1.4	1.1	3.3	4.7	2.9	2.1	1.6	13.1	1.4	10.6	1.4	1.0	1.2	1.2	1.5	1.3	4.5	1.1	1.2	6.5	1.2	1.9	3.0	2.2	0.0	1.3	0.0	1.2	1.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	2.0	5.2	0.2	0.6	1.5	4.4	1.3	0.9	0.9	2.3	0.2	0.0	4.9	0.9	2.3	0.8	0.9	0.2	0.9	1.1	0.1	1.7	1.4	2.2	0.1	1.8	1.2	0.5	1.1	0.3	0.6	2.7	0.1	0.6	3.9	0.0	1.3	3.6	2.1	4.3	0.8	0.3	0.2	0.5	3.2	8.6	0.0	0.1	4.5	0.6	0.9	1.7	1.8	5.5	5.1	1.6	0.5	0.5	0.0	1.4	0.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	12.1	3.6	17.9	8.5	5.6	3.3	4.7	10.6	2.2
CCDC152	LOC100129792	ENSG00000198865	"Coiled-coil domain containing 152"	Q4G0S7	5	42756801-42802360	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 52.8;pituitary gland: 24.3"	"Cell line enhanced"	"Detected in some"		"HeLa: 10.8;U-2 OS: 19.5;U-266/84: 13.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036240	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA036240: AB_10671242"	"unprognostic (1.83e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.44e-3)"	"unprognostic (3.24e-3)"	"unprognostic (1.71e-2)"	"unprognostic (2.88e-1)"	"unprognostic (6.25e-3)"	"unprognostic (9.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.29e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.40e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.14e-3)"	4.0	6.0	7.5	2.5	10.2	1.6	3.0	1.0	8.4	2.1	2.3	4.1	0.5	5.0	2.7	1.9	2.0	1.6	6.1	4.6	7.1	3.2	3.6	52.8	3.2	8.6	4.9	5.5	8.2	2.1	0.0	24.3	2.8	20.9	2.1	0.3	1.9	2.1	0.3	1.5	3.1	12.4	0.6	8.8	6.9	1.9	5.7	8.5	8.5	1.7	0.5	3.0	2.9	3.1	3.6	10.0	0.3	0.7	6.2	6.1	1.3	0.3	0.1	0.9	0.1	2.8	3.5	0.0	4.7	0.1	0.0	0.3	0.0	0.2	0.0	0.3	2.1	3.7	0.0	0.0	0.4	0.0	0.3	0.2	10.8	4.5	2.8	0.1	0.0	4.5	0.0	1.9	0.0	1.4	0.5	1.1	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.4	0.0	0.0	0.3	5.4	0.0	0.1	0.0	0.4	0.1	0.1	0.2	19.5	4.5	0.1	0.1	13.0	0.1	5.7	0.1	0.1	0.1	0.1	0.1	4.0	0.7	4.9	2.2	3.0	5.0	0.7	3.6	4.0	6.1	0.3	6.2	0.3	10.0	1.9	1.3	7.5	10.2	1.0	8.4	7.1	3.2	4.9	5.5	20.9	8.5
CCDC153	LOC283152	ENSG00000248712	"Coiled-coil domain containing 153"	Q494R4	11	119189638-119196769	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 15.1;fallopian tube: 15.8;pituitary gland: 20.0"	"Cell line enhanced"	"Detected in many"		"T-47d: 12.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 15.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA041497	Uncertain		Uncertain	Cytosol				Cytosol	Cytosol	"HPA041497: AB_10794378"	"unprognostic (4.66e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.22e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.23e-3)"	"unprognostic (5.19e-2)"	"unprognostic (9.43e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.92e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.98e-3)"	1.4	1.1	2.2	0.6	4.8	3.8	0.8	0.5	0.9	1.4	0.6	2.0	0.5	0.5	1.1	5.3	1.5	15.8	3.1	2.0	2.6	3.9	1.5	0.6	5.2	0.5	0.5	0.5	1.7	0.5	3.3	20.0	1.3	9.8	0.5	0.6	0.5	0.7	1.6	0.5	1.4	0.8	0.7	1.2	0.8	1.6	2.8	2.4	0.5	1.1	0.5	0.9	0.7	0.5	0.4	1.6	15.1	2.4	0.3	0.6	0.7	2.2	2.9	1.8	1.8	0.3	0.3	4.3	1.2	1.4	0.6	0.7	4.8	7.5	1.5	6.2	0.3	1.6	0.4	1.4	0.1	2.9	2.5	7.0	2.2	3.2	1.0	2.3	0.9	0.7	1.0	1.6	0.4	1.5	2.1	2.8	0.1	8.7	1.5	2.2	0.9	5.1	1.9	2.5	1.4	0.5	2.1	2.3	1.2	2.9	1.4	1.7	12.8	2.7	2.9	3.3	2.6	1.9	2.6	1.1	1.7	1.2	1.4	1.3	3.9	0.4	2.4	3.8	0.3	1.5	0.2	0.4	0.2	0.4	1.6	0.4	0.6	0.5	15.1	0.3	1.5	1.6	0.4	0.7	2.2	4.8	0.5	0.9	2.6	3.9	0.5	0.5	9.8	2.4
CCDC173	"C2orf77, LOC129881"	ENSG00000154479	"Coiled-coil domain containing 173"	Q0VFZ6	2	169645425-169694433	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 19.5;testis: 53.4"	"Cell line enhanced"	"Detected in some"		"HEL: 14.9;HMC-1: 3.6;SCLC-21H: 3.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 2.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA042995, HPA048454"	Uncertain									"HPA042995: AB_2678260, HPA048454: AB_2680400"	"unprognostic (1.66e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.16e-2)"	"unprognostic (9.20e-2)"	"unprognostic (4.18e-2)"	"unprognostic (3.56e-3)"	"unprognostic (3.05e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.26e-6)"	"unprognostic (8.73e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.41e-1)"	0.6	0.6	2.8	0.9	5.1	2.5	1.4	0.7	3.5	1.3	0.6	5.6	1.8	0.8	1.8	7.8	0.6	11.0	1.0	0.5	4.8	3.2	2.1	0.8	4.0	0.5	1.3	2.6	4.1	1.4	1.3	19.5	0.5	14.3	0.7	0.7	0.7	0.5	1.0	0.4	0.5	0.7	0.8	1.4	0.5	0.7	53.4	4.0	0.0	3.1	0.0	0.4	0.5	0.5	0.3	0.4	2.2	0.9	0.2	1.0	0.1	0.7	1.2	1.2	0.3	0.0	0.1	1.3	0.6	0.0	0.6	0.1	0.4	0.2	0.2	0.2	0.0	0.9	1.0	1.3	1.0	0.1	0.7	14.9	1.1	0.4	0.0	1.4	3.6	0.0	0.2	1.9	0.0	0.0	3.3	0.1	0.0	1.8	0.3	0.4	0.3	0.8	0.0	0.0	0.0	0.4	0.7	3.8	1.0	0.1	0.0	0.1	0.9	0.1	0.1	0.4	0.2	1.0	0.5	0.5	0.4	0.4	0.9	0.0	0.3	2.2	0.2	0.0	0.3	0.9	1.0	0.3	0.2	0.5	0.3	0.2	0.3	0.3	0.8	0.2	0.0	0.4	0.0	0.1	2.8	5.1	0.7	2.9	4.8	3.2	1.3	2.6	14.3	4.0
CCDC181	"C1orf114, FLJ25846"	ENSG00000117477	"Coiled-coil domain containing 181"	Q5TID7	1	169394870-169460669	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 22.3;testis: 29.2"	"Cell line enhanced"	"Detected in some"		"AF22: 7.2;NTERA-2: 13.9;SCLC-21H: 8.5;SH-SY5Y: 10.1;U-251 MG: 6.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"basophil: 3.2"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027189, HPA027275, HPA027281, HPA027312"	Enhanced		Approved	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA027189: AB_10599252, HPA027275: AB_10602172, HPA027281: AB_10601452, HPA027312: AB_10601349"	"unprognostic (2.45e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.00e-1)"	"unprognostic (5.97e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.89e-4)"	"unprognostic (4.03e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.18e-2)"	"unprognostic (8.41e-2)"	0.8	3.3	6.3	1.0	8.3	0.9	0.9	5.9	8.4	2.6	0.7	1.6	0.4	0.7	4.6	2.7	0.9	14.5	4.6	2.3	6.6	9.9	7.5	0.6	2.4	0.6	5.2	5.0	8.0	3.0	17.3	22.3	0.5	8.7	2.9	0.7	5.3	0.8	2.9	0.7	1.1	0.9	2.7	4.9	0.5	1.2	29.2	4.1	0.0	1.1	0.0	0.5	1.4	0.8	0.1	0.0	3.2	0.1	0.0	0.2	0.0	0.2	0.3	7.2	0.1	0.2	0.2	0.2	0.1	0.0	1.8	3.8	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.0	0.3	0.2	1.6	1.7	0.1	0.0	0.0	1.9	0.1	0.7	0.0	0.4	0.0	0.1	0.1	0.1	1.3	0.1	4.3	0.0	13.9	0.0	0.0	6.0	0.1	1.1	0.0	8.5	10.1	0.0	0.3	0.5	0.0	0.0	0.5	1.5	4.5	0.2	6.2	2.1	1.9	0.0	2.9	0.1	5.5	3.2	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	6.3	8.3	5.9	8.4	6.6	9.9	5.2	5.0	8.7	4.1
CCDC188		ENSG00000234409	"Coiled-coil domain containing 188"	H7C350	22	20148427-20151065	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 6.1;testis: 23.1"	"Cell line enhanced"	"Detected in some"		"AF22: 5.7;SCLC-21H: 7.8;SH-SY5Y: 10.2;U-2 OS: 4.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	47	"plasmacytoid DC: 4.7"	"Lineage enriched"	"Detected in single"	47	"dendritic cells: 4.7"					"Low region specificity"	"Detected in single"			HPA049901			Approved	"Nucleoplasm,Nuclear bodies"				"Nuclear bodies"	"Nuclear bodies"	"HPA049901: AB_2680943"	"unprognostic (9.83e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.79e-2)"	"unprognostic (6.42e-3)"	"unprognostic (2.45e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.67e-5)"	"unprognostic (1.16e-1)"	"unprognostic (5.37e-5)"	"unprognostic (1.55e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.40e-2)"	1.1	0.9	0.4	0.5	0.6	0.5	0.5	1.4	1.2	0.4	0.4	0.4	0.4	1.0	0.6	0.4	0.4	0.4	0.4	0.4	0.4	1.9	0.4	0.4	0.6	0.7	0.5	0.4	0.4	0.4	0.0	6.1	0.8	0.4	0.4	0.0	0.4	0.4	0.4	0.7	1.5	0.5	0.4	0.4	1.8	0.8	23.1	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	5.7	0.3	0.0	0.7	0.0	1.6	0.8	1.3	0.9	0.1	0.1	0.0	0.2	0.8	0.3	0.0	0.0	0.1	0.2	0.0	1.4	0.2	0.0	0.1	0.0	4.0	0.0	0.0	0.0	0.5	0.1	0.2	3.7	1.2	0.5	0.0	0.3	0.0	0.0	1.1	0.2	0.0	0.0	0.1	7.8	10.2	0.5	0.0	0.6	0.0	0.1	4.1	2.4	4.4	3.0	0.2	0.6	0.1	0.2	3.8	0.3	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.4	0.6	1.4	0.6	0.4	1.9	0.5	0.4	0.4	0.4
CCDC30	"FLJ20972, LOC728621, PFD6L"	ENSG00000186409	"Coiled-coil domain containing 30"	Q5VVM6	1	42463330-42654664	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pituitary gland: 27.1"	"Cell line enriched"	"Detected in single"	18	"HMC-1: 16.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in single"											"HPA036344, HPA036345"	Approved									"HPA036344: AB_10795572, HPA036345: AB_10796213"	"unprognostic (3.21e-2)"	"unprognostic (8.48e-2)"	"unprognostic (3.33e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.72e-3)"	"unprognostic (6.77e-3)"	"unprognostic (7.68e-3)"	"unprognostic (4.61e-3)"	"unprognostic (1.41e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.70e-3)"	"unprognostic (6.95e-3)"	1.4	1.7	5.5	1.2	11.1	1.1	2.5	4.1	7.9	3.2	1.4	1.9	9.2	1.1	2.1	14.3	1.1	8.0	1.9	1.2	4.9	3.7	5.5	1.2	6.5	1.1	2.2	6.0	3.2	2.1	6.8	27.1	1.4	13.7	2.3	1.1	1.7	1.5	9.5	1.1	1.3	1.3	1.3	2.0	1.8	1.2	12.4	2.2	0.0	5.3	0.0	1.2	1.4	1.4	0.6	0.5	2.9	0.3	0.4	0.8	0.2	0.2	0.1	0.4	0.4	0.6	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	16.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.8	0.0	0.4	0.2	0.0	0.1	0.1	0.2	0.8	0.0	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.2	0.2	0.3	2.9	0.3	0.9	0.4	0.1	0.4	0.4	0.3	0.1	0.4	0.6	0.8	0.4	1.6	0.4	0.2	0.5	0.6	0.2	5.5	11.1	4.1	7.9	4.9	3.7	2.2	6.0	13.7	2.2
CDH12	"Br-cadherin, CDHB"	ENSG00000154162	"Cadherin 12"	P55289	5	21750673-22853622	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.7;cervix, uterine: 9.3;pituitary gland: 8.6"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.5;PC-3: 5.1;SCLC-21H: 7.4;U-2 OS: 3.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029325	Uncertain		Uncertain	Vesicles				Vesicles	Vesicles	"HPA029325: AB_2672998"	"unprognostic (2.38e-1)"	"unprognostic (3.21e-1)"		"unprognostic (4.95e-2)"	"unprognostic (8.61e-2)"	"unprognostic (3.31e-2)"		"unprognostic (3.91e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.25e-4)"	"unprognostic (7.35e-2)"	"unprognostic (3.48e-2)"		"unprognostic (5.19e-2)"	0.5	5.2	5.8	0.3	17.7	0.4	1.7	2.0	13.8	9.3	0.5	0.0	0.0	0.5	1.3	1.0	0.4	6.7	0.3	0.5	6.3	3.4	0.7	0.5	0.8	0.3	1.4	4.8	0.5	0.5	0.6	8.6	0.7	4.2	0.5	0.6	1.4	3.1	0.9	0.5	2.5	0.4	0.9	2.5	0.3	0.4	2.9	0.5	0.0	0.4	0.0	0.5	1.5	0.2	0.1	0.3	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.3	0.0	1.0	0.4	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.7	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	5.1	0.2	0.0	0.1	0.0	0.1	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.0	5.8	17.7	2.0	13.8	6.3	3.4	1.4	4.8	4.2	0.5
CDKN2A	"ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, p14, p14ARF, p16, p16INK4a, p19, p19Arf"	ENSG00000147889	"Cyclin dependent kinase inhibitor 2A"	"P42771, Q8N726"	9	21967753-21995301	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 22.6;pituitary gland: 39.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 50.0;HEK 293: 56.7;HeLa: 53.1;SK-MEL-30: 53.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 22.6"	"Group enriched"	"Detected in many"	8	"B-cells: 7.2;T-cells: 22.6"					"Low region specificity"	"Detected in many"			"CAB000093, CAB000445, CAB018232, HPA047838"	Enhanced		Supported	Nucleoli				Nucleoli	Nucleoli	"CAB000093: AB_442119, CAB000445: , CAB018232: AB_785018, HPA047838: "	"unprognostic (3.41e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.00e-3)"	"prognostic unfavourable (1.82e-7)"	"unprognostic (5.22e-2)"	"prognostic favourable (5.19e-4)"	"prognostic unfavourable (2.17e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.56e-2)"	"prognostic unfavourable (5.76e-7)"	"unprognostic (9.41e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.55e-1)"	5.4	8.6	2.9	4.5	3.9	1.8	5.3	1.7	3.1	1.2	2.5	4.4	0.1	1.2	1.2	1.9	6.3	3.0	2.6	0.7	1.7	1.0	0.9	1.2	3.0	3.0	3.6	1.6	1.5	1.5	8.5	39.3	6.7	5.0	1.9	1.1	1.2	2.4	2.9	0.9	1.3	3.7	1.0	3.0	8.9	6.0	13.0	1.9	3.9	1.4	3.0	14.0	2.7	1.5	7.2	0.2	0.8	1.8	0.4	22.6	2.2	2.1	0.0	0.3	14.1	0.1	0.1	6.1	2.3	0.0	19.6	34.9	3.5	50.0	7.2	32.2	1.6	6.0	5.9	36.4	15.8	30.9	56.7	0.0	53.1	2.3	1.5	3.5	3.0	3.8	0.0	19.8	11.0	2.0	0.0	32.9	17.9	0.1	0.3	0.0	0.4	29.2	0.0	13.3	26.4	4.0	0.0	33.0	2.3	38.0	6.3	53.0	7.5	0.1	6.5	0.1	0.4	0.0	0.1	14.7	8.3	29.4	0.0	9.4	0.1	0.8	1.3	0.2	6.2	0.6	9.7	7.2	8.0	11.0	0.2	7.0	0.5	4.7	0.4	0.4	1.8	0.0	22.6	2.2	2.9	3.9	1.7	3.1	1.7	1.0	3.6	1.6	5.0	1.9
CELF3	"BRUNOL1, CAGH4, ERDA4, MGC57297, TNRC4"	ENSG00000159409	"CUGBP Elav-like family member 3"	Q5SZQ8	1	151702404-151716814	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 16.8;brain: 44.0;pituitary gland: 31.2"	"Group enriched"	"Detected in some"	7	"SCLC-21H: 27.9;SH-SY5Y: 19.5"	"Group enriched"	"Detected in many"	5	"glioma: 4.4;pancreatic cancer: 4.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006292	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA006292: AB_10602250"	"unprognostic (2.01e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.12e-1)"	"unprognostic (3.48e-3)"	"unprognostic (3.49e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.82e-8)"	"unprognostic (8.50e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.05e-2)"	1.1	16.8	21.4	1.4	28.9	1.1	1.0	29.2	44.0	1.0	2.1	2.0	0.0	5.0	1.0	1.0	1.1	2.1	1.0	1.0	19.5	16.2	1.1	1.0	1.1	1.0	5.3	15.3	1.0	8.8	1.0	31.2	1.2	3.7	1.1	2.1	3.7	1.0	1.0	1.0	1.0	3.8	1.2	1.5	1.0	8.5	2.0	4.4	0.0	1.1	0.0	1.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	27.9	19.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	28.9	29.2	29.1	19.5	16.2	5.3	15.3	3.7	4.4
CELSR3	"ADGRC3, CDHF11, EGFL1, FMI1, HFMI1, MEGF2"	ENSG00000008300	"Cadherin EGF LAG seven-pass G-type receptor 3"	Q9NYQ7	3	48636469-48662915	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.7;pituitary gland: 11.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 12.9;SH-SY5Y: 14.7;SiHa: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062866	Approved									"HPA062866: AB_2684886"	"unprognostic (7.80e-2)"	"unprognostic (3.80e-2)"	"unprognostic (4.89e-1)"	"unprognostic (9.12e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.59e-6)"	"unprognostic (3.61e-6)"	"unprognostic (1.86e-1)"	"unprognostic (1.46e-3)"	"unprognostic (5.07e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.87e-3)"	"unprognostic (3.26e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.73e-1)"	0.7	4.0	10.9	1.2	8.3	1.7	0.8	19.7	11.1	0.6	1.3	0.0	0.0	1.2	0.8	1.2	0.6	0.7	0.7	0.5	7.1	1.4	0.6	0.6	0.8	1.4	2.0	10.4	0.9	2.6	1.4	11.2	1.0	3.6	0.7	1.2	1.4	0.6	0.8	0.5	1.2	1.3	0.8	3.3	1.0	2.1	5.4	1.4	0.0	0.9	0.0	1.0	0.7	0.7	0.3	0.1	0.0	0.1	0.2	1.5	0.4	3.8	2.9	4.8	2.8	0.6	0.9	1.2	0.2	0.5	0.6	0.9	5.4	2.9	0.8	0.7	0.2	0.4	1.5	0.2	0.3	12.9	0.8	1.3	11.1	1.9	0.9	1.2	2.1	0.4	3.8	0.3	6.9	0.0	0.5	3.9	0.9	4.1	0.1	0.0	2.7	1.3	0.3	0.7	4.0	0.0	2.6	10.8	14.7	12.9	0.3	0.5	6.4	2.5	0.0	4.8	4.6	6.2	2.3	0.3	7.0	3.4	3.4	0.9	7.4	0.0	0.1	0.0	1.0	0.0	0.2	0.3	0.2	0.2	0.1	0.0	0.3	1.5	0.0	0.2	0.0	0.0	1.1	0.4	10.9	8.3	19.7	11.1	7.1	1.4	2.0	10.4	3.6	1.4
CEP126	KIAA1377	ENSG00000110318	"Centrosomal protein 126"	Q9P2H0	11	101915015-102001058	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 47.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 10.0;EFO-21: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038381, HPA038399"			Uncertain	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA038381: , HPA038399: "	"unprognostic (7.61e-2)"	"unprognostic (6.75e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.31e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.55e-4)"	"unprognostic (1.52e-2)"	"unprognostic (5.77e-2)"	"unprognostic (9.55e-2)"	"unprognostic (7.72e-3)"	"unprognostic (8.87e-2)"	"prognostic unfavourable (5.00e-4)"	"unprognostic (1.30e-2)"	"unprognostic (3.41e-1)"	"unprognostic (9.61e-2)"	"unprognostic (6.99e-3)"	7.6	11.1	9.0	2.4	20.2	2.4	8.3	16.8	14.8	7.9	4.2	5.0	4.2	2.0	9.1	6.7	5.3	17.5	4.9	4.5	9.6	8.3	3.8	1.4	6.1	3.3	7.5	10.2	11.4	5.0	6.4	47.3	2.6	12.4	6.6	4.8	3.2	3.2	7.6	2.3	8.5	2.7	7.3	9.2	3.1	4.0	19.2	8.9	0.5	7.4	1.5	2.5	3.9	9.7	2.5	4.8	1.4	0.5	3.3	2.0	0.5	0.9	2.2	1.0	1.3	10.0	5.5	0.4	2.1	1.8	1.0	0.9	0.6	3.0	1.3	9.5	1.9	0.9	1.2	2.3	0.9	3.0	1.4	0.3	3.7	1.1	1.1	0.2	0.3	1.9	4.7	1.3	2.8	2.9	0.3	0.4	2.5	1.1	1.0	0.3	0.8	1.6	0.2	1.1	0.2	1.9	1.2	2.7	4.2	1.3	1.9	0.3	3.7	0.4	1.7	3.3	1.9	1.0	2.2	2.2	1.2	0.2	3.2	0.3	1.3	0.7	0.5	1.0	2.0	0.1	0.9	1.8	1.2	1.6	0.4	2.5	1.7	1.7	1.4	3.3	0.2	4.8	0.3	0.5	9.0	20.2	16.8	14.8	9.6	8.3	7.5	10.2	12.4	8.9
CFAP47	"CHDC2, CXorf22, CXorf30, CXorf59, FLJ36601, MGC34831, RP13-11B7.1"	ENSG00000165164	"Cilia and flagella associated protein 47"	Q6ZTR5	X	35919734-36385319	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 12.4;fallopian tube: 12.8;pituitary gland: 24.5"	"Group enriched"	"Detected in some"	7	"Karpas-707: 4.1;U-266/70: 7.7"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044633, HPA054859"	Uncertain									"HPA044633: AB_10960684, HPA054859: AB_2682627"	"unprognostic (1.88e-1)"	"unprognostic (4.38e-2)"	"unprognostic (9.62e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.50e-5)"	"unprognostic (2.69e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.48e-2)"	"unprognostic (5.19e-3)"	0.3	0.3	2.0	0.2	5.9	0.2	0.3	0.3	1.2	0.9	0.3	6.2	1.2	0.2	0.7	7.0	0.3	12.8	0.2	0.3	3.7	1.3	0.4	0.5	3.7	0.2	1.2	1.5	5.3	0.3	2.3	24.5	0.3	12.4	0.3	0.2	2.0	0.3	0.3	0.3	0.3	0.3	0.2	1.1	0.3	0.3	2.1	2.7	0.0	1.0	0.0	0.2	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	4.1	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	5.9	0.3	1.2	3.7	1.3	1.2	1.5	12.4	2.7
CFAP61	"C20orf26, CaM-IP3, dJ1002M8.3, DKFZP434K156"	ENSG00000089101	"Cilia and flagella associated protein 61"	Q8NHU2	20	20052514-20360702	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 15.1;heart muscle: 14.8;pituitary gland: 15.0;skeletal muscle: 23.9;testis: 25.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.2;HMC-1: 4.1;SCLC-21H: 9.5;SK-MEL-30: 3.7;U-87 MG: 7.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdTCR: 2.3;plasmacytoid DC: 1.5"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA009079	Approved									"HPA009079: AB_1078344"	"unprognostic (5.93e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.38e-3)"	"unprognostic (6.20e-3)"	"unprognostic (3.67e-3)"	"unprognostic (8.58e-4)"	"unprognostic (8.24e-2)"	"unprognostic (8.29e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.76e-4)"	"unprognostic (2.77e-1)"	"unprognostic (9.27e-2)"	"unprognostic (3.10e-3)"	"unprognostic (3.06e-1)"	0.2	1.2	1.0	0.2	9.5	0.1	0.5	0.6	2.6	0.9	0.2	5.3	0.8	0.1	1.1	4.5	0.2	15.1	0.3	14.8	4.0	1.9	1.1	0.2	3.5	0.2	0.9	2.0	3.3	0.5	1.0	15.0	0.2	11.4	0.5	0.2	0.1	0.3	0.4	23.9	0.5	0.3	0.3	0.7	0.2	0.3	25.5	1.1	0.0	1.1	0.0	0.2	0.2	0.2	0.0	1.5	0.0	0.0	0.6	2.3	0.0	0.4	1.3	0.2	0.5	0.0	0.0	0.5	0.1	0.4	0.0	0.4	0.0	0.7	4.2	0.1	0.0	0.1	0.2	0.0	0.1	1.1	1.5	0.0	0.4	0.0	0.0	0.0	4.1	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.3	0.3	0.0	0.3	2.1	0.7	0.0	9.5	0.2	0.2	0.4	3.7	0.7	0.0	0.7	0.0	0.4	0.6	0.3	1.4	0.4	0.0	7.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.6	0.0	1.5	0.0	0.0	1.0	9.5	0.6	2.6	4.0	1.9	0.9	2.0	11.4	1.1
CFAP70	"FLJ25765, TTC18"	ENSG00000156042	"Cilia and flagella associated protein 70"	Q5T0N1	10	73253759-73358859	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 27.2;testis: 22.3"	"Cell line enhanced"	"Detected in many"		"PC-3: 9.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037582, HPA070304"	Enhanced									"HPA037582: AB_2675560, HPA070304: AB_2732153"	"unprognostic (2.29e-3)"	"unprognostic (4.42e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.94e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.67e-3)"	"unprognostic (5.95e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.16e-1)"	1.6	3.8	3.8	1.1	7.1	0.6	3.9	3.3	4.3	2.6	0.8	8.2	8.7	1.6	2.1	13.8	0.9	17.3	1.8	1.4	4.2	5.3	4.0	2.2	3.3	1.0	3.7	3.8	4.0	2.4	10.1	27.2	0.8	14.7	4.2	0.9	4.0	2.9	8.5	1.2	3.5	0.8	1.3	4.4	1.4	1.7	22.3	6.5	0.5	6.1	0.5	1.1	0.8	1.0	2.7	1.2	1.1	0.5	1.5	4.1	1.0	1.7	2.1	2.4	2.0	4.1	3.6	0.7	0.9	0.3	0.6	0.6	1.7	7.7	0.9	1.2	0.3	1.2	1.3	1.7	0.9	1.6	3.7	1.5	1.9	1.7	0.4	0.8	0.9	2.2	4.1	1.3	1.1	0.0	0.7	5.0	0.7	3.0	2.0	1.6	0.8	9.0	1.3	2.0	3.9	3.8	0.6	3.3	0.3	0.8	1.6	1.3	3.0	1.3	1.4	0.6	2.1	0.9	2.2	5.1	2.8	2.2	2.9	1.7	0.6	0.2	0.1	1.1	1.0	0.5	2.2	1.8	2.0	1.6	0.6	2.7	4.1	3.6	0.3	1.5	0.4	1.2	1.8	1.0	3.8	7.1	3.3	4.3	4.2	5.3	3.7	3.8	14.7	6.5
CGB3	CGB	ENSG00000104827	"Chorionic gonadotropin beta subunit 3"	P0DN86	19	49022869-49024333	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"pituitary gland: 6.7;placenta: 15.0"	"Cell line enriched"	"Detected in some"	20	"BEWO: 38.8"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.9;testis cancer: 4.2"					"Cell type enhanced"	"Detected in single"		"T-reg: 1.0"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.0"									"CAB000042, CAB010884, HPA038925, HPA038934"	Enhanced		Approved	Cytosol	"Secreted to blood"			Cytosol	Cytosol	"CAB000042: , CAB010884: AB_259037, HPA038925: AB_2676272, HPA038934: AB_2676277"									"unprognostic (1.39e-1)"		"unprognostic (7.88e-2)"				"unprognostic (6.92e-2)"		"unprognostic (1.04e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	3.2	0.0	6.7	15.0		0.0	0.0		0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0			0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	38.8	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.0	1.9	0.7	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0										
CHD5		ENSG00000116254	"Chromodomain helicase DNA binding protein 5"	Q8TDI0	1	6101793-6180123	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.4;pituitary gland: 22.3;testis: 16.4"	"Group enriched"	"Detected in some"	4	"SCLC-21H: 16.6;U-2 OS: 7.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA015809			Supported	"Nucleoplasm,Nuclear speckles,Cytosol"				"Nucleoplasm, Nuclear speckles"	"Nucleoplasm, Nuclear speckles"	"HPA015809: "	"unprognostic (5.03e-4)"	"unprognostic (1.89e-1)"	"unprognostic (2.47e-3)"	"unprognostic (9.40e-6)"	"unprognostic (1.91e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.64e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.34e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.98e-1)"	1.1	7.9	19.8	1.3	17.1	1.0	1.0	12.1	41.4	1.2	1.4	0.7	0.0	1.3	1.2	1.2	1.5	1.2	1.2	1.6	15.3	10.1	1.3	1.0	1.2	1.0	4.3	19.1	1.1	1.4	1.3	22.3	1.0	8.0	1.9	1.3	2.3	1.2	4.8	1.2	1.0	1.4	1.2	1.6	1.1	1.2	16.4	0.8	0.0	1.0	0.0	1.0	1.1	0.4	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.7	0.0	0.1	0.1	0.0	0.0	0.1	0.2	2.5	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.3	1.5	0.0	0.3	1.3	0.0	0.0	0.0	0.0	16.6	0.2	0.1	0.0	0.0	2.8	0.1	0.0	0.1	7.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	19.8	17.1	12.1	34.2	15.3	10.1	4.3	19.1	8.0	0.8
CHGB	"SCG1, SgI"	ENSG00000089199	"Chromogranin B"	P05060	20	5911430-5925361	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 424.9;pituitary gland: 177.5"	"Group enriched"	"Detected in some"	23	"SCLC-21H: 65.1;SH-SY5Y: 99.7"	"Cancer enriched"	"Detected in many"	6	"pancreatic cancer: 154.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.6;T-reg: 1.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008759, CAB009403, HPA012602"	Enhanced	Supported	Enhanced	Vesicles	"Intracellular and membrane"	24000000	24000000	Vesicles	Vesicles	"CAB009403: AB_2081255, HPA008759: AB_1846704, HPA012602: AB_1846706"	"unprognostic (1.79e-3)"	"unprognostic (7.72e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.68e-2)"	"prognostic unfavourable (1.89e-4)"	"unprognostic (7.96e-3)"	"unprognostic (2.86e-1)"	"unprognostic (6.18e-3)"	"unprognostic (7.93e-2)"	"prognostic favourable (9.96e-4)"	"unprognostic (8.56e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.01e-2)"	3.4	424.9	8.2	1.4	10.2	0.8	1.0	82.5	16.4	0.8	3.0	2.1	1.2	7.7	0.9	1.3	0.8	2.5	0.8	7.6	20.7	15.4	1.7	0.7	1.0	1.1	7.2	9.1	3.0	17.0	0.8	177.5	0.8	51.8	5.6	2.5	0.7	0.9	1.2	2.1	0.9	4.4	0.9	2.3	0.8	19.7	2.4	0.8	0.0	1.9	0.4	0.9	0.8	0.1	0.0	0.6	0.0	0.0	0.0	2.6	0.2	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.7	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	65.1	99.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.1	0.4	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.2	8.2	10.2	82.5	16.4	20.7	15.4	7.2	9.1	51.8	0.8
CHRNA9	NACHRA9	ENSG00000174343	"Cholinergic receptor nicotinic alpha 9 subunit"	Q9UGM1	4	40335329-40355217	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.3;fallopian tube: 3.9;pituitary gland: 4.6;salivary gland: 2.7;skin 1: 2.7"	"Cell line enriched"	"Detected in some"	8	"U-87 MG: 18.8"	"Cancer enhanced"	"Detected in some"		"glioma: 3.5"	"Region enhanced"	"Detected in some"		"pons and medulla: 2.6"	"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.5;naive CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.5"	"Region enriched"	"Detected in single"	6	"basal ganglia: 1.0"	"Low region specificity"	"Detected in many"														"unprognostic (6.20e-3)"	"unprognostic (9.18e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.54e-1)"	"unprognostic (3.48e-1)"		"unprognostic (1.58e-1)"	"unprognostic (1.89e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.94e-1)"		"unprognostic (8.96e-6)"	"unprognostic (9.00e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.01e-2)"	"unprognostic (9.18e-3)"	0.0	0.0	0.9	0.0	0.2	0.0	0.1	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.9	0.0	0.0	0.2	0.6	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.2	4.6	0.7	2.6	0.0	0.0	0.0	2.7	0.0	0.0	2.7	0.0	0.0	3.3	0.1	0.0	0.4	0.0	0.0	0.4	0.0	0.4	0.7	0.2	0.3	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.0	2.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.1	0.1	0.1	0.1	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.4	0.5	0.0	0.3	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.2	0.0	1.4	0.2	0.6	0.0	0.0	2.6	0.0
CLDN25		ENSG00000228607	"Claudin 25"	C9JDP6	11	113779747-113780500	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"pituitary gland: 2.5;skin 1: 1.2"	"Cell line enriched"	"Detected in single"	33	"T-47d: 3.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"			HPA053555	Uncertain									"HPA053555: AB_2682186"	"unprognostic (1.02e-2)"											"unprognostic (3.22e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0		0.0	0.0	0.0	2.5	0.0		0.0	0.0		0.2	0.0	0.9	1.2	0.0	0.0	0.0	0.0	0.0	0.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CLDN9		ENSG00000213937	"Claudin 9"	O95484	16	3012456-3014505	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.5;pancreas: 9.6;pituitary gland: 15.9;placenta: 10.2"	"Group enriched"	"Detected in some"	4	"CAPAN-2: 5.5;MCF7: 19.1;SCLC-21H: 15.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"cerebellum: 16.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA076613			Supported	"Vesicles,Cell Junctions"				"Cell Junctions"	"Cell Junctions"	"HPA076613: AB_2686808"	"unprognostic (7.93e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavourable (2.24e-6)"	"unprognostic (4.91e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.64e-2)"	"unprognostic (5.06e-2)"	"unprognostic (8.97e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavourable (4.67e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.71e-3)"	"unprognostic (5.55e-2)"	0.3	0.4	0.4	0.5	2.1	5.2	0.3	16.5	1.4	0.6	1.0	0.3	0.3	1.8	0.3	0.9	0.3	2.3	1.1	0.4	0.8	0.8	0.6	2.6	1.5	0.3	1.4	0.3	0.3	9.6	4.8	15.9	10.2	0.5	0.3	0.1	0.3	1.7	0.3	1.5	0.4	1.2	0.3	2.2	1.0	0.3	0.3	0.3	1.2	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.2	0.1	0.0	2.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	5.5	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	19.1	0.0	1.6	0.0	0.1	0.0	0.0	0.2	0.2	0.1	15.0	0.1	0.7	0.8	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	2.1	16.5	1.4	0.8	0.8	1.4	0.3	0.5	0.3
CLGN		ENSG00000153132	Calmegin	O14967	4	140388455-140427968	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 40.3;pituitary gland: 23.6;testis: 52.6"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 18.4;U-251 MG: 29.2"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 19.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 3.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020709, HPA048761, HPA058627"	Enhanced		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB020709: , HPA048761: AB_2680514, HPA058627: "	"unprognostic (6.74e-2)"	"unprognostic (8.28e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.73e-3)"	"unprognostic (6.14e-2)"	"unprognostic (4.80e-2)"	"unprognostic (3.11e-1)"	"unprognostic (5.38e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.00e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.01e-1)"	0.4	3.6	2.1	0.7	3.7	1.2	1.6	5.9	3.5	0.8	1.4	0.5	0.0	0.4	1.0	1.6	0.9	7.0	0.4	40.3	0.9	3.4	0.4	3.7	0.5	0.5	1.4	1.6	1.8	1.6	0.2	23.6	0.3	8.6	11.9	0.8	2.4	0.6	0.6	0.4	0.3	0.8	0.9	0.8	0.3	1.6	52.6	0.3	3.1	1.5	0.0	0.8	0.6	0.4	0.5	1.0	3.4	1.1	0.0	0.0	0.1	0.0	4.0	4.3	2.7	1.7	8.9	1.0	0.0	3.8	4.1	7.6	0.1	0.3	0.0	11.6	0.4	0.1	2.9	0.0	6.7	0.2	3.5	1.1	4.1	3.0	17.6	14.8	0.2	1.0	16.3	0.4	0.4	0.1	0.7	0.0	0.0	0.2	18.4	0.2	4.8	11.5	12.3	0.0	0.1	0.0	0.1	6.9	12.4	2.6	1.6	0.7	0.8	2.2	0.0	11.1	2.0	4.0	29.2	5.9	12.7	8.0	17.9	0.6	1.2	3.4	1.1	1.5	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	3.7	5.9	3.5	0.9	3.4	1.4	1.6	8.6	0.3
CNTN5	"hNB-2, NB-2"	ENSG00000149972	"Contactin 5"	O94779	11	99020953-100358885	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.9;pituitary gland: 12.0;salivary gland: 28.4"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.2;TIME: 2.1;U-138 MG: 1.0;U-266/70: 3.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"HPA039492, HPA041223"	Approved				"Intracellular and membrane"	100000	100000			"HPA039492: AB_10795108, HPA041223: AB_10794549"	"unprognostic (2.09e-2)"	"unprognostic (3.40e-1)"		"unprognostic (8.99e-3)"	"unprognostic (4.20e-2)"	"unprognostic (6.51e-5)"	"unprognostic (3.85e-2)"	"unprognostic (9.25e-2)"		"unprognostic (6.13e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.72e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.25e-1)"	0.3	0.5	6.5	0.3	4.0	0.2	0.2	0.6	10.9	0.7	0.4	0.5	0.0	0.3	0.6	0.3	0.3	3.8	0.3	0.4	5.0	3.4	1.4	0.5	0.7	0.3	1.4	2.0	0.4	0.9	0.2	12.0	7.4	3.9	0.5	0.3	0.0	28.4	1.1	0.2	0.2	0.3	0.4	0.5	0.2	0.5	0.8	0.3	0.0	5.9	0.0	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.2	0.0	0.0	0.1	0.0	0.8	0.2	2.1	1.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	4.0	0.6	10.9	5.0	3.4	1.4	2.0	3.9	0.3
COL22A1		ENSG00000169436	"Collagen type XXII alpha 1 chain"	Q8NFW1	8	138588235-138914006	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 46.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 23.4;RT4: 9.9;SCLC-21H: 6.7;U-2 OS: 5.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA024830	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"			Vesicles	Vesicles	"HPA024830: AB_1847102"	"unprognostic (1.06e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.19e-6)"	"prognostic unfavourable (4.15e-4)"	"unprognostic (1.05e-2)"	"unprognostic (5.57e-3)"	"prognostic unfavourable (2.13e-6)"	"unprognostic (2.01e-1)"	"unprognostic (9.24e-2)"	"unprognostic (5.74e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.66e-15)"	"unprognostic (2.38e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.09e-1)"	0.1	12.0	0.2	1.3	1.1	0.0	0.1	6.8	1.1	1.3	0.7	1.4	10.8	0.3	2.4	1.9	0.2	0.5	0.4	0.2	0.3	0.8	2.8	0.1	0.1	0.5	0.3	0.0	0.3	0.2	1.7	46.5	0.0	1.9	4.7	0.1	1.6	0.8	5.1	0.5	0.1	0.4	2.2	1.8	0.3	3.7	0.8	0.1	1.4	0.3	0.7	1.7	1.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	9.9	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	6.8	0.3	0.3	0.8	0.3	0.0	1.9	0.1
COL25A1		ENSG00000188517	"Collagen type XXV alpha 1 chain"	Q9BXS0	4	108808725-109302752	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 17.4;retina: 22.1;testis: 23.6"	"Cell line enriched"	"Detected in some"	8	"HeLa: 30.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							HPA029107			Approved	"Endoplasmic reticulum,Vesicles,Cytosol"				"Vesicles, Cytosol"	"Vesicles, Cytosol"	"HPA029107: "	"unprognostic (1.77e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.87e-5)"	"unprognostic (2.43e-2)"	"unprognostic (3.20e-1)"	"unprognostic (7.62e-3)"	"unprognostic (6.86e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.30e-3)"	"unprognostic (2.82e-3)"	"unprognostic (9.75e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.96e-1)"	9.0	0.8	6.7	0.2	4.4	0.0	5.1	0.8	3.4	1.6	0.9	0.4	0.9	4.0	2.1	3.5	0.8	1.4	3.1	2.0	4.7	2.1	2.9	3.2	0.9	0.1	0.8	0.0	1.6	0.9	3.9	17.4	0.4	2.5	0.9	0.4	22.1	6.7	1.4	1.4	1.1	3.1	1.5	0.9	1.0	0.9	23.6	1.5	0.0	3.7	0.1	0.0	1.6	3.4	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	3.8	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.4	0.0	1.9	0.0	0.1	0.0	2.3	4.1	30.8	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.0	0.0	0.8	0.2	3.9	0.0	0.5	0.0	1.1	0.1	0.0	2.1	0.0	0.0	0.0	0.8	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	4.4	0.8	3.4	4.7	2.1	0.8	0.0	2.5	1.5
COL6A6		ENSG00000206384	"Collagen type VI alpha 6 chain"	A6NMZ7	3	130560334-130678155	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 5.6;lung: 11.1;pituitary gland: 5.7"	"Cell line enhanced"	"Detected in some"		"HEL: 1.1;SH-SY5Y: 1.9"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045239	Uncertain				"Secreted to extracellular matrix"	490000	490000			"HPA045239: AB_2679268"	"unprognostic (4.86e-3)"	"unprognostic (2.16e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.08e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.11e-5)"	"unprognostic (3.74e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.50e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.96e-4)"	"unprognostic (5.82e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.07e-1)"	2.3	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0			0.0	0.7	0.3	1.2	0.3	0.0	5.6	0.0	0.0	0.0	0.9	11.1	0.0	0.0		0.2	0.0	0.0	5.7	0.8		0.0	0.0		2.2	0.0	0.0	0.4	0.0	0.5	0.0	1.5	0.0	0.3			0.0		0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.6	0.8	0.0	0.0	0.3	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.3	1.9	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.7	0.3	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.3	0.1	0.0	0.1	0.0	0.2	0.0										
COL9A2	"EDM2, MED"	ENSG00000049089	"Collagen type IX alpha 2 chain"	Q14055	1	40300487-40317813	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.3;pituitary gland: 32.1;retina: 40.8"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 34.6;HMC-1: 33.4;THP-1: 37.4"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 68.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 6.4;myeloid DC: 2.7"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.7;granulocytes: 6.4"	"Low region specificity"	"Detected in all"							"HPA056316, HPA075286"	Supported		Approved	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"			Vesicles	Vesicles	"HPA056316: AB_2683099, HPA075286: AB_2732288"	"unprognostic (1.42e-2)"	"unprognostic (3.54e-2)"	"unprognostic (8.94e-2)"	"prognostic unfavourable (5.13e-4)"	"unprognostic (4.46e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.06e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.56e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.16e-3)"	"unprognostic (4.28e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.71e-2)"	0.7	2.3	17.2	2.6	19.5	7.6	3.1	2.3	12.1	10.0	3.6	32.0	17.4	4.6	3.9	1.5	0.7	3.7	6.5	1.0	20.8	14.5	4.3	0.6	2.8	4.2	29.8	10.5	0.6	1.7	28.3	32.1	0.9	16.3	8.8	2.6	40.8	13.7	21.3	0.3	2.0	3.3	1.3	35.3	3.2	12.8	0.8	19.7	0.2	4.3	0.9	2.5	4.0	0.5	0.7	2.7	6.4	0.7	0.4	0.3	0.1	4.2	0.1	0.6	0.3	0.9	0.5	2.9	0.0	0.0	0.2	0.5	0.1	2.4	1.2	3.7	0.1	0.7	0.0	0.0	0.1	34.6	0.5	0.7	0.3	9.7	0.6	0.3	33.4	1.8	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.9	0.4	0.7	0.8	0.4	0.8	0.0	2.4	0.0	5.1	0.5	0.8	0.0	4.3	0.4	5.4	37.4	0.0	0.0	4.4	0.0	0.1	0.5	0.0	1.1	0.3	4.4	0.2	0.0	0.2	6.4	0.0	0.5	0.0	0.5	0.2	0.0	2.7	0.7	0.1	0.0	1.1	0.4	0.7	0.3	0.3	0.1	17.2	19.5	2.3	10.8	20.8	14.5	29.8	10.5	16.3	19.7
CRMP1	"DPYSL1, DRP-1"	ENSG00000072832	"Collapsin response mediator protein 1"	Q14194	4	5748084-5893058	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 63.1;pituitary gland: 23.0"	"Cell line enhanced"	"Detected in some"		"AF22: 20.4;HAP1: 29.2;NTERA-2: 21.2;REH: 55.5;RH-30: 32.7;SCLC-21H: 42.4;SH-SY5Y: 26.8"	"Cancer enhanced"	"Detected in all"		"glioma: 37.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"naive B-cell: 2.5"	"Lineage enriched"	"Detected in single"	25	"B-cells: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035640, CAB037313"	Approved		Supported	Centrosome,Cytosol				Centrosome	Centrosome	"CAB037313: AB_1078571, HPA035640: AB_10670838"	"unprognostic (1.56e-1)"	"unprognostic (7.22e-2)"	"unprognostic (5.14e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.79e-1)"	"unprognostic (9.71e-2)"	"prognostic favourable (4.54e-4)"	"unprognostic (2.26e-1)"	"unprognostic (8.52e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.60e-3)"	1.8	8.2	24.2	2.5	21.7	0.7	1.0	32.0	63.1	3.3	2.0	5.9	0.1	1.5	11.7	0.7	2.7	4.3	4.3	2.6	22.2	23.9	2.4	0.9	4.2	1.8	9.9	18.1	6.9	4.8	0.9	23.0	4.6	12.3	3.0	1.9	4.6	2.6	3.1	1.0	3.3	2.5	11.6	4.7	1.4	3.5	2.8	4.5	0.0	2.4	0.9	1.3	2.9	1.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	20.4	0.7	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.4	29.2	0.0	0.0	0.5	0.2	0.0	1.0	0.1	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	21.2	0.6	55.5	32.7	4.9	0.0	0.0	42.4	26.8	0.0	0.1	0.3	0.2	0.0	1.7	1.0	7.1	0.6	0.6	3.7	0.5	0.0	2.5	0.2	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.2	21.7	32.0	34.2	22.2	23.9	9.9	18.1	12.3	4.5
CSRNP3	"FAM130A2, FLJ32093, PPP1R73, TAIP-2"	ENSG00000178662	"Cysteine and serine rich nuclear protein 3"	Q8WYN3	2	165469647-165689407	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 31.7;pituitary gland: 21.1"	"Cell line enhanced"	"Detected in some"		"AF22: 12.7;PC-3: 3.1;SCLC-21H: 9.3;SH-SY5Y: 7.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017905	Supported		Uncertain	Nucleoplasm,Nucleoli				Nucleoli	Nucleoli	"HPA017905: AB_1857757"	"unprognostic (2.85e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.61e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.82e-3)"	"unprognostic (7.41e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.08e-2)"	2.1	5.5	9.3	1.4	24.9	0.7	6.7	8.8	31.7	5.7	2.0	3.2	0.4	2.1	6.3	2.3	2.0	2.5	2.5	3.4	9.3	10.2	3.7	1.8	1.4	1.1	5.3	13.2	7.8	8.0	6.0	21.1	1.1	7.8	3.9	2.5	4.0	4.9	5.1	0.9	2.1	1.7	5.7	2.9	2.1	2.0	1.9	4.8	0.0	5.3	0.0	1.0	1.9	2.5	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.2	0.6	0.2	0.6	0.0	0.4	0.2	0.6	0.0	0.0	0.9	0.6	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	3.1	0.0	0.0	0.7	0.7	0.0	9.3	7.6	0.0	0.0	0.0	0.4	0.0	0.0	0.8	0.3	0.0	0.3	0.6	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.3	24.9	8.8	31.7	9.3	10.2	5.3	13.2	7.8	4.8
CXorf57	"FLJ10178, FLJ14191"	ENSG00000147231	"Chromosome X open reading frame 57"	Q6NSI4	X	106611930-106679442	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.8;pituitary gland: 32.3"	"Cell line enhanced"	"Detected in many"		"HEK 293: 22.2;Karpas-707: 11.4;RT4: 23.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"gdTCR: 3.5;MAIT T-cell: 2.6;memory B-cell: 3.9;memory CD4 T-cell: 3.0;memory CD8 T-cell: 2.4;naive B-cell: 2.9;naive CD4 T-cell: 3.7;naive CD8 T-cell: 3.0;NK-cell: 2.1;T-reg: 1.1"	"Group enriched"	"Detected in many"	11	"B-cells: 3.9;NK-cells: 2.1;T-cells: 3.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA000896, HPA001374"	Uncertain		Approved	"Intermediate filaments"				"Intermediate filaments"	"Intermediate filaments"	"HPA000896: AB_1078880, HPA001374: AB_2666288"	"unprognostic (3.30e-2)"	"unprognostic (5.59e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.46e-3)"	"unprognostic (4.85e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.02e-1)"	"unprognostic (5.49e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.20e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.23e-3)"	1.4	12.0	5.2	2.1	23.0	0.8	2.3	0.9	8.5	2.9	1.3	6.8	1.0	1.8	5.1	3.7	1.3	6.3	1.0	1.5	5.9	25.8	4.2	2.2	3.8	4.8	4.7	5.3	11.3	2.5	0.1	32.3	5.7	6.3	2.3	1.3	2.6	1.1	2.2	2.2	4.0	2.0	1.5	4.5	2.9	4.2	6.0	5.4	1.9	5.2	0.4	3.3	5.9	2.0	3.9	0.2	0.2	0.0	2.1	3.7	1.2	4.1	0.0	4.3	6.0	2.5	2.1	6.5	0.1	0.8	0.0	0.0	0.9	0.8	8.7	0.0	0.5	1.1	11.0	1.8	0.0	0.0	22.2	2.8	0.0	0.2	0.1	0.0	1.9	1.2	1.3	0.3	0.8	0.0	0.1	11.4	0.9	0.0	7.9	0.0	3.9	0.7	0.0	4.0	0.0	1.8	23.3	7.1	0.0	0.4	0.1	2.5	1.0	0.1	0.0	1.9	1.6	0.0	2.6	4.1	1.7	10.7	3.3	0.0	3.1	0.0	0.0	0.0	3.5	0.0	2.6	3.9	3.0	2.4	0.0	2.9	3.7	3.0	0.2	2.1	0.0	0.2	1.1	1.2	5.2	23.0	0.9	6.8	5.9	25.8	4.7	5.3	6.3	5.4
CXXC4	IDAX	ENSG00000168772	"CXXC finger protein 4"		4	104468312-104494901	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"brain: 19.4;pituitary gland: 17.2"	"Cell line enhanced"	"Detected in some"		"AF22: 7.1;AN3-CA: 9.8;Karpas-707: 9.1;RPMI-8226: 5.3;SCLC-21H: 12.3;U-266/70: 10.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdTCR: 1.9;memory CD8 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	20	"T-cells: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036600, HPA036925"	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA036600: AB_10673659, HPA036925: "	"unprognostic (1.37e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.75e-2)"	"unprognostic (5.86e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.45e-1)"	"prognostic favourable (2.19e-4)"	"unprognostic (1.82e-1)"	"unprognostic (4.52e-3)"	"unprognostic (5.69e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.42e-3)"	2.2	4.3	10.3	0.9	12.0	0.6	4.3	17.5	19.4	2.4	2.5	7.4	0.8	5.4	1.9	5.3	1.0	6.7	1.5	5.3	9.9	14.4	1.7	2.7	2.3	0.7	7.9	9.9	5.6	5.8	3.2	17.2	1.4	10.2	2.1	2.9	7.9	7.5	2.1	1.3	0.8	5.5	1.8	5.3	1.4	4.3	4.9	13.3	0.0	7.1	0.1	0.7	1.6	1.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.2	7.1	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.8	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.5	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	2.6	0.0	2.5	0.1	0.0	0.0	5.3	0.0	0.1	12.3	2.2	0.0	0.6	0.0	0.3	0.0	0.0	0.0	1.6	0.0	0.1	10.0	2.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.9	0.0	0.8	0.0	0.1	1.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	10.3	12.0	17.5	19.4	9.9	14.4	7.9	9.9	10.2	13.3
CYP2F1	CYP2F	ENSG00000197446	"Cytochrome P450 family 2 subfamily F member 1"	P24903	19	41114432-41128366	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lung: 10.4;lymphoid tissue: 6.1;pituitary gland: 4.6;testis: 4.9"	"Cell line enriched"	"Detected in some"	7	"HMC-1: 7.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"basophil: 1.6"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"						"unprognostic (2.04e-1)"	"unprognostic (8.79e-2)"	"unprognostic (4.63e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.54e-1)"	"unprognostic (7.29e-3)"		"unprognostic (6.23e-3)"		"unprognostic (2.87e-2)"	"unprognostic (3.91e-2)"		"unprognostic (1.58e-6)"	"unprognostic (1.59e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.50e-1)"	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.9	0.0	0.0	0.0	3.1	6.1	0.0	2.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
DCDC1		ENSG00000170959	"Doublecortin domain containing 1"	P59894	11	30830369-31369810	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 19.2;pituitary gland: 26.7"	"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 2.8;U-266/70: 5.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"basal ganglia: 5.6;pons and medulla: 19.2"	"Cell type enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in many"														"unprognostic (1.01e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.06e-2)"	"unprognostic (5.68e-2)"	"unprognostic (4.73e-1)"	"unprognostic (3.17e-1)"	"unprognostic (4.47e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.61e-1)"	0.6	0.6	1.0	0.1	5.6	0.2	1.0	0.4	1.0	1.3	0.5	2.7	3.3	0.1	1.3	13.3	0.4	9.9	4.3	0.5	1.9	1.6	3.4	6.4	4.8	0.2	0.6	0.2	4.2	2.4	3.9	26.7	0.2	19.2	0.6	0.2	2.8	0.7	2.0	0.4	0.5	0.4	0.2	0.6	0.4	0.5	11.5	1.1	0.0	2.8	0.0	0.2	0.5	1.3	0.0	0.0	1.4	0.0	0.0	0.9	0.0	0.2	1.1	0.8	0.6	0.2	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.4	0.1	0.1	1.0	0.4	0.5	0.0	0.1	1.4	0.0	0.1	0.3	0.7	0.0	0.3	0.3	0.0	0.3	0.1	0.2	0.1	0.2	0.0	1.4	0.0	0.0	0.3	0.0	2.8	0.0	0.8	0.1	1.4	0.0	0.1	0.2	0.0	0.1	0.5	0.7	1.1	0.2	5.4	0.3	0.2	1.2	0.0	0.3	1.4	0.0	0.0	0.4	0.0	0.9	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	5.6	0.4	1.0	1.9	1.6	0.6	0.2	19.2	1.1
DIRAS3	"ARHI, NOEY2"	ENSG00000162595	"DIRAS family GTPase 3"	O95661	1	68045896-68051631	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 49.9;ovary: 33.2;pituitary gland: 35.2"	"Cell line enhanced"	"Detected in some"		"HHSteC: 7.3;HSkMC: 15.3;TIME: 9.5;U-251 MG: 7.7;U-87 MG: 14.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 49.9"	"Group enriched"	"Detected in some"	18	"plasmacytoid DC: 2.1;T-reg: 1.8"	"Group enriched"	"Detected in many"	20	"dendritic cells: 2.1;T-cells: 1.8"					"Low region specificity"	"Detected in all"			"HPA028483, HPA028557, HPA029384"	Approved		Approved	"Nuclear membrane,Cytosol"				"Nuclear membrane, Cytosol"	"Nuclear membrane, Cytosol"	"HPA028483: AB_10599599, HPA028557: AB_10602091, HPA029384: AB_10601343"	"prognostic favourable (9.21e-4)"	"unprognostic (3.45e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.86e-2)"	"unprognostic (8.35e-2)"	"unprognostic (4.33e-1)"	"prognostic favourable (9.21e-4)"	"unprognostic (1.34e-1)"	"unprognostic (4.99e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.07e-3)"	1.0	10.2	2.0	0.2	49.9	0.0	2.4	0.9	2.9	2.3	1.6	1.0	0.0	3.4	1.2	5.4	1.3	1.3	5.9	5.7	1.3	8.7	3.2	4.5	2.3	0.0	1.3	1.1	33.2	9.9	8.8	35.2	0.0	17.3	2.3	0.1	2.4	1.3	1.1	1.0	1.1	1.2	0.3	1.7	1.2	1.9	2.4	0.5	0.0	1.6	0.3	0.1	1.2	1.9	0.0	2.1	0.0	0.0	0.0	1.8	0.0	0.0	1.3	1.4	0.0	4.7	3.5	0.5	4.0	1.4	0.3	1.1	0.0	0.7	0.0	0.2	4.1	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.6	0.0	7.3	0.0	0.0	15.3	0.1	0.6	0.0	0.9	0.2	0.0	4.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.2	0.0	0.1	0.1	0.0	9.5	0.0	0.4	0.2	7.7	2.4	0.0	0.0	14.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.8	0.0	2.0	49.9	0.9	2.9	1.3	8.7	1.3	1.1	17.3	0.5
DMBX1	"OTX3, PAXB"	ENSG00000197587	"Diencephalon/mesencephalon homeobox 1"	Q8NFW5	1	46506996-46514226	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 2.7;testis: 3.5"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 15.5;CAPAN-2: 5.0;K-562: 5.1;SiHa: 5.0;T-47d: 4.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"hypothalamus: 1.2;midbrain: 1.3"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"midbrain: 1.8;pons and medulla: 1.0"	"Region enhanced"	"Detected in some"		"thalamus: 5.1"	HPA026811	Uncertain									"HPA026811: AB_10603660"	"unprognostic (1.14e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (7.13e-5)"	"unprognostic (2.33e-2)"	"unprognostic (8.92e-3)"	"unprognostic (1.07e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.00e-4)"	"unprognostic (1.19e-2)"	"unprognostic (2.12e-12)"	"unprognostic (7.91e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.35e-2)"	0.3	1.8	0.1	0.1	0.1	0.6	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.4	0.1	0.0	0.1	0.1	0.1	1.2	0.1	0.1	0.1	0.1	1.3	0.1	0.1	0.1	0.0	2.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.0	3.5	0.1	0.1	1.4	0.1	0.1	0.9	0.1	0.6	0.3	1.9	0.2	0.0	0.1	0.0	2.1	1.5	0.0	15.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	5.0	0.0	0.8	0.0	1.3	3.0	0.0	0.0	1.1	1.8	0.0	1.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	1.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	5.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	1.9	0.0	0.0	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	1.2	1.3	0.1	0.1	0.1
DMP1		ENSG00000152592	"Dentin matrix acidic phosphoprotein 1"	Q13316	4	87650307-87664361	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 2.9;testis: 3.6"	"Group enriched"	"Detected in some"	5	"RH-30: 1.4;U-266/70: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA037465	Approved				"Secreted to extracellular matrix"					"HPA037465: AB_10672492"	"unprognostic (6.77e-2)"	"unprognostic (1.55e-1)"		"unprognostic (1.42e-3)"	"unprognostic (1.80e-1)"	"unprognostic (4.96e-3)"		"unprognostic (7.73e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.35e-2)"		"unprognostic (8.50e-9)"	"unprognostic (5.82e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.74e-3)"	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	3.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.9	0.0
DMRTC1B		ENSG00000184911	"DMRT like family C1B"	Q5HYR2	X	72777009-72848802	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 15.1;ovary: 12.1;pituitary gland: 12.1"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.1;SK-BR-3: 1.1;U-138 MG: 1.0;U-266/70: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 2.8"	"Group enriched"	"Detected in many"	12	"B-cells: 2.1;T-cells: 2.8"									"HPA046874, HPA046992"	Uncertain									"HPA046874: AB_2679850, HPA046992: AB_2679894"					"unprognostic (2.00e-1)"						"unprognostic (1.91e-2)"	"unprognostic (1.54e-1)"				"unprognostic (6.52e-2)"		0.3	4.6	11.0	1.7	15.1	0.1	0.7	4.5	14.3	1.7	0.6	2.2	1.4	0.5	2.2	9.6	0.3	3.3	0.6	0.2	8.6	14.2	1.6	0.2	1.1	1.4	4.9	9.1	12.1	5.2	1.5	12.1	0.2	2.2	3.8	0.8	2.4	1.0	1.9	0.2	0.5	0.5	0.6	2.2	1.3	1.2	7.1	2.9	0.7	3.9	0.2	2.1	0.3	0.2	2.1	0.0	0.0	0.0	0.2	2.8	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.8	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.5	0.4	0.0	2.1	2.1	2.8	0.0	0.2	0.0	0.0	0.0	0.2	11.0	15.1	4.5	11.4	8.6	14.2	4.9	9.1	2.2	2.9
DNAAF4	"CILD25, DYX1C1, EKN1, FLJ37882"	ENSG00000256061	"Dynein axonemal assembly factor 4"	Q8WXU2	15	55410525-55508234	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 26.6"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 17.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA051048	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA051048: AB_2681325"	"unprognostic (5.97e-4)"	"unprognostic (3.60e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.45e-4)"	"unprognostic (1.74e-1)"	"unprognostic (5.30e-3)"	"unprognostic (4.05e-2)"	"unprognostic (3.08e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.91e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.84e-1)"	1.8	3.0	11.4	1.8	14.7	1.6	4.9	1.8	8.0	4.3	2.1	3.2	5.9	1.1	7.0	15.3	1.8	15.7	3.4	1.6	9.2	7.8	7.2	1.0	6.2	1.5	4.2	8.9	4.8	3.5	13.6	26.6	1.2	9.1	3.2	1.5	6.9	2.4	3.2	1.3	2.4	1.3	3.1	3.7	2.0	1.7	14.6	4.5	0.1	14.3	0.9	1.3	2.8	2.0	2.9	4.2	4.3	1.8	0.7	1.1	0.4	6.5	4.3	4.7	10.0	1.9	3.3	1.5	0.8	2.4	3.1	3.6	0.9	2.6	0.5	4.2	2.0	1.8	1.8	2.6	3.7	2.0	2.1	2.3	2.8	1.5	1.8	5.0	4.1	2.0	5.5	7.5	2.8	7.0	0.7	0.3	4.6	2.3	0.9	4.3	2.6	3.6	0.8	2.3	0.8	17.1	2.3	4.8	10.5	4.3	1.1	5.8	6.0	1.2	2.3	5.0	2.5	4.1	4.8	1.8	4.8	1.4	8.2	1.0	1.1	0.0	1.8	1.3	0.6	1.2	0.4	2.9	0.9	0.7	1.2	2.6	1.1	0.8	4.3	0.7	1.2	4.2	0.9	0.4	11.4	14.7	1.8	8.0	9.2	7.8	4.2	8.9	9.1	4.5
DNAH14	"C1orf67, DKFZp781B1548, Dnahc14, HL-18, HL18, MGC27277"	ENSG00000185842	"Dynein axonemal heavy chain 14"	Q0VDD8	1	224896262-225399292	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 32.4;testis: 29.9"	"Cell line enhanced"	"Detected in many"		"K-562: 25.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"NK-cell: 3.5"	"Low lineage specificity"	"Detected in single"											"HPA027718, HPA028545, HPA031379"	Uncertain		Supported	Centrosome				Centrosome	Centrosome	"HPA027718: AB_10601210, HPA028545: AB_2672665, HPA031379: "	"unprognostic (1.16e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.09e-3)"	"unprognostic (9.94e-4)"	"unprognostic (4.23e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.33e-9)"	"unprognostic (6.76e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.78e-2)"	1.6	5.2	6.3	2.7	2.5	2.5	5.2	0.9	3.4	3.1	2.9	0.2	3.8	1.7	3.3	6.5	2.0	2.6	5.3	3.7	7.0	5.5	4.2	6.8	5.4	0.6	2.9	4.6	5.5	11.2	3.4	32.4	2.6	7.2	4.3	3.7	3.6	3.4	7.8	0.6	1.0	1.1	4.6	8.5	1.0	3.8	29.9	0.8	3.2	7.1	0.9	0.4	2.5	1.9	0.6	0.2	0.4	0.2	3.5	0.9	0.0	10.2	5.3	4.9	5.3	1.9	4.0	11.7	2.1	2.0	4.0	3.5	8.3	11.4	0.0	5.4	2.1	0.1	7.5	2.0	6.7	0.0	12.5	4.9	3.6	1.8	2.4	10.2	1.7	3.9	4.6	5.4	3.8	1.3	25.2	0.0	6.7	2.7	1.8	10.6	13.7	6.5	0.0	18.5	9.4	3.6	4.8	8.2	9.3	8.3	6.3	16.7	11.5	8.9	0.2	0.0	7.9	0.2	0.0	11.5	7.1	0.1	0.0	0.0	7.4	0.0	0.1	0.3	0.1	0.2	0.0	0.6	0.3	0.7	0.2	0.3	0.4	0.5	0.4	3.5	0.1	0.0	0.9	0.0	6.3	2.5	0.9	3.4	7.0	5.5	2.9	4.6	7.2	0.8
DNAH6	"Dnahc6, DNHL1, FLJ37357, HL-2"	ENSG00000115423	"Dynein axonemal heavy chain 6"	Q9C0G6	2	84516455-84819589	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.7;fallopian tube: 15.3;pituitary gland: 17.4"	"Cell line enhanced"	"Detected in some"		"AF22: 1.3;CACO-2: 1.5;SK-MEL-30: 2.9;U-266/70: 1.6"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"naive CD4 T-cell: 3.8;naive CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	16	"T-cells: 3.8"	"Low region specificity"	"Detected in many"							HPA036391	Enhanced									"HPA036391: AB_10672220"	"unprognostic (4.87e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.43e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.46e-1)"	"unprognostic (8.11e-8)"	"unprognostic (2.04e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.97e-2)"	1.4	1.2	7.7	0.8	17.7	0.7	1.7	0.6	10.0	1.8	1.0	3.2	0.7	0.7	2.0	11.0	0.6	15.3	0.8	0.6	7.9	3.5	1.9	3.6	4.8	1.0	0.9	7.2	5.1	1.2	6.2	17.4	0.7	23.7	1.1	1.1	0.5	0.6	1.3	0.5	0.7	0.8	0.8	1.6	0.8	2.0	7.2	3.0	0.0	3.9	0.0	0.8	0.7	0.6	0.0	0.2	0.1	0.0	0.0	3.8	0.4	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.5	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.9	1.1	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.1	0.4	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.0	0.9	0.0	2.9	0.0	0.5	0.0	0.5	0.5	0.4	0.2	1.6	0.1	0.0	0.8	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	3.8	1.2	0.0	0.0	0.0	0.2	0.0	0.4	7.7	17.7	0.6	10.0	7.9	3.5	0.9	7.2	23.7	3.0
DNAH7	KIAA0944	ENSG00000118997	"Dynein axonemal heavy chain 7"	Q8WXX0	2	195737703-196068812	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.7;fallopian tube: 19.4;pituitary gland: 25.2"	"Cell line enhanced"	"Detected in some"		"PC-3: 10.5;RPTEC TERT1: 4.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"neutrophil: 2.0;plasmacytoid DC: 2.0"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.0;granulocytes: 2.0"					"Low region specificity"	"Detected in many"			"HPA034724, HPA044070"	Approved		Supported	Cytosol				Cytosol	Cytosol	"HPA034724: AB_10670977, HPA044070: AB_2678798"	"unprognostic (1.71e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.58e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.25e-3)"	"unprognostic (2.24e-1)"	"unprognostic (7.76e-2)"	"unprognostic (2.52e-3)"	"unprognostic (3.98e-2)"	1.0	2.6	6.8	1.4	9.9	0.7	1.9	0.6	6.4	3.3	1.9	4.6	4.3	0.9	2.2	12.9	1.1	19.4	1.9	1.4	7.1	5.8	4.5	1.2	9.5	0.9	3.4	3.5	3.9	4.2	3.6	25.2	0.9	21.7	1.9	1.6	1.8	1.8	2.5	0.6	0.9	1.9	1.2	2.1	0.8	1.5	18.3	2.3	0.0	5.9	0.0	1.0	1.3	0.5	0.3	2.0	2.0	0.0	0.1	0.2	0.2	0.6	2.4	0.5	0.2	1.3	0.9	0.1	0.2	1.4	0.5	0.5	0.5	1.7	0.0	0.7	0.5	0.1	0.0	0.3	0.4	0.0	1.4	0.0	2.9	0.7	0.2	0.1	0.2	0.3	0.4	2.1	0.4	0.0	0.6	3.3	0.9	2.4	0.0	0.1	0.5	10.5	0.1	0.6	0.8	4.9	0.3	1.1	1.9	0.6	0.4	0.2	0.9	0.2	0.0	1.3	0.4	2.0	0.6	2.6	2.3	0.0	2.9	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.3	0.0	0.1	2.0	0.1	0.0	2.0	0.0	0.2	6.8	9.9	0.6	6.4	7.1	5.8	3.4	3.5	21.7	2.3
DYNC2H1	"DHC1b, DHC2, DNCH2, DYH1B, hdhc11"	ENSG00000187240	"Dynein cytoplasmic 2 heavy chain 1"	Q8NCM8	11	103109431-103479863	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 35.7"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 17.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.9"	"Group enriched"	"Detected in many"	5	"NK-cells: 2.9;T-cells: 2.2"	"Low region specificity"	"Detected in all"							"HPA039015, HPA039016"	Approved		Supported	Mitochondria				Mitochondria	Mitochondria	"HPA039015: AB_2676309, HPA039016: AB_10673410"	"unprognostic (3.11e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.14e-3)"	"unprognostic (2.07e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.87e-2)"	"unprognostic (7.13e-2)"	"prognostic favourable (8.49e-5)"	"unprognostic (3.75e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.88e-2)"	"unprognostic (4.11e-3)"	7.3	5.7	6.3	3.8	8.9	1.4	8.4	13.2	9.3	11.5	4.8	5.5	11.0	4.1	11.3	9.6	3.9	14.6	7.8	3.7	7.1	7.1	8.5	2.6	10.2	2.6	4.8	7.9	11.4	5.1	24.2	35.7	3.9	11.2	7.6	2.6	6.2	4.5	10.7	1.6	5.7	3.4	7.8	5.1	4.8	4.2	14.3	5.2	1.1	10.7	3.0	2.4	6.1	6.6	0.5	0.4	0.4	0.2	2.9	2.2	0.0	1.0	2.1	5.7	2.7	7.9	17.9	0.3	3.2	5.2	5.3	5.8	1.2	1.1	0.0	4.4	6.2	4.3	4.4	5.9	4.3	0.0	4.0	0.8	3.7	0.1	7.6	1.7	1.0	11.1	2.3	12.0	13.8	2.1	0.1	0.0	6.9	4.1	0.5	0.4	1.5	6.0	0.0	4.7	0.1	5.7	0.7	4.1	2.9	5.0	1.4	2.3	5.3	1.1	5.0	6.4	2.6	6.0	2.1	0.0	0.0	0.0	1.9	5.2	1.9	0.4	0.2	0.0	0.9	0.1	2.2	0.5	0.7	1.1	0.4	0.3	0.8	1.1	0.0	2.9	0.1	0.2	0.0	0.0	6.3	8.9	13.2	9.3	7.1	7.1	4.8	7.9	11.2	5.2
DZIP3	"hRUL138, PPP1R66"	ENSG00000198919	"DAZ interacting zinc finger protein 3"	Q86Y13	3	108589682-108694846	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 57.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035066, HPA049232"	Approved		Approved	Vesicles				Vesicles	Vesicles	"HPA035066: AB_10601549, HPA049232: AB_2680684"	"unprognostic (1.14e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.33e-1)"	"unprognostic (5.16e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.59e-3)"	"unprognostic (5.38e-2)"	"prognostic favourable (3.65e-4)"	"unprognostic (6.06e-2)"	"unprognostic (2.78e-2)"	"unprognostic (5.51e-3)"	"unprognostic (3.81e-2)"	4.6	9.3	14.1	4.5	25.7	3.1	5.0	14.5	23.7	5.2	4.4	5.8	2.1	2.8	7.4	9.7	3.8	17.4	5.4	10.8	13.2	18.5	10.5	3.9	6.0	8.4	10.3	16.0	10.3	4.9	10.3	57.4	4.5	20.3	9.2	4.5	4.0	3.3	7.0	10.1	3.4	3.6	7.9	9.2	7.0	6.0	29.9	8.0	10.4	12.0	2.8	7.0	5.0	3.5	6.8	1.8	5.2	1.6	11.7	6.5	1.8	6.6	6.0	17.2	10.3	7.6	8.0	5.9	4.2	8.3	7.0	9.5	8.4	4.5	12.0	9.0	4.4	2.5	9.8	3.6	14.8	4.4	4.2	5.5	2.3	5.8	4.6	2.1	3.1	8.3	1.9	6.5	8.1	4.3	5.2	5.9	13.2	6.0	5.3	2.3	10.5	4.3	6.9	14.2	1.1	5.8	3.2	11.7	11.2	7.0	0.7	7.5	10.3	1.9	5.0	6.3	9.6	1.2	3.6	6.8	3.9	23.3	4.8	1.7	7.6	5.2	0.7	1.4	5.0	1.0	6.0	6.8	5.1	6.1	0.6	6.0	4.5	6.0	0.1	11.7	1.6	1.8	6.5	1.8	14.1	25.7	14.5	23.7	13.2	18.5	10.3	16.0	20.3	8.0
EFCAB6	"dJ185D5.1, DJBP, FLJ23588, HSCBCIP1, KIAA1672"	ENSG00000186976	"EF-hand calcium binding domain 6"	Q5THR3	22	43528744-43812337	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 17.2;testis: 32.2"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.5;RPTEC TERT1: 3.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"							HPA003098			Uncertain	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA003098: AB_1079087"	"unprognostic (1.85e-1)"	"unprognostic (8.85e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.04e-5)"	"unprognostic (1.00e-1)"	"unprognostic (4.25e-2)"	"unprognostic (4.96e-2)"	"unprognostic (8.82e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.91e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.71e-3)"	"unprognostic (4.54e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.33e-2)"	1.2	1.8	3.3	0.8	4.8	0.6	2.1	1.2	4.7	2.2	1.3	3.0	8.9	1.0	2.3	9.3	1.2	11.5	2.2	1.3	2.3	2.6	2.7	1.1	2.6	0.8	1.4	2.4	4.0	2.3	5.2	17.2	0.8	5.7	1.9	0.9	5.2	1.7	4.8	1.0	1.2	0.9	1.3	1.3	0.8	1.8	32.2	1.3	0.0	5.0	0.5	0.8	1.3	1.2	0.3	0.0	0.0	1.3	0.0	0.6	0.1	0.3	0.8	1.2	1.7	1.5	5.5	0.0	1.3	1.0	0.3	0.6	0.0	0.3	0.0	0.8	0.6	1.6	0.0	0.4	1.2	0.0	0.4	0.0	0.0	0.0	3.3	0.1	0.0	1.8	2.0	1.3	0.4	0.4	0.1	0.1	0.9	3.5	0.0	0.3	1.5	0.5	0.1	0.0	0.1	3.7	0.7	2.2	0.9	3.3	0.1	1.8	0.6	0.0	0.3	1.0	0.2	1.2	0.2	0.2	0.2	0.0	2.2	0.0	0.5	0.0	0.0	0.0	0.0	1.3	0.6	0.0	0.2	0.0	0.0	0.3	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	3.3	4.8	1.2	4.7	2.3	2.6	1.4	2.4	5.7	1.3
ESPNL	FLJ42568	ENSG00000144488	"Espin like"	Q6ZVH7	2	238100157-238133287	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 9.9;pituitary gland: 8.2"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.6;Daudi: 5.0;fHDF/TERT166: 4.6;HHSteC: 5.3;THP-1: 3.6;U-87 MG: 4.3"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	5	"cerebellum: 9.9"	"Cell type enriched"	"Detected in single"	5	"memory B-cell: 1.5"	"Lineage enriched"	"Detected in single"	16	"B-cells: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055103	Uncertain									"HPA055103: AB_2682694"	"unprognostic (8.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.51e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.94e-6)"	"unprognostic (3.49e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.67e-2)"	0.6	0.5	0.3	6.0	0.3	0.0	0.6	9.9	0.6	1.2	1.1	0.6	0.3	1.4	1.5	0.3	0.8	2.8	0.3	1.3	0.3	0.0	1.1	3.5	0.7	2.6	0.3	0.3	4.0	1.3	0.0	8.2	0.3	2.0	1.5	0.2	0.6	2.0	3.5	0.3	0.1	4.9	1.6	0.3	3.8	0.8	0.4	0.8	0.3	2.0	0.3	2.8	0.4	0.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.7	1.4	0.6	1.9	1.0	1.6	1.8	0.0	0.0	5.0	2.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.9	1.8	5.3	0.0	1.1	1.9	0.0	0.2	0.0	0.0	1.7	0.0	2.0	0.0	0.0	2.2	0.3	0.0	1.6	0.2	0.7	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.2	4.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	9.9	0.6	0.3	0.0	0.3	0.3	2.0	0.8
EYA1	BOR	ENSG00000104313	"EYA transcriptional coactivator and phosphatase 1"	Q99502	8	71197433-71592025	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 45.5;pituitary gland: 30.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 16.4;RH-30: 12.7;SH-SY5Y: 31.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"NK-cell: 9.8"	"Lineage enriched"	"Detected in many"	4	"NK-cells: 9.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028917			Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"HPA028917: AB_2672826"	"unprognostic (3.74e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.72e-3)"	"unprognostic (5.95e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.91e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.22e-12)"	"unprognostic (1.06e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.81e-4)"	"unprognostic (1.25e-2)"	1.0	1.1	2.8	0.6	16.8	0.5	0.6	0.2	6.8	4.0	0.6	1.9	0.0	0.7	0.6	2.2	1.0	2.5	0.8	4.6	2.8	2.2	0.6	0.5	1.0	0.6	2.9	2.8	0.8	0.6	45.5	30.8	0.6	4.2	12.4	0.7	15.3	1.2	4.6	3.2	0.6	0.7	3.9	0.4	0.7	0.9	1.3	5.1	4.4	0.9	2.9	0.6	3.5	5.7	0.8	1.9	1.8	2.3	9.8	2.3	0.2	0.1	0.0	3.7	16.4	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.9	0.0	0.0	2.7	0.0	1.2	0.0	0.0	0.3	0.0	3.6	0.0	0.0	0.1	0.0	0.0	1.2	0.6	0.0	0.0	0.0	1.2	0.9	0.0	12.7	5.4	0.0	0.0	1.3	31.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	3.7	0.0	1.2	1.8	0.3	0.6	0.9	0.9	1.9	0.8	0.7	1.9	0.7	0.8	1.3	1.4	1.6	9.8	2.3	1.9	2.3	0.2	2.8	16.8	0.2	2.8	2.8	2.2	2.9	2.8	4.2	5.1
FAAH2	"AMDD, FAAH-2, FLJ31204, RP11-479E16.1"	ENSG00000165591	"Fatty acid amide hydrolase 2"	Q6GMR7	X	57286706-57489196	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 43.6;pituitary gland: 42.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 10.5;HDLM-2: 9.4;RPMI-8226: 19.0;U-266/70: 15.9;U-266/84: 8.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"cerebellum: 18.0"	"Cell type enhanced"	"Detected in many"		"T-reg: 13.6"	"Lineage enriched"	"Detected in many"	8	"T-cells: 13.6"																				"unprognostic (1.37e-1)"	"unprognostic (1.78e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.93e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.94e-1)"	"prognostic favourable (5.99e-4)"	"unprognostic (1.77e-1)"	"unprognostic (2.03e-1)"	"prognostic favourable (2.47e-13)"	"unprognostic (9.16e-3)"	"unprognostic (2.27e-1)"	"prognostic favourable (2.66e-4)"	"prognostic favourable (6.83e-5)"	1.0	1.4	1.0	6.8	1.5	0.0	6.7	18.0	1.0	3.5	3.9	0.2	3.8	2.6	1.4	4.7	5.5	5.8	2.4	0.6	1.2	2.3	9.7	20.1	3.5	5.7	1.1	0.5	1.9	43.6	12.7	42.8	1.4	1.8	9.3	3.6	3.8	9.1	5.3	0.3	10.0	6.4	0.6	1.1	2.3	4.1	0.6	0.3	8.5	15.3	2.7	11.0	3.0	3.6	1.8	1.0	0.3	0.0	0.7	13.6	1.5	2.4	0.2	0.0	0.1	0.1	0.1	2.3	0.0	0.0	0.0	0.0	1.7	10.5	0.1	3.0	0.0	0.4	0.8	1.8	0.0	9.4	5.1	0.3	2.4	0.7	0.0	1.1	0.0	0.0	3.2	0.0	0.0	0.0	1.2	4.7	0.0	1.0	0.5	0.0	1.8	0.0	0.0	1.8	19.0	6.2	3.3	1.8	0.1	0.1	3.0	0.0	2.9	0.0	0.0	0.0	0.2	0.0	0.1	15.9	8.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	4.7	1.8	7.7	3.2	0.0	0.6	7.5	0.9	0.3	0.7	0.0	1.0	13.6	1.5	1.0	1.5	18.0	1.0	1.2	2.3	1.1	0.5	1.8	0.3
FAM155A		ENSG00000204442	"Family with sequence similarity 155 member A"	B1AL88	13	107163510-107866735	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.0;pituitary gland: 10.3"	"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 11.6;SCLC-21H: 7.1;SH-SY5Y: 16.1;U-138 MG: 5.0;U-87 MG: 10.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA039453, HPA058768"	Enhanced		Approved	Nucleoplasm,Vesicles,Centrosome				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA039453: AB_10795290, HPA058768: AB_2683813"	"unprognostic (8.40e-2)"	"unprognostic (9.98e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.38e-3)"	"unprognostic (2.69e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.26e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.02e-5)"	"unprognostic (5.56e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.45e-2)"	"unprognostic (3.69e-3)"	0.9	2.7	10.7	0.6	4.3	0.4	0.6	6.9	19.0	1.5	0.7	0.6	0.0	0.5	1.7	4.0	0.7	0.7	1.3	0.7	8.8	10.8	0.7	0.4	1.2	0.5	6.4	4.9	0.7	0.5	0.4	10.3	1.2	2.0	2.7	0.7	0.7	0.3	3.8	0.4	0.5	0.7	1.2	2.7	0.6	0.7	2.3	0.5	0.0	1.3	0.0	0.9	1.4	0.2	0.2	0.0	0.4	0.1	0.8	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.6	0.0	2.4	0.1	2.3	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.0	0.0	0.2	0.0	11.6	1.9	7.1	16.1	0.0	0.0	0.0	4.1	0.0	0.2	5.0	2.0	1.7	0.2	0.0	0.0	0.0	10.2	0.0	3.4	0.4	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.4	0.8	0.0	0.0	0.0	0.0	10.7	4.3	6.9	12.3	8.8	10.8	6.4	4.9	2.0	0.5
FAM163A	"C1orf76, MGC16664, NDSP"	ENSG00000143340	"Family with sequence similarity 163 member A"	Q96GL9	1	179743163-179816198	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 19.2;lymphoid tissue: 25.5;pituitary gland: 24.2"	"Cell line enriched"	"Detected in some"	36	"SH-SY5Y: 50.0"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	9	"pons and medulla: 19.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (8.74e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.67e-6)"	"unprognostic (5.56e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.81e-3)"	"unprognostic (9.14e-2)"	"unprognostic (7.75e-5)"	"unprognostic (1.67e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.98e-2)"	0.2	10.9	0.7	2.1	1.5	0.0	0.0	0.4	2.1	0.0	1.3	0.7	0.0	1.9	0.1	1.7	0.0	0.6	5.5	0.3	0.4	0.8	0.1	0.4	0.0	1.0	1.2	1.0	0.4	0.6	0.0	24.2	0.4	19.2	0.4	0.9	0.2	0.0	0.1	0.1	0.1	1.3	0.6	0.2	0.4	1.7	9.0	0.0	25.5	1.5	0.0	1.2	0.1	0.1	0.0	0.1	0.7	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	50.0	0.0	0.0	0.2	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.7	1.5	0.4	2.1	0.4	0.8	1.2	1.0	19.2	0.0
FAM227A		ENSG00000184949	"Family with sequence similarity 227 member A"	F5H4B4	22	38578120-38656629	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 26.2;testis: 15.6"	"Group enriched"	"Detected in some"	5	"HDLM-2: 11.1;Karpas-707: 21.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA003077	Uncertain		Uncertain	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA003077: AB_1079264"	"unprognostic (7.52e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.14e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.91e-3)"	"unprognostic (4.79e-5)"	"unprognostic (5.91e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.85e-2)"	"unprognostic (4.62e-2)"	"unprognostic (6.46e-6)"	"unprognostic (3.74e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.35e-2)"	0.5	1.2	4.7	0.9	7.0	1.5	2.8	0.9	3.1	2.6	0.8	5.0	5.5	0.7	2.3	7.8	0.7	9.3	2.2	0.8	4.2	3.4	2.0	0.5	2.4	0.7	1.9	2.5	1.6	1.5	2.3	26.2	0.6	6.7	1.5	1.0	2.7	1.1	1.8	0.5	2.4	0.6	1.5	0.9	0.7	1.3	15.6	3.0	0.8	3.5	0.1	0.6	1.1	0.7	1.4	1.0	2.3	0.7	1.0	1.3	0.3	0.4	1.2	1.7	2.3	0.3	1.2	0.4	0.2	0.2	0.3	0.2	0.0	1.0	0.2	0.5	0.2	1.0	0.7	0.2	0.4	11.1	1.1	0.1	3.2	0.2	0.2	0.5	0.5	0.6	0.7	1.3	0.4	0.2	0.4	21.0	0.1	0.5	0.5	0.5	0.8	0.7	1.1	0.1	0.6	0.8	0.3	2.3	0.6	1.4	0.1	0.1	1.3	0.2	0.4	0.6	0.5	0.5	0.1	2.0	0.9	0.1	0.8	0.2	0.3	2.0	0.7	0.7	0.7	0.6	0.5	0.8	0.7	0.6	0.3	1.4	0.9	1.3	2.3	1.0	0.6	1.0	0.7	0.3	4.7	7.0	0.9	3.1	4.2	3.4	1.9	2.5	6.7	3.0
FANCL	"FAAP43, FLJ10335, PHF9, Pog"	ENSG00000115392	"Fanconi anemia complementation group L"	Q9NW38	2	58159243-58241372	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 62.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033842, HPA036685, HPA036686"	Supported		Approved	"Nuclear bodies,Vesicles"				"Nuclear bodies"	"Nuclear bodies"	"CAB033842: AB_1122766, HPA036685: AB_10672474, HPA036686: AB_10670844"	"unprognostic (3.02e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.02e-3)"	"unprognostic (6.24e-2)"	"unprognostic (2.92e-2)"	"prognostic unfavourable (2.81e-7)"	"unprognostic (4.71e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.17e-2)"	"prognostic unfavourable (1.12e-7)"	"unprognostic (1.50e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.08e-3)"	"prognostic favourable (7.80e-5)"	6.3	29.2	16.0	11.2	22.9	10.6	16.2	7.1	18.1	11.6	9.6	30.7	7.9	9.2	16.6	15.7	8.6	11.7	9.8	10.2	17.0	23.5	7.1	16.7	7.7	10.9	25.0	15.2	21.3	10.8	16.8	62.5	10.0	33.5	11.6	12.4	13.7	14.8	9.1	6.5	14.4	10.1	11.3	23.4	12.0	10.5	14.7	28.2	8.6	14.2	6.9	12.0	10.1	12.7	10.8	7.1	5.6	6.9	8.8	5.5	2.7	18.4	13.5	27.6	13.5	4.9	6.5	14.7	13.6	8.5	13.5	17.6	11.9	23.3	12.8	17.7	4.4	10.8	15.3	10.3	22.6	30.0	24.2	21.0	19.0	16.1	5.3	20.2	11.6	4.8	4.9	9.8	3.9	10.5	19.5	11.7	9.1	9.4	7.1	25.1	29.8	2.8	13.5	20.9	10.0	11.8	18.3	31.3	15.7	19.4	8.0	12.7	7.3	13.6	6.2	12.1	18.2	8.8	14.9	12.1	7.6	7.5	25.7	13.7	18.3	2.7	3.7	5.6	4.9	6.9	3.8	10.8	4.1	5.4	7.1	10.0	1.4	3.1	1.1	8.8	4.9	6.5	5.5	2.7	16.0	22.9	7.1	18.1	17.0	23.5	25.0	15.2	33.5	28.2
FBXO16	FBX16	ENSG00000214050	"F-box protein 16"	Q8IX29	8	28348287-28490318	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 22.9;pituitary gland: 42.3"	"Cell line enhanced"	"Detected in many"		"AF22: 15.4;Karpas-707: 17.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"plasmacytoid DC: 11.5"	"Lineage enriched"	"Detected in many"	8	"dendritic cells: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058676, HPA076472"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Nucleoplasm, Vesicles, Plasma membrane, Cytosol"	"Nucleoplasm, Vesicles, Plasma membrane, Cytosol"	"HPA058676: AB_2683795, HPA076472: "	"unprognostic (3.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.37e-3)"	"unprognostic (5.56e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.55e-3)"	"unprognostic (4.95e-3)"	"unprognostic (6.49e-2)"	"prognostic favourable (6.70e-5)"	"unprognostic (3.41e-3)"	"unprognostic (4.90e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.07e-1)"	0.9	2.3	7.3	1.3	17.6	2.6	3.4	15.8	9.9	5.4	2.0	1.1	7.6	2.6	1.8	22.9	1.1	5.7	2.1	2.0	4.2	6.8	4.0	7.2	1.9	1.5	4.4	7.5	1.2	6.3	7.2	42.3	1.0	6.3	4.3	2.6	4.6	5.9	7.3	1.1	0.8	3.8	1.2	2.1	1.7	2.7	4.8	1.4	0.0	8.7	0.2	3.3	1.9	1.1	0.6	11.5	1.4	0.3	0.1	0.5	0.2	12.0	2.5	15.4	6.0	0.4	0.0	0.4	0.1	0.6	2.4	4.5	2.4	3.6	4.6	5.6	0.1	4.1	1.7	2.5	2.3	1.8	2.9	2.2	0.2	1.3	0.3	2.6	1.6	0.2	8.3	0.6	2.5	0.0	0.8	17.8	1.0	4.1	0.3	3.6	3.3	3.5	0.1	3.6	7.1	3.2	2.1	10.0	4.2	0.3	2.5	6.7	10.7	4.5	0.5	1.3	4.7	2.7	2.2	3.9	3.4	3.9	5.2	0.6	2.7	0.5	0.3	0.1	0.2	0.2	0.5	0.4	0.4	0.3	0.9	0.6	0.2	0.3	1.4	0.1	0.2	11.5	0.3	0.2	7.3	17.6	15.8	9.9	4.2	6.8	4.4	7.5	6.3	1.4
FERD3L	"bHLHa31, N-TWIST, NATO3"	ENSG00000146618	"Fer3 like bHLH transcription factor"	Q96RJ6	7	19144782-19145421	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 2.7;pituitary gland: 2.4"	"Cell line enriched"	"Detected in single"	156	"SCLC-21H: 15.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"thalamus: 1.0"	"Region enriched"	"Detected in single"	19	"midbrain: 34.7"	HPA043494	Uncertain									"HPA043494: AB_10964193"																		0.3	0.4	1.4	0.0	0.1	0.0	0.5	0.0	2.7	0.2	0.0	2.2	0.0	0.0	0.5	0.0	0.4	0.2	0.0	0.9	1.1	1.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.4	1.3	1.4	0.1	0.2	0.0	0.5	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	1.8	1.1	1.5	1.3	0.0	1.4	0.0
FEV	Pet-1	ENSG00000163497	"FEV, ETS transcription factor"	Q99581	2	218981087-218985657	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 6.9;intestine: 7.0;pituitary gland: 5.4;stomach 1: 6.1"	"Group enriched"	"Detected in some"	6	"HMC-1: 18.7;SH-SY5Y: 23.9"	"Group enriched"	"Detected in some"	10	"pancreatic cancer: 3.0;prostate cancer: 9.9;stomach cancer: 2.4"	"Region enhanced"	"Detected in many"		"pons and medulla: 6.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"midbrain: 2.3;pons and medulla: 0.9"	"Group enriched"	"Detected in some"	34	"midbrain: 7.3;pons and medulla: 3.9"	HPA067679		Supported	Supported	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA067679: AB_2685884"			"unprognostic (4.58e-1)"		"unprognostic (1.60e-1)"					"unprognostic (7.21e-2)"	"prognostic favourable (4.85e-4)"	"unprognostic (2.87e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.15e-1)"			0.1	4.1	0.0	1.2	3.5	0.0	0.0	0.0	2.6	0.0	2.0	0.7	0.0	7.0	0.1	0.0	0.0	0.1	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.2	0.0	5.4	0.0	6.9	4.0	3.2	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.1	0.0	6.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	23.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	2.6	1.1	0.2	0.2	0.0	6.9	1.0
FOXI2	FLJ46831	ENSG00000186766	"Forkhead box I2"	Q6ZQN5	10	127737235-127741186	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"kidney: 6.5;pituitary gland: 10.3"	"Cell line enriched"	"Detected in single"	16	"NTERA-2: 3.8"	"Cancer enriched"	"Detected in some"	6	"renal cancer: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (4.39e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.28e-1)"			"unprognostic (2.02e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.12e-3)"	"unprognostic (4.71e-4)"	"unprognostic (6.78e-3)"	"prognostic favourable (4.23e-7)"	"unprognostic (6.31e-3)"	"unprognostic (2.66e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.65e-2)"	0.7	0.0	0.1	3.0	0.1	0.0	0.7	0.1	0.3	5.4	0.4	0.1	3.1	0.1	1.8	2.7	4.7	0.7	0.2	0.5	0.1	0.1	6.5	0.1	0.4	0.9	0.1	0.1	1.2	0.2	0.1	10.3	0.1	0.4	1.2	0.0	0.1	2.3	1.7	0.3	1.4	0.4	0.5	0.1	2.3	0.5	0.3	0.1	0.4	0.1	0.9	0.8	1.6	2.5	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.4	0.1
FSIP1	FLJ35989	ENSG00000150667	"Fibrous sheath interacting protein 1"	Q8NA03	15	39588357-39782830	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 17.8;pituitary gland: 11.8;testis: 13.9"	"Cell line enhanced"	"Detected in many"		"BJ: 7.2"	"Cancer enriched"	"Detected in some"	8	"breast cancer: 6.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			HPA041002	Uncertain		Uncertain	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA041002: AB_10796565"	"unprognostic (1.55e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.43e-3)"	"unprognostic (5.17e-3)"	"unprognostic (5.37e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.81e-1)"	0.8	0.7	2.9	0.7	9.3	1.1	1.9	1.0	5.7	0.8	11.7	1.5	0.8	0.5	1.4	2.5	0.6	2.3	0.7	0.8	3.1	3.0	1.6	0.7	0.9	0.5	1.2	4.1	0.7	0.6	1.7	11.8	0.8	4.5	0.8	17.8	0.6	0.5	0.7	0.9	1.7	0.6	0.9	1.1	0.6	1.1	13.9	1.4	0.5	1.0	0.0	0.5	1.0	0.9	1.0	1.0	1.8	1.3	1.5	3.4	1.4	0.6	2.3	6.1	0.8	1.1	2.1	0.1	7.2	1.5	1.2	2.2	1.7	0.6	0.5	0.5	2.1	1.5	1.0	1.2	1.9	2.5	0.6	4.4	1.7	0.1	0.6	0.9	4.9	1.4	5.1	2.8	1.2	1.3	0.2	0.6	1.8	0.3	0.6	0.4	0.7	1.2	0.6	1.2	0.1	2.4	2.7	1.5	4.6	1.5	0.2	0.3	2.1	0.5	1.0	3.0	1.7	1.6	0.8	1.2	2.6	0.3	6.1	1.6	1.4	1.8	1.3	1.5	3.4	0.8	2.7	0.8	1.8	2.1	1.0	1.0	1.1	0.9	1.1	1.5	1.0	0.0	0.4	1.4	2.9	9.3	1.0	5.7	3.1	3.0	1.2	4.1	4.5	1.4
GAGE10		ENSG00000215274	"G antigen 10"	A6NGK3	X	49303669-49319844	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"ovary: 3.9;pituitary gland: 3.1;testis: 2.9"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.0;BJ hTERT+: 1.4;T-47d: 1.3;WM-115: 2.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043232	Supported		Uncertain	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA043232: AB_2678376"					"unprognostic (2.81e-2)"					"unprognostic (2.26e-1)"						"unprognostic (3.97e-1)"		0.0	0.0	0.6	0.0	1.8	0.1	0.8	0.5	0.3	0.0	0.2			0.0	0.5	2.0	0.0	1.7	0.1	0.5	0.5	0.5	0.0	0.0	0.0	0.6	0.4		3.9	0.0	0.0	3.1	0.0		0.4	0.3		0.2	1.1	0.2	0.0	0.0	1.4	0.2	0.3	0.0	2.9			0.8		0.2	0.0	0.1	0.0	0.7	0.0	0.5	0.1	0.5	0.3	0.0	0.0	0.6	7.0	0.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.3	0.0	0.1	0.5	0.7	0.3	0.3										
GALR1	"GALNR, GALNR1"	ENSG00000166573	"Galanin receptor 1"	P47211	18	77250549-77277896	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 5.3;brain: 3.5;pituitary gland: 4.9"	"Low cell line specificity"	"Detected in some"			"Cancer enriched"	"Detected in single"	6	"glioma: 1.0"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"hypothalamus: 6.1"	"Low region specificity"	"Detected in many"														"unprognostic (1.65e-1)"				"unprognostic (1.56e-2)"	"unprognostic (2.85e-1)"			"unprognostic (3.00e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.31e-2)"	"unprognostic (5.34e-3)"	"unprognostic (7.33e-3)"	"unprognostic (9.49e-2)"	"unprognostic (2.18e-1)"		1.1	5.3	1.2	0.3	0.8	0.7	0.5	0.0	3.5	0.0	0.3			0.4	0.2	0.5	0.0	0.3	0.1	0.1	0.7	2.0	0.1	0.5	0.0	0.1	0.8		0.1	0.5	0.0	4.9	0.0		0.8	0.5		0.5	0.7	0.1	0.4	0.5	0.1	0.9	0.0	0.3	0.4			0.3		0.0	0.0	0.1	0.4	0.4	1.6	0.2	0.5	0.3	0.0	0.2	0.4	0.6	0.8	0.5	1.2	0.6	0.2	0.5	0.1	0.1	0.8	1.1	0.8	0.2	0.4	0.4	0.3	0.2	0.1	1.1	0.6	1.1	0.8	0.5	0.3	0.5	0.8	0.8	0.4	0.3	0.3	0.3	0.4	1.6	0.1	0.9	0.4	0.9	0.6	0.5	0.5	0.4	0.4	0.2	0.6	1.5	0.5	0.2	0.4	0.4	0.5	0.4	0.6	0.6	0.7	1.1	0.1	0.6	0.3	0.4	0.8	0.3	0.4	1.0	0.2	0.3	0.3	0.2	0.3	0.3	0.3	0.2	0.1	0.4	0.2	0.2	1.6	0.5	0.2	0.4	0.1	0.0										
GHSR		ENSG00000121853	"Growth hormone secretagogue receptor"	Q92847	3	172445133-172448456	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 2.4;blood: 2.4;pituitary gland: 7.4"	"Cell line enriched"	"Detected in single"	4	"HMC-1: 1.7"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	25	"NK-cell: 2.4"	"Lineage enriched"	"Detected in single"	25	"NK-cells: 2.4"	"Region enhanced"	"Detected in some"		"hypothalamus: 3.8"	"Low region specificity"	"Detected in all"																								"unprognostic (1.27e-1)"			"unprognostic (3.31e-2)"				0.0	2.4	0.0	0.8	0.5	0.7	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	1.8	0.0	0.0	0.6	0.0	0.0		0.0	0.1	0.0	7.4	0.0		0.0	0.1		0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.4			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1										
GJD2	"CX36, GJA9"	ENSG00000159248	"Gap junction protein delta 2"	Q9UKL4	15	34751032-34754965	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 13.8;pancreas: 8.7;pituitary gland: 23.9;retina: 9.1"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 2.3;SCLC-21H: 3.0"	"Cancer enriched"	"Detected in single"	32	"pancreatic cancer: 4.2"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"																		"unprognostic (4.30e-2)"						"unprognostic (2.87e-2)"			"unprognostic (1.28e-3)"	"unprognostic (1.15e-1)"			0.3	13.8	1.3	0.3	2.1	0.3	0.2	1.4	4.5	0.4	0.3	0.1	0.0	0.2	0.4	0.2	0.2	0.2	0.3	7.0	1.1	1.6	0.9	0.2	0.3	0.2	0.8	2.8	0.2	8.7	0.2	23.9	0.3	3.4	0.2	0.3	9.1	0.2	0.2	0.3	0.3	0.3	0.3	0.2	0.3	0.4	0.4	0.0	0.0	0.3	0.0	0.3	0.3	0.0	0.5	0.6	2.1	1.1	1.0	0.7	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.8	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.4	0.8	0.5	0.6	0.7	0.5	0.5	0.3	0.5	0.5	0.6	0.6	2.1	1.0	1.1	0.6	0.5	0.4	1.3	2.1	1.4	4.5	1.1	1.6	0.8	2.8	3.4	0.0
GNAS	"GNAS1, GNASXL, GPSA, NESP, NESP55, SCG6, SgVI"	ENSG00000087460	"GNAS complex locus"	"O95467, P63092, P84996, Q5JWF2"	20	58839718-58911192	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 303.3;thyroid gland: 304.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010337, HPA018122, HPA027478, HPA028386"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"CAB010337: AB_631538, HPA018122: AB_1849236, HPA027478: AB_10599284, HPA028386: AB_10601983"	"unprognostic (7.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.90e-2)"	"unprognostic (4.77e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.82e-2)"	"unprognostic (4.53e-3)"	"unprognostic (8.01e-2)"	"unprognostic (4.29e-2)"	"prognostic favourable (8.76e-4)"	"unprognostic (2.07e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (3.49e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.61e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.36e-1)"	56.2	79.0	84.2	34.4	44.5	42.1	87.4	86.0	107.4	43.2	42.3	25.4	27.0	33.2	37.2	44.7	41.0	43.6	34.4	106.0	71.0	144.0	39.6	35.3	46.6	44.6	75.8	64.7	43.6	118.1	120.9	303.3	49.8	85.6	36.3	31.5	42.7	171.6	31.1	172.9	26.3	34.9	40.5	61.4	36.9	42.4	18.2	27.4	56.0	304.5	80.6	41.0	37.3	44.6	27.3	41.5	29.9	36.2	25.3	24.2	24.6	9.6	32.5	54.8	25.5	93.1	42.6	49.2	55.8	51.0	63.9	45.8	94.7	50.1	31.7	86.9	72.5	41.8	50.2	74.3	43.3	20.9	30.2	35.2	49.4	62.0	43.1	20.4	22.2	50.7	37.8	31.0	41.7	48.3	30.9	43.3	42.0	132.2	104.3	50.1	17.4	34.4	64.2	48.0	55.9	51.2	38.2	68.0	155.7	77.6	77.0	62.2	58.9	56.1	53.1	84.8	76.2	30.5	52.5	75.9	49.0	66.9	37.2	10.0	43.2	29.9	24.8	29.5	20.7	35.7	22.1	26.7	22.0	22.2	37.8	27.3	21.3	24.2	29.1	25.3	36.2	41.5	23.3	24.6	84.2	44.5	86.0	107.4	71.0	144.0	75.8	64.7	85.6	27.4
GNG4		ENSG00000168243	"G protein subunit gamma 4"	P50150	1	235547687-235650754	"Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.1;ovary: 25.1;pituitary gland: 18.8"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 28.3;SCLC-21H: 30.0;SH-SY5Y: 42.2;U-2197: 12.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"olfactory region: 574.6"	"Region enhanced"	"Detected in all"		"olfactory region: 427.7"												"unprognostic (1.50e-3)"	"unprognostic (8.33e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.56e-9)"	"unprognostic (1.22e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.68e-3)"	"unprognostic (5.01e-3)"	1.9	9.4	16.8	2.0	21.5	0.9	1.1	8.6	24.1	1.8	3.4	6.5	0.5	2.5	8.3	1.1	8.4	1.6	1.2	0.9	10.2	20.8	1.3	0.8	0.9	4.7	6.3	7.7	25.1	4.5	0.8	18.8	4.2	11.2	17.1	3.0	1.7	1.4	1.4	0.8	1.1	4.8	5.8	7.1	0.9	3.6	2.1	2.8	3.1	0.9	0.0	3.9	1.2	1.1	1.3	0.8	3.8	0.6	1.0	0.8	0.3	6.6	0.4	5.0	0.0	0.0	0.2	0.4	0.0	0.0	0.6	0.8	0.0	0.3	0.0	0.0	2.0	0.7	5.3	0.2	1.2	3.5	1.9	0.0	0.1	2.5	0.1	0.0	2.3	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	1.3	0.2	28.3	0.0	0.0	2.6	0.1	0.0	0.2	30.0	42.2	0.2	0.1	0.6	0.0	0.9	0.0	0.3	0.9	12.6	0.9	0.9	0.0	0.0	0.9	0.0	8.3	3.8	0.6	0.6	0.5	0.5	0.4	1.0	0.8	0.5	0.2	1.3	0.6	0.6	2.3	1.0	0.5	0.8	0.6	0.3	16.8	21.5	8.6	21.7	10.2	20.8	6.3	7.7	11.2	2.8
GPR19		ENSG00000183150	"G protein-coupled receptor 19"	Q15760	12	12660891-12696207	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 9.2;brain: 13.3;pituitary gland: 9.8;testis: 9.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 23.2;NTERA-2: 24.1;WM-115: 12.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 9.2"	"Group enriched"	"Detected in many"	16	"granulocytes: 4.2;T-cells: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013955	Uncertain									"HPA013955: AB_1849287"	"unprognostic (1.92e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.62e-5)"	"unprognostic (1.60e-1)"	"unprognostic (3.21e-1)"	"unprognostic (8.25e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.67e-12)"	"unprognostic (5.19e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.60e-1)"	1.0	2.4	7.5	4.8	13.3	2.3	1.2	11.5	13.0	0.8	1.5	2.8	0.0	1.1	0.7	0.7	1.5	1.0	1.1	0.7	8.5	8.4	0.7	0.8	0.8	4.3	5.6	6.3	0.5	1.1	1.0	9.8	1.1	3.7	0.5	1.9	0.4	0.6	0.6	0.4	2.2	1.1	1.1	6.7	1.7	1.3	9.8	3.6	0.3	0.7	0.0	5.8	1.3	0.2	0.3	0.0	4.2	0.0	0.4	9.2	0.5	0.9	0.3	10.0	0.2	0.0	0.0	4.3	0.9	1.0	1.8	1.5	3.9	6.0	4.0	1.5	0.7	0.8	1.6	0.2	2.9	23.2	0.2	0.9	0.4	0.6	0.0	1.0	0.4	0.0	0.0	1.9	1.1	0.3	0.1	8.3	0.3	1.4	0.3	0.5	24.1	1.8	2.6	1.5	0.1	0.1	0.8	3.3	3.0	0.4	0.9	7.7	0.5	1.0	0.0	0.5	4.5	0.8	2.3	4.6	4.0	7.7	1.9	2.8	12.3	0.0	0.0	0.0	1.8	0.0	1.4	0.3	3.8	2.1	0.0	0.1	0.7	1.4	4.2	0.4	0.0	0.0	9.2	0.5	7.5	13.3	11.5	10.6	8.5	8.4	5.6	6.3	3.7	3.6
GPR61	BALGR	ENSG00000156097	"G protein-coupled receptor 61"	Q9BZJ8	1	109539872-109548406	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 10.6;pituitary gland: 6.3;retina: 6.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.1;U-266/70: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 1.1;naive CD8 T-cell: 1.0"	"Group enriched"	"Detected in many"	11	"granulocytes: 1.1;T-cells: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007326, HPA026088"	Approved									"HPA007326: AB_1849308, HPA026088: AB_10602323"	"unprognostic (1.70e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.70e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.63e-3)"	"unprognostic (2.94e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.46e-4)"	"unprognostic (3.27e-1)"	"unprognostic (4.08e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.72e-2)"	"unprognostic (3.85e-2)"	0.5	4.0	4.9	0.7	8.2	0.7	0.5	6.4	10.6	0.5	0.6	0.2	0.0	0.8	0.8	0.6	0.7	0.5	0.7	0.9	5.4	3.9	0.6	0.6	0.5	0.8	1.7	8.3	0.6	0.5	0.5	6.3	0.6	4.9	0.6	0.5	6.3	0.7	0.5	2.3	0.8	1.0	0.5	1.2	0.6	0.6	1.7	1.2	0.0	3.6	0.0	0.5	0.7	0.3	0.0	0.0	1.1	0.0	0.0	1.0	0.0	0.4	0.5	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.4	0.2	0.3	0.2	0.2	0.3	0.3	0.0	0.0	0.1	0.6	0.1	0.2	0.0	0.1	0.1	0.0	0.2	0.2	0.4	0.5	0.0	2.4	0.4	0.2	0.0	0.3	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.0	0.1	0.0	0.0	0.0	0.1	0.0	4.9	8.2	6.4	10.6	5.4	3.9	1.7	8.3	4.9	1.2
GPR68	OGR1	ENSG00000119714	"G protein-coupled receptor 68"	Q15743	14	91232532-91253925	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 17.0"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 7.1;U-87 MG: 26.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"gdTCR: 16.4"	"Group enriched"	"Detected in many"	10	"NK-cells: 12.8;T-cells: 16.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (3.44e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.64e-1)"	"prognostic favourable (3.06e-5)"	"unprognostic (3.20e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.84e-2)"	"unprognostic (9.63e-2)"	"unprognostic (9.42e-2)"	"unprognostic (3.73e-1)"	"unprognostic (8.31e-9)"	"unprognostic (1.70e-2)"	"unprognostic (3.19e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.78e-3)"	5.1	1.6	2.1	7.9	2.0	1.6	4.4	6.1	6.1	3.9	2.6	0.4	0.0	2.6	1.0	0.7	8.6	0.9	6.3	3.0	1.1	5.2	1.1	0.8	5.4	7.8	0.9	3.9	0.8	1.8	1.5	17.0	4.8	2.3	3.1	2.2	0.9	4.0	0.8	0.5	9.2	3.2	5.3	1.4	4.3	6.5	1.5	0.0	0.8	2.2	3.7	9.6	7.3	3.2	0.4	0.1	1.5	0.1	12.8	16.4	2.5	0.1	0.1	0.4	0.0	0.1	1.0	0.4	0.8	0.4	0.0	0.0	0.1	0.8	0.7	0.3	7.1	0.7	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.4	3.3	0.3	0.0	4.3	0.0	0.3	4.3	0.7	3.1	0.9	0.6	4.9	0.1	0.1	0.3	0.2	0.2	0.1	0.3	2.6	3.7	0.1	0.1	0.0	1.2	0.3	2.1	5.3	0.1	0.9	0.3	0.8	0.9	0.1	26.0	0.9	0.1	0.0	0.1	0.0	16.4	0.0	10.1	0.4	3.6	9.4	0.1	0.2	0.5	3.4	1.5	12.8	0.0	0.0	5.8	2.5	2.1	2.0	6.1	6.1	1.1	5.2	0.9	3.9	2.3	0.0
GRIK3	"GluK3, GLUR7"	ENSG00000163873	"Glutamate ionotropic receptor kainate type subunit 3"	Q13003	1	36795527-37034129	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.7;pituitary gland: 13.1"	"Cell line enriched"	"Detected in some"	4	"T-47d: 29.1"	"Cancer enhanced"	"Detected in some"		"glioma: 13.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (4.20e-2)"	"unprognostic (1.90e-1)"	"unprognostic (7.66e-2)"	"unprognostic (9.26e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.60e-3)"	"unprognostic (9.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.06e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.08e-2)"	1.7	4.6	5.4	1.8	9.4	0.6	5.4	5.7	24.7	2.1	8.4	3.3	1.5	2.1	0.8	4.5	3.1	1.2	2.2	1.9	3.8	9.6	0.8	0.7	0.9	0.9	9.1	10.4	1.3	1.6	1.5	13.1	0.6	13.1	1.9	3.3	9.0	2.2	5.8	0.7	1.1	2.9	1.8	3.6	1.0	2.1	2.0	2.7	0.0	1.0	0.2	1.4	1.1	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	29.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	9.4	5.7	14.2	3.8	9.6	9.1	10.4	13.1	2.7
GRP		ENSG00000134443	"Gastrin releasing peptide"	P07492	18	59220168-59230774	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 15.6;pituitary gland: 13.2;retina: 22.5"	"Group enriched"	"Detected in some"	12	"BJ hTERT+: 8.4;fHDF/TERT166: 10.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 12.7;hippocampal formation: 34.7;midbrain: 24.8"						"Secreted to blood"						"unprognostic (3.91e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.30e-3)"	"unprognostic (3.21e-2)"	"unprognostic (7.86e-3)"	"unprognostic (3.01e-3)"		"unprognostic (1.14e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.86e-4)"	"unprognostic (2.65e-4)"	"unprognostic (9.94e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.16e-2)"	0.7	0.7	3.6	0.5	0.7	0.2	5.2	0.5	3.7	0.5	2.3	1.3	0.0	0.4	0.9	0.9	0.6	0.3	1.3	0.2	11.7	5.6	0.3	0.2	15.6	0.2	4.9	0.7	0.2	4.7	4.7	13.2	0.2	10.5	1.9	0.4	22.5	0.2	0.5	0.2	0.4	0.7	2.3	1.6	0.3	12.7	3.0	0.1	0.1	11.2	0.2	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.3	0.0	0.0	0.0	0.7	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.7	0.5	3.7	11.7	5.6	4.9	0.7	10.5	0.1
HEPACAM2	FLJ38683	ENSG00000188175	"HEPACAM family member 2"	A8MVW5	7	93188586-93226524	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 43.4;kidney: 24.5;pituitary gland: 16.1"	"Cell line enriched"	"Detected in some"	37	"SCLC-21H: 61.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA012381			Supported	"Nucleoplasm,Vesicles,Mitotic spindle"		89000	89000	"Vesicles, Mitotic spindle"	"Vesicles, Mitotic spindle"	"HPA012381: "	"unprognostic (2.01e-3)"	"unprognostic (6.05e-2)"	"prognostic favourable (9.73e-5)"	"unprognostic (1.33e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.24e-2)"	"unprognostic (4.48e-2)"	"unprognostic (8.40e-3)"	"unprognostic (7.61e-2)"	"unprognostic (8.68e-2)"	"unprognostic (5.37e-3)"	"unprognostic (4.93e-2)"	"unprognostic (3.64e-3)"	"unprognostic (2.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.82e-1)"	"unprognostic (6.34e-2)"	0.1	0.2	0.2	8.5	0.2	0.6	3.4	0.1	0.1	0.1	29.4	0.1	5.3	11.8	0.1	0.4	0.2	0.1	0.8	0.3	0.2	0.2	24.5	0.2	0.4	0.1	0.2	0.1	0.1	5.5	0.0	16.1	0.4	0.2	0.7	38.9	0.1	4.1	1.2	0.1	0.1	43.4	0.4	0.2	0.2	4.0	1.4	0.1	0.3	0.1	0.1	2.1	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.1	0.1	0.2	0.2	0.2	0.1	0.2	0.1
HMGCLL1	"bA418P12.1, DKFZP434G1411"	ENSG00000146151	"3-hydroxymethyl-3-methylglutaryl-CoA lyase like 1"	Q8TB92	6	55434369-55579214	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.4;pituitary gland: 14.8"	"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 11.6"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (2.74e-3)"		"unprognostic (1.54e-2)"	"unprognostic (4.08e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.54e-3)"	"unprognostic (8.97e-3)"		"unprognostic (2.12e-2)"	"unprognostic (9.27e-3)"	"unprognostic (4.11e-2)"	"unprognostic (1.18e-4)"	"unprognostic (3.13e-3)"	"unprognostic (7.57e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.52e-1)"	2.2	7.7	7.7	0.9	14.5	0.5	3.4	10.1	18.4	2.2	1.7	3.1	0.3	0.8	0.8	0.6	2.5	1.5	1.8	4.1	8.7	12.6	2.2	1.8	5.7	1.1	9.1	10.0	1.3	3.6	0.8	14.8	12.5	14.6	7.0	2.2	4.8	2.1	2.9	2.4	0.6	2.4	1.6	10.1	0.6	2.9	5.5	3.3	0.0	0.9	0.0	1.0	2.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	14.5	10.1	12.6	8.7	12.6	9.1	10.0	14.6	3.3
HYDIN	"CILD5, DKFZp434D0513, KIAA1864, PPP1R31"	ENSG00000157423	"HYDIN, axonemal central pair apparatus protein"	Q4G0P3	16	70807378-71230722	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.5;pituitary gland: 23.6;testis: 19.1"	"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 5.2;SiHa: 10.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA067155, HPA074129"	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA067155: AB_2685792, HPA074129: AB_2686665"	"unprognostic (8.90e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.88e-4)"	"unprognostic (4.25e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.95e-1)"	"unprognostic (3.42e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.21e-1)"	"unprognostic (2.52e-5)"	"unprognostic (2.13e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.97e-2)"	0.8	0.9	6.3	1.2	13.9	1.7	1.5	2.9	4.2	2.1	1.2	13.3	4.4	1.0	2.4	18.4	0.9	14.5	1.9	1.0	6.9	4.3	3.5	1.8	7.1	1.1	2.3	4.1	7.2	1.6	9.0	23.6	0.7	21.5	1.4	0.8	3.9	0.9	1.5	0.8	1.7	1.1	1.0	3.1	1.5	1.1	19.1	3.8	0.0	3.2	0.0	0.6	1.2	0.8	0.9	1.1	3.7	1.3	0.7	1.2	0.2	0.1	0.1	2.1	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.9	0.3	0.2	0.3	0.3	0.7	0.3	0.2	1.6	0.4	0.5	0.1	0.1	0.2	0.4	0.5	0.2	0.4	0.5	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.7	0.8	1.3	0.7	0.2	0.2	0.8	5.2	0.7	2.4	0.5	10.9	0.3	0.4	0.7	0.0	0.3	0.3	0.8	0.1	0.3	1.8	0.1	1.0	0.9	0.2	0.6	1.5	1.0	0.8	1.2	0.9	1.2	0.6	1.0	1.1	0.3	0.9	0.9	0.8	3.7	0.7	1.3	1.1	0.6	0.2	6.3	13.9	2.9	4.2	6.9	4.3	2.3	4.1	21.5	3.8
IBSP	"BSP, BSP-II, SP-II"	ENSG00000029559	"Integrin binding sialoprotein"	P21815	4	87799581-87812435	"Cancer-related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 4.5;cervix, uterine: 4.0;pituitary gland: 6.2"	"Cell line enriched"	"Detected in some"	6	"U-138 MG: 12.6"	"Cancer enhanced"	"Detected in many"		"glioma: 12.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 0.9"	"Not detected"	"Not detected"								"Secreted in other tissues"						"unprognostic (2.53e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.75e-2)"	"unprognostic (9.48e-3)"	"unprognostic (1.03e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.02e-3)"		"unprognostic (5.81e-11)"	"unprognostic (6.20e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.30e-3)"	"unprognostic (2.11e-1)"	0.2	0.0	1.9	0.6	0.4	1.0	0.1	2.0	4.5	4.0	0.1	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.8	1.3	1.0	0.1	0.0	0.0	0.2	0.1	0.9	0.0	0.0	0.2	0.8	6.2	1.1	2.6	0.4	0.0	0.0	0.3	0.0	0.6	0.1	0.0	0.3	0.2	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	1.8	0.3	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.4	2.0	1.5	1.0	0.1	0.9	0.0	2.6	0.0
IFT80	"KIAA1374, WDR56"	ENSG00000068885	"Intraflagellar transport 80"	Q9P2H3	3	160256986-160399880	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 52.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA035868	Uncertain									"HPA035868: AB_10959463"	"unprognostic (2.71e-2)"	"unprognostic (4.47e-3)"	"unprognostic (2.13e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.03e-1)"	"unprognostic (7.25e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.29e-2)"	"unprognostic (5.95e-2)"	"unprognostic (6.70e-2)"	"unprognostic (8.31e-2)"	"unprognostic (4.24e-3)"	"unprognostic (4.52e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.60e-3)"	6.2	8.9	14.9	7.1	15.9	4.6	10.1	16.2	22.2	12.4	6.4	9.0	11.1	5.6	13.4	15.3	7.4	15.8	10.2	8.3	19.3	13.4	14.0	5.8	12.7	9.6	17.1	17.1	15.2	8.3	26.2	52.0	6.3	14.2	9.5	9.0	10.4	6.1	9.8	3.5	10.6	6.5	9.9	16.5	7.8	9.3	20.2	9.3	21.0	15.9	4.9	9.9	8.7	7.3	3.4	5.0	3.1	2.0	3.5	4.2	2.2	12.2	8.4	19.8	9.0	18.6	32.8	4.9	10.4	15.6	8.5	10.5	6.9	17.8	8.1	14.0	10.2	10.8	6.9	9.9	18.6	12.3	8.0	10.8	11.3	5.1	18.5	5.0	9.3	18.1	7.0	9.5	10.0	9.0	4.6	15.7	12.8	6.0	9.5	5.9	6.6	5.2	8.4	10.4	13.3	17.1	3.6	12.1	13.2	11.4	11.0	13.2	19.2	4.9	8.2	8.5	5.9	11.6	10.3	22.6	14.6	14.7	14.2	9.1	8.3	3.1	2.0	1.7	2.7	0.9	2.4	3.4	3.2	2.9	2.7	3.2	4.2	2.9	2.3	3.5	1.7	5.0	3.9	2.2	14.9	15.9	16.2	22.2	19.3	13.4	17.1	17.1	14.2	9.3
IL13RA2	"CD213a2, CT19, IL-13R, IL13BP"	ENSG00000123496	"Interleukin 13 receptor subunit alpha 2"	Q14627	X	115003975-115019977	"Cancer-related genes, CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 16.1;testis: 31.5"	"Group enriched"	"Detected in some"	9	"PC-3: 26.4;U-2197: 84.9;U-251 MG: 57.0;U-87 MG: 33.8"	"Cancer enhanced"	"Detected in many"		"glioma: 17.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"olfactory region: 8.7"	"Low region specificity"	"Detected in many"			"HPA045831, HPA067363"			Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"	"Plasma membrane, Cell Junctions"	"HPA045831: , HPA067363: "	"unprognostic (1.97e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.62e-4)"	"unprognostic (7.39e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.80e-1)"	"prognostic favourable (3.55e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.20e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.53e-5)"	"unprognostic (1.58e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.20e-1)"	0.5	4.8	3.7	3.9	11.3	0.0	0.8	0.3	3.1	1.2	0.4	2.1	5.7	0.3	0.9	4.4	0.5	0.1	0.8	0.6	5.1	11.2	3.5	9.6	1.0	0.1	1.2	2.6	0.1	0.1	0.5	16.1	2.1	3.9	4.3	0.7	1.6	0.8	3.7	0.0	0.1	0.3	0.4	0.6	0.2	0.1	31.5	1.4	0.0	1.3	0.2	0.2	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.7	0.0	5.8	5.5	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.1	0.9	5.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	26.4	0.0	0.0	0.0	0.4	0.0	0.0	1.3	0.4	0.0	0.1	0.0	0.0	0.0	3.0	0.0	84.9	57.0	0.0	0.0	0.0	33.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	11.3	0.3	3.1	5.1	11.2	1.2	2.6	3.9	1.4
INSM1	"IA-1, IA1"	ENSG00000173404	"INSM transcriptional repressor 1"	Q01101	20	20368121-20370949	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 13.2;brain: 15.5;pituitary gland: 29.2"	"Cell line enriched"	"Detected in some"	20	"SCLC-21H: 91.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"plasmacytoid DC: 1.3"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 1.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"														"unprognostic (1.86e-2)"	"unprognostic (5.25e-4)"	"unprognostic (7.59e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-3)"		"unprognostic (4.34e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.23e-1)"	"unprognostic (1.22e-1)"	0.4	13.2	2.4	1.2	4.6	0.2	0.5	15.5	3.8	0.1	6.2	2.8	0.2	5.5	0.1	0.1	0.1	0.1	0.2	0.1	3.4	4.4	0.2	0.1	0.3	1.1	1.8	1.4	0.1	5.5	0.1	29.2	0.1	1.0	0.6	3.6	0.0	0.1	0.6	0.1	0.3	3.7	0.2	0.4	0.5	10.4	0.7	1.4	8.3	0.2	0.0	0.7	0.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.7	4.5	0.0	0.0	91.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	2.4	4.6	15.5	3.8	3.4	4.4	1.8	1.4	1.0	1.4
IQCA1	"DRC11, FLJ22527, IQCA"	ENSG00000132321	"IQ motif containing with AAA domain 1"	Q86XH1	2	236324147-236507542	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 27.8;thyroid gland: 30.0"	"Cell line enhanced"	"Detected in some"		"EFO-21: 4.2;HBEC3-KT: 3.9;HeLa: 4.7;U-2 OS: 16.0"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 9.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 4.4"	"Group enriched"	"Detected in many"	4	"NK-cells: 1.2;T-cells: 4.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA057320			Uncertain	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA057320: "	"unprognostic (1.73e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.62e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.23e-5)"	"unprognostic (1.55e-1)"	"unprognostic (7.23e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.62e-1)"	"prognostic favourable (2.54e-4)"	"unprognostic (1.19e-3)"	"unprognostic (1.67e-3)"	"unprognostic (1.91e-3)"	"unprognostic (5.30e-2)"	1.8	2.7	13.4	1.4	19.2	0.8	3.5	3.8	11.6	2.2	1.0	6.7	0.4	0.9	3.4	9.1	1.6	17.8	3.5	1.1	12.9	10.0	6.6	0.8	5.1	1.3	8.8	9.3	4.7	2.4	0.9	27.8	1.1	13.0	3.1	1.0	2.7	2.6	2.8	0.8	0.9	1.2	1.5	3.2	5.5	1.1	7.4	8.0	1.4	30.0	0.0	1.6	3.0	1.0	0.7	0.0	0.0	0.0	1.2	4.4	0.1	0.1	0.0	0.3	0.3	0.0	0.0	0.4	0.2	0.0	0.1	0.4	0.1	0.0	0.0	4.2	0.0	0.0	0.0	3.9	0.0	0.0	0.1	0.0	4.7	0.0	0.1	0.0	0.0	0.3	2.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	16.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.2	0.8	0.0	0.7	1.1	4.4	0.0	1.2	0.0	0.0	0.3	0.1	13.4	19.2	3.8	10.0	12.9	10.0	8.8	9.3	13.0	8.0
IQCH	FLJ12476	ENSG00000103599	"IQ motif containing H"	Q86VS3	15	67254800-67502260	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 14.5;testis: 20.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 1.0;dendritic cells: 1.2;T-cells: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA040845	Uncertain		Approved	Cytosol				Cytosol	Cytosol	"HPA040845: AB_10672898"	"unprognostic (2.69e-1)"	"unprognostic (2.94e-3)"	"unprognostic (3.11e-2)"	"unprognostic (5.89e-5)"	"unprognostic (2.48e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.25e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.81e-2)"	"unprognostic (6.16e-3)"	"unprognostic (6.42e-2)"	0.9	1.8	1.3	0.4	2.9	0.2	2.5	0.9	2.8	1.4	0.8	2.9	4.1	0.3	1.3	6.4	0.9	10.0	2.1	1.3	1.6	2.1	3.3	1.5	2.4	0.5	1.2	1.8	2.7	1.4	6.5	14.5	0.5	2.6	1.2	1.1	3.5	1.0	1.4	0.9	1.0	0.8	0.6	1.4	0.8	1.6	20.9	1.4	0.6	6.1	0.7	0.4	1.3	1.0	1.0	1.2	0.1	0.3	0.2	2.1	0.3	2.8	3.0	1.3	2.2	2.0	4.6	1.0	1.5	1.2	2.4	1.6	0.3	3.1	1.8	1.4	2.5	4.7	4.3	1.7	3.9	0.3	2.0	0.6	3.0	0.4	3.4	0.9	0.6	3.1	1.8	5.0	4.8	0.9	4.2	1.9	1.6	3.0	0.7	0.7	1.6	1.9	0.6	2.1	2.1	2.7	1.2	4.5	1.2	2.0	2.8	7.8	7.2	0.4	2.0	2.6	1.3	4.1	1.7	4.0	5.3	0.5	5.3	2.1	2.6	0.0	0.3	0.1	1.2	0.0	2.1	0.4	1.0	1.1	1.1	1.0	0.9	0.8	0.0	0.2	0.1	1.2	0.8	0.3	1.3	2.9	0.9	2.8	1.6	2.1	1.2	1.8	2.6	1.4
IQUB	FLJ35834	ENSG00000164675	"IQ motif and ubiquitin domain containing"	Q8NA54	7	123452400-123535077	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 20.8;testis: 35.5"	"Cell line enhanced"	"Detected in some"		"K-562: 1.8;RPTEC TERT1: 7.1;T-47d: 2.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA049626			Approved	"Nuclear speckles,Intermediate filaments,Cytosol"				"Nuclear speckles, Intermediate filaments"	"Nuclear speckles, Intermediate filaments"	"HPA049626: AB_2732554"	"unprognostic (8.71e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.98e-1)"	"unprognostic (6.42e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.44e-2)"	"unprognostic (6.23e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.76e-1)"	"unprognostic (5.44e-6)"	"unprognostic (2.79e-1)"	"unprognostic (9.78e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.30e-2)"	0.6	1.0	1.3	0.3	2.9	0.3	0.9	3.0	3.5	1.2	0.5	1.8	3.2	0.4	1.4	6.9	1.8	5.7	1.6	0.6	2.6	1.2	8.5	0.4	3.2	0.3	0.7	1.2	2.7	0.7	2.7	20.8	0.5	6.4	0.9	0.4	0.3	0.7	4.3	0.6	0.5	0.5	0.6	1.0	0.4	0.6	35.5	2.8	0.0	5.6	0.0	0.3	0.7	0.6	0.8	0.0	0.0	0.3	0.5	0.7	0.0	0.3	0.0	1.3	0.6	0.6	0.6	0.1	0.0	0.1	0.0	0.3	0.0	0.8	0.8	0.0	0.4	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.7	0.3	0.2	0.3	0.0	1.8	0.2	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	7.1	1.6	1.1	0.4	0.0	0.0	0.1	2.5	0.0	0.0	0.5	0.3	0.4	0.2	0.4	0.1	0.1	0.2	0.2	0.1	0.0	0.2	0.0	0.7	0.3	0.4	0.2	0.2	0.2	0.0	0.8	0.7	0.2	0.0	0.5	0.1	0.0	0.3	0.0	1.3	2.9	3.0	3.5	2.6	1.2	0.7	1.2	6.4	2.8
ISL2	FLJ10160	ENSG00000159556	"ISL LIM homeobox 2"	Q96A47	15	76336724-76342476	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 11.3;pituitary gland: 12.6;salivary gland: 11.8"	"Cell line enhanced"	"Detected in many"		"HEK 293: 15.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"neutrophil: 11.3;non-classical monocyte: 3.9"	"Group enriched"	"Detected in many"	6	"granulocytes: 11.3;monocytes: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA075192			Approved	"Rods & Rings"				"Rods & Rings"	"Rods & Rings"	"HPA075192: AB_2686738"	"unprognostic (7.30e-2)"	"unprognostic (7.96e-2)"	"unprognostic (9.01e-3)"	"unprognostic (4.44e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.84e-1)"	"unprognostic (9.03e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.55e-15)"	"unprognostic (1.78e-1)"	"unprognostic (4.19e-1)"	"unprognostic (4.07e-1)"	"unprognostic (2.26e-1)"	0.9	0.2	0.0	0.8	1.1	0.3	0.3	0.0	0.9	2.8	3.8	2.0	0.0	2.9	0.2	0.2	1.2	0.2	1.9	0.7	0.3	0.0	0.2	0.2	0.4	0.9	0.7	0.0	0.2	0.2	0.2	12.6	0.3	1.0	4.1	0.5	1.9	11.8	0.3	0.2	1.1	2.0	0.4	1.8	1.0	3.2	2.7	1.9	0.0	0.2	4.0	1.2	0.2	6.4	1.2	0.2	11.3	3.9	0.0	0.6	0.5	1.4	1.7	0.0	1.6	0.1	0.1	1.4	4.3	2.0	1.1	1.5	3.4	0.7	3.3	2.1	0.0	1.8	6.2	0.1	0.2	3.0	15.5	1.5	3.6	3.9	1.4	3.3	4.1	0.0	0.9	0.0	0.0	0.0	4.7	2.4	0.3	0.1	4.1	8.0	0.0	2.9	2.7	2.0	4.0	0.0	0.6	4.8	5.2	2.8	0.0	0.0	0.3	7.5	0.0	1.4	3.1	0.6	4.1	3.7	3.9	1.9	1.0	2.4	0.0	0.0	1.0	0.0	0.2	1.0	0.0	1.0	0.0	0.6	0.2	1.2	0.2	0.1	11.3	0.0	3.9	0.0	0.0	0.5	0.0	1.1	0.0	0.9	0.3	0.0	0.7	0.0	1.0	1.9
KCNB2	Kv2.2	ENSG00000182674	"Potassium voltage-gated channel subfamily B member 2"	Q92953	8	72537391-72938349	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.7;lymphoid tissue: 8.6;pituitary gland: 9.2"	"Group enriched"	"Detected in some"	5	"HaCaT: 3.2;HDLM-2: 3.0;HEK 293: 7.4;SCLC-21H: 6.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA065970			Approved	"Nucleoli,Plasma membrane,Midbody"				"Plasma membrane"	"Plasma membrane"	"HPA065970: AB_2685591"	"unprognostic (9.87e-3)"	"unprognostic (1.71e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.34e-1)"		"unprognostic (1.44e-2)"		"unprognostic (2.72e-1)"	"unprognostic (6.93e-5)"	"unprognostic (5.53e-3)"	"unprognostic (3.30e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.26e-1)"		0.8	1.9	3.8	0.6	5.3	0.4	0.7	0.3	9.7	0.5	0.7	0.0	0.0	1.2	0.4	0.4	1.1	2.1	0.5	0.4	7.1	3.1	0.5	0.4	0.6	0.5	0.9	7.8	0.4	2.4	0.4	9.2	0.5	3.2	0.7	0.7	4.2	0.5	0.5	0.4	0.4	1.6	0.5	1.6	8.6	2.4	1.7	0.4	0.9	0.4	0.0	0.9	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	3.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	5.3	0.3	9.7	7.1	3.1	0.9	7.8	3.2	0.4
KCNH6	"erg2, HERG2, Kv11.2"	ENSG00000173826	"Potassium voltage-gated channel subfamily H member 6"	Q9H252	17	63523334-63548977	"Predicted membrane proteins, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 8.7;kidney: 15.4;pituitary gland: 7.6;retina: 7.6"	"Group enriched"	"Detected in some"	6	"SCLC-21H: 8.5;SH-SY5Y: 3.3"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 5.3"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"olfactory region: 4.7"	HPA061704	Approved									"HPA061704: "	"unprognostic (8.00e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.46e-2)"	"unprognostic (5.68e-2)"	"unprognostic (5.98e-5)"	"unprognostic (3.39e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.19e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.66e-1)"	"unprognostic (8.05e-2)"	"unprognostic (9.15e-2)"	0.0	0.2	0.3	0.7	1.1	0.3	0.0	0.1	1.2	0.0	4.2	0.0	0.0	3.9	0.0	0.5	0.0	0.3	0.1	0.6	0.3	2.8	15.4	0.0	0.9	0.1	1.1	0.5	0.1	2.4	0.1	7.6	0.6	1.0	6.2	0.4	7.6	0.1	0.0	0.2	0.3	8.7	0.0	0.7	0.1	1.7	1.4	0.3	0.3	0.1	0.0	0.0	0.1	0.0	0.8	0.4	1.7	0.5	0.7	0.5	0.4	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.2	0.7	0.2	0.1	0.1	0.0	0.0	0.3	8.5	3.3	0.0	0.2	0.1	0.3	0.2	0.0	0.3	1.0	0.2	0.1	0.2	0.1	0.2	0.1	0.1	0.2	1.2	0.5	0.4	0.4	0.3	0.1	0.6	0.2	0.2	0.2	0.8	0.5	0.4	1.7	0.7	0.3	0.4	0.2	0.4	0.3	1.1	0.1	1.2	0.3	2.8	1.1	0.5	1.0	0.3
KCNH7	"erg3, HERG3, Kv11.3"	ENSG00000184611	"Potassium voltage-gated channel subfamily H member 7"	Q9NS40	2	162371407-162838730	"Predicted membrane proteins, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.0;pituitary gland: 5.4"	"Group enriched"	"Detected in some"	13	"SCLC-21H: 10.5;SK-BR-3: 9.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"eosinophil: 1.5;neutrophil: 3.0"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 3.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA018039	Uncertain									"HPA018039: AB_1852125"	"unprognostic (1.80e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.66e-1)"	"unprognostic (5.55e-2)"	"unprognostic (3.05e-2)"	"unprognostic (5.51e-2)"	"unprognostic (8.12e-3)"	"unprognostic (7.31e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.52e-2)"	"unprognostic (7.55e-3)"	"unprognostic (2.76e-3)"	"unprognostic (2.13e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.68e-2)"	0.4	1.0	4.4	0.9	6.8	0.8	0.4	6.0	11.0	0.4	0.4	0.0	0.7	0.7	0.4	0.6	0.4	0.5	0.4	1.0	2.6	1.8	0.6	2.7	0.5	0.5	0.7	4.6	0.4	1.0	0.3	5.4	0.6	3.1	0.4	0.3	0.4	0.4	1.5	0.3	0.4	0.5	0.4	0.7	1.1	2.5	1.6	0.3	0.0	0.4	0.0	0.3	0.4	0.4	0.1	0.1	3.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	10.5	0.7	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	3.0	0.0	0.1	0.0	0.0	0.0	4.4	6.8	6.0	11.0	2.6	1.8	0.7	4.6	3.1	0.3
KCNH8	"elk3, Kv12.1"	ENSG00000183960	"Potassium voltage-gated channel subfamily H member 8"	Q96L42	3	19148454-19535646	"Predicted membrane proteins, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 31.3;pituitary gland: 16.1"	"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.1;naive B-cell: 4.5"	"Lineage enriched"	"Detected in single"	5	"B-cells: 4.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA016586, HPA077537, HPA077773"	Approved		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA016586: , HPA077537: , HPA077773: "	"unprognostic (6.68e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.99e-2)"	"unprognostic (8.56e-6)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.13e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.04e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.89e-2)"	"unprognostic (8.71e-5)"	"unprognostic (1.72e-1)"	0.6	7.0	8.4	1.6	22.0	1.4	2.4	1.3	11.4	1.3	1.9	31.3	0.0	2.2	1.2	1.2	0.7	1.4	2.2	1.0	11.8	5.7	0.7	0.7	0.8	3.2	16.4	10.2	0.7	2.7	0.8	16.1	0.6	15.0	2.2	2.5	0.1	3.3	1.4	0.6	1.9	1.8	1.1	9.9	2.6	5.9	4.0	18.1	0.0	1.1	0.0	3.2	0.9	0.5	4.5	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.1	9.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	4.5	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	8.4	22.0	1.3	11.4	11.8	5.7	16.4	10.2	15.0	18.1
KCNJ5	"CIR, GIRK4, KATP1, Kir3.4, LQT13"	ENSG00000120457	"Potassium voltage-gated channel subfamily J member 5"	P48544	11	128891356-128921035	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 40.7;ductus deferens: 54.6;pituitary gland: 23.4"	"Cell line enriched"	"Detected in some"	13	"HBEC3-KT: 17.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.9"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	6	"basal ganglia: 3.1;hypothalamus: 8.0;midbrain: 2.2;thalamus: 4.0"	"Low region specificity"	"Detected in all"			"HPA014722, HPA017353, CAB022569"	Enhanced									"CAB022569: , HPA014722: AB_1852133, HPA017353: AB_1852135"	"unprognostic (2.01e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.56e-3)"	"unprognostic (5.81e-2)"	"unprognostic (4.24e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.54e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.82e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.23e-2)"	1.8	40.7	0.8	0.3	1.9	0.2	0.9	0.3	1.2	0.8	0.8	1.9	54.6	0.4	0.3	1.1	0.6	0.6	1.3	8.7	1.6	2.5	2.0	0.3	3.4	0.8	3.7	0.8	0.8	16.6	0.7	23.4	4.3	3.4	0.8	0.4	3.3	0.9	21.7	0.3	0.4	0.5	0.7	4.5	7.7	1.5	0.7	0.9	2.3	0.7	0.4	0.3	1.1	0.5	0.9	0.4	2.9	0.7	0.6	0.4	0.4	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.3	0.1	0.1	0.0	0.1	0.4	17.1	0.0	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.4	0.3	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.5	0.2	0.1	0.1	1.3	0.0	2.2	0.7	0.6	0.4	0.3	0.3	0.3	0.2	0.3	0.3	0.9	0.3	0.4	2.9	0.6	0.4	0.4	0.2	0.4	0.8	1.9	0.3	1.2	1.6	2.5	3.7	0.8	3.4	0.9
KCNJ6	"BIR1, GIRK2, hiGIRK2, KATP2, KCNJ7, Kir3.2"	ENSG00000157542	"Potassium voltage-gated channel subfamily J member 6"	P48051	21	37607376-38121345	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.0;pituitary gland: 12.2"	"Cell line enriched"	"Detected in some"	7	"LHCN-M2: 25.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"basophil: 4.2;eosinophil: 3.6;neutrophil: 2.0"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 4.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (1.43e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.26e-3)"	"unprognostic (6.75e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.68e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.96e-10)"	"unprognostic (2.42e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.21e-1)"	2.0	1.2	7.7	0.9	8.4	1.0	1.1	24.0	15.6	0.9	1.4	0.8	0.0	1.1	1.4	0.6	0.7	0.7	0.8	1.2	14.6	1.1	1.2	0.9	1.0	1.4	1.3	10.8	0.8	2.7	0.7	12.2	7.4	13.5	1.5	0.9	0.0	0.8	0.6	2.2	1.1	1.1	0.5	1.5	1.6	2.7	2.0	0.4	0.0	0.8	0.0	0.6	0.8	0.8	0.3	0.3	4.2	0.3	0.3	0.2	0.0	0.0	0.0	0.6	0.3	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.7	1.4	0.0	2.9	0.1	25.0	0.1	0.0	0.0	0.2	2.4	0.0	0.1	0.8	3.6	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.3	0.0	0.0	0.1	3.7	1.0	0.0	0.0	0.0	0.0	4.2	0.3	3.6	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.3	0.1	0.2	2.0	0.3	0.2	0.3	0.1	0.0	7.7	8.4	24.0	15.6	14.6	1.1	1.3	10.8	13.5	0.4
KIAA0825	"C5orf36, DKFZp686F0372, MGC34713"	ENSG00000185261	KIAA0825	Q8IV33	5	94152966-94618597	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 22.4"	"Cell line enhanced"	"Detected in many"		"HeLa: 13.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	18	"neutrophil: 13.4"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 13.4"									"HPA038030, HPA038031"	Uncertain									"HPA038030: AB_10672735, HPA038031: AB_2675794"	"unprognostic (1.26e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.93e-4)"	"unprognostic (2.72e-3)"	"unprognostic (1.41e-1)"	"unprognostic (7.63e-3)"	"unprognostic (4.44e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.37e-1)"	"unprognostic (4.95e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.02e-5)"	"unprognostic (3.00e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.09e-2)"	2.7	3.5	5.1	1.9	10.4	2.9	3.6	14.1	10.7	4.5	2.1	1.2	4.1	1.4	4.4	5.4	3.4	8.0	3.8	2.7	4.9	4.8	5.4	2.9	3.1	2.1	2.6	4.2	5.2	2.8	5.5	22.4	2.8	5.3	3.4	2.4	4.9	2.2	3.0	1.9	1.9	2.3	3.0	2.6	4.0	1.9	8.5	1.9	4.1	5.9	1.3	1.6	3.7	2.6	0.7	0.6	13.4	0.6	0.6	0.7	0.2	0.7	0.3	1.0	2.5	3.3	4.3	0.3	2.3	2.1	1.5	2.2	0.0	1.7	0.4	2.5	0.9	1.2	0.4	1.6	2.1	0.0	0.5	0.4	13.6	0.3	2.3	0.4	0.2	2.3	1.7	2.0	0.5	1.6	0.3	0.1	2.9	1.5	1.1	1.1	1.3	0.3	1.2	0.2	0.1	3.1	0.7	1.5	1.9	2.4	0.2	0.4	1.2	1.7	1.5	1.3	0.3	1.9	0.9	0.6	0.5	0.0	3.0	0.8	1.2	0.0	0.6	0.0	0.4	0.3	0.2	0.7	0.4	0.7	0.5	0.5	0.2	0.4	13.4	0.6	0.4	0.6	0.2	0.2	5.1	10.4	14.1	10.7	4.9	4.8	2.6	4.2	5.3	1.9
KRT40	"FLJ36600, KA36"	ENSG00000204889	"Keratin 40"	Q6A162	17	40977716-40987135	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 9.5;skin 1: 5.2"	"Cell line enriched"	"Detected in single"	7	"SK-BR-3: 4.3"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA075961	Supported									"HPA075961: "	"unprognostic (2.33e-2)"	"unprognostic (9.35e-4)"	"unprognostic (8.90e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.92e-1)"		"unprognostic (9.09e-3)"		"unprognostic (2.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.01e-4)"	"unprognostic (1.47e-2)"			"unprognostic (9.60e-2)"	0.2	0.0	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.2	1.0	0.1	0.1	1.5	0.1	0.1	1.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	1.3	0.1	0.1	0.1	0.1	0.6	0.0	9.5	0.1	0.4	0.1	0.4	1.8	0.7	0.2	0.1	5.2	0.9	0.1	0.1	0.1	0.3	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	4.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.4	0.1
LHFPL1		ENSG00000182508	"LHFPL tetraspan subfamily member 1"	Q86WI0	X	112630648-112680054	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 13.7;pituitary gland: 15.9;salivary gland: 8.2"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 1.4;NTERA-2: 2.5;REH: 1.5;SK-MEL-30: 7.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 2.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in many"	5	"olfactory region: 6.1"	HPA003029	Uncertain									"HPA003029: AB_1079248"	"unprognostic (2.23e-2)"	"unprognostic (2.78e-3)"		"unprognostic (2.49e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.31e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.41e-3)"	"unprognostic (5.19e-5)"	"unprognostic (1.33e-1)"	"unprognostic (7.63e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.92e-1)"	0.2	0.6	3.1	0.4	13.7	0.1	2.0	0.1	3.8	1.5	0.3	0.6	0.9	0.3	0.6	0.9	0.5	1.3	0.2	2.2	2.8	2.5	0.6	0.2	0.2	0.4	4.5	1.5	1.1	0.1	0.3	15.9	0.5	3.8	1.2	0.4	0.0	8.2	3.3	0.5	0.3	0.5	0.3	0.5	0.4	0.2	0.4	1.6	0.3	6.1	0.1	0.5	0.5	0.2	0.7	0.0	0.0	0.0	0.8	2.6	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	2.5	0.0	1.5	0.3	0.9	0.1	0.4	0.2	0.2	0.0	0.0	7.0	0.0	0.0	0.0	0.2	0.3	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.2	0.7	1.0	2.6	0.0	0.6	0.2	0.8	0.0	0.8	0.0	0.0	0.1	0.4	3.1	13.7	0.1	2.7	2.8	2.5	4.5	1.5	3.8	1.6
LHFPL4		ENSG00000156959	"LHFPL tetraspan subfamily member 4"	Q7Z7J7	3	9498361-9553802	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 29.1;pituitary gland: 9.0"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 4.6;SCLC-21H: 10.7;SH-SY5Y: 13.4;U-266/84: 11.2;WM-115: 4.1"	"Group enriched"	"Detected in some"	13	"glioma: 6.8;pancreatic cancer: 1.3;testis cancer: 5.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041421	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA041421: AB_10796673"	"unprognostic (6.81e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.50e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.90e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.03e-3)"	"unprognostic (8.21e-2)"	0.9	4.9	8.0	1.0	11.4	0.9	0.9	16.0	29.1	0.9	1.4	1.5	0.0	1.2	0.9	0.8	0.9	0.9	0.9	0.8	8.4	8.5	0.9	0.8	1.0	0.8	4.2	8.6	0.8	1.8	1.2	9.0	0.8	9.2	0.9	1.4	1.7	0.9	0.9	0.8	0.9	1.3	0.9	4.2	0.8	1.3	1.6	1.8	0.0	0.9	0.0	0.8	0.8	0.1	0.0	1.2	0.6	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	10.7	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3.0	0.0	11.2	0.0	0.5	0.0	4.1	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	1.2	0.0	0.0	8.0	11.4	16.0	15.6	8.4	8.5	4.2	8.6	9.2	1.8
LMNTD1	"FLJ36004, IFLTD1, Pas1c1"	ENSG00000152936	"Lamin tail domain containing 1"	Q8N9Z9	12	25409307-25648579	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.4;fallopian tube: 19.0;pituitary gland: 21.3;testis: 15.0"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 5.4;RT4: 6.6;SH-SY5Y: 6.7;U-2197: 23.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA038640			Approved	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"	"Nucleoplasm, Centrosome"	"HPA038640: AB_2676127"				"unprognostic (8.92e-3)"	"unprognostic (3.21e-1)"			"unprognostic (2.41e-1)"		"unprognostic (1.19e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.68e-1)"		"unprognostic (6.18e-2)"	"unprognostic (2.42e-1)"	"unprognostic (7.80e-2)"	"unprognostic (3.89e-2)"	0.4	0.3	4.3	0.7	6.7	0.4	1.1	3.3	1.6	1.4	3.9	7.1	0.0	1.5	0.8	6.0	0.3	19.0	0.9	0.5	8.5	2.8	0.8	0.2	4.1	0.4	1.1	3.0	4.0	0.7	0.1	21.3	0.3	13.4	0.4	3.8	1.3	0.2	0.3	0.2	0.6	0.6	1.2	4.1	0.6	0.6	15.0	6.5	0.0	1.1	0.0	0.2	0.4	0.3	2.6	2.2	2.7	0.9	0.7	1.6	0.6	0.3	0.3	0.1	0.2	0.2	1.5	2.3	3.1	5.4	1.2	0.2	0.0	0.3	0.2	0.1	0.0	0.0	0.2	0.1	0.3	0.9	0.1	0.9	0.8	1.9	0.3	0.1	0.1	0.5	0.2	1.6	0.4	0.1	1.9	0.3	0.0	0.4	0.0	0.3	1.6	0.5	0.4	0.2	0.2	0.2	6.6	0.1	6.7	0.2	0.4	3.8	0.3	1.5	0.3	0.2	0.9	23.5	0.2	0.8	1.3	1.6	0.3	1.5	2.5	1.9	0.9	0.6	1.4	0.3	0.5	2.1	1.0	1.3	0.4	2.6	1.4	1.6	2.7	0.7	0.4	2.2	0.5	0.6	4.3	6.7	3.3	1.6	8.5	2.8	1.1	3.0	13.4	6.5
LMX1A	"LMX1, LMX1.1"	ENSG00000162761	"LIM homeobox transcription factor 1 alpha"	Q8TE12	1	165201867-165356715	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 7.3;pituitary gland: 8.0"	"Cell line enriched"	"Detected in single"	12	"SCLC-21H: 4.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"pons and medulla: 7.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA028051, HPA030088"			Approved	"Nucleoplasm,Golgi apparatus,Vesicles"				"Nucleoplasm, Golgi apparatus, Vesicles"	"Nucleoplasm, Golgi apparatus, Vesicles"	"HPA028051: AB_10599731, HPA030088: AB_10601106"	"unprognostic (1.73e-1)"		"unprognostic (9.57e-2)"	"unprognostic (7.58e-2)"		"unprognostic (1.59e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.82e-1)"		"unprognostic (2.63e-1)"	"unprognostic (3.22e-2)"			"unprognostic (2.10e-3)"	"unprognostic (1.51e-1)"	"unprognostic (9.82e-3)"		2.2	0.0	0.0	2.0	0.0	0.0	1.2	2.6	0.5	0.5	1.7	3.4	3.1	4.0	0.1	1.3	1.1	0.5	0.2	0.2	0.9	1.5	0.0	0.1	0.1	0.0	2.2	0.0	0.0	0.0	0.1	8.0	0.0	7.3	0.2	2.1	0.5	1.5	0.3	1.4	0.3	2.2	0.9	0.1	0.0	0.2	4.3	0.3	0.0	0.3	3.5	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.5	0.9	1.5	2.2	0.0	7.3	0.3
LRGUK	"CFAP246, FLJ32786"	ENSG00000155530	"Leucine rich repeats and guanylate kinase domain containing"	Q96M69	7	134127299-134264591	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.5;pituitary gland: 11.5;testis: 22.4"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 5.0;SH-SY5Y: 4.8;SK-MEL-30: 5.0"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"pons and medulla: 12.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA029505, HPA029506"	Uncertain									"HPA029505: AB_10599606, HPA029506: AB_10601752"	"unprognostic (4.08e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.94e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.64e-2)"	"unprognostic (7.85e-4)"	"unprognostic (6.92e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.28e-2)"	"unprognostic (5.57e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.27e-3)"	"unprognostic (2.22e-3)"	"unprognostic (3.83e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.10e-2)"	0.7	0.6	2.3	0.6	6.4	1.3	1.2	0.5	1.4	1.2	0.5	4.1	0.3	0.5	1.5	4.0	0.4	9.1	0.7	0.4	2.4	1.2	1.2	0.9	3.4	0.4	0.3	0.6	2.4	1.9	0.4	11.5	0.4	12.5	1.6	0.7	2.2	1.3	0.5	0.2	1.2	0.5	0.5	1.6	1.3	0.6	22.4	0.9	0.0	2.2	0.0	0.6	0.5	0.4	0.5	0.3	0.0	0.4	0.0	0.0	0.0	0.3	0.4	0.7	1.1	0.1	0.3	0.3	0.0	0.1	0.5	0.4	0.0	0.9	0.2	0.3	0.1	0.3	0.4	0.1	0.8	0.5	0.5	0.1	0.3	0.2	0.1	0.2	0.5	0.3	0.7	0.9	0.0	0.2	0.2	0.8	0.8	0.2	0.3	0.6	5.0	1.2	0.7	0.1	0.0	0.8	0.4	1.6	4.8	1.5	0.0	5.0	0.2	1.1	0.0	0.3	0.5	0.3	0.6	1.1	1.7	1.5	1.3	0.2	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.3	6.4	0.5	1.4	2.4	1.2	0.3	0.6	12.5	0.9
LRRC56	"DKFZp761L1518, FLJ00101"	ENSG00000161328	"Leucine rich repeat containing 56"	Q8IYG6	11	537527-554916	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pituitary gland: 15.5;testis: 20.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.1;Daudi: 2.9;Karpas-707: 5.8;SK-BR-3: 3.7;T-47d: 4.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA038728	Uncertain									"HPA038728: AB_10671864"	"unprognostic (2.77e-2)"	"unprognostic (9.54e-3)"	"unprognostic (1.28e-2)"	"prognostic favourable (7.39e-4)"	"unprognostic (3.18e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.29e-2)"	"prognostic favourable (6.19e-4)"	"unprognostic (2.65e-3)"	"unprognostic (1.86e-1)"	"prognostic favourable (6.32e-4)"	"unprognostic (1.17e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.52e-3)"	0.6	0.7	2.4	2.9	9.6	1.1	0.6	3.2	1.7	1.6	1.7	1.2	8.1	0.9	1.2	9.1	2.1	4.6	5.0	0.5	2.1	1.6	1.7	0.8	7.8	3.0	0.5	1.3	3.4	4.5	0.4	15.5	0.6	2.8	1.9	0.8	1.7	2.2	2.0	1.1	4.8	2.8	0.5	0.4	1.0	3.6	20.8	0.7	0.3	1.8	0.1	5.3	1.0	0.8	0.5	0.1	0.2	0.3	0.3	1.2	0.7	0.0	0.0	0.1	4.1	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.5	0.0	2.9	0.0	0.0	0.9	0.1	0.4	0.0	0.0	0.0	0.0	1.5	0.1	1.7	1.0	2.6	0.9	1.8	0.0	0.3	0.0	0.0	5.8	0.0	0.0	0.2	1.5	0.0	1.6	0.0	0.0	1.1	0.5	0.0	0.8	0.5	0.0	3.7	0.0	4.5	0.1	0.1	0.7	0.1	0.2	0.2	0.8	0.2	0.1	0.0	0.0	1.0	0.2	0.2	0.0	0.2	0.3	0.1	0.5	0.1	0.6	0.1	0.1	0.1	0.6	0.0	0.3	0.1	0.0	1.2	0.7	2.4	9.6	3.2	1.7	2.1	1.6	0.5	1.3	2.8	0.7
LRRC9	FLJ46156	ENSG00000131951	"Leucine rich repeat containing 9"	Q6ZRR7	14	59919713-60063559	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 16.4;pituitary gland: 13.9;testis: 14.3"	"Cell line enhanced"	"Detected in some"		"AF22: 1.3;CACO-2: 2.0;NTERA-2: 4.2;SCLC-21H: 1.9;SH-SY5Y: 1.3;U-2 OS: 1.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 7.3;pons and medulla: 16.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA040965, HPA041381"	Uncertain									"HPA040965: AB_2677225, HPA041381: AB_2677444"	"unprognostic (1.01e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.45e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.95e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.45e-3)"	"unprognostic (6.06e-2)"	"unprognostic (2.62e-3)"	"unprognostic (8.54e-3)"	"unprognostic (8.30e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.29e-2)"	0.6	0.4	0.6	0.1	7.3	0.2	0.1	0.2	1.1	0.3	0.1	3.2	0.0	0.1	0.2	1.4	0.1	3.4	0.1	0.1	1.4	1.2	0.2	0.2	0.1	0.1	0.5	1.3	1.0	0.2	4.8	13.9	0.1	16.4	1.3	0.1	0.0	0.1	0.2	0.1	0.1	0.7	0.1	0.9	0.1	0.2	14.3	2.2	0.0	0.1	0.0	0.1	0.2	0.1	0.6	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	7.3	0.2	1.1	1.4	1.2	0.5	1.3	16.4	2.2
LRRIQ1	"FLJ12303, KIAA1801"	ENSG00000133640	"Leucine rich repeats and IQ motif containing 1"	Q96JM4	12	85036314-85263224	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.5;pituitary gland: 24.9;testis: 20.1"	"Cell line enhanced"	"Detected in many"		"AF22: 3.8;RPTEC TERT1: 6.5;SH-SY5Y: 4.3;U-138 MG: 3.6"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"pons and medulla: 21.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA046162	Uncertain									"HPA046162: AB_10963055"	"unprognostic (3.55e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.37e-3)"	"unprognostic (1.01e-2)"	"unprognostic (9.69e-2)"		"unprognostic (4.81e-2)"	"unprognostic (4.05e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.97e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.25e-3)"	"unprognostic (3.35e-2)"	"unprognostic (6.10e-3)"	"unprognostic (1.64e-1)"	0.4	1.2	2.4	0.5	8.2	0.3	1.5	0.4	3.1	2.0	0.5	2.2	2.0	0.2	1.9	8.2	0.3	13.4	0.9	0.5	4.7	3.7	5.3	0.3	4.6	0.3	1.0	3.4	4.7	0.7	3.1	24.9	0.3	21.5	1.8	0.3	1.0	0.6	1.0	0.2	0.3	0.3	1.0	1.0	0.4	0.6	20.1	3.4	0.0	2.8	0.2	0.3	0.3	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	3.8	0.0	1.0	2.0	0.4	0.6	0.6	1.7	0.4	0.0	0.1	0.0	0.2	0.4	0.1	1.4	1.7	0.4	0.0	2.5	0.6	0.2	0.0	0.0	0.0	0.0	1.0	2.7	1.3	1.9	0.3	0.1	0.0	0.0	0.0	0.0	0.0	1.0	2.4	0.0	0.6	0.0	6.5	0.0	2.4	4.3	0.2	0.2	0.2	1.9	0.0	0.0	3.6	1.0	1.4	0.2	0.0	1.1	0.0	2.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	8.2	0.4	3.1	4.7	3.7	1.0	3.4	21.5	3.4
M1AP	"C2orf65, D6Mm5e, SPATA37"	ENSG00000159374	"Meiosis 1 associated protein"	Q8TC57	2	74557883-74648338	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 8.8;testis: 13.2"	"Group enriched"	"Detected in some"	9	"NTERA-2: 5.9;RT4: 5.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA045420, HPA059302"	Uncertain		Approved	Nucleoli,Mitochondria				Mitochondria	Mitochondria	"HPA045420: AB_10961177, HPA059302: AB_2683972"	"unprognostic (1.76e-1)"	"unprognostic (6.58e-3)"	"unprognostic (1.26e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.17e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.11e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.46e-1)"	0.7	0.6	5.2	0.2	1.5	3.7	3.7	1.2	3.4	4.6	0.2	0.3	1.0	0.2	2.1	0.5	0.3	4.6	0.5	0.1	0.9	1.8	1.5	0.1	0.6	0.1	0.5	1.6	0.3	0.4	1.7	8.8	1.2	0.9	0.2	0.0	2.0	1.5	1.0	0.1	0.2	0.2	0.2	0.7	0.4	0.7	13.2	0.2	1.0	3.6	0.0	0.5	0.9	0.5	0.0	0.9	0.2	1.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.5	0.2	0.5	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	5.9	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	5.2	1.5	1.2	3.4	0.9	1.8	0.5	1.6	0.9	0.2
MAATS1	"AAT1, AAT1alpha, C3orf15, CaM-IP2, SPATA26"	ENSG00000183833	"MYCBP associated and testis expressed 1"	Q7Z4T9	3	119703022-119767102	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 31.6"	"Cell line enhanced"	"Detected in some"		"AF22: 3.3;RPTEC TERT1: 4.7;SCLC-21H: 6.9;SH-SY5Y: 4.9;T-47d: 3.6;U-87 MG: 3.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA074084	Enhanced									"HPA074084: "	"unprognostic (6.70e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.11e-2)"	"unprognostic (4.07e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.46e-2)"	1.1	3.4	2.6	0.8	7.7	0.5	3.5	1.8	3.8	5.8	2.1	4.4	10.5	0.7	6.7	12.0	1.1	23.1	3.5	0.8	3.0	4.7	4.8	1.2	3.8	0.6	1.5	3.2	6.7	7.8	7.6	31.6	0.8	17.1	4.4	1.5	7.2	2.6	12.8	0.6	0.7	1.1	3.4	1.5	4.0	2.9	19.5	2.2	0.0	7.9	0.4	0.9	2.2	1.9	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	3.3	0.0	0.4	0.0	0.0	0.0	0.4	0.5	2.4	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	4.7	0.0	6.9	4.9	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	0.0	3.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.6	7.7	1.8	3.8	3.0	4.7	1.5	3.2	17.1	2.2
MAGED4	"KIAA1859, MAGE-E1, MAGE1, MGC3210"	ENSG00000154545	"MAGE family member D4"	Q96JG8	X	52184823-52192268	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 6.1;pituitary gland: 7.5"	"Cell line enhanced"	"Detected in some"		"A549: 4.7;ASC TERT1: 4.4;Hep G2: 12.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.1"	"Group enriched"	"Detected in many"	21	"B-cells: 3.1;dendritic cells: 1.3;T-cells: 1.6"									HPA003554	Uncertain									"HPA003554: AB_1853497"					"unprognostic (7.71e-2)"					"unprognostic (8.21e-2)"				"unprognostic (4.07e-4)"	"unprognostic (6.15e-2)"			1.3	2.1	5.5	1.3	6.1	0.4	3.1	0.8	4.6	2.0	1.0	2.4	0.0	0.4	1.9	0.4	0.4	0.4	1.9	1.6	5.1	4.8	1.1	0.6	0.4	0.4	3.7	5.5	1.2	1.0	0.4	7.5	1.7	3.7	1.2	1.2	0.3	1.1	1.4	0.9	0.4	0.4	2.0	5.2	0.8	0.5	0.6	1.2	0.0	0.4	0.0	0.4	0.4	0.4	3.1	1.3	0.0	0.0	0.0	1.6	0.3	0.0	4.7	0.8	0.8	0.0	4.4	0.0	0.0	0.0	1.7	0.0	0.0	0.3	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.9	0.0	0.0	12.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.9	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	1.6	0.0	3.1	0.5	0.2	0.0	0.0	0.0	1.3	1.5	0.3	5.5	6.1	0.8	4.6	5.1	4.8	3.7	5.5	3.7	1.2
MAGEL2	"NDNL1, nM15"	ENSG00000254585	"MAGE family member L2"	Q9UJ55	15	23643544-23647841	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.6;pituitary gland: 13.0"	"Group enriched"	"Detected in some"	5	"AF22: 7.7;NTERA-2: 4.7;U-2 OS: 2.5"	"Cancer enhanced"	"Detected in some"		"testis cancer: 4.3"	"Group enriched"	"Detected in many"	5	"basal ganglia: 20.6;cerebral cortex: 6.4;hypothalamus: 19.4;pons and medulla: 8.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"hypothalamus: 20.7"	"Low region specificity"	"Detected in all"														"unprognostic (3.18e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.65e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.38e-3)"	"unprognostic (3.51e-3)"	"unprognostic (8.61e-2)"	"unprognostic (1.31e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.96e-9)"	"unprognostic (1.66e-4)"	"unprognostic (3.30e-2)"	"unprognostic (2.06e-4)"	"unprognostic (1.79e-2)"	1.5	1.3	3.0	0.9	20.6	0.3	0.7	0.3	6.8	6.7	0.5	1.0	0.2	0.3	4.9	1.2	0.5	1.6	1.2	0.6	2.9	19.4	0.5	0.4	0.5	0.4	2.1	1.6	7.2	2.2	0.3	13.0	4.3	8.9	1.0	0.4	2.5	0.6	1.9	0.5	0.7	0.6	2.2	0.9	1.0	0.5	4.2	1.4	0.0	2.5	0.0	0.4	1.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.5	0.0	4.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	20.6	0.3	6.4	2.9	19.4	2.1	1.6	8.9	1.4
MARCH4	"KIAA1399, MARCH-IV, RNF174"	ENSG00000144583	"Membrane associated ring-CH-type finger 4"	Q9P2E8	2	216257865-216372027	"Enzymes, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 16.6;pituitary gland: 13.1"	"Cell line enhanced"	"Detected in many"		"BJ: 33.3;fHDF/TERT166: 21.2;TIME: 15.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014348	Approved									"HPA014348: AB_1853578"	"unprognostic (4.84e-2)"	"unprognostic (1.02e-4)"	"unprognostic (1.63e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.49e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.07e-1)"	"unprognostic (6.81e-5)"	"unprognostic (4.82e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.09e-3)"	0.7	2.9	7.0	0.7	11.9	0.7	0.6	1.0	16.6	0.6	1.1	0.3	0.0	1.5	0.7	0.7	0.6	2.5	0.6	0.6	5.8	5.6	0.6	0.6	0.8	0.6	2.0	4.8	0.6	1.5	0.6	13.1	3.1	3.4	0.7	1.2	0.1	0.6	0.6	0.6	0.7	1.4	0.6	1.6	0.6	5.1	0.7	1.1	0.0	0.6	0.0	0.6	0.6	0.1	0.0	0.0	0.0	0.0	0.5	0.4	0.0	5.5	1.2	0.0	0.0	0.1	0.8	0.0	33.3	11.4	7.2	2.5	0.0	0.5	0.0	5.2	21.2	0.0	0.0	13.1	7.1	0.0	0.0	2.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	6.5	9.9	9.3	0.0	0.0	11.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.9	0.0	0.0	0.0	0.0	0.0	15.6	11.2	11.6	0.0	8.9	0.0	0.0	0.0	2.5	0.0	7.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	7.0	11.9	1.0	16.6	5.8	5.6	2.0	4.8	3.4	1.1
MCOLN3	"FLJ11006, TRP-ML3, TRPML3"	ENSG00000055732	"Mucolipin 3"	Q8TDD5	1	85018082-85048499	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 29.2;pituitary gland: 38.3"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 9.8;HAP1: 9.8;RH-30: 11.9;SK-MEL-30: 21.2"	"Cancer enriched"	"Detected in many"	6	"melanoma: 8.0"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.9"	"Lineage enriched"	"Detected in single"	29	"T-cells: 2.9"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"olfactory region: 1.7"	"HPA018106, HPA062137"	Enhanced		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"	"Nucleoli, Cytosol"	"HPA018106: AB_1853647, HPA062137: AB_2684695"	"unprognostic (5.91e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.21e-5)"	"unprognostic (2.25e-1)"	"unprognostic (8.80e-3)"	"unprognostic (3.97e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.45e-3)"	"unprognostic (3.09e-2)"	"unprognostic (7.32e-5)"	"unprognostic (6.36e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.11e-2)"	"unprognostic (6.43e-2)"	4.7	29.2	1.5	0.8	0.8	0.0	3.0	0.2	0.4	6.1	2.8	0.9	2.1	3.2	5.4	15.6	0.8	1.1	0.6	5.1	3.4	0.3	4.5	0.2	4.1	0.0	0.5	0.0	2.2	6.5	17.9	38.3	1.8	2.7	0.5	0.5	4.5	8.1	0.4	1.9	2.5	1.9	1.1	0.3	0.9	1.6	0.4	0.3	2.6	1.5	0.9	0.4	0.7	2.8	0.0	0.0	0.0	0.0	0.0	2.9	0.7	6.4	1.5	0.0	0.0	5.2	4.7	1.6	0.1	9.8	2.5	6.9	0.5	1.2	0.0	0.7	0.1	0.0	9.8	3.2	1.6	2.6	5.8	0.0	0.5	0.0	0.0	0.0	0.0	0.5	1.2	2.1	1.1	0.0	0.0	0.0	4.8	0.6	0.0	0.0	0.7	0.6	0.0	11.9	0.0	0.3	0.0	0.4	0.0	0.3	0.0	21.2	4.0	4.9	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.8	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.5	0.8	0.2	0.4	3.4	0.3	0.5	0.0	2.7	0.3
MSMP	"PC-3, PSMP"	ENSG00000215183	"Microseminoprotein, prostate associated"	Q1L6U9	9	35752990-35756613	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.9;pituitary gland: 6.0;placenta: 5.7"	"Group enriched"	"Detected in some"	7	"HUVEC TERT2: 34.3;PC-3: 43.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"midbrain: 3.9"	"Cell type enhanced"	"Detected in some"		"basophil: 3.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.2;NK-cells: 1.2;T-cells: 1.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA055174	Uncertain		Supported	Vesicles,Cytosol	"Secreted in male reproductive system"			Vesicles	Vesicles	"HPA055174: AB_2682726"																		0.5	0.0	1.2	1.1	0.6	0.0	0.8	0.0	0.7	0.2	0.8	0.6	0.0	0.0	0.1	0.0	0.0	0.5	1.9	0.0	0.1	0.1	0.4	0.0	0.4	0.9	3.9	0.0	0.0	0.0	0.0	6.0	5.7	0.8	0.7	0.5	0.0	0.0	0.3	1.3	0.5	1.5	0.3	2.2	0.0	0.1	0.6	0.0	0.0	1.3	0.0	0.2	0.1	0.1	0.0	0.1	3.2	0.3	1.2	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.3	0.2	0.3	1.3	0.0	0.0	0.0	0.1	0.0	0.7	1.1	0.0	1.2	0.3	0.1	0.3	0.4	1.2	0.6	0.0	0.6	0.1	0.1	3.9	0.0	0.8	0.0
MTUS2	"CAZIP, ICIS, KIAA0774, TIP150"	ENSG00000132938	"Microtubule associated scaffold protein 2"	Q5JR59	13	28820348-29505947	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 46.8;pituitary gland: 19.3"	"Group enriched"	"Detected in some"	4	"HaCaT: 16.3;HeLa: 6.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"eosinophil: 1.9;intermediate monocyte: 1.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.3;granulocytes: 1.9;monocytes: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031473, HPA031474, HPA031475"	Enhanced		Supported	"Microtubules,Cytokinetic bridge"				"Microtubules, Cytokinetic bridge"	"Microtubules, Cytokinetic bridge"	"HPA031473: AB_2673901, HPA031474: AB_10600109, HPA031475: AB_10600442"	"unprognostic (1.67e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.87e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.30e-3)"	"unprognostic (3.45e-2)"	"unprognostic (3.91e-5)"	"unprognostic (2.51e-2)"	"unprognostic (5.46e-2)"	"unprognostic (5.93e-2)"	"unprognostic (9.62e-2)"	0.6	0.8	2.3	0.7	6.1	0.7	0.6	12.2	8.8	1.1	0.8	0.1	0.0	0.7	2.1	0.6	0.8	1.4	0.7	46.8	3.4	1.9	0.6	1.1	0.7	1.0	1.2	4.6	8.2	4.7	0.5	19.3	0.5	2.3	0.8	0.8	2.0	1.0	0.7	0.6	0.7	0.9	1.7	0.7	1.0	1.5	1.6	0.9	0.0	1.1	0.0	0.6	2.6	0.7	0.0	1.3	1.9	1.7	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.2	16.3	0.5	0.0	0.0	0.1	0.7	0.0	6.8	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.7	0.1	0.0	0.0	0.0	1.2	0.0	2.8	2.1	0.1	0.6	0.0	0.2	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.9	0.3	0.1	0.4	0.0	0.0	0.0	0.2	1.9	0.0	1.7	0.1	0.0	0.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	2.3	6.1	12.2	8.8	3.4	1.9	1.2	4.6	2.3	0.9
MYO3A	DFNB30	ENSG00000095777	"Myosin IIIA"	Q8NEV4	10	25934071-26212536	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 8.1;testis: 12.5"	"Cell line enhanced"	"Detected in some"		"AF22: 2.3;CAPAN-2: 2.2;HEK 293: 2.6;SCLC-21H: 2.4;U-2 OS: 4.3;U-698: 10.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 5.0;cerebral cortex: 1.9;hypothalamus: 1.3;pons and medulla: 5.4"	"Cell type enriched"	"Detected in single"	12	"naive B-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"B-cells: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA048951, HPA051893"	Approved		Supported	"Plasma membrane,Actin filaments,Cytoplasmic bodies"				"Actin filaments, Cytoplasmic bodies"	"Actin filaments, Cytoplasmic bodies"	"HPA048951: AB_2680567, HPA051893: "	"unprognostic (5.00e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.20e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.37e-2)"		"unprognostic (5.29e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.66e-3)"	"unprognostic (7.96e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.62e-2)"	"unprognostic (9.69e-2)"	0.8	0.7	0.4	0.3	5.0	0.5	1.5	0.3	1.9	2.1	0.6	0.1	0.7	0.4	0.3	3.2	0.9	1.1	0.3	0.3	0.5	1.3	0.9	0.2	1.0	0.3	0.2	0.0	0.5	2.1	0.2	8.1	0.2	5.4	0.5	1.1	3.8	0.2	0.6	0.3	2.2	0.6	1.0	0.4	0.3	0.9	12.5	0.8	0.0	1.3	1.4	0.9	0.5	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.6	0.0	0.0	1.2	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5.0	0.3	1.9	0.5	1.3	0.2	0.0	5.4	0.8
NAALAD2	"GCPIII, NAALADASE2"	ENSG00000077616	"N-acetylated alpha-linked acidic dipeptidase 2"	Q9Y3Q0	11	90131515-90192894	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 44.1"	"Group enriched"	"Detected in some"	5	"CACO-2: 19.7;SH-SY5Y: 6.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"non-classical monocyte: 2.4"	"Lineage enriched"	"Detected in single"	12	"monocytes: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060820, HPA065419"	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA060820: AB_2684373, HPA065419: AB_2685487"	"unprognostic (1.68e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.52e-3)"	"unprognostic (4.73e-3)"	"unprognostic (2.97e-1)"	"unprognostic (3.82e-3)"	"unprognostic (1.77e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.30e-2)"	"unprognostic (8.00e-2)"	"unprognostic (9.97e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.93e-1)"	7.7	13.0	5.3	1.8	9.9	1.1	3.1	2.1	9.8	7.8	2.1	3.7	2.8	1.3	10.3	5.4	1.8	4.7	3.7	2.5	5.5	7.4	2.7	1.7	2.8	1.6	6.5	5.0	12.9	2.5	0.9	44.1	8.8	11.9	5.2	2.2	5.8	1.9	3.7	2.1	1.5	2.1	3.5	6.2	4.4	1.8	16.6	7.4	0.0	1.7	1.7	1.2	1.8	3.8	0.0	0.1	0.0	2.4	0.0	0.1	0.1	0.1	0.2	1.9	0.1	0.6	0.1	2.4	0.1	0.1	0.1	0.0	19.7	0.7	0.3	0.2	0.0	0.3	1.4	0.0	0.0	0.0	0.4	1.8	0.4	1.7	0.2	0.1	0.1	2.3	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.3	0.3	1.9	0.2	0.3	0.0	0.2	0.0	0.0	0.2	6.6	0.0	0.2	0.0	0.2	0.4	2.5	0.1	1.6	0.4	0.3	1.1	0.3	0.3	0.7	0.3	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.1	0.1	5.3	9.9	2.1	9.8	5.5	7.4	6.5	5.0	11.9	7.4
NAT16	"C7orf52, FLJ39237"	ENSG00000167011	"N-acetyltransferase 16 (putative)"	Q8N8M0	7	101170493-101180276	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 9.1;pancreas: 6.0;pituitary gland: 5.8;thyroid gland: 4.6"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 4.5;SH-SY5Y: 6.8;SK-MEL-30: 5.0;U-2 OS: 5.9;U-87 MG: 3.4"	"Cancer enhanced"	"Detected in some"		"melanoma: 2.1"	"Group enriched"	"Detected in many"	4	"amygdala: 3.1;basal ganglia: 9.1;cerebral cortex: 2.9;hypothalamus: 4.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA021918	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA021918: AB_1848922"	"unprognostic (4.32e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.69e-3)"	"unprognostic (4.58e-3)"	"unprognostic (2.93e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.35e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.62e-2)"	"unprognostic (5.53e-5)"	"unprognostic (7.65e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.02e-5)"	"unprognostic (1.59e-1)"	0.2	0.4	3.1	0.2	9.1	0.7	0.1	0.4	8.2	0.1	0.2	0.0	0.0	0.2	0.0	0.3	0.1	0.2	0.1	0.1	0.9	4.8	0.1	0.5	0.1	0.2	0.7	0.6	0.1	6.0	0.2	5.8	0.1	0.8	0.2	0.3	0.5	0.3	0.1	0.3	0.4	0.2	0.2	0.4	0.3	1.2	0.4	1.2	0.0	4.6	0.0	0.0	0.1	0.0	1.2	0.7	2.2	0.6	1.3	0.8	0.0	0.5	0.0	0.1	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.7	0.2	0.0	0.0	0.1	0.0	0.0	1.3	0.5	0.5	0.1	0.1	0.8	0.6	0.2	0.1	4.5	0.0	0.4	0.1	6.8	0.0	0.3	5.0	0.3	0.0	0.0	0.4	5.9	0.5	0.1	0.1	0.0	0.1	3.4	0.0	1.6	0.4	0.6	0.3	0.3	0.4	0.3	0.2	0.2	0.1	0.2	1.2	0.8	0.4	2.2	1.3	0.3	0.7	0.3	0.0	3.1	9.1	0.4	2.9	0.9	4.8	0.7	0.6	0.8	1.2
NDST3	HSST3	ENSG00000164100	"N-deacetylase and N-sulfotransferase 3"	O95803	4	118033618-118258648	"Enzymes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 22.2;lymphoid tissue: 6.8;pituitary gland: 7.6"	"Cell line enriched"	"Detected in single"	19	"MOLT-4: 18.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 17.0;cerebellum: 22.2;cerebral cortex: 5.7"	"Cell type enhanced"	"Detected in some"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056189	Uncertain									"HPA056189: AB_2683061"	"unprognostic (1.95e-2)"	"unprognostic (7.58e-2)"	"unprognostic (4.34e-3)"	"unprognostic (2.55e-7)"	"unprognostic (4.05e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.86e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.37e-1)"	"unprognostic (4.39e-3)"	"unprognostic (6.83e-2)"	"unprognostic (8.85e-2)"	0.3	2.0	3.2	0.3	17.0	0.6	0.3	22.2	6.9	2.1	0.4	0.0	0.0	0.3	0.4	0.2	0.3	1.3	0.4	0.3	2.3	2.0	0.9	4.6	0.4	0.6	0.9	1.7	0.6	0.2	0.2	7.6	0.4	1.7	0.5	0.4	1.3	0.2	1.2	0.3	0.4	0.4	0.4	0.6	6.8	1.0	0.5	2.4	6.8	0.6	0.0	0.4	0.3	0.3	0.3	0.4	1.3	0.2	0.4	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.9	1.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	1.3	0.4	0.1	0.4	0.0	0.0	3.2	17.0	22.2	5.7	2.3	2.0	0.9	1.7	1.7	2.4
NKX2-4	"NKX2.4, NKX2D"	ENSG00000125816	"NK2 homeobox 4"	Q9H2Z4	20	21395367-21398028	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.5;pituitary gland: 1.2;testis: 5.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 3.6;HEK 293: 7.6;SCLC-21H: 5.0;SK-MEL-30: 5.8;WM-115: 1.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	22	"hypothalamus: 3.1"	"Region enriched"	"Detected in single"	24	"hypothalamus: 1.4"	HPA074996			Approved	"Nuclear bodies"				"Nuclear bodies"	"Nuclear bodies"	"HPA074996: AB_2686725"					"unprognostic (3.77e-1)"				"unprognostic (2.15e-1)"						"unprognostic (1.68e-1)"			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	1.2	0.0		0.0	0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	5.0	0.0	0.0	0.0	5.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
NSG1	"D4S234E, NEEP21, P21"	ENSG00000168824	"Neuronal vesicle trafficking associated 1"	P42857	4	4348140-4419058	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.8;pituitary gland: 49.1;skin 1: 70.0"	"Cell line enhanced"	"Detected in some"		"HAP1: 22.9;SCLC-21H: 46.6;SH-SY5Y: 22.7;SK-MEL-30: 21.8;TIME: 55.1;U-698: 19.8"	"Cancer enhanced"	"Detected in many"		"melanoma: 61.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 25.5"	"Lineage enriched"	"Detected in single"	58	"T-cells: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (3.21e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.29e-3)"	"unprognostic (7.60e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.32e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.91e-3)"	"prognostic favourable (9.49e-4)"	"unprognostic (2.50e-1)"	"unprognostic (6.85e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.41e-2)"	1.4	16.1	8.9	2.8	44.8	1.0	4.2	32.2	32.0	4.7	5.1	3.1	0.4	4.4	5.3	2.6	17.2	12.7	1.3	3.8	6.0	31.9	1.3	0.7	1.4	2.3	15.8	19.2	29.5	1.6	0.5	49.1	20.9	38.8	14.4	4.8	7.6	4.5	12.5	1.0	70.0	3.8	4.7	6.2	1.8	5.3	9.8	4.4	3.7	0.8	4.3	2.6	10.2	8.3	0.0	0.0	0.4	0.0	0.3	25.5	6.9	0.0	0.0	0.2	0.1	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	2.8	0.1	0.6	22.9	1.4	0.1	0.0	0.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	3.3	0.0	0.6	3.9	0.0	0.0	0.3	0.0	1.7	0.1	2.7	0.1	0.0	0.0	0.1	0.0	1.2	46.6	22.7	0.1	0.0	21.8	0.2	0.0	55.1	0.0	3.6	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.1	0.0	0.0	0.0	19.2	0.0	25.5	0.0	18.0	15.6	0.0	0.0	4.7	12.0	0.4	0.3	0.0	0.0	1.7	6.9	8.9	44.8	32.2	32.0	6.0	31.9	15.8	19.2	38.8	4.4
NTN5		ENSG00000142233	"Netrin 5"	Q8WTR8	19	48661407-48673081	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pituitary gland: 7.0"	"Cell line enhanced"	"Detected in some"		"HSkMC: 3.0;Karpas-707: 4.1;U-266/70: 3.0;U-266/84: 2.6"	"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.4"	"Region enriched"	"Detected in many"	5	"cerebellum: 7.5"						"Secreted in brain"						"unprognostic (8.20e-3)"	"unprognostic (5.54e-2)"	"unprognostic (5.26e-6)"	"unprognostic (4.48e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.33e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.89e-3)"	"unprognostic (9.40e-3)"	"unprognostic (1.74e-3)"	"unprognostic (4.60e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.60e-3)"	"unprognostic (3.51e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.71e-3)"	0.3	0.8	1.1	0.3	1.6	0.6	1.5	1.6	0.9	1.1	0.3			0.3	2.6	1.6	0.8	3.9	1.8	0.1	0.9	0.6	0.6	0.1	0.3	1.9	0.7		3.7	0.0	2.1	7.0	0.0		3.1	0.0		3.2	2.4	0.6	3.5	0.4	0.1	0.7	1.3	0.6	0.3			2.3		0.7	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.7	0.1	0.1	0.1	0.4	1.0	0.0	0.0	0.5	0.9	1.7	0.7	0.0	0.0	1.9	0.0	0.8	3.0	0.3	0.0	0.0	0.6	0.0	4.1	0.0	1.2	0.9	0.8	0.0	2.2	0.6	0.0	0.0	1.1	0.6	0.3	0.4	0.0	0.6	0.1	0.5	0.0	0.0	0.0	0.4	0.2	0.0	3.0	2.6	0.1	0.8	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR13C9		ENSG00000136839	"Olfactory receptor family 13 subfamily C member 9"	Q8NGT0	9	104617248-104618204	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"pituitary gland: 1.2;skeletal muscle: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0			0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	1.2	0.0		0.0	0.0		0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR7A5	HTPCR2	ENSG00000188269	"Olfactory receptor family 7 subfamily A member 5"	Q15622	19	14824251-14835285	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 16.4;pituitary gland: 33.6"	"Low cell line specificity"	"Detected in some"			"Cancer enriched"	"Detected in single"	8	"melanoma: 2.0"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA053823	Uncertain									"HPA053823: AB_2682274"	"unprognostic (3.26e-4)"	"unprognostic (1.44e-1)"		"unprognostic (7.46e-2)"	"unprognostic (6.19e-3)"	"unprognostic (4.89e-2)"		"unprognostic (1.49e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.01e-7)"	"unprognostic (6.45e-2)"	"unprognostic (9.64e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.47e-3)"	0.3	0.7	1.7	0.4	7.3	1.0	2.0	0.4	3.8	0.7	0.5	4.7	3.2	0.5	0.4	10.1	0.5	0.5	0.5	0.3	4.4	2.1	0.6	0.8	0.6	0.5	16.4	1.3	0.4	0.8	6.9	33.6	0.4	10.9	1.5	0.6	7.0	0.9	2.6	0.5	2.2	0.7	0.3	6.1	0.5	6.4	5.0	16.4	0.0	0.5	0.0	0.3	0.4	0.9	1.0	0.7	1.3	0.3	0.4	0.5	0.0	0.5	0.6	0.4	0.6	0.1	0.1	0.7	0.2	0.2	0.0	0.1	0.5	0.7	0.6	0.3	0.0	0.5	0.2	0.1	0.0	0.3	0.3	0.5	1.7	0.6	0.1	1.1	0.3	1.8	0.7	0.4	0.2	0.2	0.4	1.0	0.0	0.6	0.3	0.5	1.1	0.2	0.6	0.1	0.6	0.0	1.5	0.4	0.4	0.6	0.2	1.8	0.1	0.1	0.7	0.4	0.5	0.5	0.3	1.0	0.3	0.5	0.4	0.6	0.7	1.1	0.3	0.3	0.5	0.2	0.3	0.4	0.3	0.2	0.1	1.0	0.4	0.5	1.3	0.4	0.2	0.7	0.1	0.0	1.7	7.3	0.4	3.8	4.4	2.1	16.4	1.3	10.9	16.4
OR7C1	"OR19-5, OR7C4"	ENSG00000127530	"Olfactory receptor family 7 subfamily C member 1"	O76099	19	14789260-14835376	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 16.6;pituitary gland: 34.0"	"Low cell line specificity"	"Detected in many"			"Cancer enriched"	"Detected in single"	9	"melanoma: 1.8"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.8;monocytes: 1.5"									HPA047127	Uncertain									"HPA047127: AB_2679944"	"unprognostic (7.68e-4)"	"unprognostic (1.31e-1)"			"unprognostic (2.13e-1)"	"unprognostic (1.71e-1)"		"unprognostic (1.90e-1)"	"unprognostic (1.39e-1)"			"unprognostic (4.30e-2)"	"unprognostic (6.11e-4)"		"unprognostic (1.90e-1)"	"unprognostic (6.80e-2)"	"unprognostic (6.91e-2)"	0.5	3.3	1.4	0.7	7.4	1.9	1.5	0.5	3.9	0.7	0.5	4.7	3.2	0.7	0.5	5.9	0.5	0.5	0.6	0.5	3.2	0.9	0.6	0.6	0.5	0.8	16.6	1.4	0.5	0.5	7.3	34.0	0.5	11.0	3.0	0.4	7.1	1.1	2.9	3.6	3.1	0.7	0.3	3.8	0.7	0.6	6.3	16.6	0.0	1.0	0.0	0.4	0.5	1.0	0.7	0.5	4.8	1.5	0.5	0.4	0.2	0.8	1.1	0.8	2.2	0.7	0.5	1.1	0.5	0.3	0.6	0.8	1.1	1.8	1.3	1.5	0.6	1.0	0.3	0.5	0.8	0.7	0.6	1.0	2.1	0.6	0.5	0.9	1.4	0.8	0.3	0.4	0.4	0.3	0.7	3.0	0.3	0.5	0.6	1.4	1.1	1.0	0.8	0.4	0.6	0.7	1.3	1.6	1.0	0.6	0.7	1.0	0.6	1.5	0.9	1.0	2.2	1.1	0.7	1.3	0.7	1.0	0.9	0.8	0.7	2.9	0.9	1.7	0.3	0.8	0.3	0.4	0.3	0.2	0.4	0.7	0.3	0.4	4.8	0.5	1.5	0.5	0.2	0.2	1.4	7.4	0.5	3.9	3.2	0.9	16.6	1.4	11.0	16.6
OTOGL	"C12orf64, FLJ90579"	ENSG00000165899	"Otogelin like"	Q3ZCN5	12	80099537-80380879	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 9.8;kidney: 13.3;pituitary gland: 21.0"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 3.8;U-2 OS: 2.5;U-87 MG: 7.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Group enriched"	"Detected in many"	4	"amygdala: 3.5;basal ganglia: 4.3;cerebral cortex: 5.8;olfactory region: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in single"	5	"basal ganglia: 5.2"	"HPA040364, HPA053392"	Uncertain		Approved	Cytosol	"Intracellular and membrane"			Cytosol	Cytosol	"HPA040364: , HPA053392: AB_2682135"	"unprognostic (2.43e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.99e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.34e-3)"	"unprognostic (4.76e-2)"	"unprognostic (2.72e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.95e-5)"	"unprognostic (1.41e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.04e-2)"	0.4	0.2	3.5	0.2	4.3	0.1	0.4	0.2	5.8	0.4	2.7	0.0	0.0	0.2	0.5	3.1	0.5	0.5	0.4	9.8	1.0	0.4	13.3	0.1	0.3	0.5	0.5	3.6	0.2	0.7	0.2	21.0	1.4	0.3	0.5	0.3	1.4	0.3	0.5	1.0	0.3	0.6	0.6	0.3	0.4	0.4	0.8	0.0	0.0	0.2	0.0	0.3	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.5	0.0	1.0	0.9	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.5	3.8	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.5	2.5	0.0	0.2	0.9	0.0	0.1	7.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	4.3	0.2	5.8	1.0	0.4	0.5	3.6	0.3	0.0
PACRG	"FLJ32724, Glup, HAK005771, PARK2CRG"	ENSG00000112530	"Parkin coregulated"	Q96M98	6	162727132-163315492	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 30.3;pituitary gland: 55.9;testis: 44.6"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 10.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066293	Enhanced									"HPA066293: AB_2685652"	"unprognostic (3.06e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.84e-1)"	"unprognostic (6.26e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.34e-1)"	"unprognostic (8.31e-3)"	"unprognostic (1.48e-1)"	"prognostic favourable (2.55e-6)"	"unprognostic (1.00e-1)"	"unprognostic (3.68e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.93e-3)"	0.7	2.3	8.6	1.0	15.5	4.7	1.8	2.3	10.6	2.3	1.1	6.5	4.4	1.2	4.7	8.6	2.7	30.3	4.3	10.7	10.3	12.1	6.8	4.1	5.5	1.4	4.7	9.4	3.8	3.4	2.0	55.9	0.4	17.7	3.2	2.3	2.0	2.5	3.4	1.8	4.3	0.7	1.9	3.7	1.5	1.7	44.6	5.9	0.0	3.7	0.0	0.9	4.5	0.9	1.7	1.1	6.0	2.0	0.1	3.3	0.5	0.7	2.5	1.1	1.6	0.0	1.0	1.8	0.6	2.3	0.0	0.5	5.0	0.5	4.6	0.6	0.0	2.6	1.2	0.0	2.6	0.0	1.7	0.0	2.5	0.0	0.0	0.6	0.8	2.1	0.0	0.8	0.0	0.0	0.7	0.9	0.5	0.1	0.3	1.7	0.0	4.3	0.8	0.0	0.0	5.5	5.3	10.5	4.7	0.0	0.0	0.0	0.0	1.5	1.8	1.0	0.5	0.0	0.4	2.1	0.7	1.7	0.5	1.2	2.0	4.3	2.0	1.4	1.9	0.6	1.4	0.9	2.6	1.2	0.3	1.7	3.3	1.6	6.0	0.1	0.2	1.1	1.1	0.5	8.6	15.5	2.3	10.6	10.3	12.1	4.7	9.4	17.7	5.9
PCDHA3	PCDH-ALPHA3	ENSG00000255408	"Protocadherin alpha 3"	Q9Y5H8	5	140801028-141012344	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 10.3;pituitary gland: 9.9"	"Cell line enhanced"	"Detected in some"		"A549: 2.7;AF22: 2.3;SH-SY5Y: 2.3;T-47d: 14.0;WM-115: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (5.21e-2)"	"unprognostic (2.77e-2)"	"unprognostic (7.20e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.12e-2)"	"unprognostic (7.10e-2)"	"unprognostic (5.68e-3)"	"unprognostic (3.09e-3)"	"unprognostic (1.72e-2)"	"unprognostic (7.25e-3)"	"unprognostic (8.41e-2)"	"unprognostic (5.66e-3)"	"unprognostic (2.67e-2)"	2.0	3.8	3.1	0.7	5.0	0.2	2.2	10.3	5.8	2.6	1.4	2.6	0.3	1.0	5.9	1.4	0.9	2.3	2.6	0.9	2.8	3.1	3.4	0.6	2.6	0.9	3.7	2.5	4.9	4.8	0.6	9.9	0.4	3.7	2.2	1.0	1.3	1.0	1.8	0.6	0.6	1.4	2.1	6.4	0.9	1.1	2.9	4.8	0.0	2.6	0.4	0.4	1.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	2.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.5	0.0	0.0	0.0	0.0	0.0	1.1	2.3	0.0	0.3	1.0	14.0	0.0	0.5	0.1	0.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	5.0	10.3	5.6	2.8	3.1	3.7	2.5	3.7	4.8
PCDHA6	"CNR2, CNRS2, CRNR2, PCDH-ALPHA6"	ENSG00000081842	"Protocadherin alpha 6"	Q9UN73	5	140827958-141012344	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.7;pituitary gland: 11.2"	"Cell line enhanced"	"Detected in some"		"AF22: 2.9;EFO-21: 12.4;U-2 OS: 5.2;WM-115: 7.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA059326, HPA078110"	Enhanced		Approved	Vesicles	"Intracellular and membrane"			Vesicles	Vesicles	"HPA059326: AB_2683980, HPA078110: AB_2732371"	"unprognostic (1.15e-1)"	"unprognostic (7.00e-2)"	"unprognostic (5.07e-1)"	"unprognostic (2.79e-1)"	"unprognostic (4.39e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.18e-4)"	"unprognostic (4.23e-3)"	"unprognostic (8.38e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.23e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.56e-1)"	"unprognostic (5.66e-3)"	"unprognostic (3.55e-2)"	1.1	1.8	2.9	0.8	7.1	0.4	1.6	10.2	10.7	1.9	0.7	2.3	0.0	1.2	2.9	2.3	0.4	1.6	1.6	0.5	3.8	3.8	2.3	0.4	1.1	0.7	4.6	4.1	2.1	3.7	4.7	11.2	0.4	3.6	1.3	0.7	1.6	0.7	0.5	0.4	0.6	1.3	1.4	3.4	0.8	0.7	1.4	3.2	0.0	0.9	0.0	0.4	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	2.1	1.3	0.6	0.0	1.9	0.0	5.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	7.1	10.2	9.6	3.8	3.8	4.6	4.1	3.6	3.2
PCDHB16	"KIAA1621, ME1, PCDH-BETA16, PCDH3X, PCDHB8a"	ENSG00000272674	"Protocadherin beta 16"	Q9NRJ7	5	141181399-141186399	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 17.5"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 11.9;T-47d: 6.6;U-138 MG: 26.3;U-2197: 7.0"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA014668			Approved	"Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"	"Vesicles, Plasma membrane"	"HPA014668: "	"unprognostic (3.44e-3)"	"unprognostic (4.03e-2)"	"unprognostic (8.14e-2)"	"unprognostic (8.60e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.13e-2)"	"unprognostic (7.55e-3)"	"unprognostic (3.49e-2)"	"unprognostic (9.57e-2)"	"unprognostic (3.55e-2)"	"unprognostic (7.49e-3)"	"unprognostic (2.00e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.83e-3)"	3.7	2.6	2.1	1.4	2.7	0.2	2.5	9.7	3.1	8.4	1.1	5.3	0.0	0.4	6.4	6.2	3.3	2.8	2.5	4.5	1.8		2.5	1.0	3.2	0.5	1.7	0.4	9.8	2.6	10.9	17.5	1.5	3.4	6.2	1.1	7.1	2.2	1.1	3.6	1.5	1.1	3.5	2.5	1.1	0.5	2.3	5.0	0.0	3.1	0.0	0.3	6.5	3.3	0.9	1.0	1.4	0.6	0.9	0.8	0.1	0.0	0.0	0.6	11.9	5.3	3.8	0.3	0.5	2.7	0.0	0.2	0.0	0.2	0.0	4.4	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.1	6.4	0.3	0.0	0.0	0.9	0.1	0.0	2.2	0.0	0.3	0.1	0.4	1.7	0.2	0.4	2.0	6.6	0.0	0.3	26.3	1.3	7.0	1.3	0.0	0.0	0.0	6.3	0.0	3.3	0.7	0.5	0.4	0.6	0.5	0.3	0.6	0.5	0.6	0.3	0.9	0.8	0.6	1.4	0.9	0.6	1.0	0.5	0.1										
PCDHB3	PCDH-BETA3	ENSG00000113205	"Protocadherin beta 3"	Q9Y5E6	5	141100473-141103827	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 17.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 12.1;HAP1: 3.7;SH-SY5Y: 16.2;U-138 MG: 5.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA050296	Uncertain		Supported	Vesicles				Vesicles	Vesicles	"HPA050296: AB_2681078"	"unprognostic (2.72e-2)"	"unprognostic (7.47e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.95e-4)"	"unprognostic (9.34e-3)"	"unprognostic (3.42e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.34e-1)"	"unprognostic (8.52e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.82e-2)"	"unprognostic (5.18e-4)"	5.7	4.6	3.1	2.6	9.3	0.4	5.9	3.8	6.2	4.8	2.5	2.2	1.3	1.4	8.0	3.0	1.3	3.1	3.1	3.6	3.8	3.0	4.9	0.8	3.3	1.0	3.0	3.8	5.6	3.9	4.4	17.3	1.8	4.0	5.4	2.1	3.4	2.4	2.4	1.9	2.0	2.1	3.8	3.0	1.5	1.8	11.6	2.0	0.0	2.1	2.3	0.7	2.4	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	3.3	2.1	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.2	0.0	3.7	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.7	1.3	0.0	0.4	0.0	0.2	0.0	0.1	0.7	0.0	0.0	0.0	0.6	16.2	0.0	0.2	0.0	2.0	0.1	0.0	5.7	0.8	0.6	0.3	0.3	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	9.3	3.8	6.2	3.8	3.0	3.0	3.8	4.0	2.0
PCSK1N	"BigLEN, PEN, proSAAS, SAAS, SCG8, SgVIII"	ENSG00000102109	"Proprotein convertase subtilisin/kexin type 1 inhibitor"	Q9UHG2	X	48831094-48835633	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 74.9;kidney: 72.9;pituitary gland: 127.7"	"Cell line enhanced"	"Detected in some"		"HEK 293: 19.6;PC-3: 49.6;SCLC-21H: 19.7;SH-SY5Y: 18.2;SiHa: 17.2;U-266/84: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"MAIT T-cell: 3.0;memory CD4 T-cell: 6.5;memory CD8 T-cell: 6.3;naive CD4 T-cell: 2.7;naive CD8 T-cell: 8.2;T-reg: 2.1"	"Lineage enriched"	"Detected in single"	77	"T-cells: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003925, HPA064734"	Enhanced	Supported	Approved	Vesicles	"Secreted to blood"	5300000	5300000	Vesicles	Vesicles	"HPA003925: AB_1079582, HPA064734: AB_2685339"	"unprognostic (2.44e-3)"	"unprognostic (5.86e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavourable (1.15e-4)"	"unprognostic (3.36e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.49e-2)"	"unprognostic (3.34e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.50e-3)"	"unprognostic (2.79e-3)"	"prognostic favourable (1.36e-4)"	"unprognostic (3.34e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.14e-1)"	4.1	27.5	49.1	2.6	72.7	2.1	2.2	15.6	70.3	3.2	9.8	10.8	1.5	12.4	4.4	10.9	2.1	2.3	2.8	2.7	38.5	74.9	72.9	2.1	2.6	2.2	33.5	29.0	2.2	20.0	12.4	127.7	2.3	32.9	4.6	2.7	6.6	2.8	3.1	2.2	2.8	8.5	2.7	18.3	2.4	26.0	3.8	9.8	0.0	2.2	0.0	2.1	2.1	0.5	0.1	0.0	0.0	0.0	0.0	8.2	0.8	0.0	1.8	0.0	5.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	3.5	0.0	0.2	0.0	0.3	0.0	0.0	19.6	0.0	0.0	2.9	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	2.7	49.6	0.0	0.0	0.1	0.4	0.0	19.7	18.2	17.2	0.0	1.4	0.0	0.0	0.0	0.0	7.6	0.0	1.6	4.5	22.9	0.0	0.1	0.0	0.5	0.0	0.0	0.0	1.1	0.0	3.0	0.0	6.5	6.3	0.0	0.1	2.7	8.2	0.0	0.0	0.0	0.0	2.1	0.8	49.1	72.7	15.6	70.3	38.5	74.9	33.5	29.0	32.9	9.8
PHF21B	"BHC80L, FLJ34161, PHF4"	ENSG00000056487	"PHD finger protein 21B"	Q96EK2	22	44881162-45009999	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"pituitary gland: 17.9"	"Cell line enhanced"	"Detected in some"		"AF22: 8.1;AN3-CA: 7.2;NTERA-2: 5.1;SCLC-21H: 6.3;SH-SY5Y: 27.9;U-2 OS: 6.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA053834, HPA074665"	Enhanced		Uncertain	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA053834: AB_2682276, HPA074665: "	"unprognostic (1.04e-1)"	"unprognostic (7.76e-2)"		"unprognostic (2.00e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.37e-1)"		"unprognostic (5.45e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.83e-3)"	"unprognostic (1.86e-3)"	"unprognostic (2.02e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.22e-1)"	0.7	3.5	8.4	0.8	7.4	0.5	0.8	3.7	10.9	10.1	0.7	3.6	0.9	0.7	8.6	1.7	1.6	2.3	0.8	1.3	7.8	3.4	2.2	0.5	0.6	0.6	4.7	3.2	5.6	1.8	2.0	17.9	0.6	4.2	4.8	0.6	6.5	0.8	2.1	0.7	0.5	0.7	2.3	4.4	0.6	1.0	8.5	7.3	0.0	3.0	0.0	0.6	0.6	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	7.2	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.6	0.9	0.0	5.1	0.3	0.0	1.9	0.1	0.0	0.1	6.3	27.9	0.0	0.0	0.0	0.0	0.0	0.0	1.1	6.3	0.0	0.2	0.3	0.0	3.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	7.4	3.7	7.3	7.8	3.4	4.7	3.2	4.2	7.3
PRLHR	"GPR10, PrRPR"	ENSG00000119973	"Prolactin releasing hormone receptor"	P49683	10	118589989-118595699	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 11.3;brain: 10.6;cervix, uterine: 8.3;pituitary gland: 11.8;smooth muscle: 8.1"	"Cell line enriched"	"Detected in single"	9	"SH-SY5Y: 3.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA039361	Enhanced									"HPA039361: AB_10673527"					"unprognostic (1.83e-1)"						"unprognostic (2.62e-3)"	"unprognostic (1.22e-1)"		"unprognostic (2.15e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.09e-2)"		0.2	11.3	1.4	0.2	3.0	0.2	0.1	3.2	5.1	8.3	0.2	0.8	0.0	0.3	5.4	0.2	0.2	0.4	0.2	0.1	0.6	4.0	0.1	0.2	0.2	0.1	3.4	0.9	0.1	0.5	0.1	11.8	0.1	10.6	0.3	0.2	0.1	0.2	1.4	0.2	0.2	0.2	8.1	0.5	0.2	0.5	0.2	1.0	0.0	0.2	0.0	0.1	0.1	5.4	0.5	0.4	1.3	0.3	0.7	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	3.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.5	0.3	0.2	0.2	0.1	0.2	0.2	0.1	0.2	0.0	0.5	0.3	0.2	1.3	0.7	0.3	0.4	0.0	0.0	1.4	3.0	3.2	1.9	0.6	4.0	3.4	0.9	10.6	1.0
PTPRN	"IA-2, ICA512"	ENSG00000054356	"Protein tyrosine phosphatase, receptor type N"	Q16849	2	219289623-219309648	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 89.6;pancreas: 28.9;pituitary gland: 43.4"	"Group enriched"	"Detected in some"	8	"U-2 OS: 19.8;U-87 MG: 73.7"	"Group enriched"	"Detected in some"	12	"glioma: 5.3;pancreatic cancer: 18.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007152, HPA007179"	Enhanced		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA007152: AB_2667759, HPA007179: AB_1079714"	"unprognostic (1.43e-1)"	"unprognostic (1.33e-4)"	"unprognostic (2.91e-3)"	"unprognostic (5.83e-3)"	"prognostic unfavourable (1.45e-7)"	"unprognostic (3.64e-2)"	"unprognostic (1.24e-4)"	"unprognostic (1.58e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.20e-4)"	"unprognostic (1.44e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.28e-10)"	"unprognostic (1.43e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.61e-2)"	1.7	22.3	19.3	4.7	35.7	1.7	1.3	17.3	89.6	1.2	2.4	2.5	0.0	2.5	1.5	1.2	1.5	1.3	1.5	1.4	21.6	40.1	1.5	1.2	1.4	1.3	14.4	19.8	1.3	28.9	1.2	43.4	1.4	22.0	1.4	1.9	3.1	1.2	1.3	1.2	2.0	2.5	2.4	3.5	1.3	6.0	1.4	2.1	0.0	1.5	0.0	1.2	2.7	0.0	0.1	0.3	0.2	0.0	0.0	0.6	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.3	1.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.5	0.0	0.1	2.5	0.0	6.1	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	4.8	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.2	73.7	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.3	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.6	3.7	19.3	35.7	17.3	54.0	21.6	40.1	14.4	19.8	22.0	2.1
RAB39A	RAB39	ENSG00000179331	"RAB39A, member RAS oncogene family"	Q14964	11	107928503-107963482	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.3;pituitary gland: 10.0"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 6.7;RPMI-8226: 11.9;SCLC-21H: 21.8;SH-SY5Y: 13.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 3.3;intermediate monocyte: 5.0;memory B-cell: 1.4;myeloid DC: 2.4;naive B-cell: 1.3;non-classical monocyte: 3.5"	"Group enriched"	"Detected in many"	7	"B-cells: 1.4;dendritic cells: 2.4;monocytes: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042505	Uncertain									"HPA042505: AB_2678030"	"unprognostic (1.45e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.99e-1)"	"unprognostic (4.30e-2)"	"unprognostic (4.26e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.55e-2)"	"unprognostic (7.36e-2)"	"unprognostic (4.22e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.43e-1)"	2.3	2.8	5.3	7.3	5.1	1.7	1.2	16.3	11.0	1.0	1.6	4.1	0.0	1.5	0.8	0.5	1.0	1.3	2.3	1.1	5.9	5.2	1.7	1.9	2.5	5.0	3.7	3.0	0.9	1.1	0.5	10.0	3.4	10.2	1.0	2.3	0.9	1.3	0.6	0.8	1.0	2.1	2.0	4.1	7.3	1.8	2.3	4.9	3.3	1.0	0.0	3.7	3.5	0.9	1.4	2.4	0.4	5.0	0.1	0.2	0.9	0.0	1.4	5.7	0.1	0.0	0.0	0.7	0.0	0.0	0.6	0.4	0.0	0.0	0.3	0.1	0.0	0.0	5.7	0.0	0.1	0.0	0.7	0.0	0.1	0.0	0.0	0.3	5.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	6.7	0.2	0.0	3.1	11.9	0.0	0.0	21.8	13.5	0.0	0.0	0.3	0.3	2.3	0.0	0.1	1.5	0.0	1.0	0.1	3.1	0.0	0.3	1.3	3.2	0.2	3.3	0.1	0.1	5.0	0.1	1.4	0.1	0.0	2.4	1.3	0.2	0.2	0.4	0.1	3.5	0.3	0.0	0.9	5.3	5.1	16.3	7.1	5.9	5.2	3.7	3.0	10.2	4.9
RIIAD1	"C1orf230, FLJ36032, NCRNA00166"	ENSG00000178796	"Regulatory subunit of type II PKA R-subunit (RIIa) domain containing 1"	A6NNX1	1	151710433-151729805	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 43.4;pituitary gland: 29.2"	"Group enriched"	"Detected in some"	9	"CACO-2: 6.4;SCLC-21H: 3.5;SH-SY5Y: 6.9;SK-BR-3: 11.0"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045703	Enhanced		Approved	Nucleoplasm,Cytosol				Cytosol	Cytosol	"HPA045703: AB_10965795"	"unprognostic (8.28e-3)"	"unprognostic (3.42e-1)"	"unprognostic (8.21e-2)"	"prognostic favourable (5.46e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.09e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.20e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.65e-3)"	"unprognostic (8.50e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.79e-2)"	"unprognostic (3.06e-2)"		"unprognostic (2.48e-4)"	0.5	2.7	4.0	0.5	9.3	0.5	1.1	0.5	5.6	1.6	1.1	0.8	1.2	0.6	2.1	6.1	0.7	43.4	0.9	0.5	4.6	5.1	0.6	0.5	3.1	0.5	2.5	5.2	2.6	1.2	1.1	29.2	0.5	3.6	1.0	1.3	1.2	0.5	1.9	0.5	0.6	0.8	1.1	0.5	0.5	2.0	14.7	2.1	0.0	0.5	0.0	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	3.5	6.9	0.0	11.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	9.3	0.5	5.6	4.6	5.1	2.5	5.2	3.6	2.1
RIMBP2	"KIAA0318, MGC15831, PPP1R133, RBP2, RIM-BP2"	ENSG00000060709	"RIMS binding protein 2"	O15034	12	130396137-130716281	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.7;parathyroid gland: 49.1;pituitary gland: 42.7"	"Group enriched"	"Detected in some"	6	"SCLC-21H: 17.2;SH-SY5Y: 33.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"naive B-cell: 2.7"	"Lineage enriched"	"Detected in single"	28	"B-cells: 2.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041494, HPA044114"			Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA041494: , HPA044114: AB_2678815"	"unprognostic (4.15e-4)"	"unprognostic (9.77e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.91e-3)"	"unprognostic (3.63e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.82e-3)"	"prognostic favourable (4.16e-4)"	"unprognostic (2.86e-1)"	"unprognostic (6.41e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.73e-2)"	0.9	11.9	14.1	1.1	13.0	0.6	0.6	1.1	24.7	6.1	1.5	1.6	0.0	2.5	2.5	2.4	0.8	6.6	1.1	0.4	15.3	11.0	2.8	0.6	0.7	0.5	5.6	12.9	2.1	2.3	49.1	42.7	0.4	4.9	1.3	1.8	4.1	0.6	1.4	0.5	2.4	2.3	2.3	5.6	1.1	5.2	2.3	1.6	0.0	0.9	0.0	0.5	0.8	0.7	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	3.3	0.0	0.0	0.2	4.1	0.0	0.0	17.2	33.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	13.0	1.1	24.7	15.3	11.0	5.6	12.9	4.9	1.6
RNF212	"FLJ38841, LOC285498"	ENSG00000178222	"Ring finger protein 212"	Q495C1	4	1056250-1113562	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pituitary gland: 18.1"	"Group enriched"	"Detected in some"	4	"A-431: 8.6;HeLa: 26.3;SiHa: 15.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA057527	Uncertain									"HPA057527: AB_2683457"	"unprognostic (2.75e-2)"	"prognostic favourable (1.39e-4)"	"unprognostic (1.55e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.45e-2)"	"unprognostic (7.65e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.05e-1)"	2.9	1.9	3.1	1.7	8.4	4.5	3.9	11.4	4.7	4.6	2.4	4.3	2.0	1.2	2.7	4.3	2.4	4.0	2.1	1.3	2.4	1.6	4.7	0.6	2.9	2.7	3.4	1.1	8.8	13.0	0.8	18.1	1.0	5.3	3.3	1.8	3.6	4.2	1.4	1.9	4.4	1.8	2.2	4.1	1.9	2.6	12.1	2.1	0.5	8.2	1.0	1.9	1.4	3.0	2.1	1.2	0.1	0.7	0.4	3.8	0.9	8.6	0.5	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.3	0.0	3.8	0.1	0.0	2.2	0.0	2.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	2.9	0.0	15.7	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	2.2	0.7	1.8	0.6	3.8	1.0	1.2	2.1	3.8	1.2	0.0	0.4	0.0	0.4	1.1	0.9	3.1	8.4	11.4	4.7	2.4	1.6	3.4	1.1	5.3	2.1
RNF224		ENSG00000233198	"Ring finger protein 224"	P0DH78	9	137227271-137229638	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"esophagus: 4.8;pituitary gland: 7.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.2;HeLa: 5.2;MCF7: 12.6"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (2.45e-1)"	"unprognostic (2.34e-3)"	"unprognostic (7.01e-4)"	"unprognostic (6.04e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.70e-3)"	"unprognostic (3.87e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.82e-3)"	"unprognostic (4.57e-2)"	"unprognostic (5.24e-2)"	"unprognostic (9.56e-2)"	"unprognostic (3.50e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.21e-1)"	0.0	0.6	0.5	0.1	0.7	0.3	0.0	0.2	0.9	0.3	0.0			1.0	0.4	0.1	4.8	2.0	1.0	0.3	0.5	0.5	2.8	0.0	1.1	0.4	0.1		0.0	1.5	0.2	7.7	0.0		0.9	0.0		4.6	0.0	0.1	1.5	1.6	0.0	0.1	0.4	1.2	1.2			1.0		0.1	0.4	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.5	0.7	1.9	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.6	7.2	0.2	0.3	0.0	3.4	0.0	0.1	0.0	2.5	0.6	0.0	5.2	1.1	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.3	0.6	0.0	12.6	0.1	0.2	0.6	1.6	0.8	0.3	0.3	0.1	0.8	0.0	1.6	0.7	2.7	0.1	2.8	0.3	0.2	0.3	0.2	1.6	0.0	0.9	0.2	0.2	0.3	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
RPEL1		ENSG00000235376	"Ribulose-5-phosphate-3-epimerase like 1"	Q2QD12	10	103245887-103248016	"Enzymes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 1.4;brain: 1.2;pituitary gland: 1.2"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.1;NB-4: 1.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA036498, HPA036499"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Cytosol	Cytosol	"HPA036498: AB_2675157, HPA036499: AB_10670109"	"unprognostic (7.52e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.83e-1)"		"unprognostic (6.01e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.91e-2)"	"unprognostic (6.59e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.72e-2)"	"unprognostic (5.06e-2)"	0.0	0.1	0.1	1.0	0.3	0.1	0.1	1.2	0.2	0.0	0.0			0.3	0.4	0.4	0.1	0.0	0.0	0.1	0.1	0.3	0.3	0.0	0.0	0.4	0.1		0.0	0.8	0.0	1.2	0.2		0.1	0.0		0.0	0.0	0.4	0.0	0.4	0.0	0.2	0.1	0.0	0.2			0.1		0.1	0.0	0.0	0.4	1.0	0.3	0.7	1.4	0.6	0.2	0.5	0.5	0.1	0.0	0.0	0.0	0.2	0.3	0.2	0.0	0.2	0.4	0.7	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.3	1.1	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	1.0	0.7	0.0	0.0	0.1	0.3	0.5	0.2	0.3	0.1	0.3	0.4	0.2	0.1	0.4	0.0	0.1	0.9	0.1	0.2	0.3	0.1	0.3	0.7	0.4	0.1	0.3	0.7	0.2	0.5	0.7	0.5	0.4	0.4	0.3	1.0	0.4	0.5	0.6	0.0	1.4	0.4	0.3	0.4	0.2										
RPGR	"COD1, CORDX1, CRD, RP15, RP3"	ENSG00000156313	"Retinitis pigmentosa GTPase regulator"	Q92834	X	38269163-38327564	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 55.4"	"Cell line enhanced"	"Detected in many"		"HL-60: 22.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 15.3"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 15.3"									"HPA001593, HPA073455"	Approved		Supported	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA001593: AB_1079835, HPA073455: AB_2686603"	"unprognostic (3.22e-2)"	"unprognostic (1.16e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.94e-2)"	"unprognostic (3.46e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.03e-6)"	"unprognostic (1.93e-1)"	"unprognostic (7.59e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.61e-3)"	16.4	5.9	6.1	7.1	9.0	17.4	13.8	7.2	7.0	8.3	8.4	7.1	2.5	5.1	8.8	9.4	5.4	20.8	9.4	6.3	7.2	9.4	4.9	4.9	10.7	7.8	8.9	4.2	7.9	7.2	3.8	55.4	6.3	14.6	5.9	6.4	6.3	3.7	4.8	13.3	4.3	6.2	8.3	9.9	5.1	4.9	11.6	5.7	5.8	8.3	3.6	5.4	7.7	10.9	1.9	2.6	15.3	2.6	1.6	3.1	1.7	3.3	4.4	2.5	2.3	2.9	4.1	1.9	4.2	4.9	3.1	3.6	1.9	1.7	4.9	1.4	2.7	3.2	3.0	1.3	4.3	5.2	5.5	1.8	2.1	3.9	2.6	22.5	4.3	5.9	1.8	6.2	7.0	14.1	2.3	0.0	4.2	1.3	6.6	12.6	6.5	5.6	4.9	8.6	4.6	2.7	2.2	1.9	3.7	4.6	1.9	5.0	1.2	3.9	16.4	3.4	6.0	8.0	5.0	1.4	2.7	4.3	8.0	4.4	4.6	1.4	2.6	5.7	1.4	2.3	3.1	1.9	1.7	1.8	2.6	1.8	2.5	2.0	15.3	1.6	1.8	1.8	1.9	1.7	6.1	9.0	7.2	7.0	7.2	9.4	8.9	4.2	14.6	5.7
RPGRIP1L	"CORS3, FTM, JBTS7, KIAA1005, MKS5, NPHP8, PPP1R134"	ENSG00000103494	"RPGRIP1 like"	Q68CZ1	16	53598153-53703938	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 25.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039405, HPA040530"	Uncertain		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA039405: AB_10794636, HPA040530: AB_2677023"	"prognostic unfavourable (6.93e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.19e-3)"	"unprognostic (2.26e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.26e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.31e-1)"	"prognostic unfavourable (5.95e-4)"	"unprognostic (5.22e-3)"	"unprognostic (1.52e-1)"	"unprognostic (4.92e-4)"	"unprognostic (5.95e-2)"	3.0	6.5	8.0	3.8	13.8	2.7	6.1	5.3	12.7	6.3	3.3	2.4	6.8	2.4	7.3	7.8	3.9	11.7	4.9	3.3	9.1	9.9	5.5	2.2	3.5	3.1	5.9	13.2	6.5	3.2	18.5	25.8	3.8	9.0	5.2	3.5	1.7	3.4	5.3	2.3	3.6	2.0	6.3	3.5	1.9	3.5	20.9	4.7	3.1	7.6	2.3	3.1	4.4	3.6	4.9	2.0	1.8	1.0	2.1	5.6	1.3	8.9	11.2	10.1	9.2	12.1	11.8	4.4	10.0	6.6	9.4	2.7	6.1	7.3	6.0	7.2	10.3	10.5	8.4	9.6	16.7	3.6	5.9	2.2	9.4	6.1	5.0	5.4	4.1	7.4	5.9	10.5	6.5	7.0	5.5	3.5	13.8	3.4	8.9	3.8	6.4	5.3	15.1	13.8	7.2	12.1	2.4	17.5	6.6	12.4	5.2	4.6	7.9	4.3	6.3	10.2	7.3	8.4	8.9	4.6	5.2	10.7	15.5	3.3	6.0	1.7	0.9	1.1	3.6	1.0	3.5	3.2	2.6	3.3	0.8	4.9	2.6	5.6	1.8	2.1	1.0	2.0	2.1	1.3	8.0	13.8	5.3	12.7	9.1	9.9	5.9	13.2	9.0	4.7
RPH3AL	Noc2	ENSG00000181031	"Rabphilin 3A like (without C2 domains)"	Q9UNE2	17	212389-386254	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 58.9"	"Cell line enhanced"	"Detected in many"		"A549: 20.3;PC-3: 6.6;TIME: 6.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA024311	Approved									"HPA024311: AB_1856429"	"unprognostic (4.55e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.85e-2)"	"unprognostic (9.43e-3)"	"unprognostic (8.40e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.33e-2)"	"prognostic favourable (1.03e-8)"	"unprognostic (9.10e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.14e-1)"	"unprognostic (3.59e-3)"	10.2	8.4	0.5	4.1	0.8	0.2	12.3	2.1	1.7	2.4	7.9	0.7	2.9	4.9	1.8	4.7	5.8	2.6	4.7	1.6	0.6	1.3	9.4	11.2	8.8	1.1	1.0	1.0	5.0	27.5	1.2	58.9	3.8	4.9	4.0	2.6	3.7	1.3	2.4	7.5	1.7	6.5	2.8	2.6	7.8	5.1	1.1	0.9	0.4	14.8	5.3	4.2	3.1	7.6	1.6	6.2	3.4	5.0	0.7	1.9	0.8	0.3	20.3	0.3	0.1	0.2	0.1	1.8	0.1	0.0	0.0	0.1	2.8	3.6	0.4	3.0	1.9	0.3	0.8	0.2	0.0	0.9	1.3	0.0	1.6	4.4	0.6	0.2	2.2	0.0	0.1	0.0	0.0	0.8	1.4	4.3	1.2	4.7	0.3	0.1	1.1	6.6	0.4	0.2	3.8	3.9	4.6	0.3	0.7	0.3	0.1	0.3	1.9	1.9	6.8	0.3	3.1	0.5	0.6	0.7	0.2	0.2	0.3	2.8	0.1	1.0	1.6	3.3	1.9	5.0	0.9	1.4	1.1	1.6	2.6	1.6	1.7	0.9	3.4	0.7	3.4	6.2	0.8	0.8	0.5	0.8	2.1	1.7	0.6	1.3	1.0	1.0	4.9	0.9
RSPH4A	"CILD11, dJ412I7.1, FLJ37974, RSHL3, RSPH6B"	ENSG00000111834	"Radial spoke head 4 homolog A"	Q5TD94	6	116616479-116632985	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.8;fallopian tube: 35.9;pituitary gland: 16.7"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 7.4;U-266/84: 5.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.6"	"Group enriched"	"Detected in many"	4	"basal ganglia: 9.4;pons and medulla: 19.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA031196, HPA031197, HPA031198"	Enhanced		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA031196: AB_10601612, HPA031197: AB_10671097, HPA031198: AB_10670025"	"unprognostic (9.83e-4)"	"unprognostic (1.26e-1)"	"unprognostic (6.94e-2)"	"unprognostic (9.69e-3)"	"unprognostic (9.37e-2)"	"unprognostic (1.13e-3)"	"unprognostic (4.52e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.08e-2)"	"unprognostic (9.56e-5)"	"unprognostic (2.87e-1)"	"unprognostic (2.69e-4)"	"unprognostic (1.96e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.21e-2)"	0.5	0.7	1.8	0.5	9.4	0.9	0.7	1.2	0.9	2.2	0.4	10.2	0.4	0.5	1.9	13.3	0.4	35.9	0.8	0.5	3.0	3.3	0.7	0.4	11.1	0.5	0.5	1.1	13.7	0.6	2.8	16.7	0.3	19.8	0.6	0.4	0.2	0.4	0.5	1.0	0.6	0.4	0.6	0.7	1.0	0.8	6.6	1.8	0.0	1.0	0.0	0.5	0.4	0.1	0.8	0.1	1.3	0.2	0.2	1.0	0.0	0.1	0.2	1.4	3.2	0.1	0.1	0.3	0.4	0.8	0.6	0.8	0.7	1.1	1.0	0.3	0.1	0.2	0.3	0.6	0.6	0.8	1.1	0.4	0.5	1.2	0.0	0.8	1.1	0.4	0.2	1.0	0.2	0.0	0.2	0.1	0.6	0.2	0.6	0.1	0.5	0.1	0.8	1.6	7.4	3.1	0.4	2.8	1.2	0.2	0.2	0.4	0.5	0.6	0.5	0.4	0.7	0.5	0.5	0.5	5.4	0.4	0.1	0.4	0.5	1.3	0.2	0.8	1.0	0.1	0.1	0.4	0.3	0.0	0.0	0.8	0.2	0.5	0.0	0.2	0.1	0.1	0.0	0.0	1.8	9.4	1.2	0.7	3.0	3.3	0.5	1.1	19.8	1.8
SAMD15	"C14orf174, FAM15A, FLJ35963"	ENSG00000100583	"Sterile alpha motif domain containing 15"	Q9P1V8	14	77376689-77391497	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 29.1;testis: 22.1"	"Cell line enhanced"	"Detected in many"		"MCF7: 10.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in many"			"HPA030673, HPA030677"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli"				"Nucleoplasm, Nuclear membrane, Nucleoli"	"Nucleoplasm, Nuclear membrane, Nucleoli"	"HPA030673: AB_10600655, HPA030677: AB_10599938"	"unprognostic (1.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.38e-2)"	"unprognostic (3.70e-3)"	"unprognostic (5.20e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.83e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.53e-3)"	"unprognostic (6.87e-3)"	"unprognostic (9.90e-2)"	"unprognostic (3.73e-3)"	"unprognostic (1.76e-2)"	0.8	1.3	5.3	0.5	6.7	0.9	1.5	0.8	3.3	1.2	0.7	2.2	3.1	0.6	1.5	7.5	0.7	6.2	1.5	0.6	3.7	2.9	6.0	0.6	1.8	1.9	1.4	3.1	3.2	2.7	5.2	29.1	0.5	7.9	1.3	0.5	4.4	0.8	1.1	0.5	0.8	0.6	0.6	1.5	0.7	0.7	22.1	2.3	0.1	6.9	0.0	1.8	1.9	0.7	0.6	0.2	2.3	0.5	0.6	0.4	0.1	3.5	4.8	1.9	4.0	0.5	2.1	1.8	1.4	1.3	3.9	3.5	3.5	3.2	3.9	1.6	1.4	3.4	1.4	2.0	5.4	0.3	0.7	0.6	1.4	0.9	0.2	0.7	4.2	1.9	1.3	3.3	0.4	2.6	0.4	1.2	1.6	10.6	0.9	0.4	0.8	1.5	1.7	1.8	0.2	6.8	1.9	4.2	2.6	5.0	0.8	0.7	6.3	1.2	1.0	3.7	2.2	3.8	1.9	0.6	3.2	2.6	4.6	0.2	1.8	0.7	0.5	1.2	0.2	0.1	0.1	0.2	0.2	0.1	0.2	0.6	0.3	0.4	2.3	0.6	0.5	0.1	0.4	0.1	5.3	6.7	0.8	3.3	3.7	2.9	1.4	3.1	7.9	2.3
SCG5	"7B2, SGNE1, SgV"	ENSG00000166922	"Secretogranin V"	P05408	15	32641676-32697098	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 71.1;pancreas: 63.5;parathyroid gland: 60.1;pituitary gland: 74.6"	"Cell line enhanced"	"Detected in some"		"HHSteC: 14.7;HSkMC: 18.2;NTERA-2: 8.2;SCLC-21H: 16.8;SH-SY5Y: 19.5;U-87 MG: 25.5"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 82.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 2.8;naive CD4 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	28	"T-cells: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013136, HPA074618"	Enhanced				"Secreted to blood"	22000	22000			"HPA013136: AB_1856657, HPA074618: AB_2732262"	"unprognostic (1.71e-1)"	"unprognostic (9.87e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.59e-3)"	"prognostic unfavourable (9.64e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.62e-3)"	"unprognostic (3.92e-1)"	"prognostic unfavourable (4.51e-9)"	"unprognostic (3.57e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.08e-3)"	"unprognostic (8.88e-2)"	1.2	30.7	24.0	2.2	47.2	0.9	2.5	36.4	71.1	1.0	4.4	13.0	0.0	9.0	3.4	21.8	1.0	2.4	3.4	1.0	30.5	36.9	1.2	2.2	2.5	1.3	25.2	23.1	2.0	63.5	60.1	74.6	0.9	30.5	3.2	5.5	15.4	0.7	1.2	0.7	1.3	3.3	3.9	24.1	1.0	21.0	3.0	9.5	0.0	1.8	0.0	0.9	2.5	0.5	0.0	0.0	0.0	0.0	0.0	2.8	0.2	0.2	0.1	0.0	0.1	0.3	2.5	0.0	2.2	0.2	0.2	0.2	0.0	0.0	0.2	1.0	0.2	0.6	0.3	0.1	0.6	0.3	0.1	0.3	0.0	0.0	14.7	0.1	0.4	18.2	0.1	0.4	0.2	0.3	0.1	0.3	0.4	0.0	0.1	0.1	8.2	0.4	0.0	0.2	0.3	0.2	0.0	16.8	19.5	0.1	0.0	0.1	0.0	0.2	0.0	2.8	1.9	0.1	0.2	0.3	1.1	0.2	25.5	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.3	0.2	24.0	47.2	36.4	50.8	30.5	36.9	25.2	23.1	30.5	9.5
SCGN	"CALBL, DJ501N12.8, SECRET, SEGN"	ENSG00000079689	"Secretagogin, EF-hand calcium binding protein"	O76038	6	25652201-25701783	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.3;pancreas: 39.7;pituitary gland: 47.9"	"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 23.1"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 38.2"	"Group enriched"	"Detected in many"	11	"cerebellum: 22.3;hippocampal formation: 6.2;hypothalamus: 22.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	16	"olfactory region: 100.5"	"Region enriched"	"Detected in some"	9	"olfactory region: 282.4"	"CAB004005, HPA006641, CAB044060, CAB062563, CAB068232"	Enhanced	Supported	Supported	Cytosol	"Intracellular and membrane"			Cytosol	Cytosol	"CAB004005: , CAB044060: , CAB062563: AB_2665612, CAB068232: AB_2665613, HPA006641: AB_1079874"	"unprognostic (8.15e-2)"		"unprognostic (4.31e-3)"		"unprognostic (1.46e-1)"		"unprognostic (1.25e-2)"	"unprognostic (4.70e-1)"			"unprognostic (1.78e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.41e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.19e-1)"		1.5	2.1	0.7	6.0	0.8	0.1	2.0	22.3	1.5	0.4	10.5	0.5	0.9	7.2	0.1	0.3	0.3	0.0	0.5	5.0	6.2	22.0	3.8	2.5	0.4	0.1	0.5	1.2	0.2	39.7	0.0	47.9	1.8	1.4	1.1	11.7	1.8	3.7	3.0	0.1	0.3	8.0	0.7	1.0	0.1	12.5	0.6	0.1	0.5	1.1	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	23.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	22.3	1.5	6.2	22.0	0.5	1.2	1.4	0.1
SEZ6L2	"FLJ90517, PSK-1"	ENSG00000174938	"Seizure related 6 homolog like 2"	Q6UXD5	16	29871159-29899547	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 52.6;pituitary gland: 36.3"	"Cell line enhanced"	"Detected in many"		"EFO-21: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064471	Enhanced					3900000	3900000			"HPA064471: AB_2685271"	"unprognostic (2.56e-2)"	"prognostic unfavourable (7.46e-4)"	"prognostic unfavourable (1.31e-4)"	"unprognostic (2.11e-1)"	"prognostic unfavourable (5.24e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.71e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.43e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.22e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.08e-1)"	2.1	21.0	21.0	1.8	27.6	0.8	4.0	42.4	52.6	11.4	4.5	7.7	0.2	9.2	6.1	1.4	1.2	4.2	8.8	1.4	18.5	32.8	3.3	0.9	4.5	1.4	15.6	27.6	2.5	34.7	32.7	36.3	3.2	31.4	13.3	3.6	5.4	18.1	4.7	1.5	2.5	5.5	4.3	12.3	1.8	14.9	7.2	7.4	0.0	1.6	0.0	1.9	4.2	0.9	0.0	0.0	0.1	0.1	0.1	0.8	0.0	0.5	4.4	0.3	4.2	0.0	0.2	3.0	5.5	2.6	5.2	2.9	6.5	20.6	2.1	30.2	6.6	1.9	1.7	1.3	1.6	0.0	3.7	0.3	3.8	13.3	11.5	0.0	13.3	12.9	2.5	6.1	1.6	0.4	0.6	13.4	2.6	22.2	0.0	0.0	6.7	7.6	0.0	0.0	0.5	4.7	1.9	20.1	16.1	1.8	14.2	0.8	13.3	19.3	0.2	17.5	8.6	0.1	0.3	1.5	1.3	0.1	21.2	3.3	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.1	0.1	0.0	0.0	0.0	21.0	27.6	42.4	52.6	18.5	32.8	15.6	27.6	31.4	7.4
SIX1	DFNA23	ENSG00000126778	"SIX homeobox 1"	Q15475	14	60643415-60658259	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 39.1;salivary gland: 55.1;skeletal muscle: 59.0"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 52.7;RH-30: 28.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"olfactory region: 1.2;pons and medulla: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001893, CAB058690"	Enhanced		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoplasm	"CAB058690: AB_2665581, HPA001893: AB_1079991"	"unprognostic (3.62e-1)"	"unprognostic (5.44e-2)"	"unprognostic (5.09e-2)"	"prognostic unfavourable (8.92e-6)"	"unprognostic (1.33e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.04e-3)"	"prognostic favourable (3.94e-4)"	"unprognostic (1.40e-1)"	"unprognostic (9.15e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.06e-8)"	"unprognostic (8.61e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.86e-1)"	7.1	0.4	0.3	0.1	0.5	0.1	4.7	0.3	0.6	7.4	0.2	0.2	0.0	0.1	0.2	2.1	1.3	0.5	0.4	0.4	0.3	0.3	0.3	0.2	1.8	0.3	0.4	1.2	0.3	0.3	16.8	39.1	0.1	4.5	8.7	0.1	2.0	55.1	0.2	59.0	0.4	0.2	0.7	0.5	0.2	0.5	1.6	0.0	6.5	2.4	22.5	3.0	1.4	9.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	8.2	1.9	0.2	11.7	6.8	8.0	0.1	2.0	4.5	2.3	2.0	0.0	3.7	0.0	1.1	0.4	2.7	3.9	3.6	0.8	0.0	9.4	0.9	0.8	2.7	0.0	0.0	0.1	6.0	1.7	1.6	0.3	0.1	2.6	0.0	52.7	1.3	0.0	0.2	0.0	4.7	0.0	28.8	0.0	2.2	6.4	1.1	0.1	2.3	0.1	2.4	1.3	0.2	6.7	3.1	3.2	3.6	2.9	0.2	0.0	0.0	0.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.3	0.5	0.3	0.3	0.4	1.2	4.5	0.0
SLC4A8	NBC3	ENSG00000050438	"Solute carrier family 4 member 8"	Q2Y0W8	12	51391317-51515763	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.6;pituitary gland: 20.0;testis: 15.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 17.2;HMC-1: 12.1;SCLC-21H: 12.9"	"Group enriched"	"Detected in some"	6	"breast cancer: 1.7;glioma: 2.7;testis cancer: 4.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077895			Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA077895: "	"unprognostic (4.01e-1)"	"unprognostic (8.15e-2)"	"unprognostic (2.49e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.46e-2)"	"unprognostic (7.72e-4)"	"unprognostic (3.13e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.07e-4)"	"unprognostic (1.70e-1)"	"unprognostic (9.60e-6)"	"unprognostic (1.35e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.47e-1)"	1.0	6.5	5.8	2.2	13.3	1.7	3.1	9.2	22.9	2.7	1.1	9.8	0.0	1.4	1.2	5.4	0.7	3.7	1.1	1.0	10.9	5.6	3.2	0.8	2.8	3.0	6.0	9.3	7.3	2.4	1.0	20.0	1.0	28.6	1.4	1.4	2.2	1.5	1.7	0.8	1.0	2.0	1.1	4.7	2.2	3.0	15.3	5.1	0.0	0.8	0.0	2.7	1.0	0.7	1.1	2.6	3.4	3.1	1.7	1.7	0.7	0.2	0.8	9.7	0.1	0.4	0.5	17.2	2.6	4.4	4.3	2.7	5.7	0.2	3.5	0.4	3.5	0.1	3.8	0.2	4.0	0.7	0.5	1.7	0.3	0.0	0.0	0.6	12.1	0.1	0.2	2.1	0.4	4.9	0.1	6.3	2.1	2.0	5.1	1.1	4.2	2.9	0.1	0.0	0.0	0.5	0.1	12.9	8.7	1.0	1.3	0.0	1.6	0.4	4.6	2.7	1.5	0.2	3.3	3.2	1.0	0.2	3.8	0.5	0.4	1.3	2.1	3.4	1.7	1.4	0.4	0.6	0.6	1.6	2.6	1.1	0.6	1.0	2.3	1.7	3.1	1.0	0.3	0.7	5.8	13.3	9.2	22.9	10.9	5.6	6.0	9.3	28.6	5.1
SLC6A14		ENSG00000268104	"Solute carrier family 6 member 14"	Q9UN76	X	116436622-116461458	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 17.8;pituitary gland: 14.4;salivary gland: 26.3;tongue: 23.5"	"Group enriched"	"Detected in some"	4	"HeLa: 3.8;Hep G2: 8.2"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA003193	Uncertain		Approved	Vesicles				Vesicles	Vesicles	"HPA003193: AB_2190122"	"unprognostic (3.06e-2)"	"unprognostic (3.55e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.49e-2)"	"unprognostic (7.41e-3)"	"unprognostic (3.67e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.83e-2)"	"prognostic unfavourable (9.74e-4)"	"unprognostic (1.34e-2)"		"unprognostic (3.89e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.59e-1)"	0.0	0.0	0.0	1.5	0.0	0.0	5.9	0.0	0.0	6.3	0.8	0.0	11.8	0.4	0.1	0.0	1.8	0.0	1.0	0.0	0.0		0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.2	0.5	0.3	0.0	26.3	5.8	0.0	1.1	0.2	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	23.5	1.2	1.0	1.0	0.4	0.2	1.1	0.4	0.3	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	3.8	8.2	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.5	0.0	0.5	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.2	0.0	1.4	0.5	0.0	0.0	0.1	0.0	1.1	0.4	0.5	0.4	0.1	0.3	0.4	0.2	0.2	0.1	0.4	0.3	0.3	0.4	0.3	0.2	0.2	0.1	0.0										
SMIM18		ENSG00000253457	"Small integral membrane protein 18"	P0DKX4	8	30638600-30646064	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 18.8;pituitary gland: 10.7"	"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 14.2"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066648	Supported		Uncertain	Nucleoplasm,Centrosome				Nucleoplasm	Nucleoplasm	"HPA066648: AB_2685697"	"unprognostic (2.19e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.60e-1)"		"unprognostic (7.29e-2)"	"unprognostic (4.70e-1)"	"unprognostic (8.91e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.25e-1)"	"unprognostic (4.14e-1)"	0.6	3.2	5.2	0.7	6.6	2.7	0.6	18.8	18.7	0.6	0.7	0.4	0.0	0.6	0.7	0.6	0.7	0.7	0.8	0.9	10.9	10.7	2.9	0.7	0.6	0.6	5.7	7.5	0.7	1.8	0.6	10.7	0.6	11.7	0.7	0.8	0.2	0.6	0.6	0.6	0.7	0.7	0.6	4.6	0.7	0.8	0.7	1.4	0.0	0.7	0.0	0.6	0.6	0.0	2.9	4.1	3.0	2.3	0.2	4.3	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.2	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	1.4	0.0	0.0	0.0	3.0	1.9	1.9	3.7	1.3	3.6	2.9	2.3	2.1	0.9	2.9	3.0	4.3	2.1	0.2	2.3	4.1	2.9	0.3	5.2	6.6	18.8	9.7	10.9	10.7	5.7	7.5	11.7	1.4
SOGA3	"C6orf174, dJ403A15.3"	ENSG00000214338	"SOGA family member 3"	Q5TF21	6	127472794-127519191	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.3;pituitary gland: 11.9"	"Cell line enhanced"	"Detected in some"		"AF22: 7.4;SCLC-21H: 23.9;SH-SY5Y: 13.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.3"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.3"									"HPA035388, HPA035389"	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA035388: AB_2674601, HPA035389: AB_10669857"	"unprognostic (1.70e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.57e-1)"		"unprognostic (2.53e-2)"	"unprognostic (1.19e-1)"		"unprognostic (8.58e-3)"	"unprognostic (8.45e-2)"	"unprognostic (7.31e-4)"	"unprognostic (5.65e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.26e-3)"	0.8	2.8	5.0	1.8	5.3	0.4	0.4	11.4	15.3	1.0	0.8	3.7	0.0	0.5	2.1	0.2	2.0	1.0	1.9	0.8	4.2	4.5	0.6	0.6	1.7	0.8	6.7	5.0	3.3	1.7	0.2	11.9	1.2	7.9	1.1	0.6	0.7	1.1	0.5	0.3	1.0	1.9	0.6	11.4	1.4	3.9	1.8	4.3	0.0	1.9	0.0	0.3	1.6	0.8	0.3	0.2	0.0	0.0	0.0	2.3	0.0	0.2	3.3	7.4	1.1	0.0	0.6	0.3	0.7	0.9	0.9	2.3	0.2	0.3	0.4	0.2	0.1	0.0	0.8	0.0	0.6	0.7	0.1	0.6	0.0	0.1	0.0	0.2	0.1	1.2	0.0	3.6	0.0	0.0	0.3	0.2	0.5	0.5	4.8	0.0	3.3	0.8	0.4	1.8	0.0	0.1	0.0	23.9	13.7	0.0	0.0	0.1	0.0	0.3	0.2	5.9	1.2	0.4	1.7	0.2	0.1	0.1	4.5	1.1	5.8	0.0	0.0	0.0	0.3	0.0	0.4	0.3	2.3	0.8	0.2	0.2	0.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	5.0	5.3	11.4	8.2	4.2	4.5	6.7	5.0	7.9	4.3
SPATA6L	"C9orf68, FLJ10058"	ENSG00000106686	"Spermatogenesis associated 6 like"	Q8N4H0	9	4553386-4666674	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 23.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.4;CAPAN-2: 5.7;HDLM-2: 3.2;RPTEC TERT1: 4.3;SCLC-21H: 3.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Lineage enriched"	"Detected in single"	18	"T-cells: 1.8"					"Low region specificity"	"Detected in all"			HPA039585	Enhanced									"HPA039585: AB_10674984"	"unprognostic (8.18e-3)"	"unprognostic (1.69e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.39e-3)"	"unprognostic (5.65e-2)"	"unprognostic (4.38e-2)"	"unprognostic (3.23e-2)"	"unprognostic (8.03e-3)"	"unprognostic (4.10e-3)"	"unprognostic (1.19e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.14e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.34e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.27e-3)"	1.7	1.1	4.9	0.6	7.3	0.2	3.0	15.3	5.3	1.5	1.6	1.7	4.1	2.6	1.7	5.4	2.3	9.4	4.0	1.4	3.2	1.7	2.5	7.6	4.0	1.7	1.2	2.5	1.7	5.3	3.9	23.0	1.3	3.8	1.9	1.2	0.0	1.3	1.6	0.9	1.6	3.6	0.5	1.3	1.0	3.4	13.2	1.5	0.0	2.9	0.8	0.9	1.6	3.1	0.0	0.0	0.0	0.0	0.0	1.8	0.4	1.1	0.4	0.6	0.0	0.0	0.1	3.4	0.1	0.3	0.0	0.1	0.1	5.7	0.0	0.2	0.2	0.3	0.5	0.0	0.0	3.2	0.1	0.9	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.4	4.3	0.0	3.7	2.0	0.0	1.4	0.0	0.6	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.4	0.0	1.0	0.9	0.0	0.0	1.7	1.8	0.0	0.0	0.0	0.0	0.9	0.4	4.9	7.3	15.3	5.3	3.2	1.7	1.2	2.5	3.8	1.5
SSTR5		ENSG00000162009	"Somatostatin receptor 5"	P35346	16	1078781-1080142	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 8.2;lymphoid tissue: 5.2;pituitary gland: 9.0"	"Group enriched"	"Detected in some"	15	"Hep G2: 9.2;PC-3: 34.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basal ganglia: 4.2;hypothalamus: 2.7"	"Low region specificity"	"Detected in many"			HPA066503			Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA066503: AB_2685679"		"unprognostic (2.16e-2)"	"unprognostic (7.31e-2)"		"unprognostic (3.69e-2)"	"unprognostic (2.39e-2)"		"unprognostic (2.14e-1)"			"unprognostic (9.89e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.05e-1)"		"unprognostic (4.09e-2)"	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.4	0.4	0.0	0.7	0.6	0.9	0.5	0.0	8.2	2.9	0.0	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	9.0	0.0	0.0	1.1	0.0	0.0	1.1	0.9	0.1	0.1	0.8	0.0	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	5.2	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.1	0.0	1.3	0.3	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0
STPG2	"C4orf37, MGC46496"	ENSG00000163116	"Sperm tail PG-rich repeat containing 2"	Q8N412	4	97184093-98143240	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pituitary gland: 17.0;testis: 11.1"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.9;U-266/70: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 1.1;plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"														"unprognostic (3.05e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.59e-3)"	"unprognostic (8.87e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.48e-2)"	"unprognostic (5.25e-2)"	"unprognostic (7.55e-3)"	"unprognostic (5.78e-2)"	1.0	1.5	2.5	1.2	5.3	0.8	2.9	1.9	2.5	1.3	0.9	4.5	3.7	1.3	0.9	3.9	1.0	1.8	1.3	1.0	1.8	1.4	3.5	1.9	1.7	1.3	3.7	1.5	1.6	2.1	2.1	17.0	1.7	3.8	1.4	1.2	1.7	1.5	5.8	0.6	1.7	1.1	0.7	2.3	1.5	1.3	11.1	3.4	0.4	3.0	0.0	1.0	1.4	1.2	1.1	1.3	0.0	0.0	0.5	0.3	0.0	0.3	0.4	0.0	0.0	1.0	0.5	0.0	0.0	0.3	0.0	0.6	0.0	1.3	0.1	0.4	0.3	0.6	0.1	0.8	0.0	0.0	1.9	0.9	0.6	0.0	0.0	0.2	0.6	0.0	0.6	0.0	0.5	0.0	0.2	1.0	0.4	0.3	0.3	0.8	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.8	0.3	0.2	0.4	0.8	0.5	0.6	0.0	0.2	0.3	0.0	0.1	2.3	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.1	0.0	0.0	0.0	0.5	0.0	1.3	0.0	0.0	2.5	5.3	1.9	2.5	1.8	1.4	3.7	1.5	3.8	3.4
STXBP4	"MGC50337, Synip"	ENSG00000166263	"Syntaxin binding protein 4"	Q6ZWJ1	17	54968727-55173632	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 36.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007760, HPA022138, HPA022888, HPA024227"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane"	"Plasma membrane"	"CAB007760: AB_562350, HPA022138: AB_1857628, HPA022888: AB_1857629, HPA024227: AB_1857630"	"unprognostic (5.89e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.30e-3)"	"unprognostic (9.27e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.00e-5)"	"unprognostic (4.11e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.44e-1)"	7.7	6.4	5.5	4.3	6.0	3.4	5.2	10.6	4.7	9.9	6.4	4.2	7.5	6.3	12.0	7.2	5.1	7.3	6.6	5.9	6.7	4.7	14.5	3.8	8.0	3.2	4.2	4.5	9.9	5.4	19.3	36.3	4.7	6.8	9.5	4.6	7.6	4.5	9.4	4.0	3.7	5.1	13.2	8.6	5.0	5.5	5.6	5.1	7.2	7.9	2.7	3.5	9.6	8.2	3.2	2.9	4.0	1.2	5.1	2.9	0.7	5.4	8.2	7.5	6.7	6.4	6.3	3.1	4.3	4.1	5.6	5.5	4.8	3.0	3.7	9.1	4.2	3.3	9.7	4.3	10.3	5.6	5.5	4.9	5.6	9.8	2.7	3.0	1.5	7.2	1.3	8.0	1.9	5.5	7.8	3.0	6.6	2.4	10.0	1.9	5.4	5.9	4.3	8.8	2.2	9.9	3.3	7.3	5.5	6.6	1.1	3.6	9.6	2.1	4.3	7.8	6.2	4.8	4.5	2.6	2.5	6.4	5.1	4.0	4.7	4.0	1.1	0.1	2.6	0.8	2.9	2.1	2.3	1.7	1.4	3.2	2.1	2.7	0.3	5.1	1.2	2.9	2.1	0.7	5.5	6.0	10.6	4.7	6.7	4.7	4.2	4.5	6.8	5.1
SYT4	"HsT1192, KIAA1342"	ENSG00000132872	"Synaptotagmin 4"	Q9H2B2	18	43267878-43277650	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 60.8;pituitary gland: 31.5"	"Cell line enriched"	"Detected in some"	11	"SH-SY5Y: 72.6"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 4.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010574	Approved		Supported	"Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"	"Vesicles, Plasma membrane"	"HPA010574: AB_2668309"			"unprognostic (2.91e-3)"		"unprognostic (2.03e-1)"			"unprognostic (2.37e-2)"		"unprognostic (2.87e-1)"	"unprognostic (7.67e-3)"	"unprognostic (5.30e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.23e-3)"	"unprognostic (3.61e-1)"	"unprognostic (3.80e-2)"		1.4	17.5	5.7	2.2	24.1	1.0	0.9	60.8	54.6	0.9	1.7	0.9	0.0	1.7	0.9	0.9	1.0	0.9	1.0	1.4	12.9	19.9	1.0	0.9	1.8	1.0	5.9	16.0	1.3	4.7	0.9	31.5	1.0	22.3	1.5	1.7	0.4	1.0	9.8	0.9	1.0	1.7	1.5	5.0	0.9	4.6	2.4	1.4	0.0	1.3	0.0	0.9	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	72.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	24.1	60.8	35.7	12.9	19.9	5.9	16.0	22.3	1.4
SYTL4		ENSG00000102362	"Synaptotagmin like 4"	Q96C24	X	100674491-100732123	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 36.2;ovary: 47.3;pituitary gland: 41.9"	"Cell line enhanced"	"Detected in many"		"HAP1: 14.9;HMC-1: 30.9;RT4: 20.3;TIME: 17.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 5.1"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 5.1"	"Region enriched"	"Detected in single"	5	"hypothalamus: 35.1"	"Not detected"	"Not detected"			"HPA001475, HPA001589, HPA075138"	Approved		Approved	Vesicles		6100000	6100000	Vesicles	Vesicles	"HPA001475: AB_1080172, HPA001589: AB_1080174, HPA075138: "	"unprognostic (7.82e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.07e-3)"	"unprognostic (5.62e-2)"	"prognostic unfavourable (2.09e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.60e-2)"	3.8	3.1	9.1	2.8	9.5	1.6	4.4	4.3	8.4	18.1	5.3	6.6	4.8	1.7	36.2	5.4	2.6	10.0	2.9	2.1	11.9	6.0	4.2	7.1	3.0	0.7	9.8	2.7	47.3	8.8	1.3	41.9	2.6	9.4	9.2	6.8	1.3	3.8	6.0	4.5	1.4	3.0	22.5	7.8	2.3	5.3	7.8	9.5	0.0	6.2	1.1	1.4	4.3	9.4	0.5	0.3	5.1	0.3	0.5	0.4	2.3	0.1	3.0	0.8	0.0	4.4	2.5	0.0	3.8	2.5	4.1	7.4	0.3	3.8	0.0	1.0	2.7	3.4	14.9	1.3	4.4	0.0	1.3	0.0	5.1	0.2	1.1	0.0	30.9	0.9	0.3	3.7	0.2	10.4	1.4	0.0	1.9	1.0	0.0	0.0	0.6	0.0	0.0	1.2	0.0	3.7	20.3	7.5	0.3	1.5	5.9	0.8	3.6	0.3	17.5	2.1	4.7	10.7	0.9	0.0	0.0	0.0	2.7	0.0	2.4	1.1	0.3	0.5	0.2	0.2	0.2	0.3	0.2	0.2	0.0	0.5	0.4	0.2	5.1	0.5	0.2	0.3	0.1	2.3	9.1	9.5	4.3	8.4	11.9	6.0	9.8	2.7	9.4	9.5
TAC4	"HK-1, PPT-C, Pptc"	ENSG00000176358	"Tachykinin 4"	Q86UU9	17	49838309-49848017	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"liver: 4.7;pituitary gland: 10.4"	"Cell line enhanced"	"Detected in some"		"A549: 4.4;BEWO: 10.5;CACO-2: 6.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"								"Secreted to blood"						"unprognostic (4.49e-2)"	"unprognostic (8.14e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.24e-2)"	"unprognostic (8.15e-2)"	"unprognostic (5.61e-2)"	"unprognostic (6.05e-3)"	"unprognostic (3.19e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.52e-2)"	"unprognostic (4.69e-3)"	"unprognostic (8.19e-5)"	"unprognostic (8.69e-2)"	"unprognostic (2.23e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.92e-1)"	0.4	0.6	0.4	0.5	0.4	1.2	0.4	0.4	0.4	0.5	0.4	0.4	0.4	0.3	0.4	0.4	1.4	0.2	0.4	2.2	0.4	0.1	0.4	4.7	0.5	0.7	0.4	0.4	0.4	0.4	0.0	10.4	0.4	0.4	0.4	0.0	0.4	1.0	0.4	0.4	4.0	0.4	0.4	0.4	1.3	0.7	0.5	0.4	0.4	1.1	0.4	0.4	0.9	0.4	0.1	0.7	0.0	0.0	0.0	0.2	0.0	0.0	4.4	0.1	0.7	0.0	0.0	10.5	0.0	0.0	0.0	0.0	6.0	0.4	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.1	0.7	1.2	0.2	0.7	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.9	0.4	0.5	0.0	0.4	0.0	0.4	0.3	0.0	0.1	0.1	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.6	0.5	0.0	0.8	0.4	0.2	0.2	0.3	0.9	0.4	0.0	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.1	0.4	0.4	0.4	0.4
TBC1D32	"bA57L9.1, BROMI, C6orf170, C6orf171, dJ310J6.1, FLJ30899, FLJ34235"	ENSG00000146350	"TBC1 domain family member 32"	Q96NH3	6	121079494-121334745	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 25.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 21.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013413	Uncertain		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA013413: AB_10602702"	"unprognostic (3.31e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.12e-3)"	"unprognostic (4.82e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.60e-4)"	"unprognostic (7.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.01e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.57e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.06e-1)"	3.2	7.3	7.3	5.5	8.8	2.4	5.0	3.9	11.1	5.7	3.5	4.8	3.8	4.5	5.1	4.1	4.1	4.8	5.6	3.5	7.0	4.1	4.5	1.8	3.2	3.0	8.1	7.8	6.5	4.0	9.7	25.4	8.2	8.0	5.0	2.4	4.2	4.6	3.2	1.7	5.5	4.6	2.4	7.0	3.1	3.8	9.2	7.9	8.1	7.0	2.1	3.2	3.7	5.1	6.4	10.7	5.8	1.3	3.4	3.7	0.4	1.6	1.9	3.1	4.2	2.8	4.4	1.6	1.8	2.7	3.1	4.5	0.1	1.1	2.9	3.0	2.0	1.5	1.5	1.6	3.7	21.6	2.1	3.6	0.6	0.7	1.2	1.7	1.4	1.7	1.1	2.8	2.0	0.6	2.1	0.0	2.4	1.0	2.0	1.1	1.8	0.7	1.8	1.6	0.2	1.7	0.7	6.5	3.2	2.2	1.3	1.0	2.0	1.5	0.4	2.0	2.0	0.5	2.0	1.4	0.0	1.2	2.7	1.0	3.2	5.8	1.3	1.7	2.6	0.7	1.9	3.4	1.9	1.8	0.8	6.4	3.7	2.8	1.1	3.4	1.1	10.7	2.1	0.4	7.3	8.8	3.9	11.1	7.0	4.1	8.1	7.8	8.0	7.9
TBXT	T	ENSG00000164458	"T-box transcription factor T"	O15178	6	166157656-166168700	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"parathyroid gland: 12.2;pituitary gland: 5.0"	"Cell line enriched"	"Detected in some"	4	"HeLa: 18.1"	"Cancer enriched"	"Detected in single"	22	"testis cancer: 6.2"	"Region enhanced"	"Detected in single"		"pons and medulla: 3.0"	"Group enriched"	"Detected in some"	24	"naive B-cell: 2.3;NK-cell: 2.5"	"Group enriched"	"Detected in many"	24	"B-cells: 2.3;NK-cells: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA003322	Uncertain		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA003322: AB_1080176"						"unprognostic (5.68e-2)"		"unprognostic (4.59e-2)"						"unprognostic (6.21e-3)"	"unprognostic (8.64e-3)"	"unprognostic (9.34e-3)"		0.3	0.0	0.1	2.0	0.0	0.0	0.1	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	12.2	5.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.4	0.0	1.9	0.0	0.0	1.2	0.0	0.6	0.0	0.0	2.3	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	18.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.5	0.9	0.1	0.0	0.0	3.0	0.0
TCP11X2		ENSG00000215029	"T-complex 11 family, X-linked 2"	Q5H9J9	X	102456862-102471842	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 3.5;pituitary gland: 3.3;testis: 3.6"	"Cell line enriched"	"Detected in single"	6	"SCLC-21H: 5.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA048311	Supported									"HPA048311: AB_2680351"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0			0.0	0.0	0.7	0.0	3.5	0.0	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.0		0.0	0.0	0.2	3.3	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.6			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TEX9		ENSG00000151575	"Testis expressed 9"	Q8N6V9	15	56244009-56445997	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 49.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"basophil: 4.1;memory B-cell: 14.4;naive B-cell: 6.8"	"Group enriched"	"Detected in many"	11	"B-cells: 14.4;granulocytes: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039415	Uncertain		Approved	"Plasma membrane,Cytosol"				Cytosol	Cytosol	"HPA039415: AB_10672775"	"unprognostic (3.27e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.34e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.85e-2)"	"unprognostic (6.91e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.24e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	1.7	5.4	5.3	9.0	14.8	2.0	7.6	4.0	2.3	7.0	4.6	7.8	6.0	8.5	5.7	11.6	7.3	21.6	6.2	1.6	6.1	7.5	11.9	1.2	5.8	4.1	4.0	3.2	7.5	4.1	13.5	49.7	1.0	25.2	5.4	3.5	9.2	9.0	4.5	0.9	4.1	9.6	2.3	4.9	5.5	9.0	19.3	4.0	2.0	14.8	2.0	8.2	2.7	2.2	14.4	0.3	4.1	0.6	0.4	0.8	0.8	5.7	5.2	11.6	10.3	2.9	8.4	1.5	1.3	4.8	3.6	4.4	1.4	5.1	11.5	5.5	0.9	5.2	4.9	5.4	4.2	1.4	6.0	6.6	5.3	3.8	0.9	3.0	1.3	4.6	10.1	4.1	3.1	0.1	3.7	1.3	1.9	3.2	4.7	2.6	5.6	2.3	1.9	5.4	4.2	12.1	3.3	18.5	7.4	6.4	3.9	4.0	11.0	3.4	0.6	15.5	4.7	5.0	4.6	1.6	11.7	8.8	6.1	1.3	3.0	4.1	0.1	0.1	0.3	0.6	0.1	14.4	0.4	0.3	0.2	6.8	0.2	0.8	0.3	0.4	0.3	0.3	0.5	0.8	5.3	14.8	4.0	2.3	6.1	7.5	4.0	3.2	25.2	4.0
TIGD4		ENSG00000169989	"Tigger transposable element derived 4"	Q8IY51	4	152769354-152779764	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 14.1;testis: 11.8"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 4.5;U-266/70: 6.6;U-266/84: 12.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA035649	Approved		Approved	Nucleoplasm,Cytosol				Cytosol	Cytosol	"HPA035649: AB_10670956"	"unprognostic (1.71e-1)"	"unprognostic (5.97e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.23e-4)"	"unprognostic (6.19e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.61e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.90e-2)"	"unprognostic (4.47e-2)"	0.7	1.0	2.2	0.7	8.6	0.2	2.1	3.5	3.6	2.5	0.8	2.1	3.9	1.1	2.0	4.2	0.6	5.5	0.8	1.0	4.8	2.1	2.0	0.6	3.5	0.5	1.6	3.2	1.7	0.9	5.4	14.1	0.5	5.8	1.3	0.9	5.4	2.0	1.1	1.2	1.3	0.8	0.9	2.7	0.8	1.0	11.8	1.3	0.3	2.1	0.6	0.5	1.0	0.8	0.4	0.0	1.6	1.1	2.1	1.3	0.0	0.6	0.5	2.9	1.2	0.2	0.4	0.3	0.1	0.7	0.3	0.6	0.5	1.3	1.0	0.1	0.1	0.5	1.1	0.5	0.5	1.0	0.2	1.5	0.7	0.3	0.2	0.6	0.3	0.1	0.5	0.5	0.3	0.1	0.4	4.5	0.3	0.3	2.8	0.3	1.3	0.4	0.5	0.6	0.0	2.0	0.1	1.4	1.6	0.2	0.3	2.8	0.7	0.2	0.0	0.4	0.6	0.5	0.6	6.6	12.9	0.6	1.0	1.5	2.1	0.0	0.3	0.8	0.0	1.1	0.2	0.0	0.3	1.3	0.0	0.4	0.1	0.4	1.6	2.1	0.2	0.0	0.0	0.0	2.2	8.6	3.5	3.6	4.8	2.1	1.6	3.2	5.8	1.3
TMC2	"C20orf145, dJ686C3.3"	ENSG00000149488	"Transmembrane channel like 2"	Q8TDI7	20	2536607-2641784	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 8.1;pituitary gland: 3.2"	"Cell line enhanced"	"Detected in single"		"ASC diff: 3.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"gdTCR: 1.4"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (4.73e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.88e-2)"	"unprognostic (8.30e-4)"	"unprognostic (2.86e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.54e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.05e-5)"	"unprognostic (2.90e-1)"	"unprognostic (3.21e-7)"	"unprognostic (2.47e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.74e-2)"	2.3	0.4	0.3	0.3	0.8	0.0	0.7	8.1	0.4	0.0	0.0			0.4	0.0	0.0	0.2	0.2	0.9	0.0	0.2	0.9	0.0	0.0	3.0	0.2	0.1		0.5	0.1	0.1	3.2	0.1		0.0	0.1		0.3	0.0	0.1	0.2	0.1	0.1	0.1	0.2	0.0	2.5			0.2		0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.1	0.2	0.4	0.3	0.2	3.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.1										
TMEM178B	DKFZp547G036	ENSG00000261115	"Transmembrane protein 178B"	H3BS89	7	141074232-141480380	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.4;parathyroid gland: 20.6;pituitary gland: 18.5"	"Cell line enhanced"	"Detected in many"		"HAP1: 6.9;HDLM-2: 6.3;NTERA-2: 5.9;RPTEC TERT1: 9.6;SCLC-21H: 7.6;WM-115: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA048771	Uncertain		Approved	Nucleoli,Vesicles				Vesicles	Vesicles	"HPA048771: AB_2680517"	"unprognostic (7.33e-3)"	"unprognostic (2.02e-2)"	"unprognostic (2.83e-2)"	"unprognostic (7.79e-4)"	"unprognostic (1.94e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.69e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.17e-4)"	"unprognostic (1.05e-1)"	"prognostic favourable (4.10e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.35e-3)"	"unprognostic (8.98e-2)"	0.9	1.7	5.2	0.7	7.4	0.1	0.7	3.2	13.4	0.5	0.8	1.0	2.3	0.1	1.1	0.6	1.8	0.3	0.7	11.6	4.8	5.8	2.9	0.6	0.4	1.5	4.9	1.0	0.2	2.6	20.6	18.5	0.1	1.8	2.8	0.4	0.5	4.4	0.8	4.5	0.2	1.2	1.3	2.4	0.8	0.5	0.8	0.4	1.0	9.5	0.1	3.3	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.6	0.3	1.8	0.1	2.7	0.8	1.0	0.0	0.0	2.2	2.3	0.2	0.0	6.9	0.0	2.3	6.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.9	0.2	0.0	0.0	0.0	5.0	0.0	0.0	0.0	5.9	0.0	0.4	1.1	2.9	9.6	2.7	7.6	4.6	0.1	0.3	1.0	1.0	0.0	0.0	0.1	1.1	3.1	0.0	0.1	0.0	0.0	0.5	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	7.4	3.2	9.6	4.8	5.8	4.9	1.0	1.8	0.4
TMEM196	MGC42090	ENSG00000173452	"Transmembrane protein 196"	Q5HYL7	7	19719310-19773598	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 15.0;pituitary gland: 12.6"	"Group enriched"	"Detected in some"	9	"ASC diff: 8.6;ASC TERT1: 8.5"	"Cancer enhanced"	"Detected in single"		"glioma: 0.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA043163	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"			"Nucleoplasm, Golgi apparatus"	"Nucleoplasm, Golgi apparatus"	"HPA043163: AB_10794772"					"unprognostic (6.08e-3)"					"unprognostic (1.88e-2)"	"unprognostic (2.14e-2)"		"unprognostic (9.30e-2)"	"unprognostic (5.63e-2)"				0.7	3.7	8.0	0.6	8.6	0.4	0.4	0.3	15.0	1.2	0.6	0.3	0.0	0.4	3.8	1.5	0.5	1.2	0.4	0.4	3.6	10.1	0.6	0.4	0.4	0.4	2.9	7.4	0.4	3.0	0.7	12.6	0.4	5.0	0.5	0.5	0.5	0.4	0.4	0.4	0.4	0.4	1.0	1.4	0.4	2.6	0.5	2.8	0.0	0.4	0.0	0.4	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	8.6	8.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	8.6	0.3	7.3	3.6	10.1	2.9	7.4	5.0	2.8
TMEM232	FLJ43080	ENSG00000186952	"Transmembrane protein 232"	C9JQI7	5	110289233-110738956	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 21.8;pituitary gland: 19.8;testis: 23.7"	"Cell line enhanced"	"Detected in some"		"U-266/70: 6.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA049386	Uncertain									"HPA049386: AB_2680739"	"unprognostic (1.12e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.27e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.40e-1)"	"unprognostic (8.49e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.32e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.14e-4)"	"unprognostic (8.96e-2)"	1.2	2.3	4.6	0.7	5.9	0.5	2.0	3.0	6.8	2.1	1.0	3.7	4.9	1.2	1.7	4.8	1.2	21.8	2.8	1.4	4.7	4.5	6.1	1.4	2.9	0.9	2.9	4.8	3.4	1.3	3.6	19.8	1.1	9.2	1.6	0.9	3.1	1.3	1.6	0.7	1.0	0.9	1.0	3.1	0.8	1.7	23.7	4.4	0.5	6.1	0.0	0.8	1.3	0.9	1.1	0.0	0.8	0.1	0.3	0.6	0.1	0.9	0.4	2.7	0.9	2.4	4.0	0.5	0.0	0.0	0.5	0.5	0.4	0.4	1.2	0.8	0.1	0.9	0.5	2.0	0.6	2.5	0.4	0.4	0.0	0.0	2.0	0.7	0.5	1.1	0.3	0.6	1.0	0.4	0.7	0.8	1.6	0.3	1.4	0.8	0.3	0.0	0.5	0.3	0.5	2.8	0.0	2.6	2.7	0.3	0.0	2.3	1.0	0.3	0.0	2.6	0.3	0.2	0.1	6.6	2.2	1.0	2.1	0.7	0.4	0.0	0.1	0.8	0.0	0.0	0.5	1.1	0.0	0.1	0.0	0.0	0.4	0.6	0.0	0.3	0.0	0.0	0.0	0.1	4.6	5.9	3.0	6.8	4.7	4.5	2.9	4.8	9.2	4.4
TMEM244	"bA174C7.4, C6orf191"	ENSG00000203756	"Transmembrane protein 244"	Q5VVB8	6	129831244-129861547	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"pituitary gland: 12.2;retina: 22.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.1;LHCN-M2: 8.2;U-2 OS: 2.9;U-251 MG: 6.2;U-266/70: 6.0;WM-115: 4.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 3.9;T-reg: 4.2"	"Lineage enriched"	"Detected in single"	8	"T-cells: 4.2"					"Not detected"	"Not detected"														"unprognostic (4.65e-1)"	"unprognostic (3.65e-2)"				"unprognostic (1.10e-1)"		"unprognostic (1.54e-1)"			"unprognostic (1.15e-1)"			"unprognostic (2.15e-1)"	"unprognostic (9.57e-2)"			0.3	0.2	2.7	0.4	2.7	0.4	0.4	0.2	5.2	0.4	0.5	1.5	0.0	0.0	0.2	1.6	0.3	0.4	0.3	0.7	2.5	0.7	0.7	0.2	0.6	2.3	4.8	3.3	0.2	0.2	0.0	12.2	0.2	0.9	1.1	0.6	22.7	1.2	0.2	1.0	0.4	0.3	0.0	1.9	0.7	1.1	0.4	2.0	0.0	0.3	0.0	2.5	0.8	0.4	0.5	0.0	0.0	0.0	0.0	4.2	0.4	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.8	8.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.9	0.9	6.2	6.0	0.0	0.0	1.6	0.0	4.0	0.0	0.0	0.0	2.5	0.0	0.0	0.5	3.9	1.1	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	4.2	0.4	2.7	2.7	0.2	2.7	2.5	0.7	4.8	3.3	0.9	2.0
TMEM61		ENSG00000143001	"Transmembrane protein 61"	Q8N0U2	1	54980792-54992293	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"kidney: 22.1;pituitary gland: 29.1;salivary gland: 34.1"	"Cell line enriched"	"Detected in some"	9	"RPMI-8226: 22.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebellum: 5.2;pons and medulla: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA030614	Uncertain									"HPA030614: AB_10603216"	"unprognostic (7.62e-2)"	"unprognostic (1.67e-3)"	"prognostic favourable (1.07e-4)"	"unprognostic (1.00e-1)"	"unprognostic (6.63e-4)"	"unprognostic (6.15e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.91e-2)"	"unprognostic (7.24e-2)"	"prognostic favourable (1.78e-7)"	"unprognostic (8.47e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.62e-3)"	0.2	3.9	0.4	0.7	1.0	0.0	2.7	5.2	0.5	0.9	3.7	0.2	4.9	2.4	0.2	3.8	2.9	2.0	1.7	0.0	0.5	0.6	22.1	0.0	2.4	0.0	1.1	0.7	1.1	4.2	7.8	29.1	0.5	5.2	2.4	2.3	0.5	34.1	6.7	0.4	1.8	3.5	5.3	0.8	0.4	2.2	0.2	0.1	0.1	0.6	0.8	1.8	4.7	0.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.2	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.0	22.1	2.3	0.0	1.1	0.0	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.0	5.2	0.5	0.5	0.6	1.1	0.7	5.2	0.1
TMEM63C	"C14orf171, CSC1, DKFZp434P0111, hsCSC1"	ENSG00000165548	"Transmembrane protein 63C"	Q9P1W3	14	77116568-77259495	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 63.8;pituitary gland: 21.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 11.6;Karpas-707: 15.6;RPMI-8226: 7.9;SCLC-21H: 21.2;SK-BR-3: 18.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 63.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030657	Uncertain		Approved	Centrosome				Centrosome	Centrosome	"HPA030657: AB_10601699"	"unprognostic (2.74e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.30e-8)"	"unprognostic (2.85e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.68e-3)"	"unprognostic (1.61e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.35e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.34e-7)"	"unprognostic (5.90e-3)"	0.4	14.1	3.4	1.0	8.4	1.1	5.2	63.8	16.3	1.5	5.8	1.9	0.0	1.8	0.3	6.8	4.8	0.6	0.5	0.3	3.2	9.7	0.7	0.4	0.9	0.6	4.6	6.0	0.4	6.7	1.2	21.1	1.1	6.6	0.4	4.3	0.9	1.3	0.2	0.8	4.4	2.2	1.1	1.8	3.2	3.1	9.9	1.2	0.0	3.2	0.6	0.6	0.3	2.9	0.1	0.7	2.0	1.7	1.7	1.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	11.6	2.2	0.0	1.6	2.4	0.9	0.0	0.7	0.9	0.2	1.1	0.0	0.0	2.0	0.1	0.0	4.9	0.0	0.1	0.0	0.0	15.6	0.0	5.8	1.6	0.1	0.5	0.0	0.0	0.8	7.9	0.2	0.0	21.2	3.2	0.2	18.8	0.0	1.8	1.0	0.0	0.0	4.0	0.0	0.0	1.2	0.0	0.4	0.2	0.0	0.0	0.0	0.2	0.4	0.2	0.2	0.2	0.0	0.5	1.0	0.7	0.1	0.5	0.4	2.0	1.7	1.7	0.0	0.0	0.4	3.4	8.4	63.8	13.0	3.2	9.7	4.6	6.0	6.6	1.2
TRPC3		ENSG00000138741	"Transient receptor potential cation channel subfamily C member 3"	Q13507	4	121879027-121951754	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 9.3;pituitary gland: 12.0;smooth muscle: 9.4"	"Cell line enhanced"	"Detected in some"		"HEK 293: 3.7;HEL: 5.5;Karpas-707: 5.8;U-2 OS: 3.7;U-251 MG: 3.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"MAIT T-cell: 1.7"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"														"unprognostic (1.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.12e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.12e-3)"	"unprognostic (9.80e-2)"	"unprognostic (4.80e-3)"	"unprognostic (2.38e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.67e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.42e-3)"	1.4	0.4	1.8	0.7	9.3	0.3	0.5	5.8	7.4	3.3	0.8	1.7	0.8	0.8	1.6	1.2	0.6	1.1	7.3	0.5	1.8	2.3	0.7	0.5	2.9	0.5	2.3	1.9	0.8	0.2	0.6	12.0	4.2	7.3	1.1	0.8	0.3	0.8	2.5	0.6	0.5	1.2	9.4	1.1	1.0	0.9	1.6	3.6	0.0	0.6	0.0	0.4	3.6	2.4	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.3	1.0	1.5	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.9	0.0	0.1	0.0	3.7	5.5	0.1	0.0	0.2	1.5	0.5	0.6	0.0	0.1	0.0	0.0	0.0	5.8	1.2	0.0	1.6	0.0	1.0	0.5	0.0	0.1	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.8	3.7	0.0	3.3	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	9.3	5.8	7.4	1.8	2.3	2.3	1.9	7.3	3.6
TRPC7		ENSG00000069018	"Transient receptor potential cation channel subfamily C member 7"	Q9HCX4	5	136213320-136365545	"Predicted membrane proteins, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 2.2;brain: 1.6;intestine: 1.3;kidney: 1.5;pituitary gland: 2.2;testis: 2.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.7;SCLC-21H: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB022592, HPA031126"	Uncertain		Uncertain	"Actin filaments,Focal adhesion sites"				"Focal adhesion sites"	"Focal adhesion sites"	"CAB022592: , HPA031126: AB_10603221"			"unprognostic (1.49e-1)"		"unprognostic (2.08e-1)"					"unprognostic (3.03e-2)"	"unprognostic (2.89e-5)"	"unprognostic (3.26e-1)"	"unprognostic (2.75e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.78e-2)"		0.0	2.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0			1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.5	0.0	0.0	0.0	0.0		0.0	0.0	0.0	2.2	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.4			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TSPAN19		ENSG00000231738	"Tetraspanin 19"	P0C672	12	85014311-85036277	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"lung: 9.7;pituitary gland: 20.0"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 6.3;SK-BR-3: 4.2;U-266/70: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 5.4"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA057066	Uncertain									"HPA057066: AB_2683325"				"unprognostic (1.94e-1)"	"unprognostic (9.81e-4)"	"unprognostic (8.57e-2)"		"unprognostic (8.37e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.26e-3)"	"unprognostic (9.52e-2)"	"unprognostic (5.09e-3)"		"unprognostic (2.22e-1)"	"unprognostic (3.78e-2)"		0.4	0.8	1.5	0.5	1.9	2.3	0.2	1.0	2.6	0.5	0.4	1.4	0.0	1.1	0.5	2.5	0.8	1.8	0.8	0.4	3.2	4.4	0.7	0.1	9.7	0.5	2.3	4.4	0.4	1.6	0.4	20.0	0.5	4.9	1.0	0.2	2.4	0.8	0.0	1.6	4.5	0.6	0.0	1.6	0.5	0.5	8.4	1.4	0.0	4.1	1.3	0.2	0.5	0.2	1.8	0.9	5.4	1.0	0.8	1.1	0.0	0.8	0.0	1.6	0.5	0.8	1.4	1.8	0.9	0.1	0.0	0.5	0.8	0.0	1.0	0.1	0.0	0.3	0.2	0.3	0.0	0.8	1.6	0.0	0.5	0.7	2.1	1.4	1.7	1.0	1.1	0.9	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.4	0.2	0.0	0.0	0.3	6.3	2.7	0.0	4.2	0.9	1.0	0.3	1.2	3.0	0.9	1.3	0.8	3.8	0.0	0.5	3.2	0.0	1.3	1.1	1.0	1.1	1.0	0.7	0.7	0.9	0.8	0.5	0.1	1.8	1.1	1.0	5.4	0.8	0.4	0.9	0.3	0.0	1.5	1.9	1.0	2.6	3.2	4.4	2.3	4.4	4.9	1.4
TSPEAR	"C21orf29, DFNB98, MGC11251, TSP-EAR"	ENSG00000175894	"Thrombospondin type laminin G domain and EAR repeats"	Q8WU66	21	44497892-44711580	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 14.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;Hep G2: 2.6;HMC-1: 2.5;SH-SY5Y: 5.0;U-2 OS: 3.5"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"basal ganglia: 2.5"	"Cell type enriched"	"Detected in single"	10	"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 1.4"	"Region enhanced"	"Detected in single"		"basal ganglia: 0.5"	"Region enhanced"	"Detected in some"		"olfactory region: 2.0"	"CAB034203, CAB034204, HPA052995"	Uncertain				"Secreted in other tissues"					"CAB034203: AB_1567654, CAB034204: AB_1567655, HPA052995: AB_2682008"	"unprognostic (8.61e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.86e-4)"	"unprognostic (7.87e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.00e-3)"	"unprognostic (7.92e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.86e-4)"	"unprognostic (2.13e-2)"	"unprognostic (4.80e-7)"	"unprognostic (2.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.98e-2)"	0.3	0.1	0.2	0.3	2.5	0.0	0.5	0.2	0.9	0.2	0.2	0.2	0.2	0.7	0.2	0.4	0.2	1.1	0.2	2.7	0.2	0.1	0.5	1.4	1.4	0.8	0.2	0.2	0.2	0.2	2.6	14.9	0.2	1.0	0.2	0.0	0.2	0.2	0.2	0.2	3.9	0.5	0.2	0.2	0.6	0.3	4.6	0.2	0.5	2.8	0.2	0.4	0.2	0.2	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.2	0.0	1.2	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.0	0.0	0.0	1.1	5.0	0.0	0.1	0.0	0.1	0.2	1.4	0.0	3.5	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.2	0.9	0.2	0.1	0.2	0.2	1.0	0.2
UNC5D	"KIAA1777, Unc5h4"	ENSG00000156687	"Unc-5 netrin receptor D"	Q6UXZ4	8	35235457-35796550	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 15.4;intestine: 11.7;pituitary gland: 14.2;prostate: 10.6"	"Group enriched"	"Detected in some"	4	"HEK 293: 4.1;HeLa: 3.9;NTERA-2: 13.5;SH-SY5Y: 4.8;U-251 MG: 4.1"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042940	Uncertain									"HPA042940: AB_10959525"	"unprognostic (7.88e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.87e-1)"		"unprognostic (8.47e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.48e-8)"	"unprognostic (1.34e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.28e-1)"		0.3	3.9	8.4	0.4	13.5	0.3	0.4	2.8	15.4	5.0	0.9	0.5	0.1	11.7	3.8	0.5	0.4	0.6	0.3	0.3	3.6	9.4	5.0	0.3	0.5	0.3	1.3	8.1	0.3	0.6	0.4	14.2	0.3	4.7	10.6	1.5	3.3	0.4	0.8	0.3	0.4	3.9	2.4	0.8	0.4	0.6	1.6	0.8	0.0	2.1	0.0	0.3	0.3	0.4	0.0	0.0	0.8	0.2	0.3	0.1	0.0	0.0	1.4	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	3.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	13.5	1.4	0.1	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.3	4.1	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	8.4	13.5	2.8	15.4	3.6	9.4	1.3	8.1	4.7	0.8
UNC79	KIAA1409	ENSG00000133958	"Unc-79 homolog, NALCN channel complex subunit"	Q9P2D8	14	93333219-93707876	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.6;pituitary gland: 18.9"	"Group enriched"	"Detected in some"	5	"REH: 8.3;SCLC-21H: 6.1;SH-SY5Y: 3.9;U-937: 3.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA071881			Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA071881: AB_2732189"	"unprognostic (8.42e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.70e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.73e-3)"	"unprognostic (8.03e-3)"	"unprognostic (2.87e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.66e-2)"	"unprognostic (5.57e-2)"	"unprognostic (3.03e-2)"	"unprognostic (7.47e-2)"	1.1	3.9	7.1	1.0	12.1	0.9	1.0	17.6	14.6	1.0	1.1	4.5	0.0	1.1	1.1	1.1	1.2	2.0	1.1	1.2	6.7	5.8	1.4	1.1	1.0	1.0	3.2	9.1	1.1	5.0	1.4	18.9	1.0	6.8	1.0	1.1	1.3	1.0	1.0	1.6	1.0	1.1	1.2	3.0	0.9	1.9	7.0	3.5	0.0	1.3	0.0	1.0	1.0	0.3	0.1	0.2	0.6	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.1	1.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.1	0.0	8.3	0.0	0.0	0.2	0.2	6.1	3.9	0.1	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	3.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	7.1	12.1	17.6	14.6	6.7	5.8	3.2	9.1	6.8	3.5
VEPH1	"FLJ12604, KIAA1692"	ENSG00000197415	"Ventricular zone expressed PH domain containing 1"	Q14D04	3	157259742-157533619	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 38.1;pituitary gland: 70.3"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.3;HUVEC TERT2: 64.8;TIME: 38.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"cerebellum: 2.2;pons and medulla: 5.5"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA026645	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli, Cytosol"	"Nucleoplasm, Nucleoli, Cytosol"	"HPA026645: AB_1858741"	"unprognostic (4.35e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.58e-1)"	"unprognostic (5.17e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.87e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.75e-3)"	"unprognostic (3.57e-3)"	"unprognostic (1.99e-2)"	"prognostic favourable (7.75e-9)"	"unprognostic (2.03e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.15e-4)"	"unprognostic (7.49e-2)"	0.5	16.0	0.3	0.2	0.3	1.1	1.4	2.2	3.5	1.9	0.4	0.7	2.0	0.2	0.4	12.1	0.2	3.4	1.1	0.4	0.8	0.5	20.7	0.6	38.1	0.1	0.7	0.1	1.1	8.6	0.7	70.3	1.6	5.5	1.2	0.3	17.7	6.9	4.9	0.2	0.7	0.2	0.1	0.3	2.3	0.6	1.7	0.2	0.1	1.1	0.5	0.6	0.5	0.8	0.0	0.0	1.5	0.7	0.0	0.0	5.1	1.8	0.2	4.2	0.0	2.5	9.3	0.0	11.0	24.3	3.2	4.8	0.3	1.7	0.0	4.3	11.8	0.0	0.1	0.2	18.2	0.0	0.0	1.8	0.2	0.0	0.8	0.0	0.0	2.7	0.1	13.9	2.8	64.8	0.6	0.0	8.8	0.2	0.0	0.0	1.7	1.6	0.0	0.3	0.0	1.6	0.9	0.1	0.0	0.3	0.5	4.3	18.8	0.0	38.5	13.0	0.4	4.5	15.0	0.0	0.0	0.0	10.4	0.0	3.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	5.1	0.3	0.3	2.2	0.4	0.8	0.5	0.7	0.1	5.5	0.2
VWA7	"C6orf27, G7c, NG37"	ENSG00000204396	"Von Willebrand factor A domain containing 7"	Q9Y334	6	31765590-31777294	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 19.6;pituitary gland: 20.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.1;HeLa: 3.3;Karpas-707: 3.0;RPTEC TERT1: 2.2;U-266/70: 4.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"cerebellum: 7.8;pons and medulla: 4.1"	"Low region specificity"	"Detected in many"			"HPA046954, HPA054262"	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted - unknown location"			"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA046954: AB_2679875, HPA054262: AB_2682430"	"unprognostic (9.13e-2)"	"unprognostic (8.60e-4)"	"unprognostic (9.99e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.85e-3)"	"unprognostic (4.96e-3)"	"unprognostic (6.38e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.68e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.25e-2)"	"prognostic favourable (4.35e-8)"	"unprognostic (3.75e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.48e-2)"	"unprognostic (7.66e-2)"	1.1	1.6	3.1	1.4	9.5	1.1	1.2	5.6	10.5	1.1	1.9	0.0	3.9	2.6	4.6	3.0	1.1	19.6	2.0	3.9	1.6	5.5	5.6	1.5	2.5	1.2	1.7	5.4	1.4	2.5	5.1	20.5	1.0	9.7	1.3	1.7	0.8	1.7	2.0	5.3	1.7	3.3	2.3	2.3	1.3	5.8	1.3	2.3	0.0	1.8	0.6	1.3	1.3	0.8	0.2	0.0	1.2	0.0	0.0	0.4	0.0	0.4	1.1	0.4	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.1	2.1	0.5	0.7	0.3	0.9	0.7	0.2	0.0	0.0	0.0	0.1	3.3	0.5	0.1	0.0	0.9	0.1	0.9	0.1	0.0	0.0	0.2	3.0	0.0	0.2	0.0	0.5	0.0	0.1	0.3	0.0	2.0	2.2	0.0	0.3	0.1	0.4	0.1	0.0	0.1	0.1	0.0	0.3	0.8	0.0	0.1	4.4	1.2	0.1	0.0	0.6	0.1	1.2	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.4	0.0	3.1	9.5	5.6	10.5	1.6	5.5	1.7	5.4	9.7	2.3
WDR17		ENSG00000150627	"WD repeat domain 17"	Q8IZU2	4	176065834-176182818	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.9;parathyroid gland: 19.0;pituitary gland: 22.5"	"Cell line enhanced"	"Detected in many"		"AF22: 8.9;SCLC-21H: 10.3;SH-SY5Y: 7.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042766, HPA054501"	Approved		Approved	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA042766: AB_10806372, HPA054501: AB_2732586"	"unprognostic (3.41e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.43e-7)"	"unprognostic (3.53e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.39e-3)"	"unprognostic (6.04e-4)"	"unprognostic (3.66e-4)"	"unprognostic (9.25e-3)"	"unprognostic (4.63e-2)"	"unprognostic (7.32e-3)"	"unprognostic (8.24e-3)"	2.1	5.8	12.4	2.2	22.1	1.5	3.3	12.2	23.9	2.0	2.9	3.4	0.0	1.6	4.5	6.2	1.9	3.5	3.0	1.3	9.7	7.1	6.2	1.0	3.6	1.8	4.4	16.3	4.0	3.0	19.0	22.5	0.7	7.9	2.3	3.1	6.0	1.7	2.2	0.7	1.2	1.8	2.8	4.0	2.9	3.1	4.1	6.9	0.1	10.2	0.0	1.6	1.9	1.5	1.1	0.7	2.6	1.6	1.3	0.8	0.2	0.0	3.7	8.9	0.1	0.2	0.6	0.3	0.2	0.0	0.8	3.1	0.2	0.1	6.1	0.0	0.1	0.1	3.9	2.0	0.8	0.0	3.2	0.0	0.7	0.0	0.3	3.3	4.8	1.4	1.2	0.1	0.5	0.0	0.0	0.3	0.6	1.6	3.4	0.1	2.0	1.9	0.0	3.8	0.0	0.5	0.0	10.3	7.4	0.0	2.4	6.2	0.4	0.0	0.0	1.2	1.7	0.1	5.8	4.4	2.9	3.5	7.0	0.0	2.4	2.6	0.6	0.3	0.6	1.6	0.3	1.1	0.6	0.4	0.2	0.8	0.7	0.8	1.7	1.3	0.3	0.7	0.3	0.2	12.4	22.1	12.2	21.8	9.7	7.1	4.4	16.3	7.9	6.9
WDR19	"DYF-2, FLJ23127, IFT144, KIAA1638, NPHP13, ORF26, Oseg6, Pwdmp"	ENSG00000157796	"WD repeat domain 19"	Q8NEZ3	4	39182404-39285810	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 41.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 25.2;ASC TERT1: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039616, HPA058847"	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA039616: AB_10796331, HPA058847: AB_2683834"	"unprognostic (1.80e-1)"	"unprognostic (9.32e-2)"	"unprognostic (6.40e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.26e-3)"	"prognostic unfavourable (4.43e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.63e-2)"	"prognostic favourable (2.70e-4)"	"prognostic unfavourable (8.58e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.56e-2)"	8.5	7.6	8.1	4.8	12.9	3.4	9.2	21.0	14.5	13.2	7.8	5.7	7.8	1.9	15.5	11.2	5.4	20.9	8.6	5.1	11.7	4.1	8.6	7.0	8.6	4.4	6.0	11.0	19.0	6.6	10.1	41.1	6.3	14.6	8.1	4.3	6.9	7.6	8.2	3.1	6.0	5.7	9.5	9.7	4.3	8.0	12.7	7.3	6.8	17.1	3.8	5.0	9.9	8.9	3.9	1.1	1.5	2.0	2.3	2.4	0.8	3.2	2.3	5.5	6.5	25.2	28.3	2.5	4.2	9.7	4.5	5.9	1.4	3.6	5.2	2.1	4.1	1.9	5.4	2.8	5.0	0.3	3.9	1.0	4.3	2.6	7.9	5.1	1.3	17.2	6.1	6.0	3.8	5.4	4.6	5.3	5.4	1.1	3.5	3.6	1.8	2.6	4.3	5.6	2.3	3.6	1.3	6.0	5.6	4.2	1.3	2.8	2.8	1.9	3.9	4.4	2.9	9.6	4.2	3.9	3.5	3.7	6.5	1.5	1.9	0.7	1.2	0.9	1.7	2.0	1.3	3.4	2.1	2.4	1.1	3.9	2.1	2.1	1.5	2.3	1.7	0.7	1.4	0.8	8.1	12.9	21.0	14.5	11.7	4.1	6.0	11.0	14.6	7.3
WDR66	"CaM-IP4, MGC33630"	ENSG00000158023	"WD repeat domain 66"	Q8TBY9	12	121917862-122003927	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 24.6;pituitary gland: 28.4;testis: 35.0"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 21.4;hTCEpi: 20.2;hTERT-HME1: 13.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	10	"plasmacytoid DC: 4.9"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 4.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA039902, HPA040005"	Supported		Uncertain	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA039902: AB_10795236, HPA040005: AB_10795160"	"unprognostic (4.92e-3)"	"unprognostic (9.05e-2)"	"unprognostic (7.99e-3)"	"prognostic favourable (3.11e-4)"	"unprognostic (5.58e-3)"	"unprognostic (6.89e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.72e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.35e-1)"	1.3	1.2	6.3	1.0	13.2	0.4	1.7	0.4	4.0	4.4	0.5	4.5	1.5	0.4	2.5	11.3	0.5	24.6	2.0	1.5	6.4	3.7	3.2	1.8	6.4	0.9	0.7	3.2	3.9	2.1	4.7	28.4	1.3	18.0	0.8	0.4	1.3	1.3	2.2	0.5	1.8	0.5	1.0	0.9	2.0	0.8	35.0	2.4	0.0	6.7	0.0	1.2	0.8	1.7	0.2	4.9	0.4	0.0	0.1	0.3	0.0	1.8	0.2	0.3	0.1	0.3	0.3	0.3	0.2	1.7	0.8	2.0	0.2	0.9	0.1	2.4	0.1	0.6	0.2	21.4	3.0	0.1	0.3	0.1	0.4	0.2	2.6	0.0	5.9	1.2	20.2	1.6	13.7	0.9	4.8	0.0	1.2	0.6	0.2	0.3	0.3	0.1	0.3	0.5	0.0	3.7	0.3	1.7	0.1	0.2	0.0	0.1	0.5	0.1	0.7	1.7	2.6	0.3	0.3	0.3	0.1	2.5	2.0	0.0	0.4	0.4	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.2	0.0	0.2	0.1	0.1	0.4	0.1	0.0	4.9	0.3	0.0	6.3	13.2	0.4	4.0	6.4	3.7	0.7	3.2	18.0	2.4
XKRX	"XKR2, XPLAC"	ENSG00000182489	"XK related, X-linked"	Q6PP77	X	100913445-100929433	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pituitary gland: 12.0;placenta: 12.2;skin 1: 12.9;thyroid gland: 11.0"	"Cell line enriched"	"Detected in some"	5	"CACO-2: 13.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"naive B-cell: 5.0;naive CD4 T-cell: 3.7;naive CD8 T-cell: 2.8"	"Group enriched"	"Detected in many"	44	"B-cells: 5.0;T-cells: 3.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"														"unprognostic (3.35e-1)"	"unprognostic (2.38e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.87e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.96e-2)"	"unprognostic (5.18e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.37e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.60e-6)"	"unprognostic (1.25e-1)"	"unprognostic (2.60e-1)"	"prognostic favourable (3.52e-4)"	"unprognostic (1.18e-1)"	0.1	1.0	0.2	2.1	0.3	0.1	1.1	0.1	0.1	1.2	7.2	0.2	8.3	0.4	0.2	1.9	3.5	1.1	0.5	0.1	0.2	0.4	0.3	0.1	3.3	2.4	0.2	0.0	0.3	0.2	0.0	12.0	12.2	0.2	0.5	1.3	0.0	1.0	1.8	0.2	12.9	6.8	0.0	0.2	0.6	0.5	0.4	0.0	0.8	11.0	1.9	5.4	0.5	2.4	5.0	0.0	0.0	0.0	0.0	3.7	0.6	0.3	1.0	0.1	0.0	0.1	0.0	0.1	0.1	0.6	0.0	0.0	13.0	1.6	1.0	0.1	0.0	0.2	0.0	0.9	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	2.5	0.0	0.0	0.1	0.6	0.1	0.0	0.4	0.0	0.0	0.0	2.5	0.1	2.0	0.3	1.1	0.2	1.1	0.0	0.4	0.0	2.3	0.0	0.3	0.0	0.0	1.9	0.5	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.1	0.0	0.0	5.0	3.7	2.8	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.3	0.1	0.1	0.2	0.4	0.2	0.0	0.2	0.0
ZBTB8B	"DKFZp547H154, RP1-27O5.1, ZNF916B"	ENSG00000273274	"Zinc finger and BTB domain containing 8B"	Q8NAP8	1	32465069-32496686	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 10.8"	"Cell line enhanced"	"Detected in some"		"RT4: 3.7;SCLC-21H: 3.6"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA055553	Enhanced									"HPA055553: AB_2682848"	"unprognostic (8.32e-4)"	"unprognostic (1.23e-1)"	"unprognostic (3.83e-1)"	"unprognostic (3.83e-5)"	"unprognostic (1.86e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.67e-4)"	"unprognostic (1.57e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.43e-3)"	"unprognostic (9.08e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.44e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.26e-3)"	"unprognostic (5.88e-3)"	0.4	1.3	5.1	0.6	2.8	2.5	0.6	2.2	5.0	0.4	0.3	1.3	0.7	0.5	1.2	1.3	0.7	0.7	0.6	0.4	3.3	4.7	0.6	0.6	0.5	0.9	2.6	2.7	1.0	0.8	1.0	10.8	0.7	4.1	0.8	0.4	0.2	1.7	0.5	3.4	1.7	0.5	0.5	1.6	0.8	0.5	3.1	1.6	0.0	0.8	0.0	0.6	1.0	0.4	1.4	1.2	3.2	0.8	1.3	0.7	0.2	0.2	0.1	2.0	1.5	0.2	0.5	0.6	0.2	0.1	0.7	0.6	0.2	0.5	0.4	0.7	0.1	0.7	2.3	0.2	0.5	0.7	2.5	0.3	0.7	0.4	0.0	0.3	0.4	0.2	0.2	0.5	0.0	0.2	0.2	0.9	0.1	0.3	0.3	0.6	2.1	0.9	0.3	0.2	0.3	0.4	3.7	3.6	2.2	1.3	0.5	0.2	0.4	0.3	0.9	0.5	0.4	0.6	0.3	0.7	0.7	0.4	0.5	0.4	0.4	3.2	0.8	1.0	0.6	0.5	0.6	0.8	0.6	0.5	0.3	1.4	0.7	0.7	2.9	1.3	0.7	1.2	0.5	0.2	5.1	2.8	2.2	5.0	3.3	4.7	2.6	2.7	4.1	1.6
ZFR2	KIAA1086	ENSG00000105278	"Zinc finger RNA binding protein 2"	Q9UPR6	19	3804024-3869032	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.0;pituitary gland: 19.8;testis: 20.3"	"Group enriched"	"Detected in some"	12	"HMC-1: 17.4;NTERA-2: 29.9;SiHa: 8.8"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 2.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043275, HPA055678"	Uncertain		Uncertain	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA043275: , HPA055678: AB_2682883"	"unprognostic (1.74e-3)"	"unprognostic (2.32e-3)"	"unprognostic (4.05e-3)"	"unprognostic (1.51e-2)"	"unprognostic (6.60e-3)"	"unprognostic (5.47e-4)"	"unprognostic (9.12e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.18e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.97e-3)"	"unprognostic (4.29e-2)"	"unprognostic (3.58e-1)"	"unprognostic (3.58e-1)"	"unprognostic (5.81e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.18e-2)"	1.0	6.8	13.0	1.2	17.0	1.3	1.3	2.2	16.9	1.5	0.9	1.9	0.0	0.9	0.9	0.8	0.8	2.4	1.2	1.1	7.6	12.2	0.9	0.9	1.4	1.1	4.9	10.9	1.0	1.7	0.8	19.8	0.8	7.4	1.3	1.0	5.7	1.2	1.1	0.9	1.2	1.4	0.8	3.9	1.3	1.3	20.3	2.3	0.0	1.2	0.0	1.4	0.8	0.2	0.9	0.2	1.5	0.2	1.7	4.5	1.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.2	0.7	0.0	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	29.9	0.0	0.0	0.0	0.0	1.4	0.0	1.0	0.6	8.8	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	1.5	0.2	0.2	3.4	0.0	4.5	0.2	2.6	1.9	0.0	0.9	3.9	3.4	0.5	1.7	0.0	0.2	0.8	1.4	13.0	17.0	2.2	15.0	7.6	12.2	4.9	10.9	7.4	2.3
ZNF10	KOX1	ENSG00000256223	"Zinc finger protein 10"	P21506	12	133130575-133159465	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 57.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA003204	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"	"Vesicles, Plasma membrane"	"HPA003204: AB_1080663"	"unprognostic (1.55e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.32e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.39e-3)"	"unprognostic (4.02e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.35e-3)"	"unprognostic (2.50e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.36e-2)"	"unprognostic (5.13e-3)"	4.8	12.7	5.7	4.9	11.5	6.3	10.5	13.0	9.9	9.3	7.9	7.8	14.4	3.0	12.7	20.7	5.1	10.2	9.9	6.7	5.0	5.6	7.3	7.6	6.4	4.4	8.5	6.4	18.2	10.3	22.6	57.6	4.2	8.3	12.2	5.4	8.8	6.2	16.4	5.1	7.2	5.6	12.3	8.8	5.0	8.2	12.1	7.9	6.8	17.3	5.1	5.6	8.1	7.2	4.4	4.4	1.8	0.7	8.6	8.8	2.4	3.1	2.0	9.9	0.0	11.1	4.7	6.0	4.0	3.6	5.0	3.4	3.6	2.2	0.0	5.6	4.0	1.6	6.3	3.3	3.7	0.0	5.8	7.3	9.3	3.7	3.3	4.4	2.5	4.9	3.1	5.4	6.0	4.0	5.2	0.0	5.9	1.1	10.6	9.4	10.2	4.1	8.8	6.3	4.9	3.9	7.2	10.0	6.3	8.0	1.1	3.3	6.2	4.3	3.9	3.7	3.4	3.4	3.3	0.2	0.0	11.6	1.1	1.6	3.3	1.1	0.6	1.8	4.0	0.7	4.5	4.2	4.6	5.5	1.7	4.4	8.8	4.4	0.7	8.6	0.5	4.4	1.2	2.4	5.7	11.5	13.0	9.9	5.0	5.6	8.5	6.4	8.3	7.9
ZNF19	"KOX12, MGC51021"	ENSG00000157429	"Zinc finger protein 19"	P17023	16	71464555-71565089	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 32.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA063685	Approved		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA063685: AB_2685090"	"unprognostic (5.59e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.05e-4)"	"unprognostic (6.02e-3)"	"unprognostic (4.92e-2)"	"unprognostic (3.34e-2)"	"unprognostic (6.97e-3)"	"unprognostic (2.23e-1)"	"unprognostic (4.84e-2)"	"unprognostic (8.90e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.04e-6)"	"unprognostic (3.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.87e-2)"	4.7	3.3	4.8	4.1	6.8	2.5	6.3	4.3	5.2	3.8	2.6	7.1	2.9	3.3	5.6	14.4	4.6	9.1	6.9	4.7	4.9	4.1	5.6	3.4	4.5	3.4	3.0	4.4	4.8	6.4	3.9	32.0	1.7	6.8	3.6	2.2	5.2	4.9	3.2	9.0	6.9	3.4	2.6	4.5	3.1	3.0	18.7	5.5	3.0	8.9	2.0	2.6	2.8	1.9	6.1	3.5	4.4	2.5	2.5	4.3	1.7	2.5	1.7	5.7	6.2	2.8	3.8	3.7	3.0	1.4	2.4	3.0	3.8	6.3	4.5	4.1	1.6	2.4	3.0	2.9	1.1	2.7	3.3	4.6	4.1	4.9	0.9	4.9	4.1	5.0	3.8	2.8	5.3	2.3	2.9	4.2	1.8	3.5	3.3	3.6	2.9	4.5	2.1	4.7	1.8	2.9	5.5	9.1	5.8	6.1	1.8	5.0	4.5	3.7	2.7	6.2	3.1	4.3	3.5	4.0	3.3	1.7	5.6	3.0	3.4	4.4	2.4	2.1	3.1	2.2	1.3	5.4	3.4	3.0	1.9	6.1	4.3	3.9	4.3	2.5	2.5	3.5	1.4	1.7	4.8	6.8	4.3	4.8	4.9	4.1	3.0	4.4	6.8	5.5
ZNF483	"KIAA1962, ZKSCAN16, ZSCAN48"	ENSG00000173258	"Zinc finger protein 483"	Q8TF39	9	111525159-111577844	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.3;pituitary gland: 40.4"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 11.5;SCLC-21H: 6.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055041			Approved	Nucleoli				Nucleoli	Nucleoli	"HPA055041: AB_2682681"	"unprognostic (4.33e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.11e-2)"	"unprognostic (5.95e-3)"	"unprognostic (9.18e-5)"	"unprognostic (2.02e-1)"	"unprognostic (9.50e-2)"	"unprognostic (4.44e-3)"	"unprognostic (5.49e-2)"	"unprognostic (5.19e-4)"	"unprognostic (7.19e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.30e-2)"	"unprognostic (6.17e-2)"	3.2	10.1	13.9	2.1	30.5	7.7	5.6	35.9	36.3	6.1	4.0	8.6	2.9	2.0	10.0	11.9	2.4	7.0	4.9	4.7	18.1	7.3	5.1	2.5	3.9	3.4	9.5	23.0	12.6	4.3	13.6	40.4	1.8	24.4	7.2	2.4	5.9	3.2	7.7	2.3	3.5	2.9	5.5	9.8	4.8	3.9	11.8	10.3	0.0	12.5	0.0	3.1	4.7	4.8	2.5	1.0	4.6	1.0	2.1	6.5	1.5	0.3	3.2	3.1	4.7	0.4	0.6	1.0	0.4	1.5	3.1	2.9	0.3	1.5	0.5	0.5	1.3	0.9	1.5	1.6	1.9	0.2	1.8	1.6	4.4	2.5	0.9	0.6	0.4	1.2	0.6	1.7	0.9	2.9	1.3	0.8	0.7	3.0	0.2	0.8	11.5	1.1	0.3	4.8	0.4	1.2	1.3	6.7	3.2	1.2	0.6	0.8	1.9	0.4	0.5	0.9	1.6	1.4	2.2	0.7	1.9	0.4	1.0	0.5	0.7	4.6	1.0	0.6	4.8	0.5	2.7	1.5	3.3	2.3	0.3	2.5	5.9	6.5	3.4	2.1	0.7	1.0	1.6	1.5	13.9	30.5	35.9	36.3	18.1	7.3	9.5	23.0	24.4	10.3
ZNF540	DKFZp547B0714	ENSG00000171817	"Zinc finger protein 540"	Q8NDQ6	19	37551406-37614097	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"pituitary gland: 30.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 6.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA003444	Supported		Supported	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	Nucleoplasm	"HPA003444: AB_1080732"	"unprognostic (2.51e-2)"	"unprognostic (2.30e-4)"	"unprognostic (4.92e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.80e-4)"	"unprognostic (4.24e-4)"	"unprognostic (3.44e-3)"	"unprognostic (8.88e-4)"	"unprognostic (2.65e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.38e-5)"	"unprognostic (1.50e-1)"	"unprognostic (1.09e-6)"	"unprognostic (2.74e-1)"	"unprognostic (4.75e-2)"	"unprognostic (8.08e-2)"	"unprognostic (8.33e-5)"	2.8	9.3	8.6	3.9	29.9	1.2	6.0	23.7	16.7	5.8	4.4	5.0	5.3	3.9	6.0	9.4	3.0	4.2	3.6	9.1	8.6	12.1	6.3	2.6	5.0	6.3	9.0	9.1	13.8	3.8	13.3	30.7	2.3	11.0	7.1	3.6	9.0	6.1	8.9	2.9	6.0	4.5	3.8	7.9	6.3	4.6	11.5	9.5	2.7	14.4	3.1	6.0	3.4	4.0	3.1	0.3	1.2	0.1	3.0	7.1	1.8	0.4	0.0	2.7	2.7	6.9	4.1	0.2	1.0	0.9	1.1	2.1	0.2	0.0	1.2	0.3	2.4	1.0	1.8	0.9	0.9	3.7	2.7	1.0	1.2	0.0	1.8	1.2	2.0	1.9	2.5	0.7	0.0	0.1	0.4	0.0	1.6	0.1	1.7	0.7	0.9	0.5	1.4	1.6	0.8	0.6	0.4	2.8	3.1	1.0	0.3	0.3	1.3	0.7	0.0	1.0	3.1	1.2	0.9	3.7	2.0	2.6	0.0	0.4	0.6	0.0	0.0	1.2	3.9	0.1	3.9	2.9	4.1	4.4	0.1	3.1	6.8	7.1	0.2	3.0	0.0	0.3	4.2	1.8	8.6	29.9	23.7	16.7	8.6	12.1	9.0	9.1	11.0	9.5
ZNF727	ZNF727P	ENSG00000214652	"Zinc finger protein 727"	A8MUV8	7	64045443-64078549	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"pituitary gland: 13.7"	"Cell line enriched"	"Detected in some"	8	"T-47d: 12.9"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.4"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA051027, HPA061215"	Uncertain		Uncertain	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA051027: , HPA061215: AB_2684452"	"unprognostic (5.87e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.04e-2)"	"unprognostic (5.73e-4)"	"unprognostic (8.70e-2)"	"unprognostic (6.36e-2)"	"unprognostic (8.61e-2)"	2.6	1.6	2.7	0.9	10.6	0.3	5.4	3.9	7.4	5.2	1.7	5.8	0.0	0.6	5.9	3.1	2.0	4.7	1.6	2.2	4.7		3.1	0.5	1.9	1.2	5.3	2.5	9.1	2.0	1.1	13.7	0.3	7.2	4.9	2.0	3.1	2.2	3.3	1.2	2.0	1.0	3.7	4.2	1.6	2.0	5.5	6.1	0.0	8.7	0.0	0.9	2.6	3.9	1.1	0.4	0.0	0.4	0.4	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	12.9	0.0	0.0	0.0	1.6	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.4	1.1	1.0	0.7	0.0	0.4	0.4	0.0	0.0	0.5										
ZNF831	"C20orf174, dJ492J12.1"	ENSG00000124203	"Zinc finger protein 831"	Q5JPB2	20	59123381-59259113	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 13.8;pituitary gland: 6.6"	"Group enriched"	"Detected in some"	13	"Daudi: 9.1;HMC-1: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"gdTCR: 4.1;MAIT T-cell: 3.3;memory CD4 T-cell: 2.3;memory CD8 T-cell: 3.3;naive CD4 T-cell: 1.9;naive CD8 T-cell: 2.4;NK-cell: 2.3;T-reg: 4.2"	"Group enriched"	"Detected in many"	6	"NK-cells: 2.3;T-cells: 4.2"	"Group enriched"	"Detected in many"	4	"amygdala: 5.3;basal ganglia: 4.3;cerebral cortex: 5.1;hippocampal formation: 6.0;olfactory region: 4.7"	"Group enriched"	"Detected in many"	26	"amygdala: 6.5;basal ganglia: 5.1;cerebral cortex: 4.5;hippocampal formation: 7.1;olfactory region: 11.1"	HPA016839	Uncertain									"HPA016839: AB_1859466"	"unprognostic (2.90e-3)"	"unprognostic (7.70e-6)"	"unprognostic (9.71e-4)"	"unprognostic (1.31e-3)"	"unprognostic (7.00e-2)"	"unprognostic (3.00e-5)"	"unprognostic (3.08e-3)"	"unprognostic (2.23e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.21e-3)"	"unprognostic (2.80e-3)"	"unprognostic (4.31e-1)"	"unprognostic (3.40e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.93e-2)"	0.6	0.1	1.7	9.1	3.6	1.3	0.4	0.2	1.2	0.2	0.4	0.2	0.2	0.3	0.2	0.4	0.8	0.4	0.8	0.2	1.5	0.6	0.3	0.3	1.3	10.0	0.2	0.2	0.2	0.3	0.0	6.6	0.2	0.2	0.2	0.5	0.2	0.5	0.2	0.2	0.1	4.2	0.2	0.2	9.3	0.9	0.4	0.2	0.4	0.7	0.9	13.8	3.1	0.2	0.4	0.0	0.5	0.0	2.3	4.2	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.5	4.1	0.0	3.3	0.4	2.3	3.3	0.0	0.4	1.9	2.4	0.2	2.3	0.0	0.0	4.2	0.8	1.7	3.6	0.2	1.2	1.5	0.6	0.2	0.2	0.2	0.2
ZP1		ENSG00000149506	"Zona pellucida glycoprotein 1"	P60852	11	60867562-60875693	"Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 6.5;epididymis: 2.2;pituitary gland: 3.3"	"Group enriched"	"Detected in some"	36	"RPMI-8226: 15.8;SK-BR-3: 4.5"	"Low cancer specificity"	"Detected in single"							"Cell type enriched"	"Detected in single"	66	"plasmacytoid DC: 6.5"	"Lineage enriched"	"Detected in single"	66	"dendritic cells: 6.5"	"Region enriched"	"Detected in single"	7	"basal ganglia: 0.7"										"Secreted in female reproductive system"						"unprognostic (6.40e-3)"	"unprognostic (2.18e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.02e-2)"	"unprognostic (8.27e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.94e-2)"	"unprognostic (8.15e-3)"	"unprognostic (2.52e-1)"	"unprognostic (9.25e-4)"	"unprognostic (5.31e-13)"	"unprognostic (4.13e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.27e-2)"	"unprognostic (5.61e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.7	0.0	0.0			0.0	0.0	2.2	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.8	3.3	0.0		1.3	0.0		0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.2	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.1										
ZSCAN1	"FLJ33779, ZNF915"	ENSG00000152467	"Zinc finger and SCAN domain containing 1"	Q8NBB4	19	58034032-58054631	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 13.7;epididymis: 16.4;pituitary gland: 15.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 6.2;HMC-1: 4.3;NTERA-2: 4.4;T-47d: 6.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA007938	Uncertain		Approved	Nucleoli				Nucleoli	Nucleoli	"HPA007938: AB_1080768"	"unprognostic (1.60e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.34e-1)"	"prognostic favourable (7.36e-4)"	"unprognostic (1.41e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.47e-2)"	"unprognostic (3.60e-1)"	0.9	2.2	7.0	0.7	9.5	0.9	3.2	4.0	13.7	2.2	0.8	6.5	1.0	0.8	1.7	16.4	0.8	4.3	1.3	1.6	6.3	9.7	2.8	0.7	1.4	0.8	6.0	6.7	0.9	2.1	7.3	15.8	1.3	8.2	3.7	0.7	3.4	1.6	3.0	0.8	0.8	1.0	1.1	3.7	0.9	1.0	13.3	2.4	0.9	8.1	0.0	0.7	1.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.2	0.0	0.0	1.5	0.1	0.0	0.0	0.0	6.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	4.4	0.0	0.0	0.0	0.0	0.0	1.3	0.4	1.3	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	9.5	4.0	13.7	6.3	9.7	6.0	6.7	8.2	2.4
